data_2fb7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fb7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.76 0 CA-C-O 120.114 -0.27 . . . . 1.55 112.8 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 t -88.28 123.65 33.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.514 -0.55 . . . . 2.25 109.514 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 8.4 mptt -82.32 121.35 26.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.105 -0.702 . . . . 4.73 109.105 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.58 167.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.876 -0.787 . . . . 2.94 108.876 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.5 t -123.81 124.52 42.86 Favored 'General case' 0 N--CA 1.404 -2.738 0 N-CA-C 107.628 -1.249 . . . . 1.71 107.628 174.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.503 HD22 HD12 ' A' ' 82' ' ' ILE . 5.3 tt -116.45 130.71 56.91 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.154 -0.93 . . . . 2.02 109.581 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 2.9 mp -105.52 119.91 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-N 116.332 -0.395 . . . . 1.38 110.154 175.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.9 p -78.2 169.6 18.0 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.28 -0.418 . . . . 1.7 110.599 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -49.12 -26.02 2.49 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.809 1.04 . . . . 2.63 113.809 -175.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.17 10.9 17.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 1.33 110.836 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 63.96 39.97 7.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.261 1.024 . . . . 2.59 111.087 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.9 mm -106.11 127.09 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.047 -1.433 . . . . 1.73 109.88 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -89.84 142.68 27.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.262 0.467 . . . . 5.24 112.262 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -138.33 143.79 40.08 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.681 -1.229 . . . . 3.17 107.681 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.46 134.51 55.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.886 0.374 . . . . 2.45 110.044 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -166.01 -169.38 29.55 Favored Glycine 0 CA--C 1.467 -2.962 0 N-CA-C 111.064 -0.814 . . . . 0.55 111.064 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.476 HD12 ' HG3' ' A' ' 50' ' ' LYS 0.345 1.4 pp -113.01 108.74 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.528 0 CA-C-O 123.051 1.405 . . . . 1.58 113.293 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.25 135.61 49.59 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.627 -1.624 . . . . 2.31 111.041 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -113.04 -48.14 3.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.516 -0.766 . . . . 1.37 111.553 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 m -154.09 153.11 31.31 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.848 -0.532 . . . . 1.52 109.701 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.42 126.44 48.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.777 -0.823 . . . . 1.94 108.777 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 18.7 m-20 -89.54 95.77 10.41 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.82 -1.178 . . . . 2.56 107.82 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -56.06 -29.0 59.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.351 0.871 . . . . 3.15 113.351 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.19 -39.93 90.03 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.029 0.442 . . . . 3.22 111.511 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -109.79 0.5 18.83 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.798 -0.564 . . . . 2.66 110.345 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m 65.18 16.44 10.55 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.047 -0.979 . . . . 2.54 110.645 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 40' ' ' ASP . 30.4 p -75.77 135.65 40.29 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.201 0.524 . . . . 1.78 111.132 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.7 t -104.45 125.7 59.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.846 -0.615 . . . . 1.49 110.005 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.33 106.41 17.58 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.198 0.523 . . . . 1.15 109.76 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.2 150.23 22.74 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.507 -0.77 . . . . 2.38 111.888 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.75 134.39 19.89 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 105.132 -2.173 . . . . 1.37 105.132 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HG3' HD12 ' A' ' 35' ' ' ILE 0.407 4.4 tptt 49.66 58.61 5.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 124.808 2.242 . . . . 4.1 113.148 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 44.6 t -77.38 113.94 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 112.886 -1.961 . . . . 2.19 106.204 173.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 . . . . . 0 C--N 1.313 -0.983 0 N-CA-C 107.265 -1.383 . . . . 5.94 107.265 177.313 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.1 p90 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 113.791 1.034 . . . . 5.92 113.791 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 tt -162.98 147.2 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.862 -0.608 . . . . 4.25 110.361 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.439 ' N ' HD11 ' A' ' 76' ' ' ILE . 1.7 mp -107.49 129.72 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.115 -1.068 . . . . 2.84 108.115 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -103.67 148.07 26.48 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.523 -0.308 . . . . 2.91 111.735 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -59.73 -13.71 11.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.229 1.012 . . . . 3.99 113.529 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.11 -58.72 4.94 Favored Glycine 0 CA--C 1.496 -1.109 0 C-N-CA 120.946 -0.645 . . . . 0.88 111.875 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.3 t -65.99 -11.52 48.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.243 0.544 . . . . 2.02 110.685 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.444 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 3.8 m-20 -98.05 20.78 11.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.431 0.692 . . . . 2.0 111.506 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.503 HD12 HD22 ' A' ' 24' ' ' LEU . 40.3 mm -101.07 132.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.149 -1.02 . . . . 2.27 110.334 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -87.38 -28.51 22.13 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.804 -0.635 . . . . 2.07 111.463 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 25' ' ' ILE . 20.1 t70 -166.35 135.13 2.98 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.274 0.472 . . . . 2.22 112.274 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.8 mt -122.28 100.37 6.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.587 -0.733 . . . . 3.34 110.325 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -109.96 116.71 32.09 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.124 0.488 . . . . 2.3 110.483 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.672 -0.694 . . . . 3.25 111.334 -178.209 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.853 0 CA-C-O 121.37 0.428 . . . . 1.55 113.636 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -89.76 145.73 24.98 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.482 0.713 . . . . 2.25 109.492 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 10.3 mptt -92.05 114.05 26.49 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.448 -0.945 . . . . 4.73 108.448 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 86' ' ' THR . 10.8 tt -151.93 150.61 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.17 -0.468 . . . . 2.94 111.536 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.5 m -104.01 127.84 51.57 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.509 -1.293 . . . . 1.71 107.509 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.0 tp -123.5 128.71 50.18 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.491 -0.322 . . . . 2.02 110.587 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 62.9 mt -104.29 124.63 58.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.685 -0.857 . . . . 1.38 108.685 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p -80.0 160.18 25.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.444 -0.947 . . . . 1.7 108.444 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -54.8 -12.04 0.72 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.627 0.973 . . . . 2.63 113.627 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.469 ' N ' ' HD3' ' A' ' 27' ' ' LYS . . . -85.05 5.53 29.14 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.386 0.675 . . . . 1.33 110.013 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 29' ' ' GLU . 3.1 tp10 70.46 30.65 3.17 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.153 1.781 . . . . 2.59 108.958 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -108.34 128.11 64.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.381 -0.827 . . . . 1.73 111.544 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.15 124.62 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.386 -0.825 . . . . 5.24 111.04 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.46 127.65 51.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.528 -0.545 . . . . 3.17 109.528 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -118.69 126.35 51.71 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.113 0.482 . . . . 2.45 109.734 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.28 -151.67 9.32 Favored Glycine 0 CA--C 1.468 -2.874 0 N-CA-C 110.63 -0.988 . . . . 0.55 110.63 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 50' ' ' LYS 0.317 1.1 pp -116.72 116.64 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 CA-C-O 122.192 0.996 . . . . 1.58 112.605 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.407 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -62.39 133.1 54.58 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.93 -1.486 . . . . 2.31 108.373 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -94.76 -55.98 2.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.573 -0.451 . . . . 1.37 112.14 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.5 m -153.86 154.06 33.24 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.013 -0.429 . . . . 1.52 110.33 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.7 133.79 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 109.254 -0.647 . . . . 1.94 109.254 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.536 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 7.8 t70 -92.93 110.61 22.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.893 -0.781 . . . . 2.56 108.893 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 m -73.46 -8.77 57.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.819 -0.628 . . . . 3.15 112.129 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.63 -56.35 4.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.838 -0.745 . . . . 3.22 111.168 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -96.47 0.34 50.18 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.7 -0.682 . . . . 2.66 109.432 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m 65.68 21.1 11.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.456 -1.247 . . . . 2.54 111.259 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.536 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 77.3 p -73.07 154.53 40.38 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.184 0.516 . . . . 1.78 111.675 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.4 ' CG1' HD21 ' A' ' 36' ' ' LEU . 59.8 t -124.94 125.1 69.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.724 -0.671 . . . . 1.49 110.056 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.59 109.37 21.45 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 1.15 109.018 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.542 ' HG ' ' CG2' ' A' ' 51' ' ' VAL . 45.7 tp -113.01 129.07 56.62 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.947 -0.57 . . . . 2.38 109.579 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.55 156.55 30.38 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.395 -0.965 . . . . 1.37 108.395 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 48.8 mttp 60.08 29.78 19.32 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.102 0.876 . . . . 4.1 109.885 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.542 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 46.6 t -67.0 114.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.731 -1.122 . . . . 2.19 109.086 -176.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 . . . . . 0 N--CA 1.437 -1.093 0 N-CA-C 108.36 -0.978 . . . . 5.94 108.36 -179.126 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.4 p90 . . . . . 0 C--O 1.24 0.562 0 N-CA-C 112.461 0.541 . . . . 5.92 112.461 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 tt -157.92 140.71 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.139 -0.482 . . . . 4.25 110.518 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -102.7 135.45 39.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.342 -0.984 . . . . 2.84 108.342 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.4 150.84 27.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.535 -0.543 . . . . 2.91 109.535 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -81.64 10.51 5.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.017 0.437 . . . . 3.99 111.418 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 84.41 -61.16 4.75 Favored Glycine 0 CA--C 1.47 -2.767 0 N-CA-C 111.53 -0.628 . . . . 0.88 111.53 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -62.4 -12.06 19.38 Favored 'General case' 0 CA--C 1.582 2.188 0 CA-C-O 121.092 0.472 . . . . 2.02 111.254 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.655 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 9.3 m-20 -82.53 -0.56 47.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.352 0.661 . . . . 2.0 112.268 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 79' ' ' GLY . 1.9 pp -79.6 140.65 16.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 119.18 -1.008 . . . . 2.27 112.652 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -95.64 -56.1 2.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.983 -0.747 . . . . 2.07 108.983 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -136.0 139.15 42.92 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.195 -0.912 . . . . 2.22 108.666 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 38.3 tp -135.96 99.59 4.19 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.323 -1.362 . . . . 3.34 107.323 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.501 ' O ' HG13 ' A' ' 22' ' ' ILE . 51.1 m -132.35 110.54 10.64 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.077 0.465 . . . . 2.3 111.285 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.244 0.805 0 CA-C-N 115.706 -0.679 . . . . 3.25 109.956 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 110.934 -0.866 . . . . 1.55 110.934 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -92.76 130.98 38.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.564 0.579 . . . . 2.25 112.564 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 64.4 mmtt -74.01 112.6 10.29 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.019 0.528 . . . . 4.73 110.684 175.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -141.13 164.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.855 -0.794 . . . . 2.94 108.855 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t -122.41 115.72 22.76 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.916 -1.142 . . . . 1.71 107.916 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' A' ' 77' ' ' PHE . 3.4 tt -123.04 128.69 50.49 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.298 -1.371 . . . . 2.02 107.298 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.7 mt -99.06 122.88 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.712 -0.395 . . . . 1.38 109.981 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -76.1 162.26 28.16 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.561 -0.745 . . . . 1.7 110.413 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -23.45 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.526 1.13 . . . . 2.63 113.733 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.81 22.66 3.47 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 122.841 0.456 . . . . 1.33 110.266 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.263 10.8 pt-20 50.35 50.7 18.24 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.879 1.272 . . . . 2.59 112.677 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -119.08 118.65 58.35 Favored 'Isoleucine or valine' 0 C--O 1.254 1.32 0 CA-C-N 114.455 -1.248 . . . . 1.73 110.247 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.64 109.17 15.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.534 -0.757 . . . . 5.24 110.768 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -105.57 134.19 49.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.145 -0.479 . . . . 3.17 110.443 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -134.9 129.87 35.01 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.992 -0.744 . . . . 2.45 108.992 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -174.83 -151.68 8.64 Favored Glycine 0 CA--C 1.481 -2.078 0 N-CA-C 110.43 -1.068 . . . . 0.55 110.43 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.95 107.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-O 121.413 0.625 . . . . 1.58 112.35 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 22' ' ' ILE . 6.9 tt -58.41 137.88 56.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.434 -1.257 . . . . 2.31 111.301 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -99.44 -60.56 1.51 Allowed 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.294 -0.867 . . . . 1.37 112.023 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -151.75 154.03 35.49 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.94 -0.475 . . . . 1.52 110.052 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.81 129.54 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.807 -1.183 . . . . 1.94 107.807 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.81 105.31 17.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.986 -1.116 . . . . 2.56 107.986 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -73.02 -6.08 43.13 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.925 0.713 . . . . 3.15 112.925 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.76 -56.24 3.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 3.22 110.007 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -89.65 -9.67 48.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.758 -0.656 . . . . 2.66 110.226 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m 70.28 21.86 5.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.264 1.025 . . . . 2.54 109.697 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -83.69 144.15 29.57 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.726 -0.67 . . . . 1.78 111.405 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.41 128.03 62.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.928 -0.578 . . . . 1.49 110.56 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.97 110.5 22.54 Favored 'General case' 0 C--O 1.258 1.547 0 N-CA-C 109.455 -0.572 . . . . 1.15 109.455 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.454 HD23 HG22 ' A' ' 51' ' ' VAL . 11.8 mt -108.24 146.68 32.49 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.23 -0.895 . . . . 2.38 112.141 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.69 146.29 24.16 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.47 -1.307 . . . . 1.37 107.47 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt 62.43 29.55 17.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 124.013 0.821 . . . . 4.1 111.157 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 HG22 HD23 ' A' ' 48' ' ' LEU . 49.9 t -69.42 111.64 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.538 -0.865 . . . . 2.19 109.816 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 . . . . . 0 N--CA 1.429 -1.505 0 C-N-CA 124.985 1.314 . . . . 5.94 108.673 176.304 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 26.4 m-85 . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.907 -0.405 . . . . 5.92 109.907 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.62 137.16 51.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-O 121.463 0.649 . . . . 4.25 111.749 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mm -119.5 129.1 75.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.313 -0.858 . . . . 2.84 109.176 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE2' HD23 ' A' ' 24' ' ' LEU . 20.7 m-85 -98.95 137.32 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.091 -0.504 . . . . 2.91 111.192 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -64.99 -13.65 58.25 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 123.322 0.649 . . . . 3.99 112.084 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.511 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 82.01 -61.9 4.61 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.585 -0.816 . . . . 0.88 111.988 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.0 p -63.41 -27.43 69.29 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.244 0.545 . . . . 2.02 111.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.38 21.4 11.11 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.182 -0.917 . . . . 2.0 112.701 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 79' ' ' GLY . 40.4 pt -87.01 142.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.431 -0.908 . . . . 2.27 110.406 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -88.94 -60.34 1.98 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.078 -0.51 . . . . 2.07 111.098 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -145.04 152.46 40.15 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 116.402 -0.363 . . . . 2.22 110.185 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.18 102.05 5.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 123.921 0.763 . . . . 3.34 109.291 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.5 m -97.98 120.12 37.81 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.879 -0.601 . . . . 2.3 109.949 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.546 0.813 0 CA-C-N 115.956 -0.566 . . . . 3.25 110.534 -179.062 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.721 0 N-CA-C 110.137 -1.185 . . . . 1.55 110.137 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.8 m -88.81 139.62 30.27 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 117.077 0.438 . . . . 2.25 109.823 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -87.69 106.71 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.69 -0.804 . . . . 4.73 112.025 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.85 146.27 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.135 0.574 . . . . 2.94 110.518 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 t -107.68 111.78 24.16 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.635 -1.617 . . . . 1.71 106.635 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.575 HD11 ' O ' ' A' ' 84' ' ' ASP . 61.6 tp -121.6 129.67 52.99 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.554 0.216 . . . . 2.02 111.062 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.58 118.64 53.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.645 -0.502 . . . . 1.38 109.645 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.9 p -78.45 162.83 26.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.488 -0.778 . . . . 1.7 110.313 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -10.01 0.3 Allowed 'General case' 0 C--O 1.211 -0.926 0 N-CA-C 115.896 1.813 . . . . 2.63 115.896 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.12 13.69 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.542 -0.54 . . . . 1.33 109.542 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.41 28.28 15.45 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 125.259 1.424 . . . . 2.59 110.058 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.47 129.01 66.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.712 -0.676 . . . . 1.73 111.611 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptm85 -87.11 118.98 26.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.909 -0.587 . . . . 5.24 111.932 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.29 125.79 54.68 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.251 -1.018 . . . . 3.17 108.251 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -134.99 131.61 37.35 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.334 -1.358 . . . . 2.45 107.334 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 179.91 -158.53 22.23 Favored Glycine 0 CA--C 1.49 -1.49 0 N-CA-C 111.306 -0.718 . . . . 0.55 111.306 -175.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 35' ' ' ILE 0.31 0.2 OUTLIER -92.4 109.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.581 0 CA-C-O 122.314 1.054 . . . . 1.58 113.606 -177.062 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.5 tp -67.06 133.42 49.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.568 -1.651 . . . . 2.31 109.847 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -111.95 -59.21 2.02 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 120.46 -0.496 . . . . 1.37 110.566 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.7 m -141.19 160.59 39.78 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.977 -0.379 . . . . 1.52 109.977 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.56 123.78 53.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.638 -1.616 . . . . 1.94 106.638 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 14.7 m-20 -86.84 94.24 9.51 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.647 -1.612 . . . . 2.56 106.647 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -57.73 -26.34 61.65 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.454 -0.794 . . . . 3.15 112.943 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.31 -50.27 62.56 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.567 0.747 . . . . 3.22 111.475 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -112.94 6.01 17.59 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 120.951 0.405 . . . . 2.66 109.973 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.7 m 64.93 22.03 12.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.25 1.02 . . . . 2.54 110.817 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 40' ' ' ASP . 33.1 p -73.99 148.42 42.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.86 -0.609 . . . . 1.78 110.933 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.86 126.92 65.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 116.442 -0.345 . . . . 1.49 110.572 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.33 101.54 11.24 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.452 0.644 . . . . 1.15 110.232 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 91.3 mt -100.76 153.98 19.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.427 -0.806 . . . . 2.38 109.679 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.53 136.46 22.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.425 -0.583 . . . . 1.37 109.425 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 mttt 56.21 36.6 27.72 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.555 0.742 . . . . 4.1 111.77 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 86.7 t -67.3 117.19 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.694 -1.139 . . . . 2.19 111.761 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 106.964 -1.495 . . . . 5.94 106.964 -179.19 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.547 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 22.8 p90 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 119.559 -0.258 . . . . 5.92 111.132 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 tp -145.23 132.23 15.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 120.942 0.401 . . . . 4.25 110.238 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.3 mm -112.35 126.07 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.073 -0.714 . . . . 2.84 109.073 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -101.36 160.94 14.0 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.091 -0.337 . . . . 2.91 110.091 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.474 ' C ' HG23 ' A' ' 45' ' ' THR . 10.0 mpt_? -85.2 -3.85 58.96 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.413 -0.358 . . . . 3.99 111.87 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.581 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 81.35 -61.43 4.61 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.762 -0.732 . . . . 0.88 111.813 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.3 p -75.14 1.82 12.33 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.617 0.246 . . . . 2.02 111.628 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -110.52 8.89 23.16 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.018 0.437 . . . . 2.0 110.803 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 79' ' ' GLY . 32.0 pt -92.24 148.9 4.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 O-C-N 121.48 -0.762 . . . . 2.27 110.446 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.31 -46.91 4.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.751 -0.38 . . . . 2.07 111.835 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.575 ' O ' HD11 ' A' ' 24' ' ' LEU . 6.9 m-20 -129.68 146.37 51.46 Favored 'General case' 0 C--O 1.211 -0.968 0 O-C-N 122.34 -0.225 . . . . 2.22 110.85 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 tt -150.99 111.18 4.14 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.114 -1.439 . . . . 3.34 107.114 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -105.41 109.13 20.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.026 -0.731 . . . . 2.3 109.026 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.444 -0.765 0 CA-C-O 121.412 0.625 . . . . 3.25 110.545 178.27 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' HA3' ' HB ' ' A' ' 35' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 109.449 -1.46 . . . . 1.55 109.449 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.2 m -103.38 142.38 34.33 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.125 1.462 . . . . 2.25 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -89.23 106.71 18.62 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 122.464 0.306 . . . . 4.73 110.508 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.47 -173.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-O 121.507 0.67 . . . . 2.94 110.087 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 36.6 m -139.48 124.82 19.07 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.311 -1.366 . . . . 1.71 107.311 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 tt -133.31 135.85 45.09 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.335 -0.617 . . . . 2.02 109.335 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 66.4 mt -106.96 122.51 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 109.281 -0.637 . . . . 1.38 109.281 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.5 t -84.76 162.3 19.67 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.811 0.694 . . . . 1.7 109.232 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -3.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.822 1.416 . . . . 2.63 114.822 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 8.05 38.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.466 0.65 . . . . 1.33 109.256 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.601 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 6.2 mm-40 68.03 28.8 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.255 1.422 . . . . 2.59 109.768 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 48.0 mm -107.44 128.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.277 0.473 . . . . 1.73 112.277 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -89.1 117.44 28.1 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.25 1.02 . . . . 5.24 110.202 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 23' ' ' SER . 98.3 m-85 -107.85 148.59 29.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.386 0.274 . . . . 3.17 111.148 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -138.99 126.7 22.0 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.798 -1.556 . . . . 2.45 106.798 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.44 -155.33 25.88 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.304 -0.718 . . . . 0.55 111.304 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.75 128.91 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 113.978 1.103 . . . . 1.58 113.978 -177.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.66 156.48 30.72 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.821 -1.081 . . . . 2.31 112.625 173.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -110.73 -39.21 4.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.835 -0.621 . . . . 1.37 110.806 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -151.81 153.9 35.14 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.658 -0.497 . . . . 1.52 109.658 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.87 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.941 -0.763 . . . . 1.94 108.941 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -103.06 95.73 6.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.449 0.642 . . . . 2.56 109.49 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.1 m -52.88 -41.38 64.27 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.859 1.264 . . . . 3.15 114.133 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -55.45 -42.86 74.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.013 0.746 . . . . 3.22 113.013 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.81 -0.01 25.66 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.142 0.496 . . . . 2.66 109.82 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m 64.21 18.9 11.54 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.548 1.139 . . . . 2.54 111.033 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.8 p -79.43 125.08 29.09 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.105 0.479 . . . . 1.78 111.025 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -101.21 124.06 54.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.784 -0.644 . . . . 1.49 109.469 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.9 103.5 16.03 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 108.036 -1.098 . . . . 1.15 108.036 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.586 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -100.05 147.13 25.96 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 106.114 -1.81 . . . . 2.38 106.114 -176.046 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.447 ' H ' HD13 ' A' ' 48' ' ' LEU . . . -148.94 129.82 14.28 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.479 -1.304 . . . . 1.37 107.479 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttp 48.95 54.62 10.55 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.068 0.947 . . . . 4.1 112.697 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.586 ' HB ' ' CD1' ' A' ' 48' ' ' LEU . 6.6 p -66.97 114.12 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.424 -0.807 . . . . 2.19 109.613 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 106.761 -1.57 . . . . 5.94 106.761 -179.349 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.749 0.309 . . . . 5.92 111.736 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.73 131.14 42.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-O 121.106 0.479 . . . . 4.25 110.383 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.52 128.98 65.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.194 -0.669 . . . . 2.84 109.194 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.41 130.38 43.55 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 109.441 -0.578 . . . . 2.91 109.441 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -68.47 -10.47 55.65 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.295 0.85 . . . . 3.99 113.295 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.541 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.7 -48.98 3.33 Favored Glycine 0 C--O 1.212 -1.239 0 C-N-CA 120.831 -0.699 . . . . 0.88 112.305 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 m -76.31 -16.49 59.76 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.054 0.931 . . . . 2.02 109.188 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.23 24.7 6.89 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.659 -1.155 . . . . 2.0 112.124 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 79' ' ' GLY . 21.0 pt -112.73 150.97 14.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.552 -0.859 . . . . 2.27 110.493 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.601 ' HE3' ' OE1' ' A' ' 29' ' ' GLU . 71.6 mmtt -92.89 -54.5 3.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.788 -0.642 . . . . 2.07 110.526 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -161.65 159.01 26.94 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.21 -1.033 . . . . 2.22 108.21 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.13 147.91 22.97 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.803 0.335 . . . . 3.34 110.419 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.7 t -124.21 130.8 53.15 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.153 -0.684 . . . . 2.3 109.153 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 116.134 -0.484 . . . . 3.25 111.376 -177.657 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.535 0 N-CA-C 109.953 -1.259 . . . . 1.55 109.953 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 t -96.45 124.85 40.58 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.448 -0.945 . . . . 2.25 108.448 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -68.03 121.37 15.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.533 0.938 . . . . 4.73 113.533 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 tt -153.19 152.04 10.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-N 115.412 -0.813 . . . . 2.94 110.492 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.785 ' O ' ' HB3' ' A' ' 85' ' ' LEU . 20.0 m -115.3 144.53 43.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.989 -1.856 . . . . 1.71 105.989 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.828 ' HA ' ' CB ' ' A' ' 85' ' ' LEU . 31.1 tp -147.97 129.88 15.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.529 1.307 . . . . 2.02 114.529 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.487 ' H ' ' HB2' ' A' ' 85' ' ' LEU . 66.6 mt -95.12 119.64 43.46 Favored 'Isoleucine or valine' 0 C--N 1.387 2.23 0 C-N-CA 119.82 -0.752 . . . . 1.38 109.77 174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -89.49 166.13 13.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.946 -0.57 . . . . 1.7 109.48 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -47.52 -19.61 0.19 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 115.04 1.496 . . . . 2.63 115.04 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 27' ' ' LYS . . . -74.39 -2.92 27.47 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.708 0.29 . . . . 1.33 110.43 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 74.41 22.74 2.1 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.633 1.173 . . . . 2.59 107.882 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 53.9 mt -109.99 129.48 64.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.152 -1.385 . . . . 1.73 110.971 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -92.06 119.84 32.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.74 -0.663 . . . . 5.24 110.308 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.35 159.15 16.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.976 -0.75 . . . . 3.17 108.976 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -142.43 128.01 19.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.226 -1.398 . . . . 2.45 107.226 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 175.0 -128.87 1.47 Allowed Glycine 1 CA--C 1.442 -4.469 0 N-CA-C 109.998 -1.241 . . . . 0.55 109.998 -176.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.431 HD11 ' CB ' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -135.5 161.31 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.48 0 C-N-CA 118.934 -1.106 . . . . 1.58 113.287 -174.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.403 HD11 ' N ' ' A' ' 37' ' ' TYR . 3.3 tm? -99.44 140.34 33.76 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.507 -1.224 . . . . 2.31 109.389 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' N ' HD11 ' A' ' 36' ' ' LEU . 76.9 t80 -105.88 -54.69 2.44 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 123.239 0.337 . . . . 1.37 111.121 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.5 m -153.93 154.63 34.17 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 109.744 -0.465 . . . . 1.52 109.744 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.4 HG13 HD13 ' A' ' 36' ' ' LEU . 82.2 mt -130.29 142.56 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.797 0.332 . . . . 1.94 111.416 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 2.7 t70 -111.35 116.1 30.41 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.636 0.775 . . . . 2.56 110.428 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -76.79 -18.18 58.58 Favored 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 113.035 0.754 . . . . 3.15 113.035 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -69.7 -54.98 11.28 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.85 -0.531 . . . . 3.22 111.443 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -103.9 5.72 35.89 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.953 0.406 . . . . 2.66 110.058 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.1 t 65.02 24.38 12.59 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.996 -1.002 . . . . 2.54 109.817 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 70.3 p -77.51 141.45 39.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.884 0.849 . . . . 1.78 111.525 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.5 t -115.55 126.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.168 -0.924 . . . . 1.49 110.143 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.89 99.52 10.83 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.511 -0.922 . . . . 1.15 108.511 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 74' ' ' TYR . 2.7 tt -101.3 126.12 48.01 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.759 -1.941 . . . . 2.38 105.759 -176.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 74' ' ' TYR . . . -155.1 156.56 36.04 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 107.703 -1.221 . . . . 1.37 107.703 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.431 ' CB ' HD11 ' A' ' 35' ' ' ILE . 49.6 mttm 68.26 21.27 8.53 Favored 'General case' 0 C--O 1.2 -1.507 0 CA-C-O 121.993 0.901 . . . . 4.1 109.171 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.573 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.7 p -67.1 166.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.424 -1.324 . . . . 2.19 107.424 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 C--N 1.302 -1.485 0 C-N-CA 118.341 -1.344 . . . . 5.94 114.239 -172.613 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 21.3 t80 . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 115.56 1.689 . . . . 5.92 115.56 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.3 pt -150.82 147.14 15.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.568 0.699 . . . . 4.25 110.94 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.75 129.15 52.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.6 -0.889 . . . . 2.84 108.6 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 -98.11 152.24 19.53 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.893 -0.323 . . . . 2.91 110.154 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' C ' HG21 ' A' ' 45' ' ' THR . 22.1 mmm180 -78.05 6.3 8.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.046 -0.525 . . . . 3.99 111.193 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.28 -57.6 4.05 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 111.532 -0.627 . . . . 0.88 111.532 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.8 t -74.51 5.22 4.94 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.409 1.099 . . . . 2.02 108.792 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 79' ' ' GLY . 16.4 t70 -89.88 -11.9 40.56 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-N 114.619 -1.173 . . . . 2.0 109.872 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 79' ' ' GLY . 33.2 pt -100.25 153.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.284 -0.966 . . . . 2.27 113.397 -174.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.0 -68.18 0.75 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.471 -1.24 . . . . 2.07 110.274 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.605 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 24.1 t70 -173.32 115.27 0.25 Allowed 'General case' 0 CA--C 1.479 -1.773 0 CA-C-O 118.543 -0.741 . . . . 2.22 110.111 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.828 ' CB ' ' HA ' ' A' ' 24' ' ' LEU 0.842 17.7 mt -162.24 156.78 22.08 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 119.458 3.133 . . . . 3.34 119.458 170.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -141.55 159.07 42.99 Favored 'General case' 0 CA--C 1.563 1.481 0 N-CA-C 110.476 -0.194 . . . . 2.3 110.476 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 C--N 1.36 1.045 0 C-N-CA 123.745 0.818 . . . . 3.25 111.6 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.856 0 N-CA-C 113.698 0.239 . . . . 1.55 113.698 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 61.3 m -82.64 138.82 34.04 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.216 0.206 . . . . 2.25 111.086 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 116.61 31.45 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.468 -0.938 . . . . 4.73 108.468 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.4 HD11 ' CD1' ' A' ' 85' ' ' LEU . 14.1 pt -140.71 153.37 21.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.956 -0.698 . . . . 2.94 109.543 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -100.08 116.85 33.05 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 107.235 -1.394 . . . . 1.71 107.235 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 84' ' ' ASP . 63.9 tp -123.12 129.08 50.97 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.094 -0.503 . . . . 2.02 110.284 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.2 mt -110.45 120.37 61.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.263 -0.575 . . . . 1.38 110.122 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.3 t -75.09 158.42 33.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.006 -0.997 . . . . 1.7 108.791 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -56.38 -8.08 0.47 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.148 1.536 . . . . 2.63 115.148 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.82 10.06 25.04 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.335 -0.617 . . . . 1.33 109.335 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.77 26.6 9.44 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 125.801 1.64 . . . . 2.59 109.987 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.97 129.36 52.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 1.73 110.854 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -86.22 120.99 28.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.445 -0.798 . . . . 5.24 110.917 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.78 133.27 55.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.934 -0.765 . . . . 3.17 108.934 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.72 129.13 24.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.083 -1.821 . . . . 2.45 106.083 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . 172.83 -165.52 37.91 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 110.786 -0.926 . . . . 0.55 110.786 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' SER 0.338 0.2 OUTLIER -94.67 118.83 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 117.849 -1.54 . . . . 1.58 114.777 -175.714 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.98 135.52 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.778 -1.556 . . . . 2.31 109.119 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.49 -45.11 4.33 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 123.899 0.749 . . . . 1.37 111.676 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -156.15 153.92 30.04 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 110.156 -0.313 . . . . 1.52 110.156 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.78 134.13 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 107.845 -1.168 . . . . 1.94 107.845 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.5 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 8.8 t70 -94.9 98.38 10.67 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.935 -1.505 . . . . 2.56 106.935 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 m -66.93 -15.74 63.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.619 0.6 . . . . 3.15 112.619 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.3 -46.03 36.01 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.517 0.675 . . . . 3.22 110.048 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -103.56 -5.98 22.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.646 0.778 . . . . 2.66 110.334 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 m 68.08 19.83 9.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.132 1.373 . . . . 2.54 111.311 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 75.0 p -79.3 146.53 32.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.095 0.474 . . . . 1.78 111.318 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -111.68 127.49 68.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.135 -0.484 . . . . 1.49 110.007 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.34 113.38 26.72 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-O 121.166 0.507 . . . . 1.15 110.377 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' HB3' ' A' ' 74' ' ' TYR . 96.8 mt -100.08 136.74 39.52 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.717 -0.674 . . . . 2.38 109.231 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.67 117.88 24.44 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.409 -0.589 . . . . 1.37 109.409 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp 65.17 38.39 6.06 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.317 1.047 . . . . 4.1 109.517 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.401 HG22 ' HA3' ' A' ' 34' ' ' GLY . 3.4 p -66.44 114.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 109.023 -0.732 . . . . 2.19 109.023 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 . . . . . 0 C--N 1.314 -0.976 0 N-CA-C 108.807 -0.812 . . . . 5.94 108.807 -179.124 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.515 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 7.3 m-85 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 110.023 -0.362 . . . . 5.92 110.023 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.48 139.18 11.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 109.831 -0.433 . . . . 4.25 109.831 175.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.27 134.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.215 -0.661 . . . . 2.84 109.215 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -108.87 147.21 32.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 110.061 -0.348 . . . . 2.91 110.061 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -71.55 -5.53 33.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.638 0.977 . . . . 3.99 113.638 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.14 -58.19 4.6 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 120.874 -0.679 . . . . 0.88 112.766 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.1 p -67.44 -3.42 8.37 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.533 0.733 . . . . 2.02 111.665 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.3 m-20 -118.41 19.54 13.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.83 -1.077 . . . . 2.0 111.597 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 79' ' ' GLY . 37.0 pt -98.8 138.81 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.07 -0.652 . . . . 2.27 111.216 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -93.34 -56.3 2.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.386 0.612 . . . . 2.07 110.052 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 24' ' ' LEU . 1.1 m-20 -122.93 136.45 54.87 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.57 -0.741 . . . . 2.22 110.68 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.4 ' CD1' HD11 ' A' ' 22' ' ' ILE . 58.8 tp -143.52 103.72 4.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.397 -1.705 . . . . 3.34 106.397 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -141.32 134.45 29.3 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.381 -0.528 . . . . 2.3 110.931 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 108.513 -0.921 . . . . 3.25 108.513 178.58 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.63 0 N-CA-C 108.51 -1.836 . . . . 1.55 108.51 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.9 t -93.06 129.37 39.03 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.339 -0.985 . . . . 2.25 108.339 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -87.23 114.99 24.32 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.599 -1.26 . . . . 4.73 107.599 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.86 176.4 4.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 C-N-CA 120.138 -0.625 . . . . 2.94 110.225 -175.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 15.1 m -139.14 113.24 8.71 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.774 -1.103 . . . . 1.71 108.268 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.56 148.14 47.99 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.641 0.258 . . . . 2.02 110.751 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.1 mt -119.11 128.28 75.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.027 0.441 . . . . 1.38 109.939 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -75.54 161.9 28.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 1.7 109.293 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -48.11 -35.06 10.74 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 123.24 0.616 . . . . 2.63 112.353 -176.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.9 15.7 2.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.119 0.967 . . . . 1.33 111.907 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 69.0 25.71 5.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.847 1.259 . . . . 2.59 109.46 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.7 mm -94.59 120.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.444 -0.798 . . . . 1.73 109.892 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.408 ' HD3' ' OE1' ' A' ' 33' ' ' GLU . 16.8 ttm180 -86.22 139.42 31.06 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.778 -0.646 . . . . 5.24 111.177 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -135.22 121.07 19.7 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 123.852 0.861 . . . . 3.17 109.916 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 41.4 mt-10 -125.66 143.4 51.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.688 -1.227 . . . . 2.45 107.688 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.23 12.06 Favored Glycine 0 CA--C 1.476 -2.351 0 N-CA-C 109.234 -1.547 . . . . 0.55 109.234 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.435 HD13 ' N ' ' A' ' 35' ' ' ILE 0.261 0.1 OUTLIER -113.31 121.96 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 N-CA-C 114.427 1.269 . . . . 1.58 114.427 177.967 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.56 137.02 53.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.523 -1.671 . . . . 2.31 108.448 173.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -105.39 -48.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.106 -0.497 . . . . 1.37 111.128 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.1 m -158.35 155.68 29.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.375 -0.602 . . . . 1.52 109.375 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -133.12 117.6 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 108.307 -0.998 . . . . 1.94 108.307 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.78 95.42 6.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 2.56 107.085 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.41 -19.21 64.48 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 123.084 0.553 . . . . 3.15 111.795 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -61.25 -36.94 81.35 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 122.085 -0.384 . . . . 3.22 110.96 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -125.61 -2.98 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.72 0.771 . . . . 2.66 110.188 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.4 m 72.07 19.07 4.71 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.752 1.221 . . . . 2.54 112.486 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.9 p -71.07 133.23 46.12 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.298 0.571 . . . . 1.78 111.135 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.3 t -102.3 123.0 55.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.556 -0.747 . . . . 1.49 109.93 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.65 115.36 30.2 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.119 0.485 . . . . 1.15 111.425 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.615 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 4.4 mm? -104.7 140.86 37.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.583 -0.735 . . . . 2.38 111.491 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.69 136.22 18.0 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.545 -0.539 . . . . 1.37 109.545 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm 70.47 23.62 4.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.444 1.097 . . . . 4.1 109.901 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.615 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 21.7 t -68.53 117.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.03 -0.986 . . . . 2.19 109.007 -173.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 107.96 -1.126 . . . . 5.94 107.96 -179.032 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 20.8 p90 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 113.563 0.949 . . . . 5.92 113.563 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.98 155.24 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.01 -0.541 . . . . 4.25 109.702 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.2 mm -118.45 135.52 58.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.764 -0.828 . . . . 2.84 108.764 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.62 149.35 28.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.043 0.449 . . . . 2.91 111.451 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -67.24 -11.94 58.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 3.99 112.057 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.484 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.62 -66.27 3.74 Favored Glycine 0 C--O 1.213 -1.213 0 C-N-CA 121.206 -0.521 . . . . 0.88 112.949 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 t -62.43 -15.46 49.43 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.146 0.974 . . . . 2.02 110.897 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.5 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -93.19 7.43 44.33 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 124.715 1.206 . . . . 2.0 113.107 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 79' ' ' GLY . 26.6 pt -75.37 147.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.101 -0.639 . . . . 2.27 111.461 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.38 -44.22 6.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.379 -0.373 . . . . 2.07 111.447 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -174.47 148.01 1.18 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.293 -1.003 . . . . 2.22 108.293 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 151.46 25.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 112.259 0.466 . . . . 3.34 112.259 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 t -131.9 138.73 48.51 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.589 -0.893 . . . . 2.3 108.589 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.305 -1.363 0 CA-C-N 116.536 -0.302 . . . . 3.25 111.089 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 113.962 0.345 . . . . 1.55 113.962 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.1 m -93.04 120.51 33.42 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 109.892 -0.41 . . . . 2.25 109.892 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -87.01 107.76 18.56 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 116.57 -0.287 . . . . 4.73 111.041 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.76 163.55 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.614 -0.513 . . . . 2.94 109.614 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -122.85 112.09 17.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.223 -1.029 . . . . 1.71 108.223 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 84' ' ' ASP . 27.1 tp -122.13 125.48 46.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.231 0.539 . . . . 2.02 112.315 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 53.8 mt -92.14 117.24 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.769 -0.651 . . . . 1.38 110.204 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.3 t -76.28 162.55 27.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.958 -1.019 . . . . 1.7 108.957 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -10.66 0.59 Allowed 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 125.094 1.358 . . . . 2.63 113.854 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -0.12 47.59 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.939 0.495 . . . . 1.33 110.453 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 72.24 30.65 2.03 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 122.857 1.313 . . . . 2.59 107.637 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -115.56 129.54 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.611 -1.177 . . . . 1.73 110.667 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.429 ' HE ' ' CD ' ' A' ' 33' ' ' GLU . 34.9 ttp180 -93.63 103.2 15.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.825 -0.435 . . . . 5.24 109.825 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -89.06 125.49 35.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.681 -0.859 . . . . 3.17 108.681 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 29.9 mt-10 -126.19 127.13 45.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.002 -1.11 . . . . 2.45 108.002 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 176.43 -155.51 19.04 Favored Glycine 0 CA--C 1.476 -2.382 0 CA-C-O 118.105 -1.386 . . . . 0.55 109.859 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.437 0.2 OUTLIER -103.14 139.66 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 C-N-CA 115.064 -2.654 . . . . 1.58 117.303 -176.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 37' ' ' TYR . 3.2 tm? -86.61 140.61 29.68 Favored 'General case' 0 C--O 1.271 2.194 0 CA-C-N 113.929 -1.487 . . . . 2.31 107.816 176.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.476 ' N ' HD13 ' A' ' 36' ' ' LEU . 85.5 t80 -119.65 -55.09 2.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.94 1.4 . . . . 1.37 111.812 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.428 ' HG1' ' HB2' ' A' ' 47' ' ' ALA . 2.3 p -135.06 -179.2 5.47 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.348 0.499 . . . . 1.52 112.348 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.7 mm -134.34 131.85 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 120.874 0.369 . . . . 1.94 111.974 -173.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.493 ' HB2' ' HG1' ' A' ' 45' ' ' THR . 5.2 m-20 -94.52 80.67 3.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.438 1.095 . . . . 2.56 109.198 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -55.52 -31.82 62.41 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.103 0.779 . . . . 3.15 113.103 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -56.2 -30.77 62.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.931 0.893 . . . . 3.22 112.497 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.469 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 19.5 m120 -125.44 18.94 8.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.598 -0.519 . . . . 2.66 109.598 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.9 p 54.52 34.02 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.291 1.437 . . . . 2.54 110.782 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.58 HG23 ' N ' ' A' ' 79' ' ' GLY 0.496 0.8 OUTLIER -104.22 -174.88 2.64 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 120.423 3.49 . . . . 1.78 120.423 -171.417 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 77' ' ' PHE . 2.0 m -131.34 127.38 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 113.316 -1.765 . . . . 1.49 113.463 -163.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.428 ' HB2' ' HG1' ' A' ' 38' ' ' THR . . . -104.21 107.23 18.04 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.383 -0.826 . . . . 1.15 109.283 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 74' ' ' TYR . 6.0 mp -102.33 130.13 48.96 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.444 0.64 . . . . 2.38 110.743 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 50' ' ' LYS . . . -127.27 126.98 43.63 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 106.777 -1.564 . . . . 1.37 106.777 176.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 31.5 mtmm 83.26 15.88 0.31 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 124.137 0.898 . . . . 4.1 112.855 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.552 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.4 p -83.17 105.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.579 -1.648 . . . . 2.19 110.372 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 1.5 tmt_? . . . . . 0 C--O 1.198 -1.613 0 N-CA-C 104.653 -2.351 . . . . 5.94 104.653 169.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 48' ' ' LEU 0.264 19.1 p90 . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 115.367 1.618 . . . . 5.92 115.367 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.59 153.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 109.994 -0.373 . . . . 4.25 109.994 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.4 mm -110.88 133.65 55.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.063 -1.088 . . . . 2.84 108.063 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.577 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.9 m-85 -100.46 142.1 32.4 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 118.726 -1.19 . . . . 2.91 108.232 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.555 ' C ' HG23 ' A' ' 45' ' ' THR . 5.8 mpt_? -110.02 149.17 30.36 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-O 121.481 0.657 . . . . 3.99 110.745 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.58 ' N ' HG23 ' A' ' 45' ' ' THR . . . -52.9 -23.17 14.35 Favored Glycine 0 C--N 1.276 -2.788 0 C-N-CA 126.842 2.163 . . . . 0.88 112.791 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 p -93.91 -13.01 27.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.674 -0.763 . . . . 2.02 110.85 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.04 -7.63 10.82 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.435 -0.802 . . . . 2.0 112.04 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.6 pt -83.06 142.84 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.344 0.868 . . . . 2.27 113.344 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -101.21 -65.83 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 2.07 111.124 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.7 m-20 -140.28 149.02 42.29 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 112.655 0.613 . . . . 2.22 112.655 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.5 tp -134.25 131.16 38.14 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.68 -0.691 . . . . 3.34 110.26 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -141.74 161.29 38.31 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.096 -1.076 . . . . 2.3 108.096 175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.308 -1.206 0 N-CA-C 109.518 -0.549 . . . . 3.25 109.518 -177.824 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.295 0 N-CA-C 111.058 -0.817 . . . . 1.55 111.058 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -94.09 121.86 36.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.086 -0.709 . . . . 2.25 109.086 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 5.2 mptt -89.92 94.31 9.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.989 -1.115 . . . . 4.73 107.989 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 86' ' ' THR . 1.8 pp -137.77 -179.18 2.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 120.438 -0.505 . . . . 2.94 110.318 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.8 p -132.18 131.33 42.1 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.303 -0.999 . . . . 1.71 108.303 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 6.5 tt -135.97 145.74 46.49 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 108.295 -1.002 . . . . 2.02 108.295 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.0 mt -116.4 128.77 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.71 -0.677 . . . . 1.38 109.851 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -76.9 170.52 16.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.154 -0.684 . . . . 1.7 109.154 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -58.77 -23.87 60.78 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.08 0.952 . . . . 2.63 112.221 -173.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.48 25.4 5.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.016 -0.538 . . . . 1.33 110.298 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.594 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 0.8 OUTLIER 66.59 28.72 9.21 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.618 -0.719 . . . . 2.59 112.397 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 52.1 mm -89.46 97.71 7.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.883 -0.599 . . . . 1.73 110.555 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.571 ' H ' ' HD3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.0 136.62 33.51 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.619 -0.719 . . . . 5.24 111.066 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 1.9 p90 -126.34 163.19 23.81 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.692 -0.803 . . . . 3.17 110.67 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.86 126.22 17.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.064 -1.458 . . . . 2.45 107.064 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 158.64 -150.64 21.42 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 120.97 -0.633 . . . . 0.55 111.547 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.25 0.1 OUTLIER -110.73 115.51 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 114.369 1.248 . . . . 1.58 114.369 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tt -77.42 147.14 36.15 Favored 'General case' 0 C--O 1.252 1.184 0 CA-C-N 114.205 -1.362 . . . . 2.31 109.65 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -108.5 -52.59 2.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.278 0.362 . . . . 1.37 110.089 -175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.7 m -143.11 151.49 40.79 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.43 -1.693 . . . . 1.52 106.43 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.42 HG12 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -159.47 103.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 C-N-CA 118.088 -1.445 . . . . 1.94 112.93 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 45' ' ' THR . 6.4 m-20 -127.38 131.3 50.36 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-N 115.555 -0.748 . . . . 2.56 112.19 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.2 t -69.04 -35.36 76.5 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 113.365 0.876 . . . . 3.15 113.365 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.46 -60.82 2.13 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.553 -1.659 . . . . 3.22 110.832 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -136.07 -24.61 1.26 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 116.739 2.126 . . . . 2.66 116.739 178.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.489 ' C ' ' HB2' ' A' ' 40' ' ' ASP . 19.2 m -96.19 44.88 1.07 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.234 1.016 . . . . 2.54 109.046 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 70.8 p -38.3 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 1 C-N-CA 134.141 4.976 . . . . 1.78 116.886 -178.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' PHE . 9.6 t -91.81 101.82 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 CA-C-N 115.112 -0.949 . . . . 1.49 109.197 -163.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.51 111.93 22.97 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 113.933 -1.485 . . . . 1.15 107.451 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -114.5 127.24 55.71 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.289 -0.869 . . . . 2.38 109.361 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.19 155.08 45.26 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 107.217 -1.401 . . . . 1.37 107.217 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.8 pttt 50.28 27.87 2.89 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.133 0.973 . . . . 4.1 113.534 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 p -68.25 111.08 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.019 0.914 . . . . 2.19 109.855 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 N--CA 1.406 -2.628 0 C-N-CA 125.396 1.478 . . . . 5.94 108.351 177.284 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 110.496 -0.187 . . . . 5.92 110.496 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 pt -141.24 146.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 121.62 -0.675 . . . . 4.25 112.607 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.51 151.48 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.139 -1.059 . . . . 2.84 108.139 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.588 ' O ' ' HB ' ' A' ' 45' ' ' THR . 97.6 m-85 -124.12 139.52 53.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.992 -0.373 . . . . 2.91 109.992 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 21.1 mmm180 -43.93 -26.32 0.26 Allowed 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 116.124 1.898 . . . . 3.99 116.124 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 74.21 -64.19 2.06 Favored Glycine 0 C--O 1.209 -1.454 0 C-N-CA 120.972 -0.633 . . . . 0.88 112.557 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.0 t -73.38 -7.65 52.55 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.82 0.848 . . . . 2.02 110.311 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 16.4 m-20 -121.16 30.1 6.99 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.973 -0.558 . . . . 2.0 110.316 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 79' ' ' GLY . 2.1 pp -77.44 163.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.845 -0.535 . . . . 2.27 112.42 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.594 ' HE3' ' OE2' ' A' ' 29' ' ' GLU . 15.6 tppt? -105.85 -62.05 1.42 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.937 0.399 . . . . 2.07 110.07 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.79 150.4 29.33 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.551 -0.75 . . . . 2.22 110.305 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -155.55 132.58 10.73 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 124.55 1.14 . . . . 3.34 110.957 176.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 9.4 t -125.03 139.96 53.33 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.495 -0.928 . . . . 2.3 108.495 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 C--O 1.251 1.147 0 CA-C-N 116.201 -0.454 . . . . 3.25 110.355 -176.455 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 CA--C 1.549 1.249 0 N-CA-C 114.388 0.88 . . . . 4.13 114.388 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 59.58 -148.81 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.686 1.195 . . . . 8.32 113.587 170.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.269 49.4 mm 94.54 -75.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.906 0 C-N-CA 126.192 1.797 . . . . 4.26 113.514 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.99 -159.59 7.97 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.365 -0.921 . . . . 1.55 112.8 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 t -88.28 123.65 33.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.514 -0.55 . . . . 2.25 109.514 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 8.4 mptt -82.32 121.35 26.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.105 -0.702 . . . . 4.73 109.105 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.58 167.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.876 -0.787 . . . . 2.94 108.876 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.5 t -123.81 124.52 42.86 Favored 'General case' 0 N--CA 1.404 -2.738 0 N-CA-C 107.628 -1.249 . . . . 1.71 107.628 174.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.503 HD22 HD12 ' A' ' 82' ' ' ILE . 5.3 tt -116.45 130.71 56.91 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.154 -0.93 . . . . 2.02 109.581 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 2.9 mp -105.52 119.91 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-N 116.332 -0.395 . . . . 1.38 110.154 175.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.9 p -78.2 169.6 18.0 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.28 -0.418 . . . . 1.7 110.599 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -49.12 -26.02 2.49 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.809 1.04 . . . . 2.63 113.809 -175.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.17 10.9 17.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 1.33 110.836 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 63.96 39.97 7.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.261 1.024 . . . . 2.59 111.087 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.9 mm -106.11 127.09 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.047 -1.433 . . . . 1.73 109.88 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -89.84 142.68 27.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.262 0.467 . . . . 5.24 112.262 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -138.33 143.79 40.08 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.681 -1.229 . . . . 3.17 107.681 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.46 134.51 55.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.886 0.374 . . . . 2.45 110.044 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -166.01 -169.38 29.55 Favored Glycine 0 CA--C 1.467 -2.962 0 N-CA-C 111.064 -0.814 . . . . 0.55 111.064 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.476 HD12 ' HG3' ' A' ' 50' ' ' LYS 0.345 1.4 pp -113.01 108.74 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.528 0 CA-C-O 123.051 1.405 . . . . 1.58 113.293 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.25 135.61 49.59 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.627 -1.624 . . . . 2.31 111.041 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -113.04 -48.14 3.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.516 -0.766 . . . . 1.37 111.553 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 m -154.09 153.11 31.31 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.848 -0.532 . . . . 1.52 109.701 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.42 126.44 48.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.777 -0.823 . . . . 1.94 108.777 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 18.7 m-20 -89.54 95.77 10.41 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.82 -1.178 . . . . 2.56 107.82 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -56.06 -29.0 59.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.351 0.871 . . . . 3.15 113.351 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.19 -39.93 90.03 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.029 0.442 . . . . 3.22 111.511 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -109.79 0.5 18.83 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.798 -0.564 . . . . 2.66 110.345 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m 65.18 16.44 10.55 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.047 -0.979 . . . . 2.54 110.645 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 40' ' ' ASP . 30.4 p -75.77 135.65 40.29 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.201 0.524 . . . . 1.78 111.132 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.7 t -104.45 125.7 59.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.846 -0.615 . . . . 1.49 110.005 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.33 106.41 17.58 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.198 0.523 . . . . 1.15 109.76 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.2 150.23 22.74 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.507 -0.77 . . . . 2.38 111.888 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.75 134.39 19.89 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 105.132 -2.173 . . . . 1.37 105.132 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' H ' HG23 ' A' ' 71' ' ' THR 0.407 4.4 tptt 49.66 58.61 5.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 124.808 2.242 . . . . 4.1 113.148 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 44.6 t -77.38 113.94 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 112.886 -1.961 . . . . 2.19 106.204 173.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.49 ' HD3' ' OE1' ' A' ' 73' ' ' GLU . 20.9 tpt180 -169.46 157.21 7.17 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.265 -1.383 . . . . 5.94 107.265 177.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.6 m -61.43 156.27 19.67 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 123.402 0.439 . . . . 4.16 110.547 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -132.5 95.08 3.54 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.687 0.995 . . . . 7.5 113.687 -173.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.38 101.31 0.4 Allowed Glycine 0 C--O 1.208 -1.503 0 C-N-CA 118.978 -1.582 . . . . 5.9 113.148 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.404 ' HA ' HG21 ' A' ' 61' ' ' THR . 62.1 p 69.27 133.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.708 1.603 . . . . 7.06 112.555 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.548 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 10.8 pt-20 -86.6 -149.53 0.14 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.041 1.336 . . . . 8.38 108.448 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.7 3.99 2.79 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.718 1.247 . . . . 11.7 110.593 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.562 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 39.5 mmt180 -131.8 149.78 74.37 Favored Pre-proline 0 N--CA 1.418 -2.05 0 C-N-CA 125.835 1.654 . . . . 12.76 106.797 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.8 44.69 1.33 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.9 2.4 . . . . 9.78 110.529 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.404 HG21 ' HA ' ' A' ' 56' ' ' THR 0.304 32.5 p 51.72 75.38 0.21 Allowed 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 122.331 1.062 . . . . 7.57 113.693 -171.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.562 ' OD1' ' HB3' ' A' ' 59' ' ' ARG . 6.2 m-20 -79.44 -5.42 54.68 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.365 -1.289 . . . . 10.54 108.48 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -157.55 94.62 2.11 Favored Pre-proline 0 N--CA 1.412 -2.334 0 N-CA-C 104.73 -2.322 . . . . 13.82 104.73 -178.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -45.54 126.56 8.75 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 123.997 3.131 . . . . 8.43 113.006 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mm -88.09 137.23 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 114.858 -1.064 . . . . 6.34 110.092 -173.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.1 155.77 36.22 Favored Pre-proline 0 C--N 1.283 -2.29 0 CA-C-N 113.958 -1.474 . . . . 5.1 108.137 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -58.63 86.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.643 2.228 . . . . 6.74 114.155 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -136.55 90.75 2.59 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.028 -1.442 . . . . 9.55 107.249 172.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.567 ' OD1' ' HD3' ' A' ' 50' ' ' LYS . 9.0 t70 -144.73 145.96 31.95 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.726 -1.212 . . . . 6.55 107.726 -171.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.23 156.48 36.76 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.646 0.736 . . . . 7.39 111.403 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.6 HG23 ' H ' ' A' ' 50' ' ' LYS . 27.4 m -100.46 105.57 17.05 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 113.167 0.802 . . . . 4.61 113.167 -171.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -120.04 -38.01 3.0 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.122 0.487 . . . . 8.34 111.493 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.49 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 45.2 mt-10 -80.79 -4.82 55.96 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.316 1.228 . . . . 6.86 114.316 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' HB3' ' CG2' ' A' ' 71' ' ' THR . 16.1 p90 -49.48 150.57 1.86 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.791 1.034 . . . . 5.92 113.791 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 tt -162.98 147.2 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.862 -0.608 . . . . 4.25 110.361 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.439 HD11 ' N ' ' A' ' 76' ' ' ILE . 1.7 mp -107.49 129.72 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.115 -1.068 . . . . 2.84 108.115 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -103.67 148.07 26.48 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.523 -0.308 . . . . 2.91 111.735 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -59.73 -13.71 11.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.229 1.012 . . . . 3.99 113.529 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.11 -58.72 4.94 Favored Glycine 0 CA--C 1.496 -1.109 0 C-N-CA 120.946 -0.645 . . . . 0.88 111.875 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.3 t -65.99 -11.52 48.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.243 0.544 . . . . 2.02 110.685 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.444 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 3.8 m-20 -98.05 20.78 11.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.431 0.692 . . . . 2.0 111.506 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.503 HD12 HD22 ' A' ' 24' ' ' LEU . 40.3 mm -101.07 132.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.149 -1.02 . . . . 2.27 110.334 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -87.38 -28.51 22.13 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.804 -0.635 . . . . 2.07 111.463 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 25' ' ' ILE . 20.1 t70 -166.35 135.13 2.98 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.274 0.472 . . . . 2.22 112.274 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.8 mt -122.28 100.37 6.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.587 -0.733 . . . . 3.34 110.325 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -109.96 116.71 32.09 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.124 0.488 . . . . 2.3 110.483 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 m -95.81 154.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.672 -0.694 . . . . 3.25 111.334 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 54.0 t -109.17 -32.82 7.07 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.728 -0.215 . . . . 3.45 111.51 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 9.9 pt-20 -138.6 116.09 9.09 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-O 120.88 0.372 . . . . 5.07 111.903 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 89' ' ' GLU . 5.2 Cg_exo -77.72 112.18 3.26 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 123.167 2.578 . . . . 6.81 111.89 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.96 -39.12 42.49 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.071 2.514 . . . . 8.59 112.706 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -129.83 101.16 18.57 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.343 -0.39 . . . . 12.93 110.063 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.62 -28.36 37.82 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.617 2.212 . . . . 13.22 111.252 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -111.33 122.35 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 107.978 -1.119 . . . . 15.68 107.978 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 80.2 mtp . . . . . 0 C--N 1.312 -1.063 0 CA-C-O 118.399 -0.81 . . . . 16.96 109.344 -177.537 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.548 1.188 0 CA-C-O 121.364 0.485 . . . . 4.13 112.196 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -77.61 90.35 3.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.036 -0.529 . . . . 8.32 109.804 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.0 mt -108.84 -77.58 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.939 -0.573 . . . . 4.26 112.265 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.06 -164.83 22.18 Favored Glycine 0 C--O 1.262 1.853 0 C-N-CA 120.69 -0.767 . . . . 1.55 113.636 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -89.76 145.73 24.98 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.482 0.713 . . . . 2.25 109.492 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 10.3 mptt -92.05 114.05 26.49 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.448 -0.945 . . . . 4.73 108.448 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 86' ' ' THR . 10.8 tt -151.93 150.61 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.17 -0.468 . . . . 2.94 111.536 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.5 m -104.01 127.84 51.57 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.509 -1.293 . . . . 1.71 107.509 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.0 tp -123.5 128.71 50.18 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.491 -0.322 . . . . 2.02 110.587 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 62.9 mt -104.29 124.63 58.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.685 -0.857 . . . . 1.38 108.685 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p -80.0 160.18 25.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.444 -0.947 . . . . 1.7 108.444 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -54.8 -12.04 0.72 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.627 0.973 . . . . 2.63 113.627 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.469 ' N ' ' HD3' ' A' ' 27' ' ' LYS . . . -85.05 5.53 29.14 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.386 0.675 . . . . 1.33 110.013 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 29' ' ' GLU . 3.1 tp10 70.46 30.65 3.17 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.153 1.781 . . . . 2.59 108.958 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -108.34 128.11 64.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.381 -0.827 . . . . 1.73 111.544 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.15 124.62 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.386 -0.825 . . . . 5.24 111.04 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.46 127.65 51.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.528 -0.545 . . . . 3.17 109.528 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -118.69 126.35 51.71 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.113 0.482 . . . . 2.45 109.734 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.28 -151.67 9.32 Favored Glycine 0 CA--C 1.468 -2.874 0 N-CA-C 110.63 -0.988 . . . . 0.55 110.63 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 50' ' ' LYS 0.317 1.1 pp -116.72 116.64 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 CA-C-O 122.192 0.996 . . . . 1.58 112.605 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.407 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -62.39 133.1 54.58 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.93 -1.486 . . . . 2.31 108.373 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -94.76 -55.98 2.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.573 -0.451 . . . . 1.37 112.14 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.5 m -153.86 154.06 33.24 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.013 -0.429 . . . . 1.52 110.33 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.7 133.79 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 109.254 -0.647 . . . . 1.94 109.254 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.536 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 7.8 t70 -92.93 110.61 22.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.893 -0.781 . . . . 2.56 108.893 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 m -73.46 -8.77 57.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.819 -0.628 . . . . 3.15 112.129 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.63 -56.35 4.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.838 -0.745 . . . . 3.22 111.168 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -96.47 0.34 50.18 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.7 -0.682 . . . . 2.66 109.432 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m 65.68 21.1 11.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.456 -1.247 . . . . 2.54 111.259 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.536 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 77.3 p -73.07 154.53 40.38 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.184 0.516 . . . . 1.78 111.675 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.4 ' CG1' HD21 ' A' ' 36' ' ' LEU . 59.8 t -124.94 125.1 69.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.724 -0.671 . . . . 1.49 110.056 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.59 109.37 21.45 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 1.15 109.018 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.542 ' HG ' ' CG2' ' A' ' 51' ' ' VAL . 45.7 tp -113.01 129.07 56.62 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.947 -0.57 . . . . 2.38 109.579 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.55 156.55 30.38 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.395 -0.965 . . . . 1.37 108.395 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.642 ' HA ' ' OG1' ' A' ' 71' ' ' THR . 48.8 mttp 60.08 29.78 19.32 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.102 0.876 . . . . 4.1 109.885 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.542 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 46.6 t -67.0 114.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.731 -1.122 . . . . 2.19 109.086 -176.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -169.82 164.42 9.83 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.36 -0.978 . . . . 5.94 108.36 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 p -63.28 154.59 31.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.196 0.813 . . . . 4.16 113.196 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -123.81 126.86 47.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.326 -0.852 . . . . 7.5 110.397 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.23 90.12 1.18 Allowed Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 119.687 -1.244 . . . . 5.9 112.157 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 m -143.51 -100.44 0.12 Allowed 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.502 1.668 . . . . 7.06 115.502 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 56.52 -91.5 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.046 0.938 . . . . 8.38 113.461 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.99 12.95 31.72 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 113.189 0.811 . . . . 11.7 113.189 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.523 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 mmp_? -130.17 98.49 21.01 Favored Pre-proline 0 N--CA 1.395 -3.21 0 N-CA-C 106.501 -1.666 . . . . 12.76 106.501 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -63.72 84.97 0.14 Allowed 'Trans proline' 0 N--CA 1.432 -2.105 0 C-N-CA 121.882 1.722 . . . . 9.78 110.513 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.0 t -32.08 -49.87 0.2 Allowed 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 114.855 -1.066 . . . . 7.57 112.589 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 t70 176.85 -75.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.514 1.525 . . . . 10.54 108.071 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.421 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 90.2 mtt180 -143.26 -62.27 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 115.211 -0.904 . . . . 13.82 112.047 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 25.7 Cg_endo -60.12 103.21 0.2 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 C-N-CA 122.279 1.986 . . . . 8.43 116.173 -176.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 mt -119.7 147.53 23.29 Favored 'Isoleucine or valine' 0 C--O 1.257 1.459 0 N-CA-C 106.482 -1.673 . . . . 6.34 106.482 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 68' ' ' ARG . . . -102.38 100.17 14.97 Favored Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 109.173 -0.677 . . . . 5.1 109.173 170.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.08 12.0 3.09 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.232 1.955 . . . . 6.74 111.565 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.401 ' H ' ' C ' ' A' ' 66' ' ' ALA . 61.5 ttt180 72.26 89.05 0.1 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 113.732 -1.576 . . . . 9.55 112.162 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.77 -73.79 0.5 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.16 -0.927 . . . . 6.55 108.634 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 177.51 -167.98 0.06 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.076 -1.824 . . . . 7.39 106.076 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.642 ' OG1' ' HA ' ' A' ' 50' ' ' LYS . 87.1 m -155.83 145.89 21.49 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.712 -0.848 . . . . 4.61 108.712 -175.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -105.87 -25.92 11.94 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.707 -0.849 . . . . 8.34 108.707 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.64 -7.28 25.36 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.734 1.614 . . . . 6.86 112.64 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -64.22 146.57 54.08 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 112.461 0.541 . . . . 5.92 112.461 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 tt -157.92 140.71 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.139 -0.482 . . . . 4.25 110.518 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -102.7 135.45 39.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.342 -0.984 . . . . 2.84 108.342 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.4 150.84 27.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.535 -0.543 . . . . 2.91 109.535 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -81.64 10.51 5.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.017 0.437 . . . . 3.99 111.418 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.465 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 84.41 -61.16 4.75 Favored Glycine 0 CA--C 1.47 -2.767 0 N-CA-C 111.53 -0.628 . . . . 0.88 111.53 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -62.4 -12.06 19.38 Favored 'General case' 0 CA--C 1.582 2.188 0 CA-C-O 121.092 0.472 . . . . 2.02 111.254 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.655 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 9.3 m-20 -82.53 -0.56 47.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.352 0.661 . . . . 2.0 112.268 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 79' ' ' GLY . 1.9 pp -79.6 140.65 16.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 119.18 -1.008 . . . . 2.27 112.652 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -95.64 -56.1 2.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.983 -0.747 . . . . 2.07 108.983 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -136.0 139.15 42.92 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.195 -0.912 . . . . 2.22 108.666 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 38.3 tp -135.96 99.59 4.19 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.323 -1.362 . . . . 3.34 107.323 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.501 ' O ' HG13 ' A' ' 22' ' ' ILE . 51.1 m -132.35 110.54 10.64 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.077 0.465 . . . . 2.3 111.285 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.9 136.8 22.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 115.706 -0.679 . . . . 3.25 109.956 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.1 t -178.26 119.16 0.09 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.054 0.542 . . . . 3.45 109.93 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -70.85 137.51 85.27 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 109.176 -0.676 . . . . 5.07 109.176 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -46.23 -44.69 19.54 Favored 'Trans proline' 0 CA--C 1.575 2.55 0 C-N-CA 123.553 2.835 . . . . 6.81 116.3 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -78.97 92.9 1.12 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 CA-C-N 120.931 1.368 . . . . 8.59 112.079 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -128.1 86.25 58.52 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 107.163 -1.421 . . . . 12.93 107.163 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.32 -27.37 23.89 Favored 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 122.601 2.201 . . . . 13.22 112.551 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.9 mt -78.33 -20.28 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.325 -0.991 . . . . 15.68 108.325 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.294 -1.336 . . . . 16.96 111.91 -175.885 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HA ' HD11 ' A' ' 65' ' ' ILE . 60.0 Cg_endo . . . . . 0 N--CA 1.449 -1.097 0 N-CA-C 114.088 0.765 . . . . 4.13 114.088 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -136.63 -179.77 5.89 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.281 -0.872 . . . . 8.32 109.26 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -172.96 -39.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 122.897 0.479 . . . . 4.26 110.034 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.61 -161.19 33.45 Favored Glycine 0 C--N 1.315 -0.615 0 N-CA-C 110.934 -0.866 . . . . 1.55 110.934 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -92.76 130.98 38.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.564 0.579 . . . . 2.25 112.564 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 64.4 mmtt -74.01 112.6 10.29 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.019 0.528 . . . . 4.73 110.684 175.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -141.13 164.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.855 -0.794 . . . . 2.94 108.855 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t -122.41 115.72 22.76 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.916 -1.142 . . . . 1.71 107.916 177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' A' ' 77' ' ' PHE . 3.4 tt -123.04 128.69 50.49 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.298 -1.371 . . . . 2.02 107.298 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.7 mt -99.06 122.88 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.712 -0.395 . . . . 1.38 109.981 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -76.1 162.26 28.16 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.561 -0.745 . . . . 1.7 110.413 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -23.45 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.526 1.13 . . . . 2.63 113.733 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.81 22.66 3.47 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 122.841 0.456 . . . . 1.33 110.266 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.263 10.8 pt-20 50.35 50.7 18.24 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.879 1.272 . . . . 2.59 112.677 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -119.08 118.65 58.35 Favored 'Isoleucine or valine' 0 C--O 1.254 1.32 0 CA-C-N 114.455 -1.248 . . . . 1.73 110.247 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.64 109.17 15.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.534 -0.757 . . . . 5.24 110.768 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -105.57 134.19 49.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.145 -0.479 . . . . 3.17 110.443 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -134.9 129.87 35.01 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.992 -0.744 . . . . 2.45 108.992 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -174.83 -151.68 8.64 Favored Glycine 0 CA--C 1.481 -2.078 0 N-CA-C 110.43 -1.068 . . . . 0.55 110.43 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.95 107.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-O 121.413 0.625 . . . . 1.58 112.35 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 22' ' ' ILE . 6.9 tt -58.41 137.88 56.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.434 -1.257 . . . . 2.31 111.301 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -99.44 -60.56 1.51 Allowed 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.294 -0.867 . . . . 1.37 112.023 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -151.75 154.03 35.49 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.94 -0.475 . . . . 1.52 110.052 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.81 129.54 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.807 -1.183 . . . . 1.94 107.807 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.81 105.31 17.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.986 -1.116 . . . . 2.56 107.986 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -73.02 -6.08 43.13 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.925 0.713 . . . . 3.15 112.925 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.76 -56.24 3.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 3.22 110.007 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -89.65 -9.67 48.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.758 -0.656 . . . . 2.66 110.226 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m 70.28 21.86 5.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.264 1.025 . . . . 2.54 109.697 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -83.69 144.15 29.57 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.726 -0.67 . . . . 1.78 111.405 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.41 128.03 62.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.928 -0.578 . . . . 1.49 110.56 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.97 110.5 22.54 Favored 'General case' 0 C--O 1.258 1.547 0 N-CA-C 109.455 -0.572 . . . . 1.15 109.455 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.454 HD23 HG22 ' A' ' 51' ' ' VAL . 11.8 mt -108.24 146.68 32.49 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.23 -0.895 . . . . 2.38 112.141 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.69 146.29 24.16 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.47 -1.307 . . . . 1.37 107.47 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt 62.43 29.55 17.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 124.013 0.821 . . . . 4.1 111.157 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 HG22 HD23 ' A' ' 48' ' ' LEU . 49.9 t -69.42 111.64 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.538 -0.865 . . . . 2.19 109.816 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -170.02 127.27 0.86 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.985 1.314 . . . . 5.94 108.673 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.4 m -119.35 79.81 1.47 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.388 -0.597 . . . . 4.16 109.388 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -176.12 98.23 0.06 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.645 -0.872 . . . . 7.5 108.645 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -123.72 -157.42 9.81 Favored Glycine 1 N--CA 1.395 -4.041 0 N-CA-C 106.344 -2.702 . . . . 5.9 106.344 172.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 59' ' ' ARG . 31.7 p 62.1 -40.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.66 1.584 . . . . 7.06 112.619 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 55' ' ' GLY . 8.7 mm-40 54.32 62.87 2.37 Favored 'General case' 0 C--O 1.253 1.253 0 C-N-CA 125.069 1.347 . . . . 8.38 109.14 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 66.64 32.35 7.12 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.201 -1.363 . . . . 11.7 112.898 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' A' ' 56' ' ' THR . 28.4 mmt180 -133.5 -179.05 0.97 Allowed Pre-proline 0 C--O 1.21 -0.986 0 C-N-CA 123.348 0.659 . . . . 12.76 109.343 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -105.93 57.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.664 0 C-N-CA 121.947 1.764 . . . . 9.78 111.76 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.467 ' HB ' HG21 ' A' ' 56' ' ' THR . 24.9 m -72.24 88.5 1.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.112 -0.949 . . . . 7.57 108.995 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -97.8 -52.96 3.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.636 -1.166 . . . . 10.54 112.03 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.451 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . 98.2 mtt180 -100.38 -54.38 0.16 Allowed Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 113.223 0.823 . . . . 13.82 113.223 -176.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 63' ' ' ARG . 38.5 Cg_endo -80.8 105.88 1.74 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 121.044 1.163 . . . . 8.43 112.627 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.441 HD11 ' HA ' ' A' ' 16' ' ' PRO . 4.0 pt -131.98 152.02 36.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.627 0.771 . . . . 6.34 111.844 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.99 131.74 39.84 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.125 0.97 . . . . 5.1 112.708 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.52 97.57 1.04 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.88 2.387 . . . . 6.74 113.306 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HG3' ' OE2' ' A' ' 70' ' ' GLU . 60.6 ttp180 54.13 86.17 0.05 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.53 1.132 . . . . 9.55 112.589 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -99.69 -40.64 7.67 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.15 -0.932 . . . . 6.55 110.2 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.476 ' OE2' ' HG3' ' A' ' 68' ' ' ARG . 18.9 mm-40 74.99 171.69 0.28 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 125.319 1.448 . . . . 7.39 112.164 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -99.43 -89.05 0.33 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.105 0.78 . . . . 4.61 113.105 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.566 ' CD2' ' HG2' ' A' ' 73' ' ' GLU . 30.0 t80 -169.14 -90.92 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 112.198 0.444 . . . . 8.34 112.198 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.566 ' HG2' ' CD2' ' A' ' 72' ' ' PHE . 9.0 mm-40 -91.49 -25.05 19.46 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 117.912 0.323 . . . . 6.86 111.456 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 26.4 m-85 72.59 177.59 0.25 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.811 1.245 . . . . 5.92 109.907 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.62 137.16 51.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-O 121.463 0.649 . . . . 4.25 111.749 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mm -119.5 129.1 75.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.313 -0.858 . . . . 2.84 109.176 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE2' HD23 ' A' ' 24' ' ' LEU . 20.7 m-85 -98.95 137.32 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.091 -0.504 . . . . 2.91 111.192 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -64.99 -13.65 58.25 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 123.322 0.649 . . . . 3.99 112.084 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.511 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 82.01 -61.9 4.61 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.585 -0.816 . . . . 0.88 111.988 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.0 p -63.41 -27.43 69.29 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.244 0.545 . . . . 2.02 111.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.38 21.4 11.11 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.182 -0.917 . . . . 2.0 112.701 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 79' ' ' GLY . 40.4 pt -87.01 142.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.431 -0.908 . . . . 2.27 110.406 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -88.94 -60.34 1.98 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.078 -0.51 . . . . 2.07 111.098 176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -145.04 152.46 40.15 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 116.402 -0.363 . . . . 2.22 110.185 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.18 102.05 5.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 123.921 0.763 . . . . 3.34 109.291 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.5 m -97.98 120.12 37.81 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.879 -0.601 . . . . 2.3 109.949 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -97.1 147.68 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.956 -0.566 . . . . 3.25 110.534 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.2 m -100.78 -30.14 11.87 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 112.715 0.635 . . . . 3.45 112.715 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -151.97 158.43 33.87 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 109.428 -0.582 . . . . 5.07 109.428 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.36 113.63 2.36 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.59 2.194 . . . . 6.81 112.635 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -57.42 -43.71 49.2 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.815 2.343 . . . . 8.59 112.803 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp 60.42 86.87 0.14 Allowed Pre-proline 0 CA--C 1.554 1.114 0 O-C-N 123.621 0.576 . . . . 12.93 111.585 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.04 -40.19 6.8 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.347 2.031 . . . . 13.22 111.86 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.21 174.64 7.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 123.048 0.539 . . . . 15.68 110.52 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 C--N 1.307 -1.262 0 N-CA-C 109.455 -0.572 . . . . 16.96 109.455 178.004 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo . . . . . 0 C--O 1.256 1.378 0 N-CA-C 113.02 0.354 . . . . 4.13 113.02 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -41.3 143.89 0.39 Allowed 'General case' 0 C--O 1.248 0.995 0 C-N-CA 125.242 1.417 . . . . 8.32 114.078 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 tt -176.46 -37.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.266 -1.334 . . . . 4.26 108.284 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -137.97 -177.2 15.0 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 110.137 -1.185 . . . . 1.55 110.137 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.8 m -88.81 139.62 30.27 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 117.077 0.438 . . . . 2.25 109.823 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -87.69 106.71 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.69 -0.804 . . . . 4.73 112.025 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.85 146.27 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.135 0.574 . . . . 2.94 110.518 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 t -107.68 111.78 24.16 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.635 -1.617 . . . . 1.71 106.635 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.575 HD11 ' O ' ' A' ' 84' ' ' ASP . 61.6 tp -121.6 129.67 52.99 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.554 0.216 . . . . 2.02 111.062 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.58 118.64 53.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.645 -0.502 . . . . 1.38 109.645 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.9 p -78.45 162.83 26.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.488 -0.778 . . . . 1.7 110.313 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -10.01 0.3 Allowed 'General case' 0 C--O 1.211 -0.926 0 N-CA-C 115.896 1.813 . . . . 2.63 115.896 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.12 13.69 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.542 -0.54 . . . . 1.33 109.542 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.41 28.28 15.45 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 125.259 1.424 . . . . 2.59 110.058 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.47 129.01 66.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.712 -0.676 . . . . 1.73 111.611 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptm85 -87.11 118.98 26.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.909 -0.587 . . . . 5.24 111.932 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.29 125.79 54.68 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.251 -1.018 . . . . 3.17 108.251 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -134.99 131.61 37.35 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.334 -1.358 . . . . 2.45 107.334 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 179.91 -158.53 22.23 Favored Glycine 0 CA--C 1.49 -1.49 0 N-CA-C 111.306 -0.718 . . . . 0.55 111.306 -175.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 35' ' ' ILE 0.31 0.2 OUTLIER -92.4 109.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.581 0 CA-C-O 122.314 1.054 . . . . 1.58 113.606 -177.062 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.5 tp -67.06 133.42 49.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.568 -1.651 . . . . 2.31 109.847 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -111.95 -59.21 2.02 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 120.46 -0.496 . . . . 1.37 110.566 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.7 m -141.19 160.59 39.78 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.977 -0.379 . . . . 1.52 109.977 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.56 123.78 53.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.638 -1.616 . . . . 1.94 106.638 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 14.7 m-20 -86.84 94.24 9.51 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.647 -1.612 . . . . 2.56 106.647 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -57.73 -26.34 61.65 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.454 -0.794 . . . . 3.15 112.943 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.31 -50.27 62.56 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.567 0.747 . . . . 3.22 111.475 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -112.94 6.01 17.59 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 120.951 0.405 . . . . 2.66 109.973 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.7 m 64.93 22.03 12.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.25 1.02 . . . . 2.54 110.817 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 40' ' ' ASP . 33.1 p -73.99 148.42 42.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.86 -0.609 . . . . 1.78 110.933 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.86 126.92 65.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 116.442 -0.345 . . . . 1.49 110.572 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.33 101.54 11.24 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.452 0.644 . . . . 1.15 110.232 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 91.3 mt -100.76 153.98 19.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.427 -0.806 . . . . 2.38 109.679 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.53 136.46 22.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.425 -0.583 . . . . 1.37 109.425 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' C ' HG22 ' A' ' 71' ' ' THR . 88.4 mttt 56.21 36.6 27.72 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.555 0.742 . . . . 4.1 111.77 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 86.7 t -67.3 117.19 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.694 -1.139 . . . . 2.19 111.761 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 -165.03 150.65 9.73 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.964 -1.495 . . . . 5.94 106.964 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.2 m -133.06 145.54 50.88 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.371 -0.603 . . . . 4.16 109.371 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -141.38 -91.64 0.14 Allowed 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 113.338 0.866 . . . . 7.5 113.338 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.64 -56.57 0.02 OUTLIER Glycine 0 CA--C 1.496 -1.145 0 C-N-CA 119.953 -1.117 . . . . 5.9 112.443 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 59' ' ' ARG . 53.3 m -127.39 131.13 50.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 112.891 0.7 . . . . 7.06 112.891 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.93 -43.23 6.8 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.643 0.608 . . . . 8.38 112.643 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.64 -61.77 2.09 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.493 0.717 . . . . 11.7 110.39 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.642 ' O ' HG21 ' A' ' 56' ' ' THR . 78.8 mtp180 -89.26 175.8 3.67 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 106.124 -1.806 . . . . 12.76 106.124 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.447 ' O ' HG22 ' A' ' 61' ' ' THR . 83.4 Cg_endo -91.54 35.93 0.28 Allowed 'Trans proline' 0 N--CA 1.448 -1.147 0 CA-C-N 121.231 1.475 . . . . 9.78 114.093 -177.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.6 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 1.3 t 46.97 -163.25 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 125.634 1.574 . . . . 7.57 112.398 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.442 ' N ' HG21 ' A' ' 61' ' ' THR . 2.3 m-20 -49.72 -62.79 1.36 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 125.546 1.538 . . . . 10.54 110.518 174.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 40.0 ttm180 -156.15 -55.14 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.715 0 CA-C-N 115.37 -0.832 . . . . 13.82 112.828 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 66.9 Cg_endo -90.18 126.19 1.32 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.689 1.592 . . . . 8.43 114.235 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 65' ' ' ILE . 0.1 OUTLIER -134.11 138.81 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.521 0 CA-C-N 115.413 -0.812 . . . . 6.34 110.213 177.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 68' ' ' ARG . . . -93.68 118.52 67.45 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.162 -0.681 . . . . 5.1 109.162 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.95 17.5 0.83 Allowed 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.16 2.573 . . . . 6.74 111.792 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.448 ' H ' ' C ' ' A' ' 66' ' ' ALA . 80.2 mtm180 77.69 -22.95 0.26 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.783 1.633 . . . . 9.55 111.603 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -91.82 9.45 32.7 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.597 0.359 . . . . 6.55 110.966 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -105.51 -20.59 13.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.339 0.59 . . . . 7.39 110.552 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.514 HG22 ' C ' ' A' ' 50' ' ' LYS . 41.3 m -76.64 154.73 34.04 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.895 -0.593 . . . . 4.61 110.195 -177.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -59.48 161.96 5.35 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.623 -0.88 . . . . 8.34 108.623 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 74' ' ' TYR . 44.3 mt-10 -47.68 -60.54 2.48 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 123.977 0.798 . . . . 6.86 112.756 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.547 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 22.8 p90 175.61 179.8 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.128 0.571 . . . . 5.92 111.132 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 tp -145.23 132.23 15.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 120.942 0.401 . . . . 4.25 110.238 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.3 mm -112.35 126.07 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.073 -0.714 . . . . 2.84 109.073 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -101.36 160.94 14.0 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.091 -0.337 . . . . 2.91 110.091 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.474 ' C ' HG23 ' A' ' 45' ' ' THR . 10.0 mpt_? -85.2 -3.85 58.96 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.413 -0.358 . . . . 3.99 111.87 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.581 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 81.35 -61.43 4.61 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.762 -0.732 . . . . 0.88 111.813 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.3 p -75.14 1.82 12.33 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.617 0.246 . . . . 2.02 111.628 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -110.52 8.89 23.16 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.018 0.437 . . . . 2.0 110.803 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 79' ' ' GLY . 32.0 pt -92.24 148.9 4.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 O-C-N 121.48 -0.762 . . . . 2.27 110.446 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.31 -46.91 4.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.751 -0.38 . . . . 2.07 111.835 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.575 ' O ' HD11 ' A' ' 24' ' ' LEU . 6.9 m-20 -129.68 146.37 51.46 Favored 'General case' 0 C--O 1.211 -0.968 0 O-C-N 122.34 -0.225 . . . . 2.22 110.85 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 tt -150.99 111.18 4.14 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.114 -1.439 . . . . 3.34 107.114 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -105.41 109.13 20.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.026 -0.731 . . . . 2.3 109.026 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.57 104.09 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.412 0.625 . . . . 3.25 110.545 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.0 p -148.07 97.22 2.76 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.79 0.805 . . . . 3.45 112.292 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.57 149.76 39.28 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.099 -0.955 . . . . 5.07 110.153 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -89.76 108.35 0.4 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 122.852 2.368 . . . . 6.81 112.062 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -90.37 145.13 4.09 Favored 'Trans proline' 0 N--CA 1.438 -1.751 0 C-N-CA 122.197 1.931 . . . . 8.59 112.736 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -134.57 94.14 17.56 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 105.628 -1.99 . . . . 12.93 105.628 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -78.62 -51.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.663 1.575 . . . . 13.22 113.183 -174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -146.47 -58.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 106.762 -1.57 . . . . 15.68 106.762 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 107.73 -1.211 . . . . 16.96 107.73 176.718 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' CG ' ' A' ' 54' ' ' PHE . 63.4 Cg_endo . . . . . 0 CA--C 1.542 0.896 0 CA-C-O 120.707 0.211 . . . . 4.13 112.641 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -154.71 -70.24 0.13 Allowed 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 123.866 0.866 . . . . 8.32 108.741 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -164.36 160.45 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.271 2.203 0 CA-C-N 114.931 -1.032 . . . . 4.26 108.375 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' HA3' ' HB ' ' A' ' 35' ' ' ILE . . . 150.96 159.09 8.62 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.449 -1.46 . . . . 1.55 109.449 177.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.633 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.2 m -103.38 142.38 34.33 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.125 1.462 . . . . 2.25 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -89.23 106.71 18.62 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 122.464 0.306 . . . . 4.73 110.508 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.47 -173.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-O 121.507 0.67 . . . . 2.94 110.087 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 36.6 m -139.48 124.82 19.07 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.311 -1.366 . . . . 1.71 107.311 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.1 tt -133.31 135.85 45.09 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.335 -0.617 . . . . 2.02 109.335 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 66.4 mt -106.96 122.51 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 109.281 -0.637 . . . . 1.38 109.281 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.5 t -84.76 162.3 19.67 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.811 0.694 . . . . 1.7 109.232 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -3.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.822 1.416 . . . . 2.63 114.822 -178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 8.05 38.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.466 0.65 . . . . 1.33 109.256 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.601 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 6.2 mm-40 68.03 28.8 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.255 1.422 . . . . 2.59 109.768 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 48.0 mm -107.44 128.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.277 0.473 . . . . 1.73 112.277 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -89.1 117.44 28.1 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.25 1.02 . . . . 5.24 110.202 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 23' ' ' SER . 98.3 m-85 -107.85 148.59 29.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.386 0.274 . . . . 3.17 111.148 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -138.99 126.7 22.0 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.798 -1.556 . . . . 2.45 106.798 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.44 -155.33 25.88 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.304 -0.718 . . . . 0.55 111.304 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.75 128.91 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 113.978 1.103 . . . . 1.58 113.978 -177.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.511 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.66 156.48 30.72 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.821 -1.081 . . . . 2.31 112.625 173.12 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -110.73 -39.21 4.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.835 -0.621 . . . . 1.37 110.806 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -151.81 153.9 35.14 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.658 -0.497 . . . . 1.52 109.658 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.87 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.941 -0.763 . . . . 1.94 108.941 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -103.06 95.73 6.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.449 0.642 . . . . 2.56 109.49 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.1 m -52.88 -41.38 64.27 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.859 1.264 . . . . 3.15 114.133 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -55.45 -42.86 74.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.013 0.746 . . . . 3.22 113.013 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.81 -0.01 25.66 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.142 0.496 . . . . 2.66 109.82 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m 64.21 18.9 11.54 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.548 1.139 . . . . 2.54 111.033 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.8 p -79.43 125.08 29.09 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.105 0.479 . . . . 1.78 111.025 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -101.21 124.06 54.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.784 -0.644 . . . . 1.49 109.469 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.9 103.5 16.03 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 108.036 -1.098 . . . . 1.15 108.036 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -100.05 147.13 25.96 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 106.114 -1.81 . . . . 2.38 106.114 -176.046 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.447 ' H ' HD13 ' A' ' 48' ' ' LEU . . . -148.94 129.82 14.28 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.479 -1.304 . . . . 1.37 107.479 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttp 48.95 54.62 10.55 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.068 0.947 . . . . 4.1 112.697 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.586 ' HB ' ' CD1' ' A' ' 48' ' ' LEU . 6.6 p -66.97 114.12 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.424 -0.807 . . . . 2.19 109.613 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.548 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 12.7 tpt180 -169.22 170.73 8.45 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.761 -1.57 . . . . 5.94 106.761 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.7 m -79.13 124.03 27.93 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.786 -0.45 . . . . 4.16 109.786 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 96.1 m-85 -137.25 146.87 45.28 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.958 -0.564 . . . . 7.5 111.182 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.594 ' O ' HG22 ' A' ' 61' ' ' THR . . . 145.8 125.51 1.73 Allowed Glycine 0 C--O 1.171 -3.816 0 CA-C-O 118.45 -1.194 . . . . 5.9 110.211 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.5 m -175.35 -89.9 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 124.51 1.124 . . . . 7.06 112.538 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.329 8.2 mm-40 70.61 -90.84 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 125.845 1.658 . . . . 8.38 112.569 -170.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -92.82 -25.79 17.97 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 120.53 -0.468 . . . . 11.7 111.296 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -141.37 144.35 33.72 Favored Pre-proline 0 CA--C 1.461 -2.445 0 C-N-CA 119.13 -1.028 . . . . 12.76 109.715 -169.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.8 86.57 0.37 Allowed 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.495 1.464 . . . . 9.78 110.109 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 55' ' ' GLY . 7.5 t -57.16 -179.01 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.778 -1.101 . . . . 7.57 111.579 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.64 97.49 2.17 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.0 -1.482 . . . . 10.54 107.0 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 88.15 83.04 0.04 OUTLIER Pre-proline 0 C--N 1.311 -1.069 0 C-N-CA 127.024 2.13 . . . . 13.82 108.495 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 51.7 Cg_exo -58.98 -178.45 0.13 Allowed 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 124.476 3.45 . . . . 8.43 115.751 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.497 HG23 ' C ' ' A' ' 55' ' ' GLY . 34.7 pt -87.18 149.09 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.425 0 CA-C-N 115.263 -0.881 . . . . 6.34 112.445 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -101.95 131.8 22.33 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 113.816 -1.538 . . . . 5.1 109.94 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.69 32.93 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 122.871 2.381 . . . . 6.74 112.074 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 72.42 106.54 0.07 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.363 1.465 . . . . 9.55 112.915 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.16 -75.05 0.37 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.514 -0.766 . . . . 6.55 109.557 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 176.97 122.5 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.508 0.671 . . . . 7.39 112.441 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.4 m -161.27 100.07 1.2 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.094 -1.076 . . . . 4.61 108.094 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -112.03 -37.93 4.93 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.853 -0.739 . . . . 8.34 111.281 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.32 -20.66 31.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.867 0.365 . . . . 6.86 111.636 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 62.08 -168.17 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.476 1.51 . . . . 5.92 111.736 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.73 131.14 42.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-O 121.106 0.479 . . . . 4.25 110.383 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.52 128.98 65.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.194 -0.669 . . . . 2.84 109.194 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.41 130.38 43.55 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 109.441 -0.578 . . . . 2.91 109.441 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -68.47 -10.47 55.65 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.295 0.85 . . . . 3.99 113.295 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.541 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.7 -48.98 3.33 Favored Glycine 0 C--O 1.212 -1.239 0 C-N-CA 120.831 -0.699 . . . . 0.88 112.305 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 m -76.31 -16.49 59.76 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.054 0.931 . . . . 2.02 109.188 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.23 24.7 6.89 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.659 -1.155 . . . . 2.0 112.124 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 79' ' ' GLY . 21.0 pt -112.73 150.97 14.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.552 -0.859 . . . . 2.27 110.493 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.601 ' HE3' ' OE1' ' A' ' 29' ' ' GLU . 71.6 mmtt -92.89 -54.5 3.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.788 -0.642 . . . . 2.07 110.526 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -161.65 159.01 26.94 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.21 -1.033 . . . . 2.22 108.21 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.13 147.91 22.97 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.803 0.335 . . . . 3.34 110.419 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.7 t -124.21 130.8 53.15 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.153 -0.684 . . . . 2.3 109.153 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.1 p -126.36 122.98 62.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 116.134 -0.484 . . . . 3.25 111.376 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 47.2 t 174.21 -48.21 0.01 OUTLIER 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.163 -1.051 . . . . 3.45 108.163 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 178.03 162.21 0.61 Allowed Pre-proline 0 C--O 1.248 1.02 0 N-CA-C 106.089 -1.819 . . . . 5.07 106.089 -172.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.46 117.26 2.08 Favored 'Trans proline' 0 CA--C 1.554 1.521 0 C-N-CA 122.062 1.842 . . . . 6.81 114.217 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.85 167.4 11.24 Favored 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 122.681 2.254 . . . . 8.59 111.968 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 64.24 90.75 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.591 1.157 . . . . 12.93 112.77 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.47 -66.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.289 1.993 . . . . 13.22 111.575 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.7 pt -144.78 16.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 123.804 0.842 . . . . 15.68 108.758 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.099 -0.953 . . . . 16.96 109.594 -175.891 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HA ' ' CB ' ' A' ' 70' ' ' GLU . 93.2 Cg_endo . . . . . 0 CA--C 1.588 3.225 0 CA-C-O 120.52 0.133 . . . . 4.13 111.835 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -117.83 -91.16 0.55 Allowed 'General case' 0 C--O 1.239 0.543 0 N-CA-C 114.183 1.179 . . . . 8.32 114.183 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp 166.22 154.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 107.285 -1.376 . . . . 4.26 107.285 -172.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.93 -177.55 47.59 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 109.953 -1.259 . . . . 1.55 109.953 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 t -96.45 124.85 40.58 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.448 -0.945 . . . . 2.25 108.448 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -68.03 121.37 15.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.533 0.938 . . . . 4.73 113.533 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.9 tt -153.19 152.04 10.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-N 115.412 -0.813 . . . . 2.94 110.492 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.785 ' O ' ' HB3' ' A' ' 85' ' ' LEU . 20.0 m -115.3 144.53 43.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.989 -1.856 . . . . 1.71 105.989 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.828 ' HA ' ' CB ' ' A' ' 85' ' ' LEU . 31.1 tp -147.97 129.88 15.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.529 1.307 . . . . 2.02 114.529 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.487 ' H ' ' HB2' ' A' ' 85' ' ' LEU . 66.6 mt -95.12 119.64 43.46 Favored 'Isoleucine or valine' 0 C--N 1.387 2.23 0 C-N-CA 119.82 -0.752 . . . . 1.38 109.77 174.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -89.49 166.13 13.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.946 -0.57 . . . . 1.7 109.48 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -47.52 -19.61 0.19 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 115.04 1.496 . . . . 2.63 115.04 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 27' ' ' LYS . . . -74.39 -2.92 27.47 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.708 0.29 . . . . 1.33 110.43 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 74.41 22.74 2.1 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.633 1.173 . . . . 2.59 107.882 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 53.9 mt -109.99 129.48 64.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.152 -1.385 . . . . 1.73 110.971 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -92.06 119.84 32.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.74 -0.663 . . . . 5.24 110.308 177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.35 159.15 16.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.976 -0.75 . . . . 3.17 108.976 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -142.43 128.01 19.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.226 -1.398 . . . . 2.45 107.226 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 175.0 -128.87 1.47 Allowed Glycine 1 CA--C 1.442 -4.469 0 N-CA-C 109.998 -1.241 . . . . 0.55 109.998 -176.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.431 HD11 ' CB ' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -135.5 161.31 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.48 0 C-N-CA 118.934 -1.106 . . . . 1.58 113.287 -174.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.403 HD11 ' N ' ' A' ' 37' ' ' TYR . 3.3 tm? -99.44 140.34 33.76 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.507 -1.224 . . . . 2.31 109.389 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' N ' HD11 ' A' ' 36' ' ' LEU . 76.9 t80 -105.88 -54.69 2.44 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 123.239 0.337 . . . . 1.37 111.121 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.5 m -153.93 154.63 34.17 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 109.744 -0.465 . . . . 1.52 109.744 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.4 HG13 HD13 ' A' ' 36' ' ' LEU . 82.2 mt -130.29 142.56 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.797 0.332 . . . . 1.94 111.416 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 2.7 t70 -111.35 116.1 30.41 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.636 0.775 . . . . 2.56 110.428 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -76.79 -18.18 58.58 Favored 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 113.035 0.754 . . . . 3.15 113.035 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -69.7 -54.98 11.28 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.85 -0.531 . . . . 3.22 111.443 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -103.9 5.72 35.89 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.953 0.406 . . . . 2.66 110.058 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.1 t 65.02 24.38 12.59 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.996 -1.002 . . . . 2.54 109.817 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 70.3 p -77.51 141.45 39.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.884 0.849 . . . . 1.78 111.525 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.5 t -115.55 126.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.168 -0.924 . . . . 1.49 110.143 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.89 99.52 10.83 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.511 -0.922 . . . . 1.15 108.511 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 74' ' ' TYR . 2.7 tt -101.3 126.12 48.01 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.759 -1.941 . . . . 2.38 105.759 -176.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HA ' ' CB ' ' A' ' 74' ' ' TYR . . . -155.1 156.56 36.04 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 107.703 -1.221 . . . . 1.37 107.703 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.431 ' CB ' HD11 ' A' ' 35' ' ' ILE . 49.6 mttm 68.26 21.27 8.53 Favored 'General case' 0 C--O 1.2 -1.507 0 CA-C-O 121.993 0.901 . . . . 4.1 109.171 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.578 ' N ' HG23 ' A' ' 71' ' ' THR . 14.7 p -67.1 166.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.424 -1.324 . . . . 2.19 107.424 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HG3' ' HA ' ' A' ' 69' ' ' ASP . 44.6 ttp180 -71.58 102.21 2.68 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.341 -1.344 . . . . 5.94 114.239 -172.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.3 t -92.78 -172.98 3.19 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.953 -1.499 . . . . 4.16 106.953 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -109.16 -9.46 15.03 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.872 -0.731 . . . . 7.5 111.762 -174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.57 149.87 24.66 Favored Glycine 0 N--CA 1.407 -3.281 0 C-N-CA 119.802 -1.19 . . . . 5.9 110.614 -175.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.499 HG23 ' HG1' ' A' ' 61' ' ' THR . 80.8 p 63.55 99.15 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.991 1.317 . . . . 7.06 111.776 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -100.03 21.33 12.91 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.188 -0.914 . . . . 8.38 110.428 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 168.46 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 125.776 1.63 . . . . 11.7 110.934 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HD3' ' OD2' ' A' ' 62' ' ' ASP . 45.1 mtp180 -97.44 158.8 32.52 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.518 -0.765 . . . . 12.76 109.179 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.69 42.93 0.42 Allowed 'Trans proline' 0 CA--C 1.558 1.698 0 C-N-CA 123.511 2.808 . . . . 9.78 112.938 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.499 ' HG1' HG23 ' A' ' 56' ' ' THR . 26.0 m 71.74 112.37 0.06 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.179 0.992 . . . . 7.57 113.171 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.455 ' OD2' ' HD3' ' A' ' 59' ' ' ARG . 9.5 m-20 -98.0 4.15 49.39 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.8 0.81 . . . . 10.54 110.102 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -163.7 86.14 1.26 Allowed Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.589 -1.634 . . . . 13.82 106.589 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -25.72 116.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 1 C-N-CA 125.553 4.168 . . . . 8.43 116.042 -176.203 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.4 pt -86.67 153.2 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 113.173 -1.831 . . . . 6.34 112.256 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . . . -79.13 168.48 26.52 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 114.034 -1.439 . . . . 5.1 108.245 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 66' ' ' ALA . 3.9 Cg_exo -34.15 115.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 124.425 3.417 . . . . 6.74 114.22 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -45.89 107.61 0.11 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.25 -1.795 . . . . 9.55 114.409 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.46 ' HA ' ' HG3' ' A' ' 52' ' ' ARG . 7.6 t70 -178.5 -169.12 0.17 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 101.931 -3.359 . . . . 6.55 101.931 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 45.5 mm-40 62.86 176.89 0.15 Allowed 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 119.528 1.058 . . . . 7.39 113.652 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.578 HG23 ' N ' ' A' ' 51' ' ' VAL . 6.1 t -175.98 -167.99 0.25 Allowed 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.695 0.798 . . . . 4.61 110.219 175.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -86.54 -168.49 2.25 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.534 0.733 . . . . 8.34 110.012 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.467 ' HA ' ' HB1' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -51.37 -7.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 126.527 1.931 . . . . 6.86 116.203 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 21.3 t80 53.27 -109.9 0.5 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.56 1.689 . . . . 5.92 115.56 172.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.3 pt -150.82 147.14 15.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.568 0.699 . . . . 4.25 110.94 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.75 129.15 52.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.6 -0.889 . . . . 2.84 108.6 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 -98.11 152.24 19.53 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.893 -0.323 . . . . 2.91 110.154 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.411 ' C ' HG21 ' A' ' 45' ' ' THR . 22.1 mmm180 -78.05 6.3 8.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.046 -0.525 . . . . 3.99 111.193 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.28 -57.6 4.05 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 111.532 -0.627 . . . . 0.88 111.532 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.8 t -74.51 5.22 4.94 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.409 1.099 . . . . 2.02 108.792 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 79' ' ' GLY . 16.4 t70 -89.88 -11.9 40.56 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-N 114.619 -1.173 . . . . 2.0 109.872 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 79' ' ' GLY . 33.2 pt -100.25 153.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.284 -0.966 . . . . 2.27 113.397 -174.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.0 -68.18 0.75 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.471 -1.24 . . . . 2.07 110.274 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.605 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 24.1 t70 -173.32 115.27 0.25 Allowed 'General case' 0 CA--C 1.479 -1.773 0 CA-C-O 118.543 -0.741 . . . . 2.22 110.111 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.828 ' CB ' ' HA ' ' A' ' 24' ' ' LEU 0.842 17.7 mt -162.24 156.78 22.08 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 119.458 3.133 . . . . 3.34 119.458 170.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -141.55 159.07 42.99 Favored 'General case' 0 CA--C 1.563 1.481 0 N-CA-C 110.476 -0.194 . . . . 2.3 110.476 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.7 m -56.18 155.45 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.045 0 C-N-CA 123.745 0.818 . . . . 3.25 111.6 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.75 -14.22 16.16 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.133 -0.485 . . . . 3.45 110.749 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -107.71 148.99 38.38 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.175 -0.61 . . . . 5.07 109.746 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.04 113.23 3.51 Favored 'Trans proline' 0 CA--C 1.555 1.536 0 C-N-CA 122.106 1.871 . . . . 6.81 112.292 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -74.26 123.29 8.15 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.741 2.294 . . . . 8.59 111.786 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -121.96 100.93 42.62 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 108.82 -0.808 . . . . 12.93 108.82 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -87.03 36.79 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.118 2.545 . . . . 13.22 111.265 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.4 mt 79.8 -40.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.932 1.293 . . . . 15.68 110.43 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.425 -1.681 0 CA-C-O 118.545 -0.741 . . . . 16.96 109.755 176.882 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 CA--C 1.545 1.057 0 N-CA-C 113.237 0.437 . . . . 4.13 113.237 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -130.09 101.31 5.76 Favored 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 109.68 -0.489 . . . . 8.32 109.68 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 18' ' ' ILE . 2.3 mp -109.35 -52.32 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 111.928 0.344 . . . . 4.26 111.928 -178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.87 -140.94 11.76 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.707 -0.679 . . . . 1.55 113.698 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 61.3 m -82.64 138.82 34.04 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.216 0.206 . . . . 2.25 111.086 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HZ3' ' CD ' ' A' ' 89' ' ' GLU . 0.0 OUTLIER -98.84 116.61 31.45 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.468 -0.938 . . . . 4.73 108.468 -177.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.4 HD11 ' CD1' ' A' ' 85' ' ' LEU . 14.1 pt -140.71 153.37 21.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.956 -0.698 . . . . 2.94 109.543 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -100.08 116.85 33.05 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 107.235 -1.394 . . . . 1.71 107.235 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 84' ' ' ASP . 63.9 tp -123.12 129.08 50.97 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.094 -0.503 . . . . 2.02 110.284 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.2 mt -110.45 120.37 61.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.263 -0.575 . . . . 1.38 110.122 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.3 t -75.09 158.42 33.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.006 -0.997 . . . . 1.7 108.791 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -56.38 -8.08 0.47 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.148 1.536 . . . . 2.63 115.148 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.82 10.06 25.04 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.335 -0.617 . . . . 1.33 109.335 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.77 26.6 9.44 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 125.801 1.64 . . . . 2.59 109.987 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.97 129.36 52.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 1.73 110.854 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -86.22 120.99 28.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.445 -0.798 . . . . 5.24 110.917 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.78 133.27 55.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.934 -0.765 . . . . 3.17 108.934 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.72 129.13 24.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.083 -1.821 . . . . 2.45 106.083 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . 172.83 -165.52 37.91 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 110.786 -0.926 . . . . 0.55 110.786 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' SER 0.338 0.2 OUTLIER -94.67 118.83 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 117.849 -1.54 . . . . 1.58 114.777 -175.714 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.98 135.52 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.778 -1.556 . . . . 2.31 109.119 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.49 -45.11 4.33 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 123.899 0.749 . . . . 1.37 111.676 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -156.15 153.92 30.04 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 110.156 -0.313 . . . . 1.52 110.156 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.78 134.13 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 107.845 -1.168 . . . . 1.94 107.845 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.5 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 8.8 t70 -94.9 98.38 10.67 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.935 -1.505 . . . . 2.56 106.935 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 m -66.93 -15.74 63.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.619 0.6 . . . . 3.15 112.619 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.3 -46.03 36.01 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.517 0.675 . . . . 3.22 110.048 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -103.56 -5.98 22.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.646 0.778 . . . . 2.66 110.334 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 m 68.08 19.83 9.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.132 1.373 . . . . 2.54 111.311 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.5 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 75.0 p -79.3 146.53 32.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.095 0.474 . . . . 1.78 111.318 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -111.68 127.49 68.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.135 -0.484 . . . . 1.49 110.007 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.34 113.38 26.72 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-O 121.166 0.507 . . . . 1.15 110.377 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' HB3' ' A' ' 74' ' ' TYR . 96.8 mt -100.08 136.74 39.52 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.717 -0.674 . . . . 2.38 109.231 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.67 117.88 24.44 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.409 -0.589 . . . . 1.37 109.409 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp 65.17 38.39 6.06 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.317 1.047 . . . . 4.1 109.517 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.401 HG22 ' HA3' ' A' ' 34' ' ' GLY . 3.4 p -66.44 114.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 109.023 -0.732 . . . . 2.19 109.023 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -169.3 94.03 0.29 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.807 -0.812 . . . . 5.94 108.807 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -92.77 103.17 15.56 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 120.008 -0.677 . . . . 4.16 109.536 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 179.15 32.84 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 108.294 -1.002 . . . . 7.5 108.294 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.77 -74.91 0.88 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.076 -1.059 . . . . 5.9 113.015 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.593 ' HB ' ' H ' ' A' ' 61' ' ' THR 0.397 0.7 OUTLIER 53.07 116.46 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.606 0 N-CA-C 116.0 1.852 . . . . 7.06 116.0 -174.391 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.41 ' OE2' HD12 ' A' ' 65' ' ' ILE . 10.0 mm-40 -95.91 -95.76 0.19 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.015 -0.538 . . . . 8.38 111.11 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.62 -10.86 59.74 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.255 1.026 . . . . 11.7 109.063 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 61' ' ' THR . 66.1 mtp180 -94.35 166.27 15.76 Favored Pre-proline 0 C--O 1.198 -1.65 0 N-CA-C 105.709 -1.96 . . . . 12.76 105.709 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HB2' HG23 ' A' ' 56' ' ' THR 0.368 81.1 Cg_exo 0.6 -13.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.402 3.384 2 C-N-CA 129.541 6.827 . . . . 9.78 125.094 -175.513 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.593 ' H ' ' HB ' ' A' ' 56' ' ' THR . 2.1 m -83.52 -40.67 18.87 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 119.243 0.928 . . . . 7.57 110.36 170.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 72.84 -39.68 0.45 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.317 1.047 . . . . 10.54 113.619 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -154.48 -62.56 0.02 OUTLIER Pre-proline 0 CA--C 1.583 2.221 0 N-CA-C 113.948 1.092 . . . . 13.82 113.948 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.78 102.13 1.44 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.943 1.762 . . . . 8.43 113.652 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 HD12 ' OE2' ' A' ' 57' ' ' GLU . 11.8 mt -89.47 145.52 7.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-O 120.739 0.304 . . . . 6.34 111.228 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.65 156.42 64.26 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.69 0.796 . . . . 5.1 111.307 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.56 122.48 5.54 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.382 2.055 . . . . 6.74 113.083 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -72.89 10.94 0.76 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.37 0.507 . . . . 9.55 112.37 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -117.28 -3.39 11.47 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.262 0.553 . . . . 6.55 110.625 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.2 -54.32 39.42 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.859 -0.61 . . . . 7.39 111.121 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.6 m -84.78 103.15 13.61 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.212 -0.662 . . . . 4.61 109.212 176.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -114.9 -38.55 3.89 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 113.829 1.048 . . . . 8.34 113.829 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.83 -15.86 60.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.019 0.748 . . . . 6.86 113.019 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.515 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 7.3 m-85 69.38 -174.69 0.19 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.729 1.211 . . . . 5.92 110.023 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.48 139.18 11.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 109.831 -0.433 . . . . 4.25 109.831 175.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.27 134.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.215 -0.661 . . . . 2.84 109.215 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -108.87 147.21 32.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 110.061 -0.348 . . . . 2.91 110.061 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 -71.55 -5.53 33.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.638 0.977 . . . . 3.99 113.638 -174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.14 -58.19 4.6 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 120.874 -0.679 . . . . 0.88 112.766 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.1 p -67.44 -3.42 8.37 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.533 0.733 . . . . 2.02 111.665 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.3 m-20 -118.41 19.54 13.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.83 -1.077 . . . . 2.0 111.597 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.547 HG12 ' O ' ' A' ' 79' ' ' GLY . 37.0 pt -98.8 138.81 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.07 -0.652 . . . . 2.27 111.216 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -93.34 -56.3 2.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.386 0.612 . . . . 2.07 110.052 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 24' ' ' LEU . 1.1 m-20 -122.93 136.45 54.87 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.57 -0.741 . . . . 2.22 110.68 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.4 ' CD1' HD11 ' A' ' 22' ' ' ILE . 58.8 tp -143.52 103.72 4.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.397 -1.705 . . . . 3.34 106.397 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -141.32 134.45 29.3 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.381 -0.528 . . . . 2.3 110.931 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.89 132.56 31.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.513 -0.921 . . . . 3.25 108.513 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 9.4 p -87.77 -30.61 20.14 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.687 0.625 . . . . 3.45 112.687 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 10.1 pt-20 -127.22 101.86 24.74 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.986 0.422 . . . . 5.07 110.715 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.11 109.82 2.79 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 122.751 2.301 . . . . 6.81 112.519 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.18 115.64 0.92 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.672 2.248 . . . . 8.59 113.612 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -116.9 95.83 47.59 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.954 -0.566 . . . . 12.93 110.335 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.56 -52.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.755 2.303 . . . . 13.22 112.692 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.3 mm -124.61 -72.16 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-N 115.939 -0.573 . . . . 15.68 110.102 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.527 1.131 . . . . 16.96 110.469 -177.723 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.487 1.092 0 N-CA-C 113.3 0.462 . . . . 4.13 113.3 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -136.61 134.92 37.9 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.197 -0.668 . . . . 8.32 109.197 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.39 161.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.532 -0.758 . . . . 4.26 112.559 -174.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.37 176.73 39.5 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 108.51 -1.836 . . . . 1.55 108.51 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.9 t -93.06 129.37 39.03 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.339 -0.985 . . . . 2.25 108.339 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -87.23 114.99 24.32 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.599 -1.26 . . . . 4.73 107.599 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.86 176.4 4.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 C-N-CA 120.138 -0.625 . . . . 2.94 110.225 -175.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 15.1 m -139.14 113.24 8.71 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.774 -1.103 . . . . 1.71 108.268 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.56 148.14 47.99 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.641 0.258 . . . . 2.02 110.751 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.1 mt -119.11 128.28 75.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.027 0.441 . . . . 1.38 109.939 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -75.54 161.9 28.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 1.7 109.293 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -48.11 -35.06 10.74 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 123.24 0.616 . . . . 2.63 112.353 -176.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.9 15.7 2.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.119 0.967 . . . . 1.33 111.907 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 69.0 25.71 5.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.847 1.259 . . . . 2.59 109.46 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.7 mm -94.59 120.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.444 -0.798 . . . . 1.73 109.892 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.408 ' HD3' ' OE1' ' A' ' 33' ' ' GLU . 16.8 ttm180 -86.22 139.42 31.06 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.778 -0.646 . . . . 5.24 111.177 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -135.22 121.07 19.7 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 123.852 0.861 . . . . 3.17 109.916 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 41.4 mt-10 -125.66 143.4 51.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.688 -1.227 . . . . 2.45 107.688 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.23 12.06 Favored Glycine 0 CA--C 1.476 -2.351 0 N-CA-C 109.234 -1.547 . . . . 0.55 109.234 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.435 HD13 ' N ' ' A' ' 35' ' ' ILE 0.261 0.1 OUTLIER -113.31 121.96 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 N-CA-C 114.427 1.269 . . . . 1.58 114.427 177.967 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -68.56 137.02 53.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.523 -1.671 . . . . 2.31 108.448 173.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -105.39 -48.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.106 -0.497 . . . . 1.37 111.128 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.1 m -158.35 155.68 29.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.375 -0.602 . . . . 1.52 109.375 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -133.12 117.6 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 108.307 -0.998 . . . . 1.94 108.307 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.78 95.42 6.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 2.56 107.085 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.41 -19.21 64.48 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 123.084 0.553 . . . . 3.15 111.795 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -61.25 -36.94 81.35 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 122.085 -0.384 . . . . 3.22 110.96 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -125.61 -2.98 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.72 0.771 . . . . 2.66 110.188 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.4 m 72.07 19.07 4.71 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.752 1.221 . . . . 2.54 112.486 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.9 p -71.07 133.23 46.12 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.298 0.571 . . . . 1.78 111.135 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.3 t -102.3 123.0 55.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.556 -0.747 . . . . 1.49 109.93 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.65 115.36 30.2 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.119 0.485 . . . . 1.15 111.425 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.615 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 4.4 mm? -104.7 140.86 37.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.583 -0.735 . . . . 2.38 111.491 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.69 136.22 18.0 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.545 -0.539 . . . . 1.37 109.545 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.52 ' H ' HG22 ' A' ' 71' ' ' THR . 29.2 mtmm 70.47 23.62 4.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.444 1.097 . . . . 4.1 109.901 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.615 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 21.7 t -68.53 117.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.03 -0.986 . . . . 2.19 109.007 -173.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -166.04 178.22 6.53 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.96 -1.126 . . . . 5.94 107.96 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -66.75 156.68 34.78 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 110.079 -0.341 . . . . 4.16 110.079 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -77.51 144.06 37.97 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.698 0.761 . . . . 7.5 110.807 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.43 -125.17 2.77 Favored Glycine 0 C--N 1.273 -2.954 0 CA-C-N 114.521 -1.218 . . . . 5.9 111.686 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 59' ' ' ARG . 11.9 t -145.38 148.31 33.22 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 109.644 -0.502 . . . . 7.06 109.644 -178.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -107.61 -20.24 13.29 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.437 -0.801 . . . . 8.38 111.881 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.579 ' CG ' ' HG3' ' A' ' 59' ' ' ARG . 16.2 p-10 -129.16 -16.93 3.94 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 113.669 0.989 . . . . 11.7 113.669 -174.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.579 ' HG3' ' CG ' ' A' ' 58' ' ' ASP . 76.9 mtt180 -123.49 -163.57 0.05 OUTLIER Pre-proline 0 C--N 1.308 -1.202 0 N-CA-C 108.82 -0.807 . . . . 12.76 108.82 -173.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' CD ' ' HB3' ' A' ' 59' ' ' ARG . 98.1 Cg_endo -105.31 37.64 0.04 OUTLIER 'Trans proline' 0 CA--C 1.574 2.483 0 C-N-CA 121.713 1.608 . . . . 9.78 113.746 173.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.411 HG22 ' O ' ' A' ' 64' ' ' PRO . 15.3 t 45.59 -177.14 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.788 0 N-CA-C 114.685 1.365 . . . . 7.57 114.685 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.88 -57.98 4.79 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.111 -1.07 . . . . 10.54 108.111 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -150.52 -51.8 0.02 OUTLIER Pre-proline 0 CA--C 1.571 1.756 0 CA-C-N 114.711 -1.131 . . . . 13.82 111.918 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 61' ' ' THR . 56.6 Cg_endo -97.43 147.58 0.84 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.443 2.095 . . . . 8.43 115.9 -174.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.15 151.55 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.403 1.081 . . . . 6.34 111.71 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.16 100.28 12.9 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.411 -0.358 . . . . 5.1 110.613 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.77 46.62 2.28 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.306 2.671 . . . . 6.74 112.807 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . 0.299 16.9 ptm180 56.55 97.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.289 1.436 . . . . 9.55 113.374 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -89.51 -4.4 57.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.643 -1.162 . . . . 6.55 108.921 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 67.15 15.52 10.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.975 1.31 . . . . 7.39 110.543 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.52 HG22 ' H ' ' A' ' 50' ' ' LYS . 24.9 m 72.43 87.29 0.11 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.142 1.377 . . . . 4.61 111.561 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -120.0 -32.96 4.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.469 -0.787 . . . . 8.34 110.408 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.28 -4.94 50.41 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 113.454 0.909 . . . . 6.86 113.454 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' HB3' ' CG2' ' A' ' 71' ' ' THR . 20.8 p90 -51.85 148.11 6.14 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.13 0.972 . . . . 5.92 113.563 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.98 155.24 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.01 -0.541 . . . . 4.25 109.702 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.2 mm -118.45 135.52 58.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.764 -0.828 . . . . 2.84 108.764 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.62 149.35 28.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.043 0.449 . . . . 2.91 111.451 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -67.24 -11.94 58.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 3.99 112.057 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.484 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.62 -66.27 3.74 Favored Glycine 0 C--O 1.213 -1.213 0 C-N-CA 121.206 -0.521 . . . . 0.88 112.949 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 t -62.43 -15.46 49.43 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.146 0.974 . . . . 2.02 110.897 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.5 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -93.19 7.43 44.33 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 124.715 1.206 . . . . 2.0 113.107 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 79' ' ' GLY . 26.6 pt -75.37 147.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.101 -0.639 . . . . 2.27 111.461 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.38 -44.22 6.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.379 -0.373 . . . . 2.07 111.447 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -174.47 148.01 1.18 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.293 -1.003 . . . . 2.22 108.293 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 151.46 25.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 112.259 0.466 . . . . 3.34 112.259 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 t -131.9 138.73 48.51 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.589 -0.893 . . . . 2.3 108.589 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.62 155.02 6.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 116.536 -0.302 . . . . 3.25 111.089 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 84.2 m -126.41 97.34 5.01 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.762 0.792 . . . . 3.45 109.382 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 38.5 mt-10 -127.5 148.05 64.93 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 114.391 -1.277 . . . . 5.07 108.318 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.89 -41.37 69.85 Favored 'Trans proline' 0 CA--C 1.584 3.022 0 C-N-CA 122.566 2.177 . . . . 6.81 115.494 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 89' ' ' GLU . 88.6 Cg_exo -51.55 123.9 13.18 Favored 'Trans proline' 0 C--N 1.404 3.456 0 C-N-CA 122.213 1.942 . . . . 8.59 112.801 176.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm 66.53 75.59 0.32 Allowed Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.313 1.045 . . . . 12.93 109.995 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.24 -22.84 45.93 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.31 2.007 . . . . 13.22 113.237 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.5 pt -116.6 -10.76 12.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.472 0.545 . . . . 15.68 112.472 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 C--O 1.251 1.173 0 O-C-N 124.47 1.106 . . . . 16.96 111.525 -175.631 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HA ' ' HB2' ' A' ' 69' ' ' ASP . 1.6 Cg_endo . . . . . 0 CA--C 1.57 2.3 0 N-CA-C 112.824 0.279 . . . . 4.13 112.824 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 91.76 38.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 126.061 1.744 . . . . 8.32 113.901 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 69' ' ' ASP . 2.6 mp -101.11 -43.22 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 119.577 -0.849 . . . . 4.26 113.142 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.64 -142.16 3.39 Favored Glycine 0 C--N 1.3 -1.463 0 C-N-CA 119.313 -1.422 . . . . 1.55 113.962 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.1 m -93.04 120.51 33.42 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 109.892 -0.41 . . . . 2.25 109.892 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -87.01 107.76 18.56 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 116.57 -0.287 . . . . 4.73 111.041 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.76 163.55 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.614 -0.513 . . . . 2.94 109.614 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 m -122.85 112.09 17.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.223 -1.029 . . . . 1.71 108.223 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 84' ' ' ASP . 27.1 tp -122.13 125.48 46.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.231 0.539 . . . . 2.02 112.315 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 53.8 mt -92.14 117.24 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.769 -0.651 . . . . 1.38 110.204 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.3 t -76.28 162.55 27.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.958 -1.019 . . . . 1.7 108.957 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -10.66 0.59 Allowed 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 125.094 1.358 . . . . 2.63 113.854 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -0.12 47.59 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.939 0.495 . . . . 1.33 110.453 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 72.24 30.65 2.03 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 122.857 1.313 . . . . 2.59 107.637 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -115.56 129.54 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.611 -1.177 . . . . 1.73 110.667 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' HE ' ' CD ' ' A' ' 33' ' ' GLU . 34.9 ttp180 -93.63 103.2 15.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.825 -0.435 . . . . 5.24 109.825 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -89.06 125.49 35.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.681 -0.859 . . . . 3.17 108.681 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 29.9 mt-10 -126.19 127.13 45.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.002 -1.11 . . . . 2.45 108.002 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 176.43 -155.51 19.04 Favored Glycine 0 CA--C 1.476 -2.382 0 CA-C-O 118.105 -1.386 . . . . 0.55 109.859 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.437 0.2 OUTLIER -103.14 139.66 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 C-N-CA 115.064 -2.654 . . . . 1.58 117.303 -176.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.476 HD13 ' N ' ' A' ' 37' ' ' TYR . 3.2 tm? -86.61 140.61 29.68 Favored 'General case' 0 C--O 1.271 2.194 0 CA-C-N 113.929 -1.487 . . . . 2.31 107.816 176.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.476 ' N ' HD13 ' A' ' 36' ' ' LEU . 85.5 t80 -119.65 -55.09 2.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.94 1.4 . . . . 1.37 111.812 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.428 ' HG1' ' HB2' ' A' ' 47' ' ' ALA . 2.3 p -135.06 -179.2 5.47 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.348 0.499 . . . . 1.52 112.348 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.7 mm -134.34 131.85 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 120.874 0.369 . . . . 1.94 111.974 -173.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.493 ' HB2' ' HG1' ' A' ' 45' ' ' THR . 5.2 m-20 -94.52 80.67 3.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.438 1.095 . . . . 2.56 109.198 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -55.52 -31.82 62.41 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.103 0.779 . . . . 3.15 113.103 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -56.2 -30.77 62.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.931 0.893 . . . . 3.22 112.497 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.469 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 19.5 m120 -125.44 18.94 8.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.598 -0.519 . . . . 2.66 109.598 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.9 p 54.52 34.02 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.291 1.437 . . . . 2.54 110.782 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.58 HG23 ' N ' ' A' ' 79' ' ' GLY 0.496 0.8 OUTLIER -104.22 -174.88 2.64 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 120.423 3.49 . . . . 1.78 120.423 -171.417 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 77' ' ' PHE . 2.0 m -131.34 127.38 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 113.316 -1.765 . . . . 1.49 113.463 -163.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.428 ' HB2' ' HG1' ' A' ' 38' ' ' THR . . . -104.21 107.23 18.04 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.383 -0.826 . . . . 1.15 109.283 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 74' ' ' TYR . 6.0 mp -102.33 130.13 48.96 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.444 0.64 . . . . 2.38 110.743 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 50' ' ' LYS . . . -127.27 126.98 43.63 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 106.777 -1.564 . . . . 1.37 106.777 176.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 31.5 mtmm 83.26 15.88 0.31 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 124.137 0.898 . . . . 4.1 112.855 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.552 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.4 p -83.17 105.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.579 -1.648 . . . . 2.19 110.372 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.583 ' HB3' ' O ' ' A' ' 70' ' ' GLU . 1.5 tmt_? 178.8 149.67 0.24 Allowed 'General case' 0 C--O 1.198 -1.613 0 N-CA-C 104.653 -2.351 . . . . 5.94 104.653 169.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.555 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 6.8 t -169.95 -177.49 2.62 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 121.277 1.853 . . . . 4.16 110.079 160.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -166.34 -31.72 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 124.468 1.105 . . . . 7.5 110.539 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.572 ' HA3' ' CG2' ' A' ' 65' ' ' ILE . . . 90.68 142.0 9.7 Favored Glycine 0 N--CA 1.41 -3.084 0 C-N-CA 119.482 -1.342 . . . . 5.9 112.728 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.7 m 64.92 106.44 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.532 1.133 . . . . 7.06 111.883 -178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -112.83 -103.6 0.4 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 114.945 1.461 . . . . 8.38 114.945 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.09 -19.25 62.76 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.434 1.272 . . . . 11.7 114.434 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -135.14 130.42 19.31 Favored Pre-proline 0 N--CA 1.419 -1.985 0 N-CA-C 106.151 -1.796 . . . . 12.76 106.151 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.02 82.55 0.26 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.112 1.875 . . . . 9.78 111.732 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.5 t -69.59 -174.24 0.68 Allowed 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 120.49 -0.484 . . . . 7.57 109.788 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -147.82 -41.29 0.17 Allowed 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.028 0.442 . . . . 10.54 111.593 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.481 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 29.8 ttm180 -95.88 -54.84 0.22 Allowed Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 115.77 -0.65 . . . . 13.82 112.553 -172.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 6.1 Cg_endo -93.18 104.01 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.224 1.949 . . . . 8.43 111.969 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.572 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 18.9 mm -113.12 151.95 14.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.106 -0.701 . . . . 6.34 109.106 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.549 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -85.08 109.1 18.38 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 109.977 -0.379 . . . . 5.1 109.977 173.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 65' ' ' ILE . 73.9 Cg_endo -85.6 50.71 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.811 2.341 . . . . 6.74 107.543 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HA ' ' HB3' ' A' ' 53' ' ' SER 0.266 30.3 mmt180 106.7 -179.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 129.165 2.986 . . . . 9.55 110.697 -173.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.514 ' HB3' HD11 ' A' ' 18' ' ' ILE . 0.9 OUTLIER 82.18 105.65 0.06 Allowed 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 113.785 1.031 . . . . 6.55 113.785 -176.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 44.1 tt0 141.45 115.25 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.503 0 C-N-CA 125.928 1.691 . . . . 7.39 115.001 168.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.523 HG22 ' CA ' ' A' ' 50' ' ' LYS . 2.9 t -168.46 159.73 10.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 4.61 109.975 169.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -110.4 -25.84 9.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.067 0.461 . . . . 8.34 110.242 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.27 -53.45 7.31 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.0 -0.545 . . . . 6.86 110.102 -172.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 48' ' ' LEU 0.264 19.1 p90 57.27 161.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 126.622 1.969 . . . . 5.92 115.367 -178.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.59 153.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 109.994 -0.373 . . . . 4.25 109.994 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.4 mm -110.88 133.65 55.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.063 -1.088 . . . . 2.84 108.063 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.577 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.9 m-85 -100.46 142.1 32.4 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 118.726 -1.19 . . . . 2.91 108.232 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' C ' HG23 ' A' ' 45' ' ' THR . 5.8 mpt_? -110.02 149.17 30.36 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-O 121.481 0.657 . . . . 3.99 110.745 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.58 ' N ' HG23 ' A' ' 45' ' ' THR . . . -52.9 -23.17 14.35 Favored Glycine 0 C--N 1.276 -2.788 0 C-N-CA 126.842 2.163 . . . . 0.88 112.791 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 p -93.91 -13.01 27.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.674 -0.763 . . . . 2.02 110.85 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.04 -7.63 10.82 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.435 -0.802 . . . . 2.0 112.04 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.6 pt -83.06 142.84 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.344 0.868 . . . . 2.27 113.344 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -101.21 -65.83 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 2.07 111.124 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.7 m-20 -140.28 149.02 42.29 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 112.655 0.613 . . . . 2.22 112.655 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.5 tp -134.25 131.16 38.14 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.68 -0.691 . . . . 3.34 110.26 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 t -141.74 161.29 38.31 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.096 -1.076 . . . . 2.3 108.096 175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 p -111.67 140.72 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.518 -0.549 . . . . 3.25 109.518 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.87 -44.51 7.71 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 120.359 -0.536 . . . . 3.45 109.61 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -141.16 116.44 7.24 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.572 -0.529 . . . . 5.07 109.572 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.74 110.0 2.85 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.925 1.75 . . . . 6.81 108.574 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.6 135.38 19.79 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 121.788 1.659 . . . . 8.59 113.163 -175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 95' ' ' MET . 63.6 tttp 73.43 87.9 0.09 OUTLIER Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 114.677 -1.147 . . . . 12.93 111.886 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.14 -29.34 6.58 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 123.096 2.531 . . . . 13.22 112.39 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.3 pt -116.12 138.46 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 115.956 -0.565 . . . . 15.68 109.478 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.424 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 98.3 mmm . . . . . 0 C--N 1.298 -1.649 0 CA-C-O 118.865 -0.588 . . . . 16.96 109.802 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo . . . . . 0 N--CA 1.505 2.175 0 N-CA-C 115.822 1.432 . . . . 4.13 115.822 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' H ' HD11 ' A' ' 18' ' ' ILE . 34.3 p90 -140.31 12.13 2.36 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.157 -0.474 . . . . 8.32 109.796 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.414 HD11 ' H ' ' A' ' 17' ' ' TYR . 2.2 mp -75.93 103.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.353 0.597 . . . . 4.26 111.433 -172.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.36 -170.67 22.88 Favored Glycine 0 C--N 1.284 -2.322 0 CA-C-N 114.427 -1.26 . . . . 1.55 111.058 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.4 m -94.09 121.86 36.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.086 -0.709 . . . . 2.25 109.086 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' H ' ' HD2' ' A' ' 21' ' ' LYS . 5.2 mptt -89.92 94.31 9.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.989 -1.115 . . . . 4.73 107.989 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 86' ' ' THR . 1.8 pp -137.77 -179.18 2.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 120.438 -0.505 . . . . 2.94 110.318 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.8 p -132.18 131.33 42.1 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.303 -0.999 . . . . 1.71 108.303 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.7 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 6.5 tt -135.97 145.74 46.49 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 108.295 -1.002 . . . . 2.02 108.295 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.0 mt -116.4 128.77 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.71 -0.677 . . . . 1.38 109.851 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -76.9 170.52 16.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.154 -0.684 . . . . 1.7 109.154 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -58.77 -23.87 60.78 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.08 0.952 . . . . 2.63 112.221 -173.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.48 25.4 5.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.016 -0.538 . . . . 1.33 110.298 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 0.8 OUTLIER 66.59 28.72 9.21 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.618 -0.719 . . . . 2.59 112.397 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 52.1 mm -89.46 97.71 7.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.883 -0.599 . . . . 1.73 110.555 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.571 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.0 136.62 33.51 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.619 -0.719 . . . . 5.24 111.066 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.7 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 1.9 p90 -126.34 163.19 23.81 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.692 -0.803 . . . . 3.17 110.67 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.86 126.22 17.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.064 -1.458 . . . . 2.45 107.064 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 158.64 -150.64 21.42 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 120.97 -0.633 . . . . 0.55 111.547 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.25 0.1 OUTLIER -110.73 115.51 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 114.369 1.248 . . . . 1.58 114.369 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tt -77.42 147.14 36.15 Favored 'General case' 0 C--O 1.252 1.184 0 CA-C-N 114.205 -1.362 . . . . 2.31 109.65 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -108.5 -52.59 2.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.278 0.362 . . . . 1.37 110.089 -175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.7 m -143.11 151.49 40.79 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.43 -1.693 . . . . 1.52 106.43 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.42 HG12 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -159.47 103.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 C-N-CA 118.088 -1.445 . . . . 1.94 112.93 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 45' ' ' THR . 6.4 m-20 -127.38 131.3 50.36 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-N 115.555 -0.748 . . . . 2.56 112.19 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.2 t -69.04 -35.36 76.5 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 113.365 0.876 . . . . 3.15 113.365 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.46 -60.82 2.13 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.553 -1.659 . . . . 3.22 110.832 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -136.07 -24.61 1.26 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 116.739 2.126 . . . . 2.66 116.739 178.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.489 ' C ' ' HB2' ' A' ' 40' ' ' ASP . 19.2 m -96.19 44.88 1.07 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.234 1.016 . . . . 2.54 109.046 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 70.8 p -38.3 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 1 C-N-CA 134.141 4.976 . . . . 1.78 116.886 -178.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.451 ' HB ' ' HB2' ' A' ' 77' ' ' PHE . 9.6 t -91.81 101.82 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 CA-C-N 115.112 -0.949 . . . . 1.49 109.197 -163.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.51 111.93 22.97 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 113.933 -1.485 . . . . 1.15 107.451 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 58.7 tp -114.5 127.24 55.71 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.289 -0.869 . . . . 2.38 109.361 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.19 155.08 45.26 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 107.217 -1.401 . . . . 1.37 107.217 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.508 ' HA ' ' OG1' ' A' ' 71' ' ' THR . 51.8 pttt 50.28 27.87 2.89 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.133 0.973 . . . . 4.1 113.534 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 p -68.25 111.08 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.019 0.914 . . . . 2.19 109.855 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -171.82 -174.76 1.39 Allowed 'General case' 0 N--CA 1.406 -2.628 0 C-N-CA 125.396 1.478 . . . . 5.94 108.351 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 14.6 m -70.41 -174.77 0.9 Allowed 'General case' 0 CA--C 1.571 1.759 0 O-C-N 124.091 0.87 . . . . 4.16 110.545 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -78.72 -98.48 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 114.47 1.285 . . . . 7.5 114.47 -172.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -142.29 -76.35 0.04 OUTLIER Glycine 0 C--O 1.213 -1.198 0 C-N-CA 120.761 -0.733 . . . . 5.9 114.407 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.557 HG21 ' C ' ' A' ' 59' ' ' ARG . 87.7 m 68.12 -68.29 0.17 Allowed 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.509 0.723 . . . . 7.06 112.617 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.274 8.2 mm-40 82.68 -43.59 0.13 Allowed 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 127.019 2.128 . . . . 8.38 112.494 -177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -151.7 -28.28 0.18 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.475 0.546 . . . . 11.7 112.475 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.557 ' C ' HG21 ' A' ' 56' ' ' THR . 81.1 mtp180 -138.5 137.4 20.28 Favored Pre-proline 0 CA--C 1.504 -0.817 0 C-N-CA 120.182 -0.607 . . . . 12.76 109.452 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.67 66.55 1.72 Allowed 'Trans proline' 0 N--CA 1.484 0.919 0 C-N-CA 123.143 2.562 . . . . 9.78 111.724 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.629 ' O ' HG12 ' A' ' 65' ' ' ILE . 15.0 t -113.06 -154.12 0.54 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.116 -0.947 . . . . 7.57 110.275 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.503 ' N ' HG21 ' A' ' 61' ' ' THR . 15.8 t70 30.74 71.01 0.08 Allowed 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 128.825 2.85 . . . . 10.54 111.254 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 65' ' ' ILE . 15.9 mmm180 66.07 80.01 0.23 Allowed Pre-proline 0 C--O 1.212 -0.886 0 CA-C-N 112.916 -1.947 . . . . 13.82 107.775 -175.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -14.93 88.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.6 1 C-N-CA 125.896 4.397 . . . . 8.43 117.168 -167.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.629 HG12 ' O ' ' A' ' 61' ' ' THR . 6.0 pt -101.05 153.8 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 112.766 -2.016 . . . . 6.34 112.788 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.69 149.41 37.44 Favored Pre-proline 0 C--O 1.175 -2.859 0 N-CA-C 106.787 -1.56 . . . . 5.1 106.787 -177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 72.4 Cg_endo -81.59 132.37 7.79 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 CA-C-N 121.539 1.585 . . . . 6.74 114.557 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -75.68 161.09 29.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.792 -0.64 . . . . 9.55 110.768 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -125.65 -3.09 7.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.506 0.67 . . . . 6.55 109.45 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 69.95 165.06 0.27 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.153 1.381 . . . . 7.39 112.526 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.508 ' OG1' ' HA ' ' A' ' 50' ' ' LYS . 21.1 p -138.02 165.45 26.55 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 109.326 -0.62 . . . . 4.61 109.326 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -120.73 -71.85 0.72 Allowed 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 120.216 -0.594 . . . . 8.34 112.56 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.11 -24.03 47.67 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 113.119 0.785 . . . . 6.86 113.119 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 66.13 174.42 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.943 1.297 . . . . 5.92 110.496 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 pt -141.24 146.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 121.62 -0.675 . . . . 4.25 112.607 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.51 151.48 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.139 -1.059 . . . . 2.84 108.139 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.588 ' O ' ' HB ' ' A' ' 45' ' ' THR . 97.6 m-85 -124.12 139.52 53.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.992 -0.373 . . . . 2.91 109.992 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.49 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 21.1 mmm180 -43.93 -26.32 0.26 Allowed 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 116.124 1.898 . . . . 3.99 116.124 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.5 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 74.21 -64.19 2.06 Favored Glycine 0 C--O 1.209 -1.454 0 C-N-CA 120.972 -0.633 . . . . 0.88 112.557 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.0 t -73.38 -7.65 52.55 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.82 0.848 . . . . 2.02 110.311 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 16.4 m-20 -121.16 30.1 6.99 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.973 -0.558 . . . . 2.0 110.316 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 79' ' ' GLY . 2.1 pp -77.44 163.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.845 -0.535 . . . . 2.27 112.42 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.594 ' HE3' ' OE2' ' A' ' 29' ' ' GLU . 15.6 tppt? -105.85 -62.05 1.42 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.937 0.399 . . . . 2.07 110.07 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.79 150.4 29.33 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.551 -0.75 . . . . 2.22 110.305 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 85' ' ' LEU . 0.0 OUTLIER -155.55 132.58 10.73 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 124.55 1.14 . . . . 3.34 110.957 176.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.448 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 9.4 t -125.03 139.96 53.33 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.495 -0.928 . . . . 2.3 108.495 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 54.7 t -113.86 102.71 14.27 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-N 116.201 -0.454 . . . . 3.25 110.355 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 23.9 p -169.63 121.55 0.71 Allowed 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.988 -0.551 . . . . 3.45 111.481 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 9.1 pt-20 -95.0 117.82 66.76 Favored Pre-proline 0 N--CA 1.427 -1.618 0 N-CA-C 107.774 -1.195 . . . . 5.07 107.774 172.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.21 109.3 1.52 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.562 2.175 . . . . 6.81 112.896 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 89' ' ' GLU . 36.7 Cg_endo -88.65 93.75 0.38 Allowed 'Trans proline' 0 N--CA 1.434 -2.022 0 C-N-CA 122.271 1.981 . . . . 8.59 111.579 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 58.49 87.64 0.14 Allowed Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.112 0.965 . . . . 12.93 113.285 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -69.21 -51.83 0.41 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.069 1.846 . . . . 13.22 111.919 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.2 pt -143.05 19.76 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.883 -0.599 . . . . 15.68 109.842 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 C--N 1.314 -0.946 0 N-CA-C 110.009 -0.367 . . . . 16.96 110.009 -176.462 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.76 0 CA-C-O 120.114 -0.27 . . . . 1.0700000000000001 112.8 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 46.4 t -88.28 123.65 33.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.514 -0.55 . . . . 1.8100000000000001 109.514 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 8.4 mptt -82.32 121.35 26.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.105 -0.702 . . . . 4.3499999999999996 109.105 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -140.58 167.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.876 -0.787 . . . . 2.4100000000000001 108.876 -178.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 20.5 t -123.81 124.52 42.86 Favored 'General case' 0 N--CA 1.404 -2.738 0 N-CA-C 107.628 -1.249 . . . . 1.3300000000000001 107.628 174.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 82' ' ' ILE . 5.3 tt -116.45 130.71 56.91 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.154 -0.93 . . . . 1.45 109.581 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 84' ' ' ASP . 2.9 mp -105.52 119.91 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-N 116.332 -0.395 . . . . 0.71999999999999997 110.154 175.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.9 p -78.2 169.6 18.0 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.28 -0.418 . . . . 1.3400000000000001 110.599 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -49.12 -26.02 2.49 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.809 1.04 . . . . 2.1200000000000001 113.809 -175.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.17 10.9 17.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 0.69999999999999996 110.836 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 63.96 39.97 7.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.261 1.024 . . . . 2.5899999999999999 111.087 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.9 mm -106.11 127.09 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.047 -1.433 . . . . 1.1699999999999999 109.88 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -89.84 142.68 27.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.262 0.467 . . . . 4.71 112.262 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' SER . 57.4 m-85 -138.33 143.79 40.08 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.681 -1.229 . . . . 3.0099999999999998 107.681 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.46 134.51 55.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.886 0.374 . . . . 2.4500000000000002 110.044 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -166.01 -169.38 29.55 Favored Glycine 0 CA--C 1.467 -2.962 0 N-CA-C 111.064 -0.814 . . . . 0.45000000000000001 111.064 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.776 HD11 ' HG3' ' A' ' 50' ' ' LYS 0.345 1.4 pp -113.01 108.74 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.528 0 CA-C-O 123.051 1.405 . . . . 0.93000000000000005 113.293 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' A' ' 22' ' ' ILE . 3.4 tm? -55.25 135.61 49.59 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.627 -1.624 . . . . 1.72 111.041 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -113.04 -48.14 3.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.516 -0.766 . . . . 1.1100000000000001 111.553 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 m -154.09 153.11 31.31 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.848 -0.532 . . . . 0.93999999999999995 109.701 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.42 126.44 48.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.777 -0.823 . . . . 1.45 108.777 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.487 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 18.7 m-20 -89.54 95.77 10.41 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.82 -1.178 . . . . 2.5600000000000001 107.82 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -56.06 -29.0 59.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.351 0.871 . . . . 2.7599999999999998 113.351 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.19 -39.93 90.03 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.029 0.442 . . . . 3.2200000000000002 111.511 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -109.79 0.5 18.83 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.798 -0.564 . . . . 2.2599999999999998 110.345 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m 65.18 16.44 10.55 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.047 -0.979 . . . . 2.2799999999999998 110.645 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 40' ' ' ASP . 30.4 p -75.77 135.65 40.29 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.201 0.524 . . . . 1.21 111.132 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.7 t -104.45 125.7 59.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.846 -0.615 . . . . 0.88 110.005 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.33 106.41 17.58 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.198 0.523 . . . . 0.51000000000000001 109.76 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.2 150.23 22.74 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.507 -0.77 . . . . 1.75 111.888 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 35' ' ' ILE . . . -147.75 134.39 19.89 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 105.132 -2.173 . . . . 0.76000000000000001 105.132 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.776 ' HG3' HD11 ' A' ' 35' ' ' ILE 0.407 4.4 tptt 49.66 58.61 5.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 124.808 2.242 . . . . 3.6299999999999999 113.148 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.551 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 44.6 t -77.38 113.94 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 112.886 -1.961 . . . . 1.52 106.204 173.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 . . . . . 0 C--N 1.313 -0.983 0 N-CA-C 107.265 -1.383 . . . . 5.3200000000000003 107.265 177.313 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.1 p90 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 113.791 1.034 . . . . 5.54 113.791 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 tt -162.98 147.2 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.862 -0.608 . . . . 3.7999999999999998 110.361 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.7 mp -107.49 129.72 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.115 -1.068 . . . . 2.4199999999999999 108.115 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -103.67 148.07 26.48 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.523 -0.308 . . . . 2.3100000000000001 111.735 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -59.73 -13.71 11.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.229 1.012 . . . . 3.4500000000000002 113.529 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.11 -58.72 4.94 Favored Glycine 0 CA--C 1.496 -1.109 0 C-N-CA 120.946 -0.645 . . . . 0.76000000000000001 111.875 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.3 t -65.99 -11.52 48.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.243 0.544 . . . . 1.6399999999999999 110.685 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 3.8 m-20 -98.05 20.78 11.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.431 0.692 . . . . 2.0 111.506 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.59 HD12 HD21 ' A' ' 24' ' ' LEU . 40.3 mm -101.07 132.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.149 -1.02 . . . . 1.7 110.334 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -87.38 -28.51 22.13 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.804 -0.635 . . . . 1.5900000000000001 111.463 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 25' ' ' ILE . 20.1 t70 -166.35 135.13 2.98 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.274 0.472 . . . . 2.2200000000000002 112.274 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.8 mt -122.28 100.37 6.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.587 -0.733 . . . . 2.8599999999999999 110.325 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -109.96 116.71 32.09 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.124 0.488 . . . . 1.8799999999999999 110.483 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.672 -0.694 . . . . 2.7000000000000002 111.334 -178.209 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.853 0 CA-C-O 121.37 0.428 . . . . 1.0700000000000001 113.636 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -89.76 145.73 24.98 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.482 0.713 . . . . 1.8100000000000001 109.492 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 10.3 mptt -92.05 114.05 26.49 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.448 -0.945 . . . . 4.3499999999999996 108.448 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 86' ' ' THR . 10.8 tt -151.93 150.61 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.17 -0.468 . . . . 2.4100000000000001 111.536 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.5 m -104.01 127.84 51.57 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.509 -1.293 . . . . 1.3300000000000001 107.509 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD13 HD13 ' A' ' 85' ' ' LEU . 40.0 tp -123.5 128.71 50.18 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.491 -0.322 . . . . 1.45 110.587 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 62.9 mt -104.29 124.63 58.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.685 -0.857 . . . . 0.71999999999999997 108.685 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p -80.0 160.18 25.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.444 -0.947 . . . . 1.3400000000000001 108.444 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -54.8 -12.04 0.72 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.627 0.973 . . . . 2.1200000000000001 113.627 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 27' ' ' LYS . . . -85.05 5.53 29.14 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.386 0.675 . . . . 0.69999999999999996 110.013 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 3.1 tp10 70.46 30.65 3.17 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.153 1.781 . . . . 2.5899999999999999 108.958 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -108.34 128.11 64.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.381 -0.827 . . . . 1.1699999999999999 111.544 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.15 124.62 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.386 -0.825 . . . . 4.71 111.04 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.46 127.65 51.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.528 -0.545 . . . . 3.0099999999999998 109.528 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -118.69 126.35 51.71 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.113 0.482 . . . . 2.4500000000000002 109.734 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -177.28 -151.67 9.32 Favored Glycine 0 CA--C 1.468 -2.874 0 N-CA-C 110.63 -0.988 . . . . 0.45000000000000001 110.63 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 50' ' ' LYS 0.317 1.1 pp -116.72 116.64 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 CA-C-O 122.192 0.996 . . . . 0.93000000000000005 112.605 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.435 HD21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -62.39 133.1 54.58 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.93 -1.486 . . . . 1.72 108.373 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -94.76 -55.98 2.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.573 -0.451 . . . . 1.1100000000000001 112.14 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.5 m -153.86 154.06 33.24 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.013 -0.429 . . . . 0.93999999999999995 110.33 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.7 133.79 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 109.254 -0.647 . . . . 1.45 109.254 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 7.8 t70 -92.93 110.61 22.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.893 -0.781 . . . . 2.5600000000000001 108.893 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 m -73.46 -8.77 57.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.819 -0.628 . . . . 2.7599999999999998 112.129 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.63 -56.35 4.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.838 -0.745 . . . . 3.2200000000000002 111.168 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -96.47 0.34 50.18 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.7 -0.682 . . . . 2.2599999999999998 109.432 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m 65.68 21.1 11.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.456 -1.247 . . . . 2.2799999999999998 111.259 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 77.3 p -73.07 154.53 40.38 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.184 0.516 . . . . 1.21 111.675 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' CG1' HD21 ' A' ' 36' ' ' LEU . 59.8 t -124.94 125.1 69.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.724 -0.671 . . . . 0.88 110.056 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.59 109.37 21.45 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.51000000000000001 109.018 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.556 ' HG ' ' CG2' ' A' ' 51' ' ' VAL . 45.7 tp -113.01 129.07 56.62 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.947 -0.57 . . . . 1.75 109.579 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.55 156.55 30.38 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.76000000000000001 108.395 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 48.8 mttp 60.08 29.78 19.32 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.102 0.876 . . . . 3.6299999999999999 109.885 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 46.6 t -67.0 114.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.731 -1.122 . . . . 1.52 109.086 -176.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 . . . . . 0 N--CA 1.437 -1.093 0 N-CA-C 108.36 -0.978 . . . . 5.3200000000000003 108.36 -179.126 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.4 p90 . . . . . 0 C--O 1.24 0.562 0 N-CA-C 112.461 0.541 . . . . 5.54 112.461 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 tt -157.92 140.71 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 110.518 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -102.7 135.45 39.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.342 -0.984 . . . . 2.4199999999999999 108.342 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.4 150.84 27.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.535 -0.543 . . . . 2.3100000000000001 109.535 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.644 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -81.64 10.51 5.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.017 0.437 . . . . 3.4500000000000002 111.418 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 84.41 -61.16 4.75 Favored Glycine 0 CA--C 1.47 -2.767 0 N-CA-C 111.53 -0.628 . . . . 0.76000000000000001 111.53 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -62.4 -12.06 19.38 Favored 'General case' 0 CA--C 1.582 2.188 0 CA-C-O 121.092 0.472 . . . . 1.6399999999999999 111.254 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 9.3 m-20 -82.53 -0.56 47.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.352 0.661 . . . . 2.0 112.268 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 79' ' ' GLY . 1.9 pp -79.6 140.65 16.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 119.18 -1.008 . . . . 1.7 112.652 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -95.64 -56.1 2.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.983 -0.747 . . . . 1.5900000000000001 108.983 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.429 ' O ' HD12 ' A' ' 24' ' ' LEU . 19.9 t70 -136.0 139.15 42.92 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.195 -0.912 . . . . 2.2200000000000002 108.666 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.462 HD13 HD13 ' A' ' 24' ' ' LEU . 38.3 tp -135.96 99.59 4.19 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.323 -1.362 . . . . 2.8599999999999999 107.323 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' HG13 ' A' ' 22' ' ' ILE . 51.1 m -132.35 110.54 10.64 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.077 0.465 . . . . 1.8799999999999999 111.285 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.244 0.805 0 CA-C-N 115.706 -0.679 . . . . 2.7000000000000002 109.956 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 110.934 -0.866 . . . . 1.0700000000000001 110.934 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -92.76 130.98 38.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.564 0.579 . . . . 1.8100000000000001 112.564 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 64.4 mmtt -74.01 112.6 10.29 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.019 0.528 . . . . 4.3499999999999996 110.684 175.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -141.13 164.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.855 -0.794 . . . . 2.4100000000000001 108.855 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 35.7 t -122.41 115.72 22.76 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.916 -1.142 . . . . 1.3300000000000001 107.916 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 77' ' ' PHE . 3.4 tt -123.04 128.69 50.49 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.298 -1.371 . . . . 1.45 107.298 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.7 mt -99.06 122.88 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.712 -0.395 . . . . 0.71999999999999997 109.981 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -76.1 162.26 28.16 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.561 -0.745 . . . . 1.3400000000000001 110.413 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -52.18 -23.45 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.526 1.13 . . . . 2.1200000000000001 113.733 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.81 22.66 3.47 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 122.841 0.456 . . . . 0.69999999999999996 110.266 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.263 10.8 pt-20 50.35 50.7 18.24 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.879 1.272 . . . . 2.5899999999999999 112.677 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -119.08 118.65 58.35 Favored 'Isoleucine or valine' 0 C--O 1.254 1.32 0 CA-C-N 114.455 -1.248 . . . . 1.1699999999999999 110.247 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.64 109.17 15.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.534 -0.757 . . . . 4.71 110.768 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -105.57 134.19 49.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.145 -0.479 . . . . 3.0099999999999998 110.443 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -134.9 129.87 35.01 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.992 -0.744 . . . . 2.4500000000000002 108.992 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -174.83 -151.68 8.64 Favored Glycine 0 CA--C 1.481 -2.078 0 N-CA-C 110.43 -1.068 . . . . 0.45000000000000001 110.43 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -110.95 107.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-O 121.413 0.625 . . . . 0.93000000000000005 112.35 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.599 ' HA ' HD23 ' A' ' 48' ' ' LEU . 6.9 tt -58.41 137.88 56.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.434 -1.257 . . . . 1.72 111.301 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -99.44 -60.56 1.51 Allowed 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.294 -0.867 . . . . 1.1100000000000001 112.023 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -151.75 154.03 35.49 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.94 -0.475 . . . . 0.93999999999999995 110.052 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.81 129.54 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.807 -1.183 . . . . 1.45 107.807 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.81 105.31 17.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.986 -1.116 . . . . 2.5600000000000001 107.986 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -73.02 -6.08 43.13 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.925 0.713 . . . . 2.7599999999999998 112.925 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.76 -56.24 3.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 3.2200000000000002 110.007 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -89.65 -9.67 48.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.758 -0.656 . . . . 2.2599999999999998 110.226 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m 70.28 21.86 5.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.264 1.025 . . . . 2.2799999999999998 109.697 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -83.69 144.15 29.57 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.726 -0.67 . . . . 1.21 111.405 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.41 128.03 62.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.928 -0.578 . . . . 0.88 110.56 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.97 110.5 22.54 Favored 'General case' 0 C--O 1.258 1.547 0 N-CA-C 109.455 -0.572 . . . . 0.51000000000000001 109.455 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 36' ' ' LEU . 11.8 mt -108.24 146.68 32.49 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.23 -0.895 . . . . 1.75 112.141 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.69 146.29 24.16 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.47 -1.307 . . . . 0.76000000000000001 107.47 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt 62.43 29.55 17.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 124.013 0.821 . . . . 3.6299999999999999 111.157 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.584 HG22 HD22 ' A' ' 48' ' ' LEU . 49.9 t -69.42 111.64 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.538 -0.865 . . . . 1.52 109.816 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 . . . . . 0 N--CA 1.429 -1.505 0 C-N-CA 124.985 1.314 . . . . 5.3200000000000003 108.673 176.304 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 26.4 m-85 . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.907 -0.405 . . . . 5.54 109.907 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.62 137.16 51.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-O 121.463 0.649 . . . . 3.7999999999999998 111.749 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mm -119.5 129.1 75.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.313 -0.858 . . . . 2.4199999999999999 109.176 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 24' ' ' LEU . 20.7 m-85 -98.95 137.32 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.091 -0.504 . . . . 2.3100000000000001 111.192 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 39.3 mmt180 -64.99 -13.65 58.25 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 123.322 0.649 . . . . 3.4500000000000002 112.084 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 82.01 -61.9 4.61 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.585 -0.816 . . . . 0.76000000000000001 111.988 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.0 p -63.41 -27.43 69.29 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.244 0.545 . . . . 1.6399999999999999 111.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 2.0 m-20 -98.38 21.4 11.11 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.182 -0.917 . . . . 2.0 112.701 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 79' ' ' GLY . 40.4 pt -87.01 142.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.431 -0.908 . . . . 1.7 110.406 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 73.3 mmtt -88.94 -60.34 1.98 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.078 -0.51 . . . . 1.5900000000000001 111.098 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -145.04 152.46 40.15 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 116.402 -0.363 . . . . 2.2200000000000002 110.185 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.18 102.05 5.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 123.921 0.763 . . . . 2.8599999999999999 109.291 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 23' ' ' SER . 68.5 m -97.98 120.12 37.81 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.879 -0.601 . . . . 1.8799999999999999 109.949 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.546 0.813 0 CA-C-N 115.956 -0.566 . . . . 2.7000000000000002 110.534 -179.062 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.721 0 N-CA-C 110.137 -1.185 . . . . 1.0700000000000001 110.137 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.8 m -88.81 139.62 30.27 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 117.077 0.438 . . . . 1.8100000000000001 109.823 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -87.69 106.71 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.69 -0.804 . . . . 4.3499999999999996 112.025 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.85 146.27 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.135 0.574 . . . . 2.4100000000000001 110.518 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 t -107.68 111.78 24.16 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.635 -1.617 . . . . 1.3300000000000001 106.635 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 84' ' ' ASP . 61.6 tp -121.6 129.67 52.99 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.554 0.216 . . . . 1.45 111.062 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.58 118.64 53.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.645 -0.502 . . . . 0.71999999999999997 109.645 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.9 p -78.45 162.83 26.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.488 -0.778 . . . . 1.3400000000000001 110.313 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -10.01 0.3 Allowed 'General case' 0 C--O 1.211 -0.926 0 N-CA-C 115.896 1.813 . . . . 2.1200000000000001 115.896 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.12 13.69 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.542 -0.54 . . . . 0.69999999999999996 109.542 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.41 28.28 15.45 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 125.259 1.424 . . . . 2.5899999999999999 110.058 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.47 129.01 66.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.712 -0.676 . . . . 1.1699999999999999 111.611 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptm85 -87.11 118.98 26.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.909 -0.587 . . . . 4.71 111.932 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.29 125.79 54.68 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.251 -1.018 . . . . 3.0099999999999998 108.251 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -134.99 131.61 37.35 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.334 -1.358 . . . . 2.4500000000000002 107.334 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 179.91 -158.53 22.23 Favored Glycine 0 CA--C 1.49 -1.49 0 N-CA-C 111.306 -0.718 . . . . 0.45000000000000001 111.306 -175.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.54 HD13 ' H ' ' A' ' 35' ' ' ILE 0.31 0.2 OUTLIER -92.4 109.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.581 0 CA-C-O 122.314 1.054 . . . . 0.93000000000000005 113.606 -177.062 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.5 tp -67.06 133.42 49.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.568 -1.651 . . . . 1.72 109.847 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -111.95 -59.21 2.02 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 120.46 -0.496 . . . . 1.1100000000000001 110.566 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.7 m -141.19 160.59 39.78 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.977 -0.379 . . . . 0.93999999999999995 109.977 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.56 123.78 53.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.638 -1.616 . . . . 1.45 106.638 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.488 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 14.7 m-20 -86.84 94.24 9.51 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.647 -1.612 . . . . 2.5600000000000001 106.647 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -57.73 -26.34 61.65 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.454 -0.794 . . . . 2.7599999999999998 112.943 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.31 -50.27 62.56 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.567 0.747 . . . . 3.2200000000000002 111.475 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -112.94 6.01 17.59 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 120.951 0.405 . . . . 2.2599999999999998 109.973 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.7 m 64.93 22.03 12.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.25 1.02 . . . . 2.2799999999999998 110.817 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.493 HG22 ' C ' ' A' ' 78' ' ' ARG . 33.1 p -73.99 148.42 42.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.86 -0.609 . . . . 1.21 110.933 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.86 126.92 65.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 116.442 -0.345 . . . . 0.88 110.572 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.33 101.54 11.24 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.452 0.644 . . . . 0.51000000000000001 110.232 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.643 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 91.3 mt -100.76 153.98 19.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.427 -0.806 . . . . 1.75 109.679 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.53 136.46 22.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.425 -0.583 . . . . 0.76000000000000001 109.425 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 mttt 56.21 36.6 27.72 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.555 0.742 . . . . 3.6299999999999999 111.77 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.643 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 86.7 t -67.3 117.19 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.694 -1.139 . . . . 1.52 111.761 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 106.964 -1.495 . . . . 5.3200000000000003 106.964 -179.19 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 22.8 p90 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 119.559 -0.258 . . . . 5.54 111.132 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 tp -145.23 132.23 15.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 120.942 0.401 . . . . 3.7999999999999998 110.238 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.3 mm -112.35 126.07 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.073 -0.714 . . . . 2.4199999999999999 109.073 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.447 ' HE2' HD12 ' A' ' 48' ' ' LEU . 90.2 m-85 -101.36 160.94 14.0 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.091 -0.337 . . . . 2.3100000000000001 110.091 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' C ' HG22 ' A' ' 45' ' ' THR . 10.0 mpt_? -85.2 -3.85 58.96 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.413 -0.358 . . . . 3.4500000000000002 111.87 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.588 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 81.35 -61.43 4.61 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.762 -0.732 . . . . 0.76000000000000001 111.813 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.3 p -75.14 1.82 12.33 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.617 0.246 . . . . 1.6399999999999999 111.628 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -110.52 8.89 23.16 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.018 0.437 . . . . 2.0 110.803 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 79' ' ' GLY . 32.0 pt -92.24 148.9 4.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 O-C-N 121.48 -0.762 . . . . 1.7 110.446 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.31 -46.91 4.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.751 -0.38 . . . . 1.5900000000000001 111.835 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.599 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.9 m-20 -129.68 146.37 51.46 Favored 'General case' 0 C--O 1.211 -0.968 0 O-C-N 122.34 -0.225 . . . . 2.2200000000000002 110.85 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 tt -150.99 111.18 4.14 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.114 -1.439 . . . . 2.8599999999999999 107.114 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -105.41 109.13 20.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.026 -0.731 . . . . 1.8799999999999999 109.026 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.444 -0.765 0 CA-C-O 121.412 0.625 . . . . 2.7000000000000002 110.545 178.27 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' ' HB ' ' A' ' 35' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 109.449 -1.46 . . . . 1.0700000000000001 109.449 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.2 m -103.38 142.38 34.33 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.125 1.462 . . . . 1.8100000000000001 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -89.23 106.71 18.62 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 122.464 0.306 . . . . 4.3499999999999996 110.508 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.47 -173.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-O 121.507 0.67 . . . . 2.4100000000000001 110.087 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 36.6 m -139.48 124.82 19.07 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.311 -1.366 . . . . 1.3300000000000001 107.311 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.49 HD21 HG22 ' A' ' 82' ' ' ILE . 6.1 tt -133.31 135.85 45.09 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.335 -0.617 . . . . 1.45 109.335 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 66.4 mt -106.96 122.51 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 109.281 -0.637 . . . . 0.71999999999999997 109.281 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.5 t -84.76 162.3 19.67 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.811 0.694 . . . . 1.3400000000000001 109.232 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -57.9 -3.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.822 1.416 . . . . 2.1200000000000001 114.822 -178.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 8.05 38.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.466 0.65 . . . . 0.69999999999999996 109.256 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 6.2 mm-40 68.03 28.8 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.255 1.422 . . . . 2.5899999999999999 109.768 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 48.0 mm -107.44 128.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.277 0.473 . . . . 1.1699999999999999 112.277 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -89.1 117.44 28.1 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.25 1.02 . . . . 4.71 110.202 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 23' ' ' SER . 98.3 m-85 -107.85 148.59 29.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.386 0.274 . . . . 3.0099999999999998 111.148 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -138.99 126.7 22.0 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.798 -1.556 . . . . 2.4500000000000002 106.798 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.44 -155.33 25.88 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.304 -0.718 . . . . 0.45000000000000001 111.304 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.75 128.91 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 113.978 1.103 . . . . 0.93000000000000005 113.978 -177.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.674 HD13 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.66 156.48 30.72 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.821 -1.081 . . . . 1.72 112.625 173.12 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -110.73 -39.21 4.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.835 -0.621 . . . . 1.1100000000000001 110.806 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -151.81 153.9 35.14 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.658 -0.497 . . . . 0.93999999999999995 109.658 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.87 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.941 -0.763 . . . . 1.45 108.941 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -103.06 95.73 6.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.449 0.642 . . . . 2.5600000000000001 109.49 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.1 m -52.88 -41.38 64.27 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.859 1.264 . . . . 2.7599999999999998 114.133 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -55.45 -42.86 74.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.013 0.746 . . . . 3.2200000000000002 113.013 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.81 -0.01 25.66 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.142 0.496 . . . . 2.2599999999999998 109.82 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m 64.21 18.9 11.54 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.548 1.139 . . . . 2.2799999999999998 111.033 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.8 p -79.43 125.08 29.09 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.105 0.479 . . . . 1.21 111.025 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -101.21 124.06 54.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.784 -0.644 . . . . 0.88 109.469 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.9 103.5 16.03 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 108.036 -1.098 . . . . 0.51000000000000001 108.036 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.618 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -100.05 147.13 25.96 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 106.114 -1.81 . . . . 1.75 106.114 -176.046 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' H ' HD13 ' A' ' 48' ' ' LEU . . . -148.94 129.82 14.28 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.479 -1.304 . . . . 0.76000000000000001 107.479 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttp 48.95 54.62 10.55 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.068 0.947 . . . . 3.6299999999999999 112.697 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.618 ' HB ' ' CD1' ' A' ' 48' ' ' LEU . 6.6 p -66.97 114.12 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.424 -0.807 . . . . 1.52 109.613 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 106.761 -1.57 . . . . 5.3200000000000003 106.761 -179.349 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.749 0.309 . . . . 5.54 111.736 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.405 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -137.73 131.14 42.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-O 121.106 0.479 . . . . 3.7999999999999998 110.383 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.52 128.98 65.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.194 -0.669 . . . . 2.4199999999999999 109.194 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.41 130.38 43.55 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 109.441 -0.578 . . . . 2.3100000000000001 109.441 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -68.47 -10.47 55.65 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.295 0.85 . . . . 3.4500000000000002 113.295 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.7 -48.98 3.33 Favored Glycine 0 C--O 1.212 -1.239 0 C-N-CA 120.831 -0.699 . . . . 0.76000000000000001 112.305 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 m -76.31 -16.49 59.76 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.054 0.931 . . . . 1.6399999999999999 109.188 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.23 24.7 6.89 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.659 -1.155 . . . . 2.0 112.124 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 79' ' ' GLY . 21.0 pt -112.73 150.97 14.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.552 -0.859 . . . . 1.7 110.493 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.612 ' HE3' ' OE1' ' A' ' 29' ' ' GLU . 71.6 mmtt -92.89 -54.5 3.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.788 -0.642 . . . . 1.5900000000000001 110.526 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -161.65 159.01 26.94 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.21 -1.033 . . . . 2.2200000000000002 108.21 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 82' ' ' ILE . 1.5 pt? -156.13 147.91 22.97 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.803 0.335 . . . . 2.8599999999999999 110.419 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.7 t -124.21 130.8 53.15 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.153 -0.684 . . . . 1.8799999999999999 109.153 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 116.134 -0.484 . . . . 2.7000000000000002 111.376 -177.657 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.535 0 N-CA-C 109.953 -1.259 . . . . 1.0700000000000001 109.953 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 t -96.45 124.85 40.58 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.448 -0.945 . . . . 1.8100000000000001 108.448 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -68.03 121.37 15.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.533 0.938 . . . . 4.3499999999999996 113.533 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 36' ' ' LEU . 10.9 tt -153.19 152.04 10.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-N 115.412 -0.813 . . . . 2.4100000000000001 110.492 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.788 ' O ' ' HB3' ' A' ' 85' ' ' LEU . 20.0 m -115.3 144.53 43.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.989 -1.856 . . . . 1.3300000000000001 105.989 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.977 ' HA ' ' HB2' ' A' ' 85' ' ' LEU . 31.1 tp -147.97 129.88 15.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.529 1.307 . . . . 1.45 114.529 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 85' ' ' LEU . 66.6 mt -95.12 119.64 43.46 Favored 'Isoleucine or valine' 0 C--N 1.387 2.23 0 C-N-CA 119.82 -0.752 . . . . 0.71999999999999997 109.77 174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -89.49 166.13 13.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.946 -0.57 . . . . 1.3400000000000001 109.48 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -47.52 -19.61 0.19 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 115.04 1.496 . . . . 2.1200000000000001 115.04 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 27' ' ' LYS . . . -74.39 -2.92 27.47 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.708 0.29 . . . . 0.69999999999999996 110.43 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 74.41 22.74 2.1 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.633 1.173 . . . . 2.5899999999999999 107.882 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 53.9 mt -109.99 129.48 64.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.152 -1.385 . . . . 1.1699999999999999 110.971 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.422 ' HB3' HG12 ' A' ' 25' ' ' ILE . 38.9 ptt180 -92.06 119.84 32.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.74 -0.663 . . . . 4.71 110.308 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.35 159.15 16.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.976 -0.75 . . . . 3.0099999999999998 108.976 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -142.43 128.01 19.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.226 -1.398 . . . . 2.4500000000000002 107.226 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 175.0 -128.87 1.47 Allowed Glycine 1 CA--C 1.442 -4.469 0 N-CA-C 109.998 -1.241 . . . . 0.45000000000000001 109.998 -176.073 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.441 HD11 ' CB ' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -135.5 161.31 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.48 0 C-N-CA 118.934 -1.106 . . . . 0.93000000000000005 113.287 -174.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HB2' HG21 ' A' ' 22' ' ' ILE . 3.3 tm? -99.44 140.34 33.76 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.507 -1.224 . . . . 1.72 109.389 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' N ' HD13 ' A' ' 36' ' ' LEU . 76.9 t80 -105.88 -54.69 2.44 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 123.239 0.337 . . . . 1.1100000000000001 111.121 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.5 m -153.93 154.63 34.17 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 109.744 -0.465 . . . . 0.93999999999999995 109.744 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.414 HG13 HD11 ' A' ' 36' ' ' LEU . 82.2 mt -130.29 142.56 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.797 0.332 . . . . 1.45 111.416 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.468 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 2.7 t70 -111.35 116.1 30.41 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.636 0.775 . . . . 2.5600000000000001 110.428 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -76.79 -18.18 58.58 Favored 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 113.035 0.754 . . . . 2.7599999999999998 113.035 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -69.7 -54.98 11.28 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.85 -0.531 . . . . 3.2200000000000002 111.443 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -103.9 5.72 35.89 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.953 0.406 . . . . 2.2599999999999998 110.058 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.1 t 65.02 24.38 12.59 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.996 -1.002 . . . . 2.2799999999999998 109.817 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 70.3 p -77.51 141.45 39.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.884 0.849 . . . . 1.21 111.525 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.5 t -115.55 126.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.168 -0.924 . . . . 0.88 110.143 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.89 99.52 10.83 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.511 -0.922 . . . . 0.51000000000000001 108.511 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 tt -101.3 126.12 48.01 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.759 -1.941 . . . . 1.75 105.759 -176.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' A' ' 74' ' ' TYR . . . -155.1 156.56 36.04 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 107.703 -1.221 . . . . 0.76000000000000001 107.703 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.441 ' CB ' HD11 ' A' ' 35' ' ' ILE . 49.6 mttm 68.26 21.27 8.53 Favored 'General case' 0 C--O 1.2 -1.507 0 CA-C-O 121.993 0.901 . . . . 3.6299999999999999 109.171 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.673 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.7 p -67.1 166.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.424 -1.324 . . . . 1.52 107.424 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 C--N 1.302 -1.485 0 C-N-CA 118.341 -1.344 . . . . 5.3200000000000003 114.239 -172.613 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 21.3 t80 . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 115.56 1.689 . . . . 5.54 115.56 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.3 pt -150.82 147.14 15.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.568 0.699 . . . . 3.7999999999999998 110.94 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.75 129.15 52.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.6 -0.889 . . . . 2.4199999999999999 108.6 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 -98.11 152.24 19.53 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.893 -0.323 . . . . 2.3100000000000001 110.154 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.435 ' C ' HG22 ' A' ' 45' ' ' THR . 22.1 mmm180 -78.05 6.3 8.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.046 -0.525 . . . . 3.4500000000000002 111.193 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.28 -57.6 4.05 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 111.532 -0.627 . . . . 0.76000000000000001 111.532 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.8 t -74.51 5.22 4.94 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.409 1.099 . . . . 1.6399999999999999 108.792 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' GLY . 16.4 t70 -89.88 -11.9 40.56 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-N 114.619 -1.173 . . . . 2.0 109.872 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 79' ' ' GLY . 33.2 pt -100.25 153.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.284 -0.966 . . . . 1.7 113.397 -174.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.0 -68.18 0.75 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.471 -1.24 . . . . 1.5900000000000001 110.274 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.622 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 24.1 t70 -173.32 115.27 0.25 Allowed 'General case' 0 CA--C 1.479 -1.773 0 CA-C-O 118.543 -0.741 . . . . 2.2200000000000002 110.111 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.977 ' HB2' ' HA ' ' A' ' 24' ' ' LEU 0.842 17.7 mt -162.24 156.78 22.08 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 119.458 3.133 . . . . 2.8599999999999999 119.458 170.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -141.55 159.07 42.99 Favored 'General case' 0 CA--C 1.563 1.481 0 N-CA-C 110.476 -0.194 . . . . 1.8799999999999999 110.476 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.408 ' HA ' HG13 ' A' ' 22' ' ' ILE . 33.7 m . . . . . 0 C--N 1.36 1.045 0 C-N-CA 123.745 0.818 . . . . 2.7000000000000002 111.6 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.856 0 N-CA-C 113.698 0.239 . . . . 1.0700000000000001 113.698 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 61.3 m -82.64 138.82 34.04 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.216 0.206 . . . . 1.8100000000000001 111.086 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 116.61 31.45 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.468 -0.938 . . . . 4.3499999999999996 108.468 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' CD1' ' A' ' 85' ' ' LEU . 14.1 pt -140.71 153.37 21.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.956 -0.698 . . . . 2.4100000000000001 109.543 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -100.08 116.85 33.05 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 107.235 -1.394 . . . . 1.3300000000000001 107.235 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 84' ' ' ASP . 63.9 tp -123.12 129.08 50.97 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.094 -0.503 . . . . 1.45 110.284 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.2 mt -110.45 120.37 61.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.263 -0.575 . . . . 0.71999999999999997 110.122 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.3 t -75.09 158.42 33.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.006 -0.997 . . . . 1.3400000000000001 108.791 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -56.38 -8.08 0.47 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.148 1.536 . . . . 2.1200000000000001 115.148 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.82 10.06 25.04 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.335 -0.617 . . . . 0.69999999999999996 109.335 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.77 26.6 9.44 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 125.801 1.64 . . . . 2.5899999999999999 109.987 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.97 129.36 52.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 1.1699999999999999 110.854 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -86.22 120.99 28.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.445 -0.798 . . . . 4.71 110.917 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.78 133.27 55.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.934 -0.765 . . . . 3.0099999999999998 108.934 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.72 129.13 24.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.083 -1.821 . . . . 2.4500000000000002 106.083 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.478 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . 172.83 -165.52 37.91 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 110.786 -0.926 . . . . 0.45000000000000001 110.786 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 35' ' ' ILE 0.338 0.2 OUTLIER -94.67 118.83 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 117.849 -1.54 . . . . 0.93000000000000005 114.777 -175.714 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.98 135.52 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.778 -1.556 . . . . 1.72 109.119 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.49 -45.11 4.33 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 123.899 0.749 . . . . 1.1100000000000001 111.676 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -156.15 153.92 30.04 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 110.156 -0.313 . . . . 0.93999999999999995 110.156 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.78 134.13 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 107.845 -1.168 . . . . 1.45 107.845 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.508 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 8.8 t70 -94.9 98.38 10.67 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.935 -1.505 . . . . 2.5600000000000001 106.935 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 m -66.93 -15.74 63.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.619 0.6 . . . . 2.7599999999999998 112.619 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.3 -46.03 36.01 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.517 0.675 . . . . 3.2200000000000002 110.048 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -103.56 -5.98 22.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.646 0.778 . . . . 2.2599999999999998 110.334 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 m 68.08 19.83 9.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.132 1.373 . . . . 2.2799999999999998 111.311 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 75.0 p -79.3 146.53 32.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.095 0.474 . . . . 1.21 111.318 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -111.68 127.49 68.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.135 -0.484 . . . . 0.88 110.007 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.34 113.38 26.72 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-O 121.166 0.507 . . . . 0.51000000000000001 110.377 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 74' ' ' TYR . 96.8 mt -100.08 136.74 39.52 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.717 -0.674 . . . . 1.75 109.231 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.67 117.88 24.44 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.409 -0.589 . . . . 0.76000000000000001 109.409 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 35' ' ' ILE . 23.4 mtpp 65.17 38.39 6.06 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.317 1.047 . . . . 3.6299999999999999 109.517 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 ' HA3' ' A' ' 34' ' ' GLY . 3.4 p -66.44 114.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 109.023 -0.732 . . . . 1.52 109.023 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 . . . . . 0 C--N 1.314 -0.976 0 N-CA-C 108.807 -0.812 . . . . 5.3200000000000003 108.807 -179.124 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.522 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 7.3 m-85 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 110.023 -0.362 . . . . 5.54 110.023 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.48 139.18 11.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 109.831 -0.433 . . . . 3.7999999999999998 109.831 175.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.27 134.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.215 -0.661 . . . . 2.4199999999999999 109.215 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -108.87 147.21 32.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 110.061 -0.348 . . . . 2.3100000000000001 110.061 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' C ' HG22 ' A' ' 45' ' ' THR . 16.5 mmt180 -71.55 -5.53 33.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.638 0.977 . . . . 3.4500000000000002 113.638 -174.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.552 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.14 -58.19 4.6 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 120.874 -0.679 . . . . 0.76000000000000001 112.766 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.1 p -67.44 -3.42 8.37 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.533 0.733 . . . . 1.6399999999999999 111.665 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.3 m-20 -118.41 19.54 13.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.83 -1.077 . . . . 2.0 111.597 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 79' ' ' GLY . 37.0 pt -98.8 138.81 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.07 -0.652 . . . . 1.7 111.216 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -93.34 -56.3 2.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.386 0.612 . . . . 1.5900000000000001 110.052 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.1 m-20 -122.93 136.45 54.87 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.57 -0.741 . . . . 2.2200000000000002 110.68 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 24' ' ' LEU . 58.8 tp -143.52 103.72 4.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.397 -1.705 . . . . 2.8599999999999999 106.397 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -141.32 134.45 29.3 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.381 -0.528 . . . . 1.8799999999999999 110.931 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 108.513 -0.921 . . . . 2.7000000000000002 108.513 178.58 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.63 0 N-CA-C 108.51 -1.836 . . . . 1.0700000000000001 108.51 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 33.9 t -93.06 129.37 39.03 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.339 -0.985 . . . . 1.8100000000000001 108.339 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -87.23 114.99 24.32 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.599 -1.26 . . . . 4.3499999999999996 107.599 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -140.86 176.4 4.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 C-N-CA 120.138 -0.625 . . . . 2.4100000000000001 110.225 -175.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.465 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 15.1 m -139.14 113.24 8.71 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.774 -1.103 . . . . 1.3300000000000001 108.268 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.56 148.14 47.99 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.641 0.258 . . . . 1.45 110.751 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.1 mt -119.11 128.28 75.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.027 0.441 . . . . 0.71999999999999997 109.939 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -75.54 161.9 28.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 1.3400000000000001 109.293 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -48.11 -35.06 10.74 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 123.24 0.616 . . . . 2.1200000000000001 112.353 -176.298 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.9 15.7 2.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.119 0.967 . . . . 0.69999999999999996 111.907 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 69.0 25.71 5.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.847 1.259 . . . . 2.5899999999999999 109.46 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.7 mm -94.59 120.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.444 -0.798 . . . . 1.1699999999999999 109.892 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HD3' ' OE1' ' A' ' 33' ' ' GLU . 16.8 ttm180 -86.22 139.42 31.06 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.778 -0.646 . . . . 4.71 111.177 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -135.22 121.07 19.7 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 123.852 0.861 . . . . 3.0099999999999998 109.916 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 41.4 mt-10 -125.66 143.4 51.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.688 -1.227 . . . . 2.4500000000000002 107.688 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.23 12.06 Favored Glycine 0 CA--C 1.476 -2.351 0 N-CA-C 109.234 -1.547 . . . . 0.45000000000000001 109.234 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.446 HG13 ' HE2' ' A' ' 50' ' ' LYS 0.261 0.1 OUTLIER -113.31 121.96 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 N-CA-C 114.427 1.269 . . . . 0.93000000000000005 114.427 177.967 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 20' ' ' SER . 2.9 tm? -68.56 137.02 53.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.523 -1.671 . . . . 1.72 108.448 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -105.39 -48.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.106 -0.497 . . . . 1.1100000000000001 111.128 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.1 m -158.35 155.68 29.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.375 -0.602 . . . . 0.93999999999999995 109.375 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -133.12 117.6 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 108.307 -0.998 . . . . 1.45 108.307 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.78 95.42 6.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 2.5600000000000001 107.085 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.41 -19.21 64.48 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 123.084 0.553 . . . . 2.7599999999999998 111.795 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -61.25 -36.94 81.35 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 122.085 -0.384 . . . . 3.2200000000000002 110.96 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -125.61 -2.98 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.72 0.771 . . . . 2.2599999999999998 110.188 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.4 m 72.07 19.07 4.71 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.752 1.221 . . . . 2.2799999999999998 112.486 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.9 p -71.07 133.23 46.12 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.298 0.571 . . . . 1.21 111.135 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.3 t -102.3 123.0 55.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.556 -0.747 . . . . 0.88 109.93 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.65 115.36 30.2 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.119 0.485 . . . . 0.51000000000000001 111.425 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 4.4 mm? -104.7 140.86 37.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.583 -0.735 . . . . 1.75 111.491 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.69 136.22 18.0 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.545 -0.539 . . . . 0.76000000000000001 109.545 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HE2' HG13 ' A' ' 35' ' ' ILE . 29.2 mtmm 70.47 23.62 4.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.444 1.097 . . . . 3.6299999999999999 109.901 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 21.7 t -68.53 117.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.03 -0.986 . . . . 1.52 109.007 -173.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 107.96 -1.126 . . . . 5.3200000000000003 107.96 -179.032 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 20.8 p90 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 113.563 0.949 . . . . 5.54 113.563 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.98 155.24 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.01 -0.541 . . . . 3.7999999999999998 109.702 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.2 mm -118.45 135.52 58.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.764 -0.828 . . . . 2.4199999999999999 108.764 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.62 149.35 28.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.043 0.449 . . . . 2.3100000000000001 111.451 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -67.24 -11.94 58.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 3.4500000000000002 112.057 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.62 -66.27 3.74 Favored Glycine 0 C--O 1.213 -1.213 0 C-N-CA 121.206 -0.521 . . . . 0.76000000000000001 112.949 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 t -62.43 -15.46 49.43 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.146 0.974 . . . . 1.6399999999999999 110.897 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -93.19 7.43 44.33 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 124.715 1.206 . . . . 2.0 113.107 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 79' ' ' GLY . 26.6 pt -75.37 147.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.101 -0.639 . . . . 1.7 111.461 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.38 -44.22 6.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.379 -0.373 . . . . 1.5900000000000001 111.447 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -174.47 148.01 1.18 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.293 -1.003 . . . . 2.2200000000000002 108.293 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 151.46 25.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 112.259 0.466 . . . . 2.8599999999999999 112.259 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 t -131.9 138.73 48.51 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.589 -0.893 . . . . 1.8799999999999999 108.589 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.305 -1.363 0 CA-C-N 116.536 -0.302 . . . . 2.7000000000000002 111.089 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 113.962 0.345 . . . . 1.0700000000000001 113.962 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.1 m -93.04 120.51 33.42 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 109.892 -0.41 . . . . 1.8100000000000001 109.892 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -87.01 107.76 18.56 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 116.57 -0.287 . . . . 4.3499999999999996 111.041 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -127.76 163.55 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.614 -0.513 . . . . 2.4100000000000001 109.614 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 86' ' ' THR . 28.9 m -122.85 112.09 17.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.223 -1.029 . . . . 1.3300000000000001 108.223 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 84' ' ' ASP . 27.1 tp -122.13 125.48 46.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.231 0.539 . . . . 1.45 112.315 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 53.8 mt -92.14 117.24 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.769 -0.651 . . . . 0.71999999999999997 110.204 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.3 t -76.28 162.55 27.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.958 -1.019 . . . . 1.3400000000000001 108.957 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -10.66 0.59 Allowed 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 125.094 1.358 . . . . 2.1200000000000001 113.854 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -0.12 47.59 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.939 0.495 . . . . 0.69999999999999996 110.453 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 72.24 30.65 2.03 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 122.857 1.313 . . . . 2.5899999999999999 107.637 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -115.56 129.54 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.611 -1.177 . . . . 1.1699999999999999 110.667 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.466 ' HE ' ' CD ' ' A' ' 33' ' ' GLU . 34.9 ttp180 -93.63 103.2 15.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.825 -0.435 . . . . 4.71 109.825 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -89.06 125.49 35.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.681 -0.859 . . . . 3.0099999999999998 108.681 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.466 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 29.9 mt-10 -126.19 127.13 45.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.002 -1.11 . . . . 2.4500000000000002 108.002 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 176.43 -155.51 19.04 Favored Glycine 0 CA--C 1.476 -2.382 0 CA-C-O 118.105 -1.386 . . . . 0.45000000000000001 109.859 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.442 HD11 ' HB3' ' A' ' 50' ' ' LYS 0.437 0.2 OUTLIER -103.14 139.66 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 C-N-CA 115.064 -2.654 . . . . 0.93000000000000005 117.303 -176.544 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB2' HD12 ' A' ' 22' ' ' ILE . 3.2 tm? -86.61 140.61 29.68 Favored 'General case' 0 C--O 1.271 2.194 0 CA-C-N 113.929 -1.487 . . . . 1.72 107.816 176.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.468 ' N ' HD13 ' A' ' 36' ' ' LEU . 85.5 t80 -119.65 -55.09 2.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.94 1.4 . . . . 1.1100000000000001 111.812 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -135.06 -179.2 5.47 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.348 0.499 . . . . 0.93999999999999995 112.348 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.7 mm -134.34 131.85 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 120.874 0.369 . . . . 1.45 111.974 -173.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.52 80.67 3.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.438 1.095 . . . . 2.5600000000000001 109.198 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -55.52 -31.82 62.41 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.103 0.779 . . . . 2.7599999999999998 113.103 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -56.2 -30.77 62.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.931 0.893 . . . . 3.2200000000000002 112.497 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.496 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 19.5 m120 -125.44 18.94 8.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.598 -0.519 . . . . 2.2599999999999998 109.598 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.9 p 54.52 34.02 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.291 1.437 . . . . 2.2799999999999998 110.782 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.645 HG21 ' N ' ' A' ' 79' ' ' GLY 0.496 0.8 OUTLIER -104.22 -174.88 2.64 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 120.423 3.49 . . . . 1.21 120.423 -171.417 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 77' ' ' PHE . 2.0 m -131.34 127.38 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 113.316 -1.765 . . . . 0.88 113.463 -163.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.4 ' CB ' HD12 ' A' ' 76' ' ' ILE . . . -104.21 107.23 18.04 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.383 -0.826 . . . . 0.51000000000000001 109.283 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.577 ' O ' ' HB2' ' A' ' 74' ' ' TYR . 6.0 mp -102.33 130.13 48.96 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.444 0.64 . . . . 1.75 110.743 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 74' ' ' TYR . . . -127.27 126.98 43.63 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 106.777 -1.564 . . . . 0.76000000000000001 106.777 176.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 31.5 mtmm 83.26 15.88 0.31 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 124.137 0.898 . . . . 3.6299999999999999 112.855 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.59 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.4 p -83.17 105.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.579 -1.648 . . . . 1.52 110.372 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 1.5 tmt_? . . . . . 0 C--O 1.198 -1.613 0 N-CA-C 104.653 -2.351 . . . . 5.3200000000000003 104.653 169.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 48' ' ' LEU 0.264 19.1 p90 . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 115.367 1.618 . . . . 5.54 115.367 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.59 153.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 109.994 -0.373 . . . . 3.7999999999999998 109.994 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' CB ' ' A' ' 47' ' ' ALA . 28.4 mm -110.88 133.65 55.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.063 -1.088 . . . . 2.4199999999999999 108.063 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.535 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.9 m-85 -100.46 142.1 32.4 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 118.726 -1.19 . . . . 2.3100000000000001 108.232 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.596 ' C ' HG21 ' A' ' 45' ' ' THR . 5.8 mpt_? -110.02 149.17 30.36 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-O 121.481 0.657 . . . . 3.4500000000000002 110.745 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.645 ' N ' HG21 ' A' ' 45' ' ' THR . . . -52.9 -23.17 14.35 Favored Glycine 0 C--N 1.276 -2.788 0 C-N-CA 126.842 2.163 . . . . 0.76000000000000001 112.791 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 p -93.91 -13.01 27.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.674 -0.763 . . . . 1.6399999999999999 110.85 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.04 -7.63 10.82 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.435 -0.802 . . . . 2.0 112.04 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.6 pt -83.06 142.84 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.344 0.868 . . . . 1.7 113.344 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -101.21 -65.83 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 1.5900000000000001 111.124 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.441 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.7 m-20 -140.28 149.02 42.29 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 112.655 0.613 . . . . 2.2200000000000002 112.655 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.5 tp -134.25 131.16 38.14 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.68 -0.691 . . . . 2.8599999999999999 110.26 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 23' ' ' SER . 9.0 t -141.74 161.29 38.31 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.096 -1.076 . . . . 1.8799999999999999 108.096 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.308 -1.206 0 N-CA-C 109.518 -0.549 . . . . 2.7000000000000002 109.518 -177.824 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.295 0 N-CA-C 111.058 -0.817 . . . . 1.0700000000000001 111.058 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.4 m -94.09 121.86 36.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.086 -0.709 . . . . 1.8100000000000001 109.086 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 5.2 mptt -89.92 94.31 9.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.989 -1.115 . . . . 4.3499999999999996 107.989 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 87' ' ' VAL . 1.8 pp -137.77 -179.18 2.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 120.438 -0.505 . . . . 2.4100000000000001 110.318 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.8 p -132.18 131.33 42.1 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.303 -0.999 . . . . 1.3300000000000001 108.303 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.712 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 6.5 tt -135.97 145.74 46.49 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 108.295 -1.002 . . . . 1.45 108.295 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.0 mt -116.4 128.77 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.71 -0.677 . . . . 0.71999999999999997 109.851 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -76.9 170.52 16.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.154 -0.684 . . . . 1.3400000000000001 109.154 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -58.77 -23.87 60.78 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.08 0.952 . . . . 2.1200000000000001 112.221 -173.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.48 25.4 5.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.016 -0.538 . . . . 0.69999999999999996 110.298 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.606 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 0.8 OUTLIER 66.59 28.72 9.21 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.618 -0.719 . . . . 2.5899999999999999 112.397 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 52.1 mm -89.46 97.71 7.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.883 -0.599 . . . . 1.1699999999999999 110.555 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.728 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.0 136.62 33.51 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.619 -0.719 . . . . 4.71 111.066 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.712 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 1.9 p90 -126.34 163.19 23.81 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.692 -0.803 . . . . 3.0099999999999998 110.67 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.86 126.22 17.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.064 -1.458 . . . . 2.4500000000000002 107.064 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . 158.64 -150.64 21.42 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 120.97 -0.633 . . . . 0.45000000000000001 111.547 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.25 0.1 OUTLIER -110.73 115.51 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 114.369 1.248 . . . . 0.93000000000000005 114.369 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 5.3 tt -77.42 147.14 36.15 Favored 'General case' 0 C--O 1.252 1.184 0 CA-C-N 114.205 -1.362 . . . . 1.72 109.65 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -108.5 -52.59 2.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.278 0.362 . . . . 1.1100000000000001 110.089 -175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.7 m -143.11 151.49 40.79 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.43 -1.693 . . . . 0.93999999999999995 106.43 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -159.47 103.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 C-N-CA 118.088 -1.445 . . . . 1.45 112.93 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 6.4 m-20 -127.38 131.3 50.36 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-N 115.555 -0.748 . . . . 2.5600000000000001 112.19 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.2 t -69.04 -35.36 76.5 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 113.365 0.876 . . . . 2.7599999999999998 113.365 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.46 -60.82 2.13 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.553 -1.659 . . . . 3.2200000000000002 110.832 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.331 21.9 p-10 -136.07 -24.61 1.26 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 116.739 2.126 . . . . 2.2599999999999998 116.739 178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.2 m -96.19 44.88 1.07 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.234 1.016 . . . . 2.2799999999999998 109.046 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 70.8 p -38.3 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 1 C-N-CA 134.141 4.976 . . . . 1.21 116.886 -178.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 39' ' ' ILE . 9.6 t -91.81 101.82 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 CA-C-N 115.112 -0.949 . . . . 0.88 109.197 -163.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.51 111.93 22.97 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 113.933 -1.485 . . . . 0.51000000000000001 107.451 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.439 HD21 HG21 ' A' ' 51' ' ' VAL . 58.7 tp -114.5 127.24 55.71 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.289 -0.869 . . . . 1.75 109.361 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.19 155.08 45.26 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 107.217 -1.401 . . . . 0.76000000000000001 107.217 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.8 pttt 50.28 27.87 2.89 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.133 0.973 . . . . 3.6299999999999999 113.534 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 34' ' ' GLY . 4.5 p -68.25 111.08 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.019 0.914 . . . . 1.52 109.855 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 N--CA 1.406 -2.628 0 C-N-CA 125.396 1.478 . . . . 5.3200000000000003 108.351 177.284 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 110.496 -0.187 . . . . 5.54 110.496 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 pt -141.24 146.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 121.62 -0.675 . . . . 3.7999999999999998 112.607 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.51 151.48 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.139 -1.059 . . . . 2.4199999999999999 108.139 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.59 ' O ' ' HB ' ' A' ' 45' ' ' THR . 97.6 m-85 -124.12 139.52 53.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.992 -0.373 . . . . 2.3100000000000001 109.992 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 21.1 mmm180 -43.93 -26.32 0.26 Allowed 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 116.124 1.898 . . . . 3.4500000000000002 116.124 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.512 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 74.21 -64.19 2.06 Favored Glycine 0 C--O 1.209 -1.454 0 C-N-CA 120.972 -0.633 . . . . 0.76000000000000001 112.557 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.0 t -73.38 -7.65 52.55 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.82 0.848 . . . . 1.6399999999999999 110.311 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 16.4 m-20 -121.16 30.1 6.99 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.973 -0.558 . . . . 2.0 110.316 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 79' ' ' GLY . 2.1 pp -77.44 163.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.845 -0.535 . . . . 1.7 112.42 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.606 ' HE3' ' OE2' ' A' ' 29' ' ' GLU . 15.6 tppt? -105.85 -62.05 1.42 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.937 0.399 . . . . 1.5900000000000001 110.07 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.79 150.4 29.33 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.551 -0.75 . . . . 2.2200000000000002 110.305 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.55 132.58 10.73 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 124.55 1.14 . . . . 2.8599999999999999 110.957 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 9.4 t -125.03 139.96 53.33 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.495 -0.928 . . . . 1.8799999999999999 108.495 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 22' ' ' ILE . 54.7 t . . . . . 0 C--O 1.251 1.147 0 CA-C-N 116.201 -0.454 . . . . 2.7000000000000002 110.355 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 CA--C 1.549 1.249 0 N-CA-C 114.388 0.88 . . . . 3.73 114.388 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 59.58 -148.81 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.686 1.195 . . . . 8.0399999999999991 113.587 170.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.269 49.4 mm 94.54 -75.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.906 0 C-N-CA 126.192 1.797 . . . . 3.8100000000000001 113.514 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.99 -159.59 7.97 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.365 -0.921 . . . . 1.0700000000000001 112.8 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 46.4 t -88.28 123.65 33.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.514 -0.55 . . . . 1.8100000000000001 109.514 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 8.4 mptt -82.32 121.35 26.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.105 -0.702 . . . . 4.3499999999999996 109.105 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -140.58 167.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.876 -0.787 . . . . 2.4100000000000001 108.876 -178.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 20.5 t -123.81 124.52 42.86 Favored 'General case' 0 N--CA 1.404 -2.738 0 N-CA-C 107.628 -1.249 . . . . 1.3300000000000001 107.628 174.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 82' ' ' ILE . 5.3 tt -116.45 130.71 56.91 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.154 -0.93 . . . . 1.45 109.581 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 84' ' ' ASP . 2.9 mp -105.52 119.91 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-N 116.332 -0.395 . . . . 0.71999999999999997 110.154 175.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.9 p -78.2 169.6 18.0 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.28 -0.418 . . . . 1.3400000000000001 110.599 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -49.12 -26.02 2.49 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.809 1.04 . . . . 2.1200000000000001 113.809 -175.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.17 10.9 17.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 0.69999999999999996 110.836 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 63.96 39.97 7.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.261 1.024 . . . . 2.5899999999999999 111.087 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.9 mm -106.11 127.09 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.047 -1.433 . . . . 1.1699999999999999 109.88 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -89.84 142.68 27.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.262 0.467 . . . . 4.71 112.262 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' SER . 57.4 m-85 -138.33 143.79 40.08 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.681 -1.229 . . . . 3.0099999999999998 107.681 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.46 134.51 55.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.886 0.374 . . . . 2.4500000000000002 110.044 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -166.01 -169.38 29.55 Favored Glycine 0 CA--C 1.467 -2.962 0 N-CA-C 111.064 -0.814 . . . . 0.45000000000000001 111.064 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.776 HD11 ' HG3' ' A' ' 50' ' ' LYS 0.345 1.4 pp -113.01 108.74 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.528 0 CA-C-O 123.051 1.405 . . . . 0.93000000000000005 113.293 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' A' ' 22' ' ' ILE . 3.4 tm? -55.25 135.61 49.59 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.627 -1.624 . . . . 1.72 111.041 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -113.04 -48.14 3.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.516 -0.766 . . . . 1.1100000000000001 111.553 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 m -154.09 153.11 31.31 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.848 -0.532 . . . . 0.93999999999999995 109.701 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.42 126.44 48.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.777 -0.823 . . . . 1.45 108.777 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.487 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 18.7 m-20 -89.54 95.77 10.41 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.82 -1.178 . . . . 2.5600000000000001 107.82 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -56.06 -29.0 59.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.351 0.871 . . . . 2.7599999999999998 113.351 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.19 -39.93 90.03 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.029 0.442 . . . . 3.2200000000000002 111.511 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -109.79 0.5 18.83 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.798 -0.564 . . . . 2.2599999999999998 110.345 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m 65.18 16.44 10.55 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.047 -0.979 . . . . 2.2799999999999998 110.645 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 40' ' ' ASP . 30.4 p -75.77 135.65 40.29 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.201 0.524 . . . . 1.21 111.132 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.7 t -104.45 125.7 59.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.846 -0.615 . . . . 0.88 110.005 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.33 106.41 17.58 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.198 0.523 . . . . 0.51000000000000001 109.76 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.2 150.23 22.74 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.507 -0.77 . . . . 1.75 111.888 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 35' ' ' ILE . . . -147.75 134.39 19.89 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 105.132 -2.173 . . . . 0.76000000000000001 105.132 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.776 ' HG3' HD11 ' A' ' 35' ' ' ILE 0.407 4.4 tptt 49.66 58.61 5.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 124.808 2.242 . . . . 3.6299999999999999 113.148 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.551 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 44.6 t -77.38 113.94 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 112.886 -1.961 . . . . 1.52 106.204 173.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.501 ' HD3' ' OE1' ' A' ' 73' ' ' GLU . 20.9 tpt180 -169.46 157.21 7.17 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.265 -1.383 . . . . 5.3200000000000003 107.265 177.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.6 m -61.43 156.27 19.67 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 123.402 0.439 . . . . 4.0 110.547 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -132.5 95.08 3.54 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.687 0.995 . . . . 6.75 113.687 -173.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.38 101.31 0.4 Allowed Glycine 0 C--O 1.208 -1.503 0 C-N-CA 118.978 -1.582 . . . . 5.9000000000000004 113.148 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.514 ' HA ' HG23 ' A' ' 61' ' ' THR . 62.1 p 69.27 133.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.708 1.603 . . . . 7.0499999999999998 112.555 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.636 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 10.8 pt-20 -86.6 -149.53 0.14 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.041 1.336 . . . . 8.3800000000000008 108.448 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.7 3.99 2.79 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.718 1.247 . . . . 11.699999999999999 110.593 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.636 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 39.5 mmt180 -131.8 149.78 74.37 Favored Pre-proline 0 N--CA 1.418 -2.05 0 C-N-CA 125.835 1.654 . . . . 12.15 106.797 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.8 44.69 1.33 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.9 2.4 . . . . 9.3200000000000003 110.529 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.514 HG23 ' HA ' ' A' ' 56' ' ' THR 0.304 32.5 p 51.72 75.38 0.21 Allowed 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 122.331 1.062 . . . . 7.5700000000000003 113.693 -171.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 59' ' ' ARG . 6.2 m-20 -79.44 -5.42 54.68 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.365 -1.289 . . . . 10.539999999999999 108.48 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -157.55 94.62 2.11 Favored Pre-proline 0 N--CA 1.412 -2.334 0 N-CA-C 104.73 -2.322 . . . . 13.1 104.73 -178.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -45.54 126.56 8.75 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 123.997 3.131 . . . . 7.79 113.006 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mm -88.09 137.23 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 114.858 -1.064 . . . . 5.96 110.092 -173.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.1 155.77 36.22 Favored Pre-proline 0 C--N 1.283 -2.29 0 CA-C-N 113.958 -1.474 . . . . 4.6900000000000004 108.137 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -58.63 86.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.643 2.228 . . . . 6.1900000000000004 114.155 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -136.55 90.75 2.59 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.028 -1.442 . . . . 8.8000000000000007 107.249 172.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.559 ' OD1' ' HD3' ' A' ' 50' ' ' LYS . 9.0 t70 -144.73 145.96 31.95 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.726 -1.212 . . . . 6.5499999999999998 107.726 -171.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.23 156.48 36.76 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.646 0.736 . . . . 7.3899999999999997 111.403 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.773 HG23 ' H ' ' A' ' 50' ' ' LYS . 27.4 m -100.46 105.57 17.05 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 113.167 0.802 . . . . 4.6100000000000003 113.167 -171.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -120.04 -38.01 3.0 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.122 0.487 . . . . 7.5999999999999996 111.493 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 45.2 mt-10 -80.79 -4.82 55.96 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.316 1.228 . . . . 6.8600000000000003 114.316 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB3' ' CG2' ' A' ' 71' ' ' THR . 16.1 p90 -49.48 150.57 1.86 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.791 1.034 . . . . 5.54 113.791 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 tt -162.98 147.2 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.862 -0.608 . . . . 3.7999999999999998 110.361 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.7 mp -107.49 129.72 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.115 -1.068 . . . . 2.4199999999999999 108.115 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -103.67 148.07 26.48 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.523 -0.308 . . . . 2.3100000000000001 111.735 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -59.73 -13.71 11.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.229 1.012 . . . . 3.4500000000000002 113.529 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.11 -58.72 4.94 Favored Glycine 0 CA--C 1.496 -1.109 0 C-N-CA 120.946 -0.645 . . . . 0.76000000000000001 111.875 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.3 t -65.99 -11.52 48.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.243 0.544 . . . . 1.6399999999999999 110.685 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 3.8 m-20 -98.05 20.78 11.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.431 0.692 . . . . 2.0 111.506 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.59 HD12 HD21 ' A' ' 24' ' ' LEU . 40.3 mm -101.07 132.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.149 -1.02 . . . . 1.7 110.334 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -87.38 -28.51 22.13 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.804 -0.635 . . . . 1.5900000000000001 111.463 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 25' ' ' ILE . 20.1 t70 -166.35 135.13 2.98 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.274 0.472 . . . . 2.2200000000000002 112.274 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.8 mt -122.28 100.37 6.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.587 -0.733 . . . . 2.8599999999999999 110.325 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -109.96 116.71 32.09 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.124 0.488 . . . . 1.8799999999999999 110.483 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 m -95.81 154.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.672 -0.694 . . . . 2.7000000000000002 111.334 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 54.0 t -109.17 -32.82 7.07 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.728 -0.215 . . . . 3.3900000000000001 111.51 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 9.9 pt-20 -138.6 116.09 9.09 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-O 120.88 0.372 . . . . 5.0700000000000003 111.903 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 89' ' ' GLU . 5.2 Cg_exo -77.72 112.18 3.26 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 123.167 2.578 . . . . 6.3099999999999996 111.89 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.96 -39.12 42.49 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.071 2.514 . . . . 8.5899999999999999 112.706 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -129.83 101.16 18.57 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.343 -0.39 . . . . 12.69 110.063 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.62 -28.36 37.82 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.617 2.212 . . . . 13.220000000000001 111.252 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -111.33 122.35 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 107.978 -1.119 . . . . 15.380000000000001 107.978 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 80.2 mtp . . . . . 0 C--N 1.312 -1.063 0 CA-C-O 118.399 -0.81 . . . . 16.629999999999999 109.344 -177.537 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.548 1.188 0 CA-C-O 121.364 0.485 . . . . 3.73 112.196 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -77.61 90.35 3.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.036 -0.529 . . . . 8.0399999999999991 109.804 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.0 mt -108.84 -77.58 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.939 -0.573 . . . . 3.8100000000000001 112.265 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.06 -164.83 22.18 Favored Glycine 0 C--O 1.262 1.853 0 C-N-CA 120.69 -0.767 . . . . 1.0700000000000001 113.636 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -89.76 145.73 24.98 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.482 0.713 . . . . 1.8100000000000001 109.492 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 10.3 mptt -92.05 114.05 26.49 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.448 -0.945 . . . . 4.3499999999999996 108.448 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 86' ' ' THR . 10.8 tt -151.93 150.61 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.17 -0.468 . . . . 2.4100000000000001 111.536 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.5 m -104.01 127.84 51.57 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.509 -1.293 . . . . 1.3300000000000001 107.509 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD13 HD13 ' A' ' 85' ' ' LEU . 40.0 tp -123.5 128.71 50.18 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.491 -0.322 . . . . 1.45 110.587 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 62.9 mt -104.29 124.63 58.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.685 -0.857 . . . . 0.71999999999999997 108.685 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p -80.0 160.18 25.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.444 -0.947 . . . . 1.3400000000000001 108.444 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -54.8 -12.04 0.72 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.627 0.973 . . . . 2.1200000000000001 113.627 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 27' ' ' LYS . . . -85.05 5.53 29.14 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.386 0.675 . . . . 0.69999999999999996 110.013 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 3.1 tp10 70.46 30.65 3.17 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.153 1.781 . . . . 2.5899999999999999 108.958 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -108.34 128.11 64.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.381 -0.827 . . . . 1.1699999999999999 111.544 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.15 124.62 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.386 -0.825 . . . . 4.71 111.04 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.46 127.65 51.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.528 -0.545 . . . . 3.0099999999999998 109.528 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -118.69 126.35 51.71 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.113 0.482 . . . . 2.4500000000000002 109.734 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -177.28 -151.67 9.32 Favored Glycine 0 CA--C 1.468 -2.874 0 N-CA-C 110.63 -0.988 . . . . 0.45000000000000001 110.63 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 50' ' ' LYS 0.317 1.1 pp -116.72 116.64 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 CA-C-O 122.192 0.996 . . . . 0.93000000000000005 112.605 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.435 HD21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -62.39 133.1 54.58 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.93 -1.486 . . . . 1.72 108.373 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -94.76 -55.98 2.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.573 -0.451 . . . . 1.1100000000000001 112.14 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.5 m -153.86 154.06 33.24 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.013 -0.429 . . . . 0.93999999999999995 110.33 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.7 133.79 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 109.254 -0.647 . . . . 1.45 109.254 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 7.8 t70 -92.93 110.61 22.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.893 -0.781 . . . . 2.5600000000000001 108.893 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 m -73.46 -8.77 57.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.819 -0.628 . . . . 2.7599999999999998 112.129 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.63 -56.35 4.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.838 -0.745 . . . . 3.2200000000000002 111.168 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -96.47 0.34 50.18 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.7 -0.682 . . . . 2.2599999999999998 109.432 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m 65.68 21.1 11.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.456 -1.247 . . . . 2.2799999999999998 111.259 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 77.3 p -73.07 154.53 40.38 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.184 0.516 . . . . 1.21 111.675 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' CG1' HD21 ' A' ' 36' ' ' LEU . 59.8 t -124.94 125.1 69.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.724 -0.671 . . . . 0.88 110.056 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.59 109.37 21.45 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.51000000000000001 109.018 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.556 ' HG ' ' CG2' ' A' ' 51' ' ' VAL . 45.7 tp -113.01 129.07 56.62 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.947 -0.57 . . . . 1.75 109.579 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.55 156.55 30.38 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.76000000000000001 108.395 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.667 ' HA ' ' OG1' ' A' ' 71' ' ' THR . 48.8 mttp 60.08 29.78 19.32 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.102 0.876 . . . . 3.6299999999999999 109.885 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 46.6 t -67.0 114.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.731 -1.122 . . . . 1.52 109.086 -176.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -169.82 164.42 9.83 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.36 -0.978 . . . . 5.3200000000000003 108.36 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 p -63.28 154.59 31.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.196 0.813 . . . . 4.0 113.196 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -123.81 126.86 47.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.326 -0.852 . . . . 6.75 110.397 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.23 90.12 1.18 Allowed Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 119.687 -1.244 . . . . 5.9000000000000004 112.157 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 m -143.51 -100.44 0.12 Allowed 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.502 1.668 . . . . 7.0499999999999998 115.502 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 56.52 -91.5 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.046 0.938 . . . . 8.3800000000000008 113.461 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.99 12.95 31.72 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 113.189 0.811 . . . . 11.699999999999999 113.189 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.576 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 mmp_? -130.17 98.49 21.01 Favored Pre-proline 0 N--CA 1.395 -3.21 0 N-CA-C 106.501 -1.666 . . . . 12.15 106.501 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -63.72 84.97 0.14 Allowed 'Trans proline' 0 N--CA 1.432 -2.105 0 C-N-CA 121.882 1.722 . . . . 9.3200000000000003 110.513 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.0 t -32.08 -49.87 0.2 Allowed 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 114.855 -1.066 . . . . 7.5700000000000003 112.589 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 t70 176.85 -75.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.514 1.525 . . . . 10.539999999999999 108.071 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 90.2 mtt180 -143.26 -62.27 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 115.211 -0.904 . . . . 13.1 112.047 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 25.7 Cg_endo -60.12 103.21 0.2 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 C-N-CA 122.279 1.986 . . . . 7.79 116.173 -176.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 mt -119.7 147.53 23.29 Favored 'Isoleucine or valine' 0 C--O 1.257 1.459 0 N-CA-C 106.482 -1.673 . . . . 5.96 106.482 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.38 100.17 14.97 Favored Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 109.173 -0.677 . . . . 4.6900000000000004 109.173 170.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.08 12.0 3.09 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.232 1.955 . . . . 6.1900000000000004 111.565 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 72.26 89.05 0.1 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 113.732 -1.576 . . . . 8.8000000000000007 112.162 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.77 -73.79 0.5 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.16 -0.927 . . . . 6.5499999999999998 108.634 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 177.51 -167.98 0.06 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.076 -1.824 . . . . 7.3899999999999997 106.076 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.667 ' OG1' ' HA ' ' A' ' 50' ' ' LYS . 87.1 m -155.83 145.89 21.49 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.712 -0.848 . . . . 4.6100000000000003 108.712 -175.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -105.87 -25.92 11.94 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.707 -0.849 . . . . 7.5999999999999996 108.707 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.64 -7.28 25.36 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.734 1.614 . . . . 6.8600000000000003 112.64 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -64.22 146.57 54.08 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 112.461 0.541 . . . . 5.54 112.461 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 tt -157.92 140.71 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 110.518 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -102.7 135.45 39.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.342 -0.984 . . . . 2.4199999999999999 108.342 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.4 150.84 27.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.535 -0.543 . . . . 2.3100000000000001 109.535 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.644 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -81.64 10.51 5.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.017 0.437 . . . . 3.4500000000000002 111.418 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 84.41 -61.16 4.75 Favored Glycine 0 CA--C 1.47 -2.767 0 N-CA-C 111.53 -0.628 . . . . 0.76000000000000001 111.53 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -62.4 -12.06 19.38 Favored 'General case' 0 CA--C 1.582 2.188 0 CA-C-O 121.092 0.472 . . . . 1.6399999999999999 111.254 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 9.3 m-20 -82.53 -0.56 47.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.352 0.661 . . . . 2.0 112.268 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 79' ' ' GLY . 1.9 pp -79.6 140.65 16.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 119.18 -1.008 . . . . 1.7 112.652 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -95.64 -56.1 2.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.983 -0.747 . . . . 1.5900000000000001 108.983 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.429 ' O ' HD12 ' A' ' 24' ' ' LEU . 19.9 t70 -136.0 139.15 42.92 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.195 -0.912 . . . . 2.2200000000000002 108.666 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.462 HD13 HD13 ' A' ' 24' ' ' LEU . 38.3 tp -135.96 99.59 4.19 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.323 -1.362 . . . . 2.8599999999999999 107.323 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' HG13 ' A' ' 22' ' ' ILE . 51.1 m -132.35 110.54 10.64 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.077 0.465 . . . . 1.8799999999999999 111.285 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.9 136.8 22.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 115.706 -0.679 . . . . 2.7000000000000002 109.956 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.1 t -178.26 119.16 0.09 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.054 0.542 . . . . 3.3900000000000001 109.93 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 10.5 mp0 -70.85 137.51 85.27 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 109.176 -0.676 . . . . 5.0700000000000003 109.176 174.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -46.23 -44.69 19.54 Favored 'Trans proline' 0 CA--C 1.575 2.55 0 C-N-CA 123.553 2.835 . . . . 6.3099999999999996 116.3 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 89' ' ' GLU . 12.7 Cg_endo -78.97 92.9 1.12 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 CA-C-N 120.931 1.368 . . . . 8.5899999999999999 112.079 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -128.1 86.25 58.52 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 107.163 -1.421 . . . . 12.69 107.163 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.32 -27.37 23.89 Favored 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 122.601 2.201 . . . . 13.220000000000001 112.551 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.9 mt -78.33 -20.28 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.325 -0.991 . . . . 15.380000000000001 108.325 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.294 -1.336 . . . . 16.629999999999999 111.91 -175.885 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.449 -1.097 0 N-CA-C 114.088 0.765 . . . . 3.73 114.088 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -136.63 -179.77 5.89 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.281 -0.872 . . . . 8.0399999999999991 109.26 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -172.96 -39.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 122.897 0.479 . . . . 3.8100000000000001 110.034 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.61 -161.19 33.45 Favored Glycine 0 C--N 1.315 -0.615 0 N-CA-C 110.934 -0.866 . . . . 1.0700000000000001 110.934 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -92.76 130.98 38.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.564 0.579 . . . . 1.8100000000000001 112.564 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 64.4 mmtt -74.01 112.6 10.29 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.019 0.528 . . . . 4.3499999999999996 110.684 175.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -141.13 164.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.855 -0.794 . . . . 2.4100000000000001 108.855 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 35.7 t -122.41 115.72 22.76 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.916 -1.142 . . . . 1.3300000000000001 107.916 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 77' ' ' PHE . 3.4 tt -123.04 128.69 50.49 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.298 -1.371 . . . . 1.45 107.298 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.7 mt -99.06 122.88 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.712 -0.395 . . . . 0.71999999999999997 109.981 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -76.1 162.26 28.16 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.561 -0.745 . . . . 1.3400000000000001 110.413 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -52.18 -23.45 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.526 1.13 . . . . 2.1200000000000001 113.733 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.81 22.66 3.47 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 122.841 0.456 . . . . 0.69999999999999996 110.266 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.263 10.8 pt-20 50.35 50.7 18.24 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.879 1.272 . . . . 2.5899999999999999 112.677 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -119.08 118.65 58.35 Favored 'Isoleucine or valine' 0 C--O 1.254 1.32 0 CA-C-N 114.455 -1.248 . . . . 1.1699999999999999 110.247 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.64 109.17 15.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.534 -0.757 . . . . 4.71 110.768 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -105.57 134.19 49.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.145 -0.479 . . . . 3.0099999999999998 110.443 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -134.9 129.87 35.01 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.992 -0.744 . . . . 2.4500000000000002 108.992 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -174.83 -151.68 8.64 Favored Glycine 0 CA--C 1.481 -2.078 0 N-CA-C 110.43 -1.068 . . . . 0.45000000000000001 110.43 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.43 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -110.95 107.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-O 121.413 0.625 . . . . 0.93000000000000005 112.35 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.599 ' HA ' HD23 ' A' ' 48' ' ' LEU . 6.9 tt -58.41 137.88 56.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.434 -1.257 . . . . 1.72 111.301 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -99.44 -60.56 1.51 Allowed 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.294 -0.867 . . . . 1.1100000000000001 112.023 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -151.75 154.03 35.49 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.94 -0.475 . . . . 0.93999999999999995 110.052 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.81 129.54 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.807 -1.183 . . . . 1.45 107.807 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.81 105.31 17.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.986 -1.116 . . . . 2.5600000000000001 107.986 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -73.02 -6.08 43.13 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.925 0.713 . . . . 2.7599999999999998 112.925 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.76 -56.24 3.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 3.2200000000000002 110.007 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -89.65 -9.67 48.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.758 -0.656 . . . . 2.2599999999999998 110.226 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m 70.28 21.86 5.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.264 1.025 . . . . 2.2799999999999998 109.697 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -83.69 144.15 29.57 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.726 -0.67 . . . . 1.21 111.405 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.41 128.03 62.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.928 -0.578 . . . . 0.88 110.56 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.97 110.5 22.54 Favored 'General case' 0 C--O 1.258 1.547 0 N-CA-C 109.455 -0.572 . . . . 0.51000000000000001 109.455 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 36' ' ' LEU . 11.8 mt -108.24 146.68 32.49 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.23 -0.895 . . . . 1.75 112.141 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.69 146.29 24.16 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.47 -1.307 . . . . 0.76000000000000001 107.47 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HA ' HG23 ' A' ' 71' ' ' THR . 44.3 mtpt 62.43 29.55 17.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 124.013 0.821 . . . . 3.6299999999999999 111.157 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.584 HG22 HD22 ' A' ' 48' ' ' LEU . 49.9 t -69.42 111.64 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.538 -0.865 . . . . 1.52 109.816 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -170.02 127.27 0.86 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.985 1.314 . . . . 5.3200000000000003 108.673 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.4 m -119.35 79.81 1.47 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.388 -0.597 . . . . 4.0 109.388 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -176.12 98.23 0.06 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.645 -0.872 . . . . 6.75 108.645 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -123.72 -157.42 9.81 Favored Glycine 1 N--CA 1.395 -4.041 0 N-CA-C 106.344 -2.702 . . . . 5.9000000000000004 106.344 172.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.484 HG22 ' HB ' ' A' ' 61' ' ' THR . 31.7 p 62.1 -40.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.66 1.584 . . . . 7.0499999999999998 112.619 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 55' ' ' GLY . 8.7 mm-40 54.32 62.87 2.37 Favored 'General case' 0 C--O 1.253 1.253 0 C-N-CA 125.069 1.347 . . . . 8.3800000000000008 109.14 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 66.64 32.35 7.12 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.201 -1.363 . . . . 11.699999999999999 112.898 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' HB ' ' A' ' 56' ' ' THR . 28.4 mmt180 -133.5 -179.05 0.97 Allowed Pre-proline 0 C--O 1.21 -0.986 0 C-N-CA 123.348 0.659 . . . . 12.15 109.343 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -105.93 57.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.664 0 C-N-CA 121.947 1.764 . . . . 9.3200000000000003 111.76 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.484 ' HB ' HG22 ' A' ' 56' ' ' THR . 24.9 m -72.24 88.5 1.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.112 -0.949 . . . . 7.5700000000000003 108.995 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -97.8 -52.96 3.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.636 -1.166 . . . . 10.539999999999999 112.03 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.509 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . 98.2 mtt180 -100.38 -54.38 0.16 Allowed Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 113.223 0.823 . . . . 13.1 113.223 -176.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 63' ' ' ARG . 38.5 Cg_endo -80.8 105.88 1.74 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 121.044 1.163 . . . . 7.79 112.627 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 pt -131.98 152.02 36.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.627 0.771 . . . . 5.96 111.844 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.99 131.74 39.84 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.125 0.97 . . . . 4.6900000000000004 112.708 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.52 97.57 1.04 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.88 2.387 . . . . 6.1900000000000004 113.306 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.504 ' HG3' ' OE2' ' A' ' 70' ' ' GLU . 60.6 ttp180 54.13 86.17 0.05 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.53 1.132 . . . . 8.8000000000000007 112.589 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -99.69 -40.64 7.67 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.15 -0.932 . . . . 6.5499999999999998 110.2 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.504 ' OE2' ' HG3' ' A' ' 68' ' ' ARG . 18.9 mm-40 74.99 171.69 0.28 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 125.319 1.448 . . . . 7.3899999999999997 112.164 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 50' ' ' LYS . 15.8 p -99.43 -89.05 0.33 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.105 0.78 . . . . 4.6100000000000003 113.105 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' HG2' ' A' ' 73' ' ' GLU . 30.0 t80 -169.14 -90.92 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 112.198 0.444 . . . . 7.5999999999999996 112.198 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' CD2' ' A' ' 72' ' ' PHE . 9.0 mm-40 -91.49 -25.05 19.46 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 117.912 0.323 . . . . 6.8600000000000003 111.456 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 26.4 m-85 72.59 177.59 0.25 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.811 1.245 . . . . 5.54 109.907 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.62 137.16 51.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-O 121.463 0.649 . . . . 3.7999999999999998 111.749 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mm -119.5 129.1 75.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.313 -0.858 . . . . 2.4199999999999999 109.176 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 24' ' ' LEU . 20.7 m-85 -98.95 137.32 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.091 -0.504 . . . . 2.3100000000000001 111.192 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 39.3 mmt180 -64.99 -13.65 58.25 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 123.322 0.649 . . . . 3.4500000000000002 112.084 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 82.01 -61.9 4.61 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.585 -0.816 . . . . 0.76000000000000001 111.988 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.0 p -63.41 -27.43 69.29 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.244 0.545 . . . . 1.6399999999999999 111.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 2.0 m-20 -98.38 21.4 11.11 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.182 -0.917 . . . . 2.0 112.701 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 79' ' ' GLY . 40.4 pt -87.01 142.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.431 -0.908 . . . . 1.7 110.406 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 73.3 mmtt -88.94 -60.34 1.98 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.078 -0.51 . . . . 1.5900000000000001 111.098 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -145.04 152.46 40.15 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 116.402 -0.363 . . . . 2.2200000000000002 110.185 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.18 102.05 5.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 123.921 0.763 . . . . 2.8599999999999999 109.291 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 23' ' ' SER . 68.5 m -97.98 120.12 37.81 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.879 -0.601 . . . . 1.8799999999999999 109.949 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -97.1 147.68 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.956 -0.566 . . . . 2.7000000000000002 110.534 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.2 m -100.78 -30.14 11.87 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 112.715 0.635 . . . . 3.3900000000000001 112.715 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -151.97 158.43 33.87 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 109.428 -0.582 . . . . 5.0700000000000003 109.428 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.36 113.63 2.36 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.59 2.194 . . . . 6.3099999999999996 112.635 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -57.42 -43.71 49.2 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.815 2.343 . . . . 8.5899999999999999 112.803 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp 60.42 86.87 0.14 Allowed Pre-proline 0 CA--C 1.554 1.114 0 O-C-N 123.621 0.576 . . . . 12.69 111.585 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.04 -40.19 6.8 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.347 2.031 . . . . 13.220000000000001 111.86 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.21 174.64 7.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 123.048 0.539 . . . . 15.380000000000001 110.52 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 C--N 1.307 -1.262 0 N-CA-C 109.455 -0.572 . . . . 16.629999999999999 109.455 178.004 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo . . . . . 0 C--O 1.256 1.378 0 N-CA-C 113.02 0.354 . . . . 3.73 113.02 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -41.3 143.89 0.39 Allowed 'General case' 0 C--O 1.248 0.995 0 C-N-CA 125.242 1.417 . . . . 8.0399999999999991 114.078 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 tt -176.46 -37.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.266 -1.334 . . . . 3.8100000000000001 108.284 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -137.97 -177.2 15.0 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 110.137 -1.185 . . . . 1.0700000000000001 110.137 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.8 m -88.81 139.62 30.27 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 117.077 0.438 . . . . 1.8100000000000001 109.823 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -87.69 106.71 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.69 -0.804 . . . . 4.3499999999999996 112.025 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.85 146.27 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.135 0.574 . . . . 2.4100000000000001 110.518 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 t -107.68 111.78 24.16 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.635 -1.617 . . . . 1.3300000000000001 106.635 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 84' ' ' ASP . 61.6 tp -121.6 129.67 52.99 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.554 0.216 . . . . 1.45 111.062 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.58 118.64 53.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.645 -0.502 . . . . 0.71999999999999997 109.645 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.9 p -78.45 162.83 26.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.488 -0.778 . . . . 1.3400000000000001 110.313 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -10.01 0.3 Allowed 'General case' 0 C--O 1.211 -0.926 0 N-CA-C 115.896 1.813 . . . . 2.1200000000000001 115.896 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.12 13.69 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.542 -0.54 . . . . 0.69999999999999996 109.542 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.41 28.28 15.45 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 125.259 1.424 . . . . 2.5899999999999999 110.058 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.47 129.01 66.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.712 -0.676 . . . . 1.1699999999999999 111.611 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptm85 -87.11 118.98 26.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.909 -0.587 . . . . 4.71 111.932 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.29 125.79 54.68 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.251 -1.018 . . . . 3.0099999999999998 108.251 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -134.99 131.61 37.35 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.334 -1.358 . . . . 2.4500000000000002 107.334 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 179.91 -158.53 22.23 Favored Glycine 0 CA--C 1.49 -1.49 0 N-CA-C 111.306 -0.718 . . . . 0.45000000000000001 111.306 -175.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.54 ' H ' HD13 ' A' ' 35' ' ' ILE 0.31 0.2 OUTLIER -92.4 109.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.581 0 CA-C-O 122.314 1.054 . . . . 0.93000000000000005 113.606 -177.062 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.5 tp -67.06 133.42 49.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.568 -1.651 . . . . 1.72 109.847 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -111.95 -59.21 2.02 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 120.46 -0.496 . . . . 1.1100000000000001 110.566 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.7 m -141.19 160.59 39.78 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.977 -0.379 . . . . 0.93999999999999995 109.977 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.56 123.78 53.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.638 -1.616 . . . . 1.45 106.638 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.488 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 14.7 m-20 -86.84 94.24 9.51 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.647 -1.612 . . . . 2.5600000000000001 106.647 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -57.73 -26.34 61.65 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.454 -0.794 . . . . 2.7599999999999998 112.943 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.31 -50.27 62.56 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.567 0.747 . . . . 3.2200000000000002 111.475 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -112.94 6.01 17.59 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 120.951 0.405 . . . . 2.2599999999999998 109.973 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.7 m 64.93 22.03 12.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.25 1.02 . . . . 2.2799999999999998 110.817 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.493 HG22 ' C ' ' A' ' 78' ' ' ARG . 33.1 p -73.99 148.42 42.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.86 -0.609 . . . . 1.21 110.933 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.86 126.92 65.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 116.442 -0.345 . . . . 0.88 110.572 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.33 101.54 11.24 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.452 0.644 . . . . 0.51000000000000001 110.232 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.643 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 91.3 mt -100.76 153.98 19.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.427 -0.806 . . . . 1.75 109.679 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.53 136.46 22.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.425 -0.583 . . . . 0.76000000000000001 109.425 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.52 ' C ' HG21 ' A' ' 71' ' ' THR . 88.4 mttt 56.21 36.6 27.72 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.555 0.742 . . . . 3.6299999999999999 111.77 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.643 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 86.7 t -67.3 117.19 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.694 -1.139 . . . . 1.52 111.761 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' NH2' ' HA ' ' A' ' 71' ' ' THR . 21.7 tpp180 -165.03 150.65 9.73 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.964 -1.495 . . . . 5.3200000000000003 106.964 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.2 m -133.06 145.54 50.88 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.371 -0.603 . . . . 4.0 109.371 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -141.38 -91.64 0.14 Allowed 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 113.338 0.866 . . . . 6.75 113.338 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.64 -56.57 0.02 OUTLIER Glycine 0 CA--C 1.496 -1.145 0 C-N-CA 119.953 -1.117 . . . . 5.9000000000000004 112.443 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.621 ' HB ' ' CA ' ' A' ' 61' ' ' THR . 53.3 m -127.39 131.13 50.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 112.891 0.7 . . . . 7.0499999999999998 112.891 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.93 -43.23 6.8 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.643 0.608 . . . . 8.3800000000000008 112.643 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.64 -61.77 2.09 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.493 0.717 . . . . 11.699999999999999 110.39 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.574 ' O ' HG22 ' A' ' 56' ' ' THR . 78.8 mtp180 -89.26 175.8 3.67 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 106.124 -1.806 . . . . 12.15 106.124 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -91.54 35.93 0.28 Allowed 'Trans proline' 0 N--CA 1.448 -1.147 0 CA-C-N 121.231 1.475 . . . . 9.3200000000000003 114.093 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.621 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 1.3 t 46.97 -163.25 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 125.634 1.574 . . . . 7.5700000000000003 112.398 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 61' ' ' THR . 2.3 m-20 -49.72 -62.79 1.36 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 125.546 1.538 . . . . 10.539999999999999 110.518 174.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 40.0 ttm180 -156.15 -55.14 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.715 0 CA-C-N 115.37 -0.832 . . . . 13.1 112.828 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 66.9 Cg_endo -90.18 126.19 1.32 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.689 1.592 . . . . 7.79 114.235 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.549 HG23 HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -134.11 138.81 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.521 0 CA-C-N 115.413 -0.812 . . . . 5.96 110.213 177.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.68 118.52 67.45 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.162 -0.681 . . . . 4.6900000000000004 109.162 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.95 17.5 0.83 Allowed 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.16 2.573 . . . . 6.1900000000000004 111.792 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 77.69 -22.95 0.26 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.783 1.633 . . . . 8.8000000000000007 111.603 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -91.82 9.45 32.7 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.597 0.359 . . . . 6.5499999999999998 110.966 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -105.51 -20.59 13.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.339 0.59 . . . . 7.3899999999999997 110.552 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.52 HG21 ' C ' ' A' ' 50' ' ' LYS . 41.3 m -76.64 154.73 34.04 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.895 -0.593 . . . . 4.6100000000000003 110.195 -177.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -59.48 161.96 5.35 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.623 -0.88 . . . . 7.5999999999999996 108.623 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -47.68 -60.54 2.48 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 123.977 0.798 . . . . 6.8600000000000003 112.756 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 22.8 p90 175.61 179.8 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.128 0.571 . . . . 5.54 111.132 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 tp -145.23 132.23 15.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 120.942 0.401 . . . . 3.7999999999999998 110.238 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.3 mm -112.35 126.07 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.073 -0.714 . . . . 2.4199999999999999 109.073 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.447 ' HE2' HD12 ' A' ' 48' ' ' LEU . 90.2 m-85 -101.36 160.94 14.0 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.091 -0.337 . . . . 2.3100000000000001 110.091 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' C ' HG22 ' A' ' 45' ' ' THR . 10.0 mpt_? -85.2 -3.85 58.96 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.413 -0.358 . . . . 3.4500000000000002 111.87 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.588 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 81.35 -61.43 4.61 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.762 -0.732 . . . . 0.76000000000000001 111.813 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.3 p -75.14 1.82 12.33 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.617 0.246 . . . . 1.6399999999999999 111.628 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -110.52 8.89 23.16 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.018 0.437 . . . . 2.0 110.803 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 79' ' ' GLY . 32.0 pt -92.24 148.9 4.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 O-C-N 121.48 -0.762 . . . . 1.7 110.446 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.31 -46.91 4.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.751 -0.38 . . . . 1.5900000000000001 111.835 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.599 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.9 m-20 -129.68 146.37 51.46 Favored 'General case' 0 C--O 1.211 -0.968 0 O-C-N 122.34 -0.225 . . . . 2.2200000000000002 110.85 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 tt -150.99 111.18 4.14 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.114 -1.439 . . . . 2.8599999999999999 107.114 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -105.41 109.13 20.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.026 -0.731 . . . . 1.8799999999999999 109.026 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.57 104.09 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.412 0.625 . . . . 2.7000000000000002 110.545 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.0 p -148.07 97.22 2.76 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.79 0.805 . . . . 3.3900000000000001 112.292 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.57 149.76 39.28 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.099 -0.955 . . . . 5.0700000000000003 110.153 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -89.76 108.35 0.4 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 122.852 2.368 . . . . 6.3099999999999996 112.062 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -90.37 145.13 4.09 Favored 'Trans proline' 0 N--CA 1.438 -1.751 0 C-N-CA 122.197 1.931 . . . . 8.5899999999999999 112.736 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -134.57 94.14 17.56 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 105.628 -1.99 . . . . 12.69 105.628 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -78.62 -51.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.663 1.575 . . . . 13.220000000000001 113.183 -174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -146.47 -58.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 106.762 -1.57 . . . . 15.380000000000001 106.762 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 107.73 -1.211 . . . . 16.629999999999999 107.73 176.718 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' CG ' ' A' ' 54' ' ' PHE . 63.4 Cg_endo . . . . . 0 CA--C 1.542 0.896 0 CA-C-O 120.707 0.211 . . . . 3.73 112.641 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -154.71 -70.24 0.13 Allowed 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 123.866 0.866 . . . . 8.0399999999999991 108.741 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -164.36 160.45 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.271 2.203 0 CA-C-N 114.931 -1.032 . . . . 3.8100000000000001 108.375 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' ' HB ' ' A' ' 35' ' ' ILE . . . 150.96 159.09 8.62 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.449 -1.46 . . . . 1.0700000000000001 109.449 177.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.2 m -103.38 142.38 34.33 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.125 1.462 . . . . 1.8100000000000001 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -89.23 106.71 18.62 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 122.464 0.306 . . . . 4.3499999999999996 110.508 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.47 -173.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-O 121.507 0.67 . . . . 2.4100000000000001 110.087 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 36.6 m -139.48 124.82 19.07 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.311 -1.366 . . . . 1.3300000000000001 107.311 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.49 HD21 HG22 ' A' ' 82' ' ' ILE . 6.1 tt -133.31 135.85 45.09 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.335 -0.617 . . . . 1.45 109.335 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 66.4 mt -106.96 122.51 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 109.281 -0.637 . . . . 0.71999999999999997 109.281 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.5 t -84.76 162.3 19.67 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.811 0.694 . . . . 1.3400000000000001 109.232 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -57.9 -3.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.822 1.416 . . . . 2.1200000000000001 114.822 -178.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 8.05 38.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.466 0.65 . . . . 0.69999999999999996 109.256 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 6.2 mm-40 68.03 28.8 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.255 1.422 . . . . 2.5899999999999999 109.768 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 48.0 mm -107.44 128.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.277 0.473 . . . . 1.1699999999999999 112.277 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -89.1 117.44 28.1 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.25 1.02 . . . . 4.71 110.202 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 23' ' ' SER . 98.3 m-85 -107.85 148.59 29.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.386 0.274 . . . . 3.0099999999999998 111.148 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -138.99 126.7 22.0 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.798 -1.556 . . . . 2.4500000000000002 106.798 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.44 -155.33 25.88 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.304 -0.718 . . . . 0.45000000000000001 111.304 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.75 128.91 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 113.978 1.103 . . . . 0.93000000000000005 113.978 -177.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.674 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.66 156.48 30.72 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.821 -1.081 . . . . 1.72 112.625 173.12 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -110.73 -39.21 4.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.835 -0.621 . . . . 1.1100000000000001 110.806 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -151.81 153.9 35.14 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.658 -0.497 . . . . 0.93999999999999995 109.658 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.87 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.941 -0.763 . . . . 1.45 108.941 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -103.06 95.73 6.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.449 0.642 . . . . 2.5600000000000001 109.49 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.1 m -52.88 -41.38 64.27 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.859 1.264 . . . . 2.7599999999999998 114.133 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -55.45 -42.86 74.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.013 0.746 . . . . 3.2200000000000002 113.013 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.81 -0.01 25.66 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.142 0.496 . . . . 2.2599999999999998 109.82 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m 64.21 18.9 11.54 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.548 1.139 . . . . 2.2799999999999998 111.033 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.8 p -79.43 125.08 29.09 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.105 0.479 . . . . 1.21 111.025 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -101.21 124.06 54.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.784 -0.644 . . . . 0.88 109.469 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.9 103.5 16.03 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 108.036 -1.098 . . . . 0.51000000000000001 108.036 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.618 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -100.05 147.13 25.96 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 106.114 -1.81 . . . . 1.75 106.114 -176.046 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' H ' HD13 ' A' ' 48' ' ' LEU . . . -148.94 129.82 14.28 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.479 -1.304 . . . . 0.76000000000000001 107.479 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttp 48.95 54.62 10.55 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.068 0.947 . . . . 3.6299999999999999 112.697 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.618 ' HB ' ' CD1' ' A' ' 48' ' ' LEU . 6.6 p -66.97 114.12 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.424 -0.807 . . . . 1.52 109.613 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 12.7 tpt180 -169.22 170.73 8.45 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.761 -1.57 . . . . 5.3200000000000003 106.761 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.7 m -79.13 124.03 27.93 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.786 -0.45 . . . . 4.0 109.786 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 96.1 m-85 -137.25 146.87 45.28 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.958 -0.564 . . . . 6.75 111.182 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 61' ' ' THR . . . 145.8 125.51 1.73 Allowed Glycine 0 C--O 1.171 -3.816 0 CA-C-O 118.45 -1.194 . . . . 5.9000000000000004 110.211 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.5 m -175.35 -89.9 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 124.51 1.124 . . . . 7.0499999999999998 112.538 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.329 8.2 mm-40 70.61 -90.84 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 125.845 1.658 . . . . 8.3800000000000008 112.569 -170.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -92.82 -25.79 17.97 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 120.53 -0.468 . . . . 11.699999999999999 111.296 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -141.37 144.35 33.72 Favored Pre-proline 0 CA--C 1.461 -2.445 0 C-N-CA 119.13 -1.028 . . . . 12.15 109.715 -169.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.8 86.57 0.37 Allowed 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.495 1.464 . . . . 9.3200000000000003 110.109 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 55' ' ' GLY . 7.5 t -57.16 -179.01 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.778 -1.101 . . . . 7.5700000000000003 111.579 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.64 97.49 2.17 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.0 -1.482 . . . . 10.539999999999999 107.0 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 88.15 83.04 0.04 OUTLIER Pre-proline 0 C--N 1.311 -1.069 0 C-N-CA 127.024 2.13 . . . . 13.1 108.495 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 51.7 Cg_exo -58.98 -178.45 0.13 Allowed 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 124.476 3.45 . . . . 7.79 115.751 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 55' ' ' GLY . 34.7 pt -87.18 149.09 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.425 0 CA-C-N 115.263 -0.881 . . . . 5.96 112.445 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.453 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -101.95 131.8 22.33 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 113.816 -1.538 . . . . 4.6900000000000004 109.94 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.69 32.93 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 122.871 2.381 . . . . 6.1900000000000004 112.074 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 72.42 106.54 0.07 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.363 1.465 . . . . 8.8000000000000007 112.915 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.16 -75.05 0.37 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.514 -0.766 . . . . 6.5499999999999998 109.557 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 176.97 122.5 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.508 0.671 . . . . 7.3899999999999997 112.441 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.4 m -161.27 100.07 1.2 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.094 -1.076 . . . . 4.6100000000000003 108.094 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -112.03 -37.93 4.93 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.853 -0.739 . . . . 7.5999999999999996 111.281 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.32 -20.66 31.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.867 0.365 . . . . 6.8600000000000003 111.636 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 62.08 -168.17 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.476 1.51 . . . . 5.54 111.736 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.405 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -137.73 131.14 42.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-O 121.106 0.479 . . . . 3.7999999999999998 110.383 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.52 128.98 65.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.194 -0.669 . . . . 2.4199999999999999 109.194 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.41 130.38 43.55 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 109.441 -0.578 . . . . 2.3100000000000001 109.441 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -68.47 -10.47 55.65 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.295 0.85 . . . . 3.4500000000000002 113.295 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.7 -48.98 3.33 Favored Glycine 0 C--O 1.212 -1.239 0 C-N-CA 120.831 -0.699 . . . . 0.76000000000000001 112.305 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 m -76.31 -16.49 59.76 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.054 0.931 . . . . 1.6399999999999999 109.188 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.23 24.7 6.89 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.659 -1.155 . . . . 2.0 112.124 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 79' ' ' GLY . 21.0 pt -112.73 150.97 14.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.552 -0.859 . . . . 1.7 110.493 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.612 ' HE3' ' OE1' ' A' ' 29' ' ' GLU . 71.6 mmtt -92.89 -54.5 3.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.788 -0.642 . . . . 1.5900000000000001 110.526 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -161.65 159.01 26.94 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.21 -1.033 . . . . 2.2200000000000002 108.21 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 82' ' ' ILE . 1.5 pt? -156.13 147.91 22.97 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.803 0.335 . . . . 2.8599999999999999 110.419 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.7 t -124.21 130.8 53.15 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.153 -0.684 . . . . 1.8799999999999999 109.153 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.1 p -126.36 122.98 62.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 116.134 -0.484 . . . . 2.7000000000000002 111.376 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 47.2 t 174.21 -48.21 0.01 OUTLIER 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.163 -1.051 . . . . 3.3900000000000001 108.163 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 178.03 162.21 0.61 Allowed Pre-proline 0 C--O 1.248 1.02 0 N-CA-C 106.089 -1.819 . . . . 5.0700000000000003 106.089 -172.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.46 117.26 2.08 Favored 'Trans proline' 0 CA--C 1.554 1.521 0 C-N-CA 122.062 1.842 . . . . 6.3099999999999996 114.217 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.85 167.4 11.24 Favored 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 122.681 2.254 . . . . 8.5899999999999999 111.968 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 64.24 90.75 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.591 1.157 . . . . 12.69 112.77 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.47 -66.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.289 1.993 . . . . 13.220000000000001 111.575 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.7 pt -144.78 16.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 123.804 0.842 . . . . 15.380000000000001 108.758 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.099 -0.953 . . . . 16.629999999999999 109.594 -175.891 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HG3' ' H ' ' A' ' 66' ' ' ALA . 93.2 Cg_endo . . . . . 0 CA--C 1.588 3.225 0 CA-C-O 120.52 0.133 . . . . 3.73 111.835 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -117.83 -91.16 0.55 Allowed 'General case' 0 C--O 1.239 0.543 0 N-CA-C 114.183 1.179 . . . . 8.0399999999999991 114.183 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp 166.22 154.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 107.285 -1.376 . . . . 3.8100000000000001 107.285 -172.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.93 -177.55 47.59 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 109.953 -1.259 . . . . 1.0700000000000001 109.953 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 t -96.45 124.85 40.58 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.448 -0.945 . . . . 1.8100000000000001 108.448 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -68.03 121.37 15.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.533 0.938 . . . . 4.3499999999999996 113.533 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 36' ' ' LEU . 10.9 tt -153.19 152.04 10.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-N 115.412 -0.813 . . . . 2.4100000000000001 110.492 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.788 ' O ' ' HB3' ' A' ' 85' ' ' LEU . 20.0 m -115.3 144.53 43.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.989 -1.856 . . . . 1.3300000000000001 105.989 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.977 ' HA ' ' HB2' ' A' ' 85' ' ' LEU . 31.1 tp -147.97 129.88 15.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.529 1.307 . . . . 1.45 114.529 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 85' ' ' LEU . 66.6 mt -95.12 119.64 43.46 Favored 'Isoleucine or valine' 0 C--N 1.387 2.23 0 C-N-CA 119.82 -0.752 . . . . 0.71999999999999997 109.77 174.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -89.49 166.13 13.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.946 -0.57 . . . . 1.3400000000000001 109.48 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -47.52 -19.61 0.19 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 115.04 1.496 . . . . 2.1200000000000001 115.04 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 27' ' ' LYS . . . -74.39 -2.92 27.47 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.708 0.29 . . . . 0.69999999999999996 110.43 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 74.41 22.74 2.1 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.633 1.173 . . . . 2.5899999999999999 107.882 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 53.9 mt -109.99 129.48 64.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.152 -1.385 . . . . 1.1699999999999999 110.971 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.422 ' HB3' HG12 ' A' ' 25' ' ' ILE . 38.9 ptt180 -92.06 119.84 32.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.74 -0.663 . . . . 4.71 110.308 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.35 159.15 16.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.976 -0.75 . . . . 3.0099999999999998 108.976 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -142.43 128.01 19.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.226 -1.398 . . . . 2.4500000000000002 107.226 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 175.0 -128.87 1.47 Allowed Glycine 1 CA--C 1.442 -4.469 0 N-CA-C 109.998 -1.241 . . . . 0.45000000000000001 109.998 -176.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.441 HD11 ' CB ' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -135.5 161.31 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.48 0 C-N-CA 118.934 -1.106 . . . . 0.93000000000000005 113.287 -174.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HB2' HG21 ' A' ' 22' ' ' ILE . 3.3 tm? -99.44 140.34 33.76 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.507 -1.224 . . . . 1.72 109.389 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' N ' HD13 ' A' ' 36' ' ' LEU . 76.9 t80 -105.88 -54.69 2.44 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 123.239 0.337 . . . . 1.1100000000000001 111.121 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.5 m -153.93 154.63 34.17 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 109.744 -0.465 . . . . 0.93999999999999995 109.744 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.414 HG13 HD11 ' A' ' 36' ' ' LEU . 82.2 mt -130.29 142.56 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.797 0.332 . . . . 1.45 111.416 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.468 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 2.7 t70 -111.35 116.1 30.41 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.636 0.775 . . . . 2.5600000000000001 110.428 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -76.79 -18.18 58.58 Favored 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 113.035 0.754 . . . . 2.7599999999999998 113.035 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -69.7 -54.98 11.28 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.85 -0.531 . . . . 3.2200000000000002 111.443 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -103.9 5.72 35.89 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.953 0.406 . . . . 2.2599999999999998 110.058 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.1 t 65.02 24.38 12.59 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.996 -1.002 . . . . 2.2799999999999998 109.817 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 70.3 p -77.51 141.45 39.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.884 0.849 . . . . 1.21 111.525 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.5 t -115.55 126.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.168 -0.924 . . . . 0.88 110.143 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.89 99.52 10.83 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.511 -0.922 . . . . 0.51000000000000001 108.511 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 tt -101.3 126.12 48.01 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.759 -1.941 . . . . 1.75 105.759 -176.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB1' ' HA ' ' A' ' 73' ' ' GLU . . . -155.1 156.56 36.04 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 107.703 -1.221 . . . . 0.76000000000000001 107.703 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 49.6 mttm 68.26 21.27 8.53 Favored 'General case' 0 C--O 1.2 -1.507 0 CA-C-O 121.993 0.901 . . . . 3.6299999999999999 109.171 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.673 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.7 p -67.1 166.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.424 -1.324 . . . . 1.52 107.424 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.552 ' HG3' ' HA ' ' A' ' 69' ' ' ASP . 44.6 ttp180 -71.58 102.21 2.68 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.341 -1.344 . . . . 5.3200000000000003 114.239 -172.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.3 t -92.78 -172.98 3.19 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.953 -1.499 . . . . 4.0 106.953 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -109.16 -9.46 15.03 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.872 -0.731 . . . . 6.75 111.762 -174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.57 149.87 24.66 Favored Glycine 0 N--CA 1.407 -3.281 0 C-N-CA 119.802 -1.19 . . . . 5.9000000000000004 110.614 -175.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p 63.55 99.15 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.991 1.317 . . . . 7.0499999999999998 111.776 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -100.03 21.33 12.91 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.188 -0.914 . . . . 8.3800000000000008 110.428 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 168.46 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 125.776 1.63 . . . . 11.699999999999999 110.934 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.434 ' HD3' ' OD2' ' A' ' 62' ' ' ASP . 45.1 mtp180 -97.44 158.8 32.52 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.518 -0.765 . . . . 12.15 109.179 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.69 42.93 0.42 Allowed 'Trans proline' 0 CA--C 1.558 1.698 0 C-N-CA 123.511 2.808 . . . . 9.3200000000000003 112.938 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 64' ' ' PRO . 26.0 m 71.74 112.37 0.06 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.179 0.992 . . . . 7.5700000000000003 113.171 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' OD2' ' HD3' ' A' ' 59' ' ' ARG . 9.5 m-20 -98.0 4.15 49.39 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.8 0.81 . . . . 10.539999999999999 110.102 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -163.7 86.14 1.26 Allowed Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.589 -1.634 . . . . 13.1 106.589 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.562 ' HA ' HG21 ' A' ' 61' ' ' THR . 0.1 OUTLIER -25.72 116.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 1 C-N-CA 125.553 4.168 . . . . 7.79 116.042 -176.203 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.4 pt -86.67 153.2 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 113.173 -1.831 . . . . 5.96 112.256 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 67' ' ' PRO . . . -79.13 168.48 26.52 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 114.034 -1.439 . . . . 4.6900000000000004 108.245 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 3.9 Cg_exo -34.15 115.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 124.425 3.417 . . . . 6.1900000000000004 114.22 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -45.89 107.61 0.11 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.25 -1.795 . . . . 8.8000000000000007 114.409 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 52' ' ' ARG . 7.6 t70 -178.5 -169.12 0.17 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 101.931 -3.359 . . . . 6.5499999999999998 101.931 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 45.5 mm-40 62.86 176.89 0.15 Allowed 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 119.528 1.058 . . . . 7.3899999999999997 113.652 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 51' ' ' VAL . 6.1 t -175.98 -167.99 0.25 Allowed 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.695 0.798 . . . . 4.6100000000000003 110.219 175.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -86.54 -168.49 2.25 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.534 0.733 . . . . 7.5999999999999996 110.012 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.626 ' HA ' ' HB1' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -51.37 -7.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 126.527 1.931 . . . . 6.8600000000000003 116.203 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 21.3 t80 53.27 -109.9 0.5 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.56 1.689 . . . . 5.54 115.56 172.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.3 pt -150.82 147.14 15.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.568 0.699 . . . . 3.7999999999999998 110.94 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.75 129.15 52.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.6 -0.889 . . . . 2.4199999999999999 108.6 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 -98.11 152.24 19.53 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.893 -0.323 . . . . 2.3100000000000001 110.154 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' C ' HG22 ' A' ' 45' ' ' THR . 22.1 mmm180 -78.05 6.3 8.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.046 -0.525 . . . . 3.4500000000000002 111.193 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.28 -57.6 4.05 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 111.532 -0.627 . . . . 0.76000000000000001 111.532 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.8 t -74.51 5.22 4.94 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.409 1.099 . . . . 1.6399999999999999 108.792 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' GLY . 16.4 t70 -89.88 -11.9 40.56 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-N 114.619 -1.173 . . . . 2.0 109.872 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 79' ' ' GLY . 33.2 pt -100.25 153.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.284 -0.966 . . . . 1.7 113.397 -174.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.0 -68.18 0.75 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.471 -1.24 . . . . 1.5900000000000001 110.274 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.622 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 24.1 t70 -173.32 115.27 0.25 Allowed 'General case' 0 CA--C 1.479 -1.773 0 CA-C-O 118.543 -0.741 . . . . 2.2200000000000002 110.111 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.977 ' HB2' ' HA ' ' A' ' 24' ' ' LEU 0.842 17.7 mt -162.24 156.78 22.08 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 119.458 3.133 . . . . 2.8599999999999999 119.458 170.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -141.55 159.07 42.99 Favored 'General case' 0 CA--C 1.563 1.481 0 N-CA-C 110.476 -0.194 . . . . 1.8799999999999999 110.476 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.408 ' HA ' HG13 ' A' ' 22' ' ' ILE . 33.7 m -56.18 155.45 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.045 0 C-N-CA 123.745 0.818 . . . . 2.7000000000000002 111.6 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.75 -14.22 16.16 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.133 -0.485 . . . . 3.3900000000000001 110.749 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -107.71 148.99 38.38 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.175 -0.61 . . . . 5.0700000000000003 109.746 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.04 113.23 3.51 Favored 'Trans proline' 0 CA--C 1.555 1.536 0 C-N-CA 122.106 1.871 . . . . 6.3099999999999996 112.292 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -74.26 123.29 8.15 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.741 2.294 . . . . 8.5899999999999999 111.786 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -121.96 100.93 42.62 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 108.82 -0.808 . . . . 12.69 108.82 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -87.03 36.79 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.118 2.545 . . . . 13.220000000000001 111.265 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.4 mt 79.8 -40.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.932 1.293 . . . . 15.380000000000001 110.43 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.425 -1.681 0 CA-C-O 118.545 -0.741 . . . . 16.629999999999999 109.755 176.882 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 CA--C 1.545 1.057 0 N-CA-C 113.237 0.437 . . . . 3.73 113.237 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -130.09 101.31 5.76 Favored 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 109.68 -0.489 . . . . 8.0399999999999991 109.68 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.35 -52.32 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 111.928 0.344 . . . . 3.8100000000000001 111.928 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.87 -140.94 11.76 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.707 -0.679 . . . . 1.0700000000000001 113.698 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 61.3 m -82.64 138.82 34.04 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.216 0.206 . . . . 1.8100000000000001 111.086 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 116.61 31.45 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.468 -0.938 . . . . 4.3499999999999996 108.468 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' CD1' ' A' ' 85' ' ' LEU . 14.1 pt -140.71 153.37 21.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.956 -0.698 . . . . 2.4100000000000001 109.543 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -100.08 116.85 33.05 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 107.235 -1.394 . . . . 1.3300000000000001 107.235 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 84' ' ' ASP . 63.9 tp -123.12 129.08 50.97 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.094 -0.503 . . . . 1.45 110.284 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.2 mt -110.45 120.37 61.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.263 -0.575 . . . . 0.71999999999999997 110.122 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.3 t -75.09 158.42 33.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.006 -0.997 . . . . 1.3400000000000001 108.791 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -56.38 -8.08 0.47 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.148 1.536 . . . . 2.1200000000000001 115.148 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.82 10.06 25.04 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.335 -0.617 . . . . 0.69999999999999996 109.335 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.77 26.6 9.44 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 125.801 1.64 . . . . 2.5899999999999999 109.987 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.97 129.36 52.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 1.1699999999999999 110.854 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -86.22 120.99 28.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.445 -0.798 . . . . 4.71 110.917 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.78 133.27 55.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.934 -0.765 . . . . 3.0099999999999998 108.934 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.72 129.13 24.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.083 -1.821 . . . . 2.4500000000000002 106.083 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.478 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . 172.83 -165.52 37.91 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 110.786 -0.926 . . . . 0.45000000000000001 110.786 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 35' ' ' ILE 0.338 0.2 OUTLIER -94.67 118.83 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 117.849 -1.54 . . . . 0.93000000000000005 114.777 -175.714 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.98 135.52 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.778 -1.556 . . . . 1.72 109.119 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.49 -45.11 4.33 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 123.899 0.749 . . . . 1.1100000000000001 111.676 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -156.15 153.92 30.04 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 110.156 -0.313 . . . . 0.93999999999999995 110.156 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.78 134.13 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 107.845 -1.168 . . . . 1.45 107.845 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.508 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 8.8 t70 -94.9 98.38 10.67 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.935 -1.505 . . . . 2.5600000000000001 106.935 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 m -66.93 -15.74 63.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.619 0.6 . . . . 2.7599999999999998 112.619 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.3 -46.03 36.01 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.517 0.675 . . . . 3.2200000000000002 110.048 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -103.56 -5.98 22.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.646 0.778 . . . . 2.2599999999999998 110.334 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 m 68.08 19.83 9.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.132 1.373 . . . . 2.2799999999999998 111.311 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 75.0 p -79.3 146.53 32.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.095 0.474 . . . . 1.21 111.318 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -111.68 127.49 68.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.135 -0.484 . . . . 0.88 110.007 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.34 113.38 26.72 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-O 121.166 0.507 . . . . 0.51000000000000001 110.377 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 74' ' ' TYR . 96.8 mt -100.08 136.74 39.52 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.717 -0.674 . . . . 1.75 109.231 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.67 117.88 24.44 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.409 -0.589 . . . . 0.76000000000000001 109.409 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 35' ' ' ILE . 23.4 mtpp 65.17 38.39 6.06 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.317 1.047 . . . . 3.6299999999999999 109.517 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 ' HA3' ' A' ' 34' ' ' GLY . 3.4 p -66.44 114.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 109.023 -0.732 . . . . 1.52 109.023 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -169.3 94.03 0.29 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.807 -0.812 . . . . 5.3200000000000003 108.807 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -92.77 103.17 15.56 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 120.008 -0.677 . . . . 4.0 109.536 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 179.15 32.84 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 108.294 -1.002 . . . . 6.75 108.294 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.77 -74.91 0.88 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.076 -1.059 . . . . 5.9000000000000004 113.015 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.622 ' HB ' ' H ' ' A' ' 61' ' ' THR 0.397 0.7 OUTLIER 53.07 116.46 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.606 0 N-CA-C 116.0 1.852 . . . . 7.0499999999999998 116.0 -174.391 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' OE2' HD13 ' A' ' 65' ' ' ILE . 10.0 mm-40 -95.91 -95.76 0.19 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.015 -0.538 . . . . 8.3800000000000008 111.11 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.62 -10.86 59.74 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.255 1.026 . . . . 11.699999999999999 109.063 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.548 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 66.1 mtp180 -94.35 166.27 15.76 Favored Pre-proline 0 C--O 1.198 -1.65 0 N-CA-C 105.709 -1.96 . . . . 12.15 105.709 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.583 ' HB2' HG21 ' A' ' 56' ' ' THR 0.368 81.1 Cg_exo 0.6 -13.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.402 3.384 2 C-N-CA 129.541 6.827 . . . . 9.3200000000000003 125.094 -175.513 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.622 ' H ' ' HB ' ' A' ' 56' ' ' THR . 2.1 m -83.52 -40.67 18.87 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 119.243 0.928 . . . . 7.5700000000000003 110.36 170.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 72.84 -39.68 0.45 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.317 1.047 . . . . 10.539999999999999 113.619 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 41.8 ttm180 -154.48 -62.56 0.02 OUTLIER Pre-proline 0 CA--C 1.583 2.221 0 N-CA-C 113.948 1.092 . . . . 13.1 113.948 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 97.8 Cg_endo -79.78 102.13 1.44 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.943 1.762 . . . . 7.79 113.652 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.411 HD13 ' OE2' ' A' ' 57' ' ' GLU . 11.8 mt -89.47 145.52 7.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-O 120.739 0.304 . . . . 5.96 111.228 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.65 156.42 64.26 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.69 0.796 . . . . 4.6900000000000004 111.307 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.56 122.48 5.54 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.382 2.055 . . . . 6.1900000000000004 113.083 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -72.89 10.94 0.76 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.37 0.507 . . . . 8.8000000000000007 112.37 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -117.28 -3.39 11.47 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.262 0.553 . . . . 6.5499999999999998 110.625 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.2 -54.32 39.42 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.859 -0.61 . . . . 7.3899999999999997 111.121 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.6 m -84.78 103.15 13.61 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.212 -0.662 . . . . 4.6100000000000003 109.212 176.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -114.9 -38.55 3.89 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 113.829 1.048 . . . . 7.5999999999999996 113.829 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.83 -15.86 60.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.019 0.748 . . . . 6.8600000000000003 113.019 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.522 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 7.3 m-85 69.38 -174.69 0.19 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.729 1.211 . . . . 5.54 110.023 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.48 139.18 11.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 109.831 -0.433 . . . . 3.7999999999999998 109.831 175.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.27 134.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.215 -0.661 . . . . 2.4199999999999999 109.215 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -108.87 147.21 32.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 110.061 -0.348 . . . . 2.3100000000000001 110.061 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' C ' HG22 ' A' ' 45' ' ' THR . 16.5 mmt180 -71.55 -5.53 33.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.638 0.977 . . . . 3.4500000000000002 113.638 -174.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.552 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.14 -58.19 4.6 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 120.874 -0.679 . . . . 0.76000000000000001 112.766 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.1 p -67.44 -3.42 8.37 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.533 0.733 . . . . 1.6399999999999999 111.665 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.3 m-20 -118.41 19.54 13.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.83 -1.077 . . . . 2.0 111.597 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 79' ' ' GLY . 37.0 pt -98.8 138.81 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.07 -0.652 . . . . 1.7 111.216 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -93.34 -56.3 2.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.386 0.612 . . . . 1.5900000000000001 110.052 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.1 m-20 -122.93 136.45 54.87 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.57 -0.741 . . . . 2.2200000000000002 110.68 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 24' ' ' LEU . 58.8 tp -143.52 103.72 4.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.397 -1.705 . . . . 2.8599999999999999 106.397 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -141.32 134.45 29.3 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.381 -0.528 . . . . 1.8799999999999999 110.931 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.89 132.56 31.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.513 -0.921 . . . . 2.7000000000000002 108.513 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 9.4 p -87.77 -30.61 20.14 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.687 0.625 . . . . 3.3900000000000001 112.687 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -127.22 101.86 24.74 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.986 0.422 . . . . 5.0700000000000003 110.715 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.11 109.82 2.79 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 122.751 2.301 . . . . 6.3099999999999996 112.519 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.18 115.64 0.92 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.672 2.248 . . . . 8.5899999999999999 113.612 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -116.9 95.83 47.59 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.954 -0.566 . . . . 12.69 110.335 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.56 -52.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.755 2.303 . . . . 13.220000000000001 112.692 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.3 mm -124.61 -72.16 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-N 115.939 -0.573 . . . . 15.380000000000001 110.102 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.527 1.131 . . . . 16.629999999999999 110.469 -177.723 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.487 1.092 0 N-CA-C 113.3 0.462 . . . . 3.73 113.3 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -136.61 134.92 37.9 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.197 -0.668 . . . . 8.0399999999999991 109.197 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.39 161.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.532 -0.758 . . . . 3.8100000000000001 112.559 -174.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.37 176.73 39.5 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 108.51 -1.836 . . . . 1.0700000000000001 108.51 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 33.9 t -93.06 129.37 39.03 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.339 -0.985 . . . . 1.8100000000000001 108.339 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -87.23 114.99 24.32 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.599 -1.26 . . . . 4.3499999999999996 107.599 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -140.86 176.4 4.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 C-N-CA 120.138 -0.625 . . . . 2.4100000000000001 110.225 -175.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.465 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 15.1 m -139.14 113.24 8.71 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.774 -1.103 . . . . 1.3300000000000001 108.268 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.56 148.14 47.99 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.641 0.258 . . . . 1.45 110.751 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.1 mt -119.11 128.28 75.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.027 0.441 . . . . 0.71999999999999997 109.939 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -75.54 161.9 28.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 1.3400000000000001 109.293 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -48.11 -35.06 10.74 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 123.24 0.616 . . . . 2.1200000000000001 112.353 -176.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.9 15.7 2.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.119 0.967 . . . . 0.69999999999999996 111.907 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 69.0 25.71 5.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.847 1.259 . . . . 2.5899999999999999 109.46 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.7 mm -94.59 120.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.444 -0.798 . . . . 1.1699999999999999 109.892 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HD3' ' OE1' ' A' ' 33' ' ' GLU . 16.8 ttm180 -86.22 139.42 31.06 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.778 -0.646 . . . . 4.71 111.177 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -135.22 121.07 19.7 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 123.852 0.861 . . . . 3.0099999999999998 109.916 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 41.4 mt-10 -125.66 143.4 51.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.688 -1.227 . . . . 2.4500000000000002 107.688 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.23 12.06 Favored Glycine 0 CA--C 1.476 -2.351 0 N-CA-C 109.234 -1.547 . . . . 0.45000000000000001 109.234 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.446 HG13 ' HE2' ' A' ' 50' ' ' LYS 0.261 0.1 OUTLIER -113.31 121.96 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 N-CA-C 114.427 1.269 . . . . 0.93000000000000005 114.427 177.967 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 20' ' ' SER . 2.9 tm? -68.56 137.02 53.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.523 -1.671 . . . . 1.72 108.448 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -105.39 -48.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.106 -0.497 . . . . 1.1100000000000001 111.128 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.1 m -158.35 155.68 29.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.375 -0.602 . . . . 0.93999999999999995 109.375 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -133.12 117.6 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 108.307 -0.998 . . . . 1.45 108.307 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.78 95.42 6.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 2.5600000000000001 107.085 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.41 -19.21 64.48 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 123.084 0.553 . . . . 2.7599999999999998 111.795 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -61.25 -36.94 81.35 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 122.085 -0.384 . . . . 3.2200000000000002 110.96 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -125.61 -2.98 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.72 0.771 . . . . 2.2599999999999998 110.188 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.4 m 72.07 19.07 4.71 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.752 1.221 . . . . 2.2799999999999998 112.486 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.9 p -71.07 133.23 46.12 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.298 0.571 . . . . 1.21 111.135 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.3 t -102.3 123.0 55.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.556 -0.747 . . . . 0.88 109.93 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.65 115.36 30.2 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.119 0.485 . . . . 0.51000000000000001 111.425 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 4.4 mm? -104.7 140.86 37.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.583 -0.735 . . . . 1.75 111.491 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.69 136.22 18.0 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.545 -0.539 . . . . 0.76000000000000001 109.545 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.531 ' H ' HG23 ' A' ' 71' ' ' THR . 29.2 mtmm 70.47 23.62 4.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.444 1.097 . . . . 3.6299999999999999 109.901 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 21.7 t -68.53 117.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.03 -0.986 . . . . 1.52 109.007 -173.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -166.04 178.22 6.53 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.96 -1.126 . . . . 5.3200000000000003 107.96 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -66.75 156.68 34.78 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 110.079 -0.341 . . . . 4.0 110.079 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -77.51 144.06 37.97 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.698 0.761 . . . . 6.75 110.807 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.43 -125.17 2.77 Favored Glycine 0 C--N 1.273 -2.954 0 CA-C-N 114.521 -1.218 . . . . 5.9000000000000004 111.686 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.9 t -145.38 148.31 33.22 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 109.644 -0.502 . . . . 7.0499999999999998 109.644 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -107.61 -20.24 13.29 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.437 -0.801 . . . . 8.3800000000000008 111.881 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' CG ' ' HG3' ' A' ' 59' ' ' ARG . 16.2 p-10 -129.16 -16.93 3.94 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 113.669 0.989 . . . . 11.699999999999999 113.669 -174.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.591 ' HG3' ' CG ' ' A' ' 58' ' ' ASP . 76.9 mtt180 -123.49 -163.57 0.05 OUTLIER Pre-proline 0 C--N 1.308 -1.202 0 N-CA-C 108.82 -0.807 . . . . 12.15 108.82 -173.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.521 ' CD ' ' HB3' ' A' ' 59' ' ' ARG . 98.1 Cg_endo -105.31 37.64 0.04 OUTLIER 'Trans proline' 0 CA--C 1.574 2.483 0 C-N-CA 121.713 1.608 . . . . 9.3200000000000003 113.746 173.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.443 HG21 HG23 ' A' ' 65' ' ' ILE . 15.3 t 45.59 -177.14 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.788 0 N-CA-C 114.685 1.365 . . . . 7.5700000000000003 114.685 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.88 -57.98 4.79 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.111 -1.07 . . . . 10.539999999999999 108.111 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 81.7 mtp180 -150.52 -51.8 0.02 OUTLIER Pre-proline 0 CA--C 1.571 1.756 0 CA-C-N 114.711 -1.131 . . . . 13.1 111.918 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' CD ' ' H ' ' A' ' 63' ' ' ARG . 56.6 Cg_endo -97.43 147.58 0.84 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.443 2.095 . . . . 7.79 115.9 -174.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG23 HG21 ' A' ' 61' ' ' THR . 2.2 pp -139.15 151.55 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.403 1.081 . . . . 5.96 111.71 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.16 100.28 12.9 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.411 -0.358 . . . . 4.6900000000000004 110.613 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.77 46.62 2.28 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.306 2.671 . . . . 6.1900000000000004 112.807 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . 0.299 16.9 ptm180 56.55 97.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.289 1.436 . . . . 8.8000000000000007 113.374 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -89.51 -4.4 57.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.643 -1.162 . . . . 6.5499999999999998 108.921 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 67.15 15.52 10.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.975 1.31 . . . . 7.3899999999999997 110.543 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 50' ' ' LYS . 24.9 m 72.43 87.29 0.11 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.142 1.377 . . . . 4.6100000000000003 111.561 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -120.0 -32.96 4.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.469 -0.787 . . . . 7.5999999999999996 110.408 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.28 -4.94 50.41 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 113.454 0.909 . . . . 6.8600000000000003 113.454 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 20.8 p90 -51.85 148.11 6.14 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.13 0.972 . . . . 5.54 113.563 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.98 155.24 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.01 -0.541 . . . . 3.7999999999999998 109.702 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.2 mm -118.45 135.52 58.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.764 -0.828 . . . . 2.4199999999999999 108.764 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.62 149.35 28.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.043 0.449 . . . . 2.3100000000000001 111.451 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -67.24 -11.94 58.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 3.4500000000000002 112.057 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.62 -66.27 3.74 Favored Glycine 0 C--O 1.213 -1.213 0 C-N-CA 121.206 -0.521 . . . . 0.76000000000000001 112.949 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 t -62.43 -15.46 49.43 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.146 0.974 . . . . 1.6399999999999999 110.897 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -93.19 7.43 44.33 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 124.715 1.206 . . . . 2.0 113.107 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 79' ' ' GLY . 26.6 pt -75.37 147.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.101 -0.639 . . . . 1.7 111.461 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.38 -44.22 6.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.379 -0.373 . . . . 1.5900000000000001 111.447 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -174.47 148.01 1.18 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.293 -1.003 . . . . 2.2200000000000002 108.293 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 151.46 25.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 112.259 0.466 . . . . 2.8599999999999999 112.259 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 t -131.9 138.73 48.51 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.589 -0.893 . . . . 1.8799999999999999 108.589 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.62 155.02 6.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 116.536 -0.302 . . . . 2.7000000000000002 111.089 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 84.2 m -126.41 97.34 5.01 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.762 0.792 . . . . 3.3900000000000001 109.382 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 38.5 mt-10 -127.5 148.05 64.93 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 114.391 -1.277 . . . . 5.0700000000000003 108.318 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.89 -41.37 69.85 Favored 'Trans proline' 0 CA--C 1.584 3.022 0 C-N-CA 122.566 2.177 . . . . 6.3099999999999996 115.494 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 89' ' ' GLU . 88.6 Cg_exo -51.55 123.9 13.18 Favored 'Trans proline' 0 C--N 1.404 3.456 0 C-N-CA 122.213 1.942 . . . . 8.5899999999999999 112.801 176.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm 66.53 75.59 0.32 Allowed Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.313 1.045 . . . . 12.69 109.995 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.24 -22.84 45.93 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.31 2.007 . . . . 13.220000000000001 113.237 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.5 pt -116.6 -10.76 12.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.472 0.545 . . . . 15.380000000000001 112.472 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 C--O 1.251 1.173 0 O-C-N 124.47 1.106 . . . . 16.629999999999999 111.525 -175.631 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 1.6 Cg_endo . . . . . 0 CA--C 1.57 2.3 0 N-CA-C 112.824 0.279 . . . . 3.73 112.824 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 91.76 38.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 126.061 1.744 . . . . 8.0399999999999991 113.901 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 69' ' ' ASP . 2.6 mp -101.11 -43.22 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 119.577 -0.849 . . . . 3.8100000000000001 113.142 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' H ' HG21 ' A' ' 35' ' ' ILE . . . -154.64 -142.16 3.39 Favored Glycine 0 C--N 1.3 -1.463 0 C-N-CA 119.313 -1.422 . . . . 1.0700000000000001 113.962 -173.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.1 m -93.04 120.51 33.42 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 109.892 -0.41 . . . . 1.8100000000000001 109.892 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -87.01 107.76 18.56 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 116.57 -0.287 . . . . 4.3499999999999996 111.041 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -127.76 163.55 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.614 -0.513 . . . . 2.4100000000000001 109.614 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 86' ' ' THR . 28.9 m -122.85 112.09 17.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.223 -1.029 . . . . 1.3300000000000001 108.223 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 84' ' ' ASP . 27.1 tp -122.13 125.48 46.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.231 0.539 . . . . 1.45 112.315 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 53.8 mt -92.14 117.24 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.769 -0.651 . . . . 0.71999999999999997 110.204 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.3 t -76.28 162.55 27.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.958 -1.019 . . . . 1.3400000000000001 108.957 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -10.66 0.59 Allowed 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 125.094 1.358 . . . . 2.1200000000000001 113.854 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -0.12 47.59 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.939 0.495 . . . . 0.69999999999999996 110.453 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 72.24 30.65 2.03 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 122.857 1.313 . . . . 2.5899999999999999 107.637 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -115.56 129.54 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.611 -1.177 . . . . 1.1699999999999999 110.667 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.466 ' HE ' ' CD ' ' A' ' 33' ' ' GLU . 34.9 ttp180 -93.63 103.2 15.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.825 -0.435 . . . . 4.71 109.825 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -89.06 125.49 35.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.681 -0.859 . . . . 3.0099999999999998 108.681 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.466 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 29.9 mt-10 -126.19 127.13 45.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.002 -1.11 . . . . 2.4500000000000002 108.002 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 176.43 -155.51 19.04 Favored Glycine 0 CA--C 1.476 -2.382 0 CA-C-O 118.105 -1.386 . . . . 0.45000000000000001 109.859 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.518 HG21 ' H ' ' A' ' 19' ' ' GLY 0.437 0.2 OUTLIER -103.14 139.66 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 C-N-CA 115.064 -2.654 . . . . 0.93000000000000005 117.303 -176.544 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB2' HD12 ' A' ' 22' ' ' ILE . 3.2 tm? -86.61 140.61 29.68 Favored 'General case' 0 C--O 1.271 2.194 0 CA-C-N 113.929 -1.487 . . . . 1.72 107.816 176.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.468 ' N ' HD13 ' A' ' 36' ' ' LEU . 85.5 t80 -119.65 -55.09 2.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.94 1.4 . . . . 1.1100000000000001 111.812 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -135.06 -179.2 5.47 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.348 0.499 . . . . 0.93999999999999995 112.348 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.7 mm -134.34 131.85 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 120.874 0.369 . . . . 1.45 111.974 -173.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.52 80.67 3.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.438 1.095 . . . . 2.5600000000000001 109.198 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -55.52 -31.82 62.41 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.103 0.779 . . . . 2.7599999999999998 113.103 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -56.2 -30.77 62.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.931 0.893 . . . . 3.2200000000000002 112.497 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.496 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 19.5 m120 -125.44 18.94 8.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.598 -0.519 . . . . 2.2599999999999998 109.598 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.9 p 54.52 34.02 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.291 1.437 . . . . 2.2799999999999998 110.782 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.645 HG21 ' N ' ' A' ' 79' ' ' GLY 0.496 0.8 OUTLIER -104.22 -174.88 2.64 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 120.423 3.49 . . . . 1.21 120.423 -171.417 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 77' ' ' PHE . 2.0 m -131.34 127.38 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 113.316 -1.765 . . . . 0.88 113.463 -163.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.4 ' CB ' HD12 ' A' ' 76' ' ' ILE . . . -104.21 107.23 18.04 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.383 -0.826 . . . . 0.51000000000000001 109.283 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.577 ' O ' ' HB2' ' A' ' 74' ' ' TYR . 6.0 mp -102.33 130.13 48.96 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.444 0.64 . . . . 1.75 110.743 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 74' ' ' TYR . . . -127.27 126.98 43.63 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 106.777 -1.564 . . . . 0.76000000000000001 106.777 176.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.641 ' HA ' HG22 ' A' ' 71' ' ' THR . 31.5 mtmm 83.26 15.88 0.31 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 124.137 0.898 . . . . 3.6299999999999999 112.855 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.59 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.4 p -83.17 105.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.579 -1.648 . . . . 1.52 110.372 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' HB3' ' O ' ' A' ' 70' ' ' GLU . 1.5 tmt_? 178.8 149.67 0.24 Allowed 'General case' 0 C--O 1.198 -1.613 0 N-CA-C 104.653 -2.351 . . . . 5.3200000000000003 104.653 169.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 6.8 t -169.95 -177.49 2.62 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 121.277 1.853 . . . . 4.0 110.079 160.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -166.34 -31.72 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 124.468 1.105 . . . . 6.75 110.539 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.605 ' HA3' ' CG2' ' A' ' 65' ' ' ILE . . . 90.68 142.0 9.7 Favored Glycine 0 N--CA 1.41 -3.084 0 C-N-CA 119.482 -1.342 . . . . 5.9000000000000004 112.728 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.434 ' CG2' ' HA ' ' A' ' 60' ' ' PRO . 89.7 m 64.92 106.44 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.532 1.133 . . . . 7.0499999999999998 111.883 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -112.83 -103.6 0.4 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 114.945 1.461 . . . . 8.3800000000000008 114.945 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.09 -19.25 62.76 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.434 1.272 . . . . 11.699999999999999 114.434 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -135.14 130.42 19.31 Favored Pre-proline 0 N--CA 1.419 -1.985 0 N-CA-C 106.151 -1.796 . . . . 12.15 106.151 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HA ' ' CG2' ' A' ' 56' ' ' THR . 17.3 Cg_exo -66.02 82.55 0.26 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.112 1.875 . . . . 9.3200000000000003 111.732 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.5 t -69.59 -174.24 0.68 Allowed 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 120.49 -0.484 . . . . 7.5700000000000003 109.788 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -147.82 -41.29 0.17 Allowed 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.028 0.442 . . . . 10.539999999999999 111.593 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.535 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 29.8 ttm180 -95.88 -54.84 0.22 Allowed Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 115.77 -0.65 . . . . 13.1 112.553 -172.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 6.1 Cg_endo -93.18 104.01 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.224 1.949 . . . . 7.79 111.969 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.605 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 18.9 mm -113.12 151.95 14.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.106 -0.701 . . . . 5.96 109.106 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -85.08 109.1 18.38 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 109.977 -0.379 . . . . 4.6900000000000004 109.977 173.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 65' ' ' ILE . 73.9 Cg_endo -85.6 50.71 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.811 2.341 . . . . 6.1900000000000004 107.543 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.61 ' HA ' ' HB3' ' A' ' 53' ' ' SER 0.266 30.3 mmt180 106.7 -179.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 129.165 2.986 . . . . 8.8000000000000007 110.697 -173.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.587 ' HB3' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER 82.18 105.65 0.06 Allowed 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 113.785 1.031 . . . . 6.5499999999999998 113.785 -176.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 44.1 tt0 141.45 115.25 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.503 0 C-N-CA 125.928 1.691 . . . . 7.3899999999999997 115.001 168.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.641 HG22 ' HA ' ' A' ' 50' ' ' LYS . 2.9 t -168.46 159.73 10.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 4.6100000000000003 109.975 169.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -110.4 -25.84 9.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.067 0.461 . . . . 7.5999999999999996 110.242 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.27 -53.45 7.31 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.0 -0.545 . . . . 6.8600000000000003 110.102 -172.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 48' ' ' LEU 0.264 19.1 p90 57.27 161.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 126.622 1.969 . . . . 5.54 115.367 -178.224 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.59 153.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 109.994 -0.373 . . . . 3.7999999999999998 109.994 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' CB ' ' A' ' 47' ' ' ALA . 28.4 mm -110.88 133.65 55.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.063 -1.088 . . . . 2.4199999999999999 108.063 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.535 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.9 m-85 -100.46 142.1 32.4 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 118.726 -1.19 . . . . 2.3100000000000001 108.232 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.596 ' C ' HG21 ' A' ' 45' ' ' THR . 5.8 mpt_? -110.02 149.17 30.36 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-O 121.481 0.657 . . . . 3.4500000000000002 110.745 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.645 ' N ' HG21 ' A' ' 45' ' ' THR . . . -52.9 -23.17 14.35 Favored Glycine 0 C--N 1.276 -2.788 0 C-N-CA 126.842 2.163 . . . . 0.76000000000000001 112.791 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 p -93.91 -13.01 27.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.674 -0.763 . . . . 1.6399999999999999 110.85 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.04 -7.63 10.82 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.435 -0.802 . . . . 2.0 112.04 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.6 pt -83.06 142.84 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.344 0.868 . . . . 1.7 113.344 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -101.21 -65.83 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 1.5900000000000001 111.124 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.441 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.7 m-20 -140.28 149.02 42.29 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 112.655 0.613 . . . . 2.2200000000000002 112.655 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.5 tp -134.25 131.16 38.14 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.68 -0.691 . . . . 2.8599999999999999 110.26 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 23' ' ' SER . 9.0 t -141.74 161.29 38.31 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.096 -1.076 . . . . 1.8799999999999999 108.096 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 p -111.67 140.72 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.518 -0.549 . . . . 2.7000000000000002 109.518 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.87 -44.51 7.71 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 120.359 -0.536 . . . . 3.3900000000000001 109.61 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -141.16 116.44 7.24 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.572 -0.529 . . . . 5.0700000000000003 109.572 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.74 110.0 2.85 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.925 1.75 . . . . 6.3099999999999996 108.574 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.6 135.38 19.79 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 121.788 1.659 . . . . 8.5899999999999999 113.163 -175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 95' ' ' MET . 63.6 tttp 73.43 87.9 0.09 OUTLIER Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 114.677 -1.147 . . . . 12.69 111.886 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.14 -29.34 6.58 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 123.096 2.531 . . . . 13.220000000000001 112.39 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.3 pt -116.12 138.46 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 115.956 -0.565 . . . . 15.380000000000001 109.478 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.456 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 98.3 mmm . . . . . 0 C--N 1.298 -1.649 0 CA-C-O 118.865 -0.588 . . . . 16.629999999999999 109.802 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD2' ' CA ' ' A' ' 55' ' ' GLY . 40.4 Cg_exo . . . . . 0 N--CA 1.505 2.175 0 N-CA-C 115.822 1.432 . . . . 3.73 115.822 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' H ' HD12 ' A' ' 18' ' ' ILE . 34.3 p90 -140.31 12.13 2.36 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.157 -0.474 . . . . 8.0399999999999991 109.796 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.507 HD12 ' H ' ' A' ' 17' ' ' TYR . 2.2 mp -75.93 103.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.353 0.597 . . . . 3.8100000000000001 111.433 -172.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.36 -170.67 22.88 Favored Glycine 0 C--N 1.284 -2.322 0 CA-C-N 114.427 -1.26 . . . . 1.0700000000000001 111.058 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.4 m -94.09 121.86 36.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.086 -0.709 . . . . 1.8100000000000001 109.086 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 5.2 mptt -89.92 94.31 9.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.989 -1.115 . . . . 4.3499999999999996 107.989 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 87' ' ' VAL . 1.8 pp -137.77 -179.18 2.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 120.438 -0.505 . . . . 2.4100000000000001 110.318 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.8 p -132.18 131.33 42.1 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.303 -0.999 . . . . 1.3300000000000001 108.303 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.712 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 6.5 tt -135.97 145.74 46.49 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 108.295 -1.002 . . . . 1.45 108.295 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.0 mt -116.4 128.77 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.71 -0.677 . . . . 0.71999999999999997 109.851 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -76.9 170.52 16.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.154 -0.684 . . . . 1.3400000000000001 109.154 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -58.77 -23.87 60.78 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.08 0.952 . . . . 2.1200000000000001 112.221 -173.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.48 25.4 5.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.016 -0.538 . . . . 0.69999999999999996 110.298 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.606 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 0.8 OUTLIER 66.59 28.72 9.21 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.618 -0.719 . . . . 2.5899999999999999 112.397 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 52.1 mm -89.46 97.71 7.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.883 -0.599 . . . . 1.1699999999999999 110.555 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.728 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.0 136.62 33.51 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.619 -0.719 . . . . 4.71 111.066 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.712 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 1.9 p90 -126.34 163.19 23.81 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.692 -0.803 . . . . 3.0099999999999998 110.67 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.86 126.22 17.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.064 -1.458 . . . . 2.4500000000000002 107.064 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . 158.64 -150.64 21.42 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 120.97 -0.633 . . . . 0.45000000000000001 111.547 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.25 0.1 OUTLIER -110.73 115.51 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 114.369 1.248 . . . . 0.93000000000000005 114.369 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 5.3 tt -77.42 147.14 36.15 Favored 'General case' 0 C--O 1.252 1.184 0 CA-C-N 114.205 -1.362 . . . . 1.72 109.65 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -108.5 -52.59 2.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.278 0.362 . . . . 1.1100000000000001 110.089 -175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.7 m -143.11 151.49 40.79 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.43 -1.693 . . . . 0.93999999999999995 106.43 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -159.47 103.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 C-N-CA 118.088 -1.445 . . . . 1.45 112.93 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 6.4 m-20 -127.38 131.3 50.36 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-N 115.555 -0.748 . . . . 2.5600000000000001 112.19 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.2 t -69.04 -35.36 76.5 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 113.365 0.876 . . . . 2.7599999999999998 113.365 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.46 -60.82 2.13 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.553 -1.659 . . . . 3.2200000000000002 110.832 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.331 21.9 p-10 -136.07 -24.61 1.26 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 116.739 2.126 . . . . 2.2599999999999998 116.739 178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.2 m -96.19 44.88 1.07 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.234 1.016 . . . . 2.2799999999999998 109.046 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 70.8 p -38.3 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 1 C-N-CA 134.141 4.976 . . . . 1.21 116.886 -178.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 39' ' ' ILE . 9.6 t -91.81 101.82 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 CA-C-N 115.112 -0.949 . . . . 0.88 109.197 -163.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.51 111.93 22.97 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 113.933 -1.485 . . . . 0.51000000000000001 107.451 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.439 HD21 HG21 ' A' ' 51' ' ' VAL . 58.7 tp -114.5 127.24 55.71 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.289 -0.869 . . . . 1.75 109.361 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.19 155.08 45.26 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 107.217 -1.401 . . . . 0.76000000000000001 107.217 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.488 ' HA ' ' OG1' ' A' ' 71' ' ' THR . 51.8 pttt 50.28 27.87 2.89 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.133 0.973 . . . . 3.6299999999999999 113.534 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 34' ' ' GLY . 4.5 p -68.25 111.08 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.019 0.914 . . . . 1.52 109.855 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -171.82 -174.76 1.39 Allowed 'General case' 0 N--CA 1.406 -2.628 0 C-N-CA 125.396 1.478 . . . . 5.3200000000000003 108.351 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 14.6 m -70.41 -174.77 0.9 Allowed 'General case' 0 CA--C 1.571 1.759 0 O-C-N 124.091 0.87 . . . . 4.0 110.545 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.436 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 76.2 m-85 -78.72 -98.48 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 114.47 1.285 . . . . 6.75 114.47 -172.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -142.29 -76.35 0.04 OUTLIER Glycine 0 C--O 1.213 -1.198 0 C-N-CA 120.761 -0.733 . . . . 5.9000000000000004 114.407 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.575 HG23 ' C ' ' A' ' 59' ' ' ARG . 87.7 m 68.12 -68.29 0.17 Allowed 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.509 0.723 . . . . 7.0499999999999998 112.617 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.274 8.2 mm-40 82.68 -43.59 0.13 Allowed 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 127.019 2.128 . . . . 8.3800000000000008 112.494 -177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -151.7 -28.28 0.18 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.475 0.546 . . . . 11.699999999999999 112.475 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.575 ' C ' HG23 ' A' ' 56' ' ' THR . 81.1 mtp180 -138.5 137.4 20.28 Favored Pre-proline 0 CA--C 1.504 -0.817 0 C-N-CA 120.182 -0.607 . . . . 12.15 109.452 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 12.2 Cg_exo -69.67 66.55 1.72 Allowed 'Trans proline' 0 N--CA 1.484 0.919 0 C-N-CA 123.143 2.562 . . . . 9.3200000000000003 111.724 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.638 ' O ' HG12 ' A' ' 65' ' ' ILE . 15.0 t -113.06 -154.12 0.54 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.116 -0.947 . . . . 7.5700000000000003 110.275 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 61' ' ' THR . 15.8 t70 30.74 71.01 0.08 Allowed 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 128.825 2.85 . . . . 10.539999999999999 111.254 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 65' ' ' ILE . 15.9 mmm180 66.07 80.01 0.23 Allowed Pre-proline 0 C--O 1.212 -0.886 0 CA-C-N 112.916 -1.947 . . . . 13.1 107.775 -175.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -14.93 88.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.6 1 C-N-CA 125.896 4.397 . . . . 7.79 117.168 -167.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 61' ' ' THR . 6.0 pt -101.05 153.8 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 112.766 -2.016 . . . . 5.96 112.788 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 53' ' ' SER . . . -104.69 149.41 37.44 Favored Pre-proline 0 C--O 1.175 -2.859 0 N-CA-C 106.787 -1.56 . . . . 4.6900000000000004 106.787 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 53' ' ' SER . 72.4 Cg_endo -81.59 132.37 7.79 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 CA-C-N 121.539 1.585 . . . . 6.1900000000000004 114.557 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -75.68 161.09 29.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.792 -0.64 . . . . 8.8000000000000007 110.768 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -125.65 -3.09 7.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.506 0.67 . . . . 6.5499999999999998 109.45 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 69.95 165.06 0.27 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.153 1.381 . . . . 7.3899999999999997 112.526 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' A' ' 50' ' ' LYS . 21.1 p -138.02 165.45 26.55 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 109.326 -0.62 . . . . 4.6100000000000003 109.326 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -120.73 -71.85 0.72 Allowed 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 120.216 -0.594 . . . . 7.5999999999999996 112.56 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.11 -24.03 47.67 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 113.119 0.785 . . . . 6.8600000000000003 113.119 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 66.13 174.42 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.943 1.297 . . . . 5.54 110.496 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 pt -141.24 146.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 121.62 -0.675 . . . . 3.7999999999999998 112.607 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.51 151.48 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.139 -1.059 . . . . 2.4199999999999999 108.139 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.59 ' O ' ' HB ' ' A' ' 45' ' ' THR . 97.6 m-85 -124.12 139.52 53.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.992 -0.373 . . . . 2.3100000000000001 109.992 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 21.1 mmm180 -43.93 -26.32 0.26 Allowed 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 116.124 1.898 . . . . 3.4500000000000002 116.124 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.512 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 74.21 -64.19 2.06 Favored Glycine 0 C--O 1.209 -1.454 0 C-N-CA 120.972 -0.633 . . . . 0.76000000000000001 112.557 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.0 t -73.38 -7.65 52.55 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.82 0.848 . . . . 1.6399999999999999 110.311 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 16.4 m-20 -121.16 30.1 6.99 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.973 -0.558 . . . . 2.0 110.316 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 79' ' ' GLY . 2.1 pp -77.44 163.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.845 -0.535 . . . . 1.7 112.42 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.606 ' HE3' ' OE2' ' A' ' 29' ' ' GLU . 15.6 tppt? -105.85 -62.05 1.42 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.937 0.399 . . . . 1.5900000000000001 110.07 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.79 150.4 29.33 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.551 -0.75 . . . . 2.2200000000000002 110.305 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.55 132.58 10.73 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 124.55 1.14 . . . . 2.8599999999999999 110.957 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 9.4 t -125.03 139.96 53.33 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.495 -0.928 . . . . 1.8799999999999999 108.495 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 22' ' ' ILE . 54.7 t -113.86 102.71 14.27 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-N 116.201 -0.454 . . . . 2.7000000000000002 110.355 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 23.9 p -169.63 121.55 0.71 Allowed 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.988 -0.551 . . . . 3.3900000000000001 111.481 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -95.0 117.82 66.76 Favored Pre-proline 0 N--CA 1.427 -1.618 0 N-CA-C 107.774 -1.195 . . . . 5.0700000000000003 107.774 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.21 109.3 1.52 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.562 2.175 . . . . 6.3099999999999996 112.896 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -88.65 93.75 0.38 Allowed 'Trans proline' 0 N--CA 1.434 -2.022 0 C-N-CA 122.271 1.981 . . . . 8.5899999999999999 111.579 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 58.49 87.64 0.14 Allowed Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.112 0.965 . . . . 12.69 113.285 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -69.21 -51.83 0.41 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.069 1.846 . . . . 13.220000000000001 111.919 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.2 pt -143.05 19.76 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.883 -0.599 . . . . 15.380000000000001 109.842 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 C--N 1.314 -0.946 0 N-CA-C 110.009 -0.367 . . . . 16.629999999999999 110.009 -176.462 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.76 0 CA-C-O 120.114 -0.27 . . . . 1.0700000000000001 112.8 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 46.4 t -88.28 123.65 33.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.514 -0.55 . . . . 1.8100000000000001 109.514 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 8.4 mptt -82.32 121.35 26.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.105 -0.702 . . . . 4.3499999999999996 109.105 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -140.58 167.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.876 -0.787 . . . . 2.4100000000000001 108.876 -178.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 20.5 t -123.81 124.52 42.86 Favored 'General case' 0 N--CA 1.404 -2.738 0 N-CA-C 107.628 -1.249 . . . . 1.3300000000000001 107.628 174.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 82' ' ' ILE . 5.3 tt -116.45 130.71 56.91 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.154 -0.93 . . . . 1.45 109.581 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 84' ' ' ASP . 2.9 mp -105.52 119.91 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-N 116.332 -0.395 . . . . 0.71999999999999997 110.154 175.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.9 p -78.2 169.6 18.0 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.28 -0.418 . . . . 1.3400000000000001 110.599 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -49.12 -26.02 2.49 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.809 1.04 . . . . 2.1200000000000001 113.809 -175.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.17 10.9 17.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 0.69999999999999996 110.836 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 63.96 39.97 7.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.261 1.024 . . . . 2.5899999999999999 111.087 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.9 mm -106.11 127.09 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.047 -1.433 . . . . 1.1699999999999999 109.88 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -89.84 142.68 27.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.262 0.467 . . . . 4.71 112.262 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' SER . 57.4 m-85 -138.33 143.79 40.08 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.681 -1.229 . . . . 3.0099999999999998 107.681 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.46 134.51 55.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.886 0.374 . . . . 2.4500000000000002 110.044 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -166.01 -169.38 29.55 Favored Glycine 0 CA--C 1.467 -2.962 0 N-CA-C 111.064 -0.814 . . . . 0.45000000000000001 111.064 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.776 HD11 ' HG3' ' A' ' 50' ' ' LYS 0.345 1.4 pp -113.01 108.74 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.528 0 CA-C-O 123.051 1.405 . . . . 0.93000000000000005 113.293 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' A' ' 22' ' ' ILE . 3.4 tm? -55.25 135.61 49.59 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.627 -1.624 . . . . 1.72 111.041 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -113.04 -48.14 3.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.516 -0.766 . . . . 1.1100000000000001 111.553 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 m -154.09 153.11 31.31 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.848 -0.532 . . . . 0.93999999999999995 109.701 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.42 126.44 48.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.777 -0.823 . . . . 1.45 108.777 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.487 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 18.7 m-20 -89.54 95.77 10.41 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.82 -1.178 . . . . 2.5600000000000001 107.82 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -56.06 -29.0 59.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.351 0.871 . . . . 2.7599999999999998 113.351 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.19 -39.93 90.03 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.029 0.442 . . . . 3.2200000000000002 111.511 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -109.79 0.5 18.83 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.798 -0.564 . . . . 2.2599999999999998 110.345 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m 65.18 16.44 10.55 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.047 -0.979 . . . . 2.2799999999999998 110.645 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 40' ' ' ASP . 30.4 p -75.77 135.65 40.29 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.201 0.524 . . . . 1.21 111.132 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.7 t -104.45 125.7 59.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.846 -0.615 . . . . 0.88 110.005 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.33 106.41 17.58 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.198 0.523 . . . . 0.51000000000000001 109.76 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.2 150.23 22.74 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.507 -0.77 . . . . 1.75 111.888 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 35' ' ' ILE . . . -147.75 134.39 19.89 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 105.132 -2.173 . . . . 0.76000000000000001 105.132 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.776 ' HG3' HD11 ' A' ' 35' ' ' ILE 0.407 4.4 tptt 49.66 58.61 5.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 124.808 2.242 . . . . 3.6299999999999999 113.148 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.551 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 44.6 t -77.38 113.94 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 112.886 -1.961 . . . . 1.52 106.204 173.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 . . . . . 0 C--N 1.313 -0.983 0 N-CA-C 107.265 -1.383 . . . . 5.3200000000000003 107.265 177.313 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 16.1 p90 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 113.791 1.034 . . . . 5.54 113.791 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 tt -162.98 147.2 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.862 -0.608 . . . . 3.7999999999999998 110.361 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.7 mp -107.49 129.72 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.115 -1.068 . . . . 2.4199999999999999 108.115 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -103.67 148.07 26.48 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.523 -0.308 . . . . 2.3100000000000001 111.735 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -59.73 -13.71 11.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.229 1.012 . . . . 3.4500000000000002 113.529 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.11 -58.72 4.94 Favored Glycine 0 CA--C 1.496 -1.109 0 C-N-CA 120.946 -0.645 . . . . 0.76000000000000001 111.875 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.3 t -65.99 -11.52 48.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.243 0.544 . . . . 1.6399999999999999 110.685 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 3.8 m-20 -98.05 20.78 11.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.431 0.692 . . . . 2.0 111.506 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.59 HD12 HD21 ' A' ' 24' ' ' LEU . 40.3 mm -101.07 132.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.149 -1.02 . . . . 1.7 110.334 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -87.38 -28.51 22.13 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.804 -0.635 . . . . 1.5900000000000001 111.463 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 25' ' ' ILE . 20.1 t70 -166.35 135.13 2.98 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.274 0.472 . . . . 2.2200000000000002 112.274 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.8 mt -122.28 100.37 6.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.587 -0.733 . . . . 2.8599999999999999 110.325 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -109.96 116.71 32.09 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.124 0.488 . . . . 1.8799999999999999 110.483 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.672 -0.694 . . . . 2.7000000000000002 111.334 -178.209 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.262 1.853 0 CA-C-O 121.37 0.428 . . . . 1.0700000000000001 113.636 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -89.76 145.73 24.98 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.482 0.713 . . . . 1.8100000000000001 109.492 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 10.3 mptt -92.05 114.05 26.49 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.448 -0.945 . . . . 4.3499999999999996 108.448 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 86' ' ' THR . 10.8 tt -151.93 150.61 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.17 -0.468 . . . . 2.4100000000000001 111.536 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.5 m -104.01 127.84 51.57 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.509 -1.293 . . . . 1.3300000000000001 107.509 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD13 HD13 ' A' ' 85' ' ' LEU . 40.0 tp -123.5 128.71 50.18 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.491 -0.322 . . . . 1.45 110.587 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 62.9 mt -104.29 124.63 58.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.685 -0.857 . . . . 0.71999999999999997 108.685 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p -80.0 160.18 25.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.444 -0.947 . . . . 1.3400000000000001 108.444 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -54.8 -12.04 0.72 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.627 0.973 . . . . 2.1200000000000001 113.627 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 27' ' ' LYS . . . -85.05 5.53 29.14 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.386 0.675 . . . . 0.69999999999999996 110.013 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 3.1 tp10 70.46 30.65 3.17 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.153 1.781 . . . . 2.5899999999999999 108.958 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -108.34 128.11 64.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.381 -0.827 . . . . 1.1699999999999999 111.544 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.15 124.62 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.386 -0.825 . . . . 4.71 111.04 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.46 127.65 51.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.528 -0.545 . . . . 3.0099999999999998 109.528 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -118.69 126.35 51.71 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.113 0.482 . . . . 2.4500000000000002 109.734 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -177.28 -151.67 9.32 Favored Glycine 0 CA--C 1.468 -2.874 0 N-CA-C 110.63 -0.988 . . . . 0.45000000000000001 110.63 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 50' ' ' LYS 0.317 1.1 pp -116.72 116.64 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 CA-C-O 122.192 0.996 . . . . 0.93000000000000005 112.605 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.435 HD21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -62.39 133.1 54.58 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.93 -1.486 . . . . 1.72 108.373 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -94.76 -55.98 2.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.573 -0.451 . . . . 1.1100000000000001 112.14 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.5 m -153.86 154.06 33.24 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.013 -0.429 . . . . 0.93999999999999995 110.33 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.7 133.79 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 109.254 -0.647 . . . . 1.45 109.254 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 7.8 t70 -92.93 110.61 22.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.893 -0.781 . . . . 2.5600000000000001 108.893 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 m -73.46 -8.77 57.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.819 -0.628 . . . . 2.7599999999999998 112.129 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.63 -56.35 4.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.838 -0.745 . . . . 3.2200000000000002 111.168 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -96.47 0.34 50.18 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.7 -0.682 . . . . 2.2599999999999998 109.432 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m 65.68 21.1 11.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.456 -1.247 . . . . 2.2799999999999998 111.259 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 77.3 p -73.07 154.53 40.38 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.184 0.516 . . . . 1.21 111.675 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.435 ' CG1' HD21 ' A' ' 36' ' ' LEU . 59.8 t -124.94 125.1 69.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.724 -0.671 . . . . 0.88 110.056 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.59 109.37 21.45 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.51000000000000001 109.018 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.556 ' HG ' ' CG2' ' A' ' 51' ' ' VAL . 45.7 tp -113.01 129.07 56.62 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.947 -0.57 . . . . 1.75 109.579 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.55 156.55 30.38 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.76000000000000001 108.395 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 35' ' ' ILE . 48.8 mttp 60.08 29.78 19.32 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.102 0.876 . . . . 3.6299999999999999 109.885 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 46.6 t -67.0 114.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.731 -1.122 . . . . 1.52 109.086 -176.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 . . . . . 0 N--CA 1.437 -1.093 0 N-CA-C 108.36 -0.978 . . . . 5.3200000000000003 108.36 -179.126 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.4 p90 . . . . . 0 C--O 1.24 0.562 0 N-CA-C 112.461 0.541 . . . . 5.54 112.461 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 tt -157.92 140.71 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 110.518 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -102.7 135.45 39.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.342 -0.984 . . . . 2.4199999999999999 108.342 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.4 150.84 27.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.535 -0.543 . . . . 2.3100000000000001 109.535 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.644 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -81.64 10.51 5.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.017 0.437 . . . . 3.4500000000000002 111.418 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 84.41 -61.16 4.75 Favored Glycine 0 CA--C 1.47 -2.767 0 N-CA-C 111.53 -0.628 . . . . 0.76000000000000001 111.53 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -62.4 -12.06 19.38 Favored 'General case' 0 CA--C 1.582 2.188 0 CA-C-O 121.092 0.472 . . . . 1.6399999999999999 111.254 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 9.3 m-20 -82.53 -0.56 47.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.352 0.661 . . . . 2.0 112.268 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 79' ' ' GLY . 1.9 pp -79.6 140.65 16.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 119.18 -1.008 . . . . 1.7 112.652 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -95.64 -56.1 2.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.983 -0.747 . . . . 1.5900000000000001 108.983 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.429 ' O ' HD12 ' A' ' 24' ' ' LEU . 19.9 t70 -136.0 139.15 42.92 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.195 -0.912 . . . . 2.2200000000000002 108.666 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.462 HD13 HD13 ' A' ' 24' ' ' LEU . 38.3 tp -135.96 99.59 4.19 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.323 -1.362 . . . . 2.8599999999999999 107.323 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' HG13 ' A' ' 22' ' ' ILE . 51.1 m -132.35 110.54 10.64 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.077 0.465 . . . . 1.8799999999999999 111.285 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--O 1.244 0.805 0 CA-C-N 115.706 -0.679 . . . . 2.7000000000000002 109.956 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.575 0 N-CA-C 110.934 -0.866 . . . . 1.0700000000000001 110.934 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -92.76 130.98 38.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.564 0.579 . . . . 1.8100000000000001 112.564 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 64.4 mmtt -74.01 112.6 10.29 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.019 0.528 . . . . 4.3499999999999996 110.684 175.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -141.13 164.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.855 -0.794 . . . . 2.4100000000000001 108.855 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 35.7 t -122.41 115.72 22.76 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.916 -1.142 . . . . 1.3300000000000001 107.916 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 77' ' ' PHE . 3.4 tt -123.04 128.69 50.49 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.298 -1.371 . . . . 1.45 107.298 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.7 mt -99.06 122.88 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.712 -0.395 . . . . 0.71999999999999997 109.981 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -76.1 162.26 28.16 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.561 -0.745 . . . . 1.3400000000000001 110.413 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -52.18 -23.45 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.526 1.13 . . . . 2.1200000000000001 113.733 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.81 22.66 3.47 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 122.841 0.456 . . . . 0.69999999999999996 110.266 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.263 10.8 pt-20 50.35 50.7 18.24 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.879 1.272 . . . . 2.5899999999999999 112.677 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -119.08 118.65 58.35 Favored 'Isoleucine or valine' 0 C--O 1.254 1.32 0 CA-C-N 114.455 -1.248 . . . . 1.1699999999999999 110.247 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.64 109.17 15.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.534 -0.757 . . . . 4.71 110.768 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -105.57 134.19 49.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.145 -0.479 . . . . 3.0099999999999998 110.443 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -134.9 129.87 35.01 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.992 -0.744 . . . . 2.4500000000000002 108.992 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -174.83 -151.68 8.64 Favored Glycine 0 CA--C 1.481 -2.078 0 N-CA-C 110.43 -1.068 . . . . 0.45000000000000001 110.43 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.43 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -110.95 107.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-O 121.413 0.625 . . . . 0.93000000000000005 112.35 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.599 ' HA ' HD23 ' A' ' 48' ' ' LEU . 6.9 tt -58.41 137.88 56.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.434 -1.257 . . . . 1.72 111.301 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -99.44 -60.56 1.51 Allowed 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.294 -0.867 . . . . 1.1100000000000001 112.023 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -151.75 154.03 35.49 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.94 -0.475 . . . . 0.93999999999999995 110.052 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.81 129.54 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.807 -1.183 . . . . 1.45 107.807 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.81 105.31 17.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.986 -1.116 . . . . 2.5600000000000001 107.986 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -73.02 -6.08 43.13 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.925 0.713 . . . . 2.7599999999999998 112.925 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.76 -56.24 3.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 3.2200000000000002 110.007 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -89.65 -9.67 48.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.758 -0.656 . . . . 2.2599999999999998 110.226 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m 70.28 21.86 5.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.264 1.025 . . . . 2.2799999999999998 109.697 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -83.69 144.15 29.57 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.726 -0.67 . . . . 1.21 111.405 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.41 128.03 62.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.928 -0.578 . . . . 0.88 110.56 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.97 110.5 22.54 Favored 'General case' 0 C--O 1.258 1.547 0 N-CA-C 109.455 -0.572 . . . . 0.51000000000000001 109.455 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 36' ' ' LEU . 11.8 mt -108.24 146.68 32.49 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.23 -0.895 . . . . 1.75 112.141 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.69 146.29 24.16 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.47 -1.307 . . . . 0.76000000000000001 107.47 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt 62.43 29.55 17.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 124.013 0.821 . . . . 3.6299999999999999 111.157 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.584 HG22 HD22 ' A' ' 48' ' ' LEU . 49.9 t -69.42 111.64 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.538 -0.865 . . . . 1.52 109.816 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 . . . . . 0 N--CA 1.429 -1.505 0 C-N-CA 124.985 1.314 . . . . 5.3200000000000003 108.673 176.304 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 26.4 m-85 . . . . . 0 N--CA 1.495 1.804 0 N-CA-C 109.907 -0.405 . . . . 5.54 109.907 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.62 137.16 51.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-O 121.463 0.649 . . . . 3.7999999999999998 111.749 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mm -119.5 129.1 75.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.313 -0.858 . . . . 2.4199999999999999 109.176 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 24' ' ' LEU . 20.7 m-85 -98.95 137.32 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.091 -0.504 . . . . 2.3100000000000001 111.192 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 39.3 mmt180 -64.99 -13.65 58.25 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 123.322 0.649 . . . . 3.4500000000000002 112.084 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 82.01 -61.9 4.61 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.585 -0.816 . . . . 0.76000000000000001 111.988 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.0 p -63.41 -27.43 69.29 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.244 0.545 . . . . 1.6399999999999999 111.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 2.0 m-20 -98.38 21.4 11.11 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.182 -0.917 . . . . 2.0 112.701 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 79' ' ' GLY . 40.4 pt -87.01 142.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.431 -0.908 . . . . 1.7 110.406 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 73.3 mmtt -88.94 -60.34 1.98 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.078 -0.51 . . . . 1.5900000000000001 111.098 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -145.04 152.46 40.15 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 116.402 -0.363 . . . . 2.2200000000000002 110.185 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.18 102.05 5.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 123.921 0.763 . . . . 2.8599999999999999 109.291 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 23' ' ' SER . 68.5 m -97.98 120.12 37.81 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.879 -0.601 . . . . 1.8799999999999999 109.949 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.546 0.813 0 CA-C-N 115.956 -0.566 . . . . 2.7000000000000002 110.534 -179.062 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.721 0 N-CA-C 110.137 -1.185 . . . . 1.0700000000000001 110.137 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.8 m -88.81 139.62 30.27 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 117.077 0.438 . . . . 1.8100000000000001 109.823 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -87.69 106.71 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.69 -0.804 . . . . 4.3499999999999996 112.025 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.85 146.27 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.135 0.574 . . . . 2.4100000000000001 110.518 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 t -107.68 111.78 24.16 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.635 -1.617 . . . . 1.3300000000000001 106.635 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 84' ' ' ASP . 61.6 tp -121.6 129.67 52.99 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.554 0.216 . . . . 1.45 111.062 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.58 118.64 53.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.645 -0.502 . . . . 0.71999999999999997 109.645 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.9 p -78.45 162.83 26.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.488 -0.778 . . . . 1.3400000000000001 110.313 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -10.01 0.3 Allowed 'General case' 0 C--O 1.211 -0.926 0 N-CA-C 115.896 1.813 . . . . 2.1200000000000001 115.896 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.12 13.69 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.542 -0.54 . . . . 0.69999999999999996 109.542 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.41 28.28 15.45 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 125.259 1.424 . . . . 2.5899999999999999 110.058 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.47 129.01 66.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.712 -0.676 . . . . 1.1699999999999999 111.611 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptm85 -87.11 118.98 26.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.909 -0.587 . . . . 4.71 111.932 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.29 125.79 54.68 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.251 -1.018 . . . . 3.0099999999999998 108.251 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -134.99 131.61 37.35 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.334 -1.358 . . . . 2.4500000000000002 107.334 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 179.91 -158.53 22.23 Favored Glycine 0 CA--C 1.49 -1.49 0 N-CA-C 111.306 -0.718 . . . . 0.45000000000000001 111.306 -175.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.54 HD13 ' H ' ' A' ' 35' ' ' ILE 0.31 0.2 OUTLIER -92.4 109.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.581 0 CA-C-O 122.314 1.054 . . . . 0.93000000000000005 113.606 -177.062 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.5 tp -67.06 133.42 49.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.568 -1.651 . . . . 1.72 109.847 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -111.95 -59.21 2.02 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 120.46 -0.496 . . . . 1.1100000000000001 110.566 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.7 m -141.19 160.59 39.78 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.977 -0.379 . . . . 0.93999999999999995 109.977 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.56 123.78 53.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.638 -1.616 . . . . 1.45 106.638 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.488 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 14.7 m-20 -86.84 94.24 9.51 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.647 -1.612 . . . . 2.5600000000000001 106.647 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -57.73 -26.34 61.65 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.454 -0.794 . . . . 2.7599999999999998 112.943 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.31 -50.27 62.56 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.567 0.747 . . . . 3.2200000000000002 111.475 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -112.94 6.01 17.59 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 120.951 0.405 . . . . 2.2599999999999998 109.973 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.7 m 64.93 22.03 12.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.25 1.02 . . . . 2.2799999999999998 110.817 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.493 HG22 ' C ' ' A' ' 78' ' ' ARG . 33.1 p -73.99 148.42 42.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.86 -0.609 . . . . 1.21 110.933 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.86 126.92 65.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 116.442 -0.345 . . . . 0.88 110.572 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.33 101.54 11.24 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.452 0.644 . . . . 0.51000000000000001 110.232 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.643 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 91.3 mt -100.76 153.98 19.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.427 -0.806 . . . . 1.75 109.679 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.53 136.46 22.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.425 -0.583 . . . . 0.76000000000000001 109.425 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.4 mttt 56.21 36.6 27.72 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.555 0.742 . . . . 3.6299999999999999 111.77 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.643 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 86.7 t -67.3 117.19 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.694 -1.139 . . . . 1.52 111.761 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.7 tpp180 . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 106.964 -1.495 . . . . 5.3200000000000003 106.964 -179.19 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 22.8 p90 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 119.559 -0.258 . . . . 5.54 111.132 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 tp -145.23 132.23 15.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 120.942 0.401 . . . . 3.7999999999999998 110.238 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.3 mm -112.35 126.07 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.073 -0.714 . . . . 2.4199999999999999 109.073 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.447 ' HE2' HD12 ' A' ' 48' ' ' LEU . 90.2 m-85 -101.36 160.94 14.0 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.091 -0.337 . . . . 2.3100000000000001 110.091 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' C ' HG22 ' A' ' 45' ' ' THR . 10.0 mpt_? -85.2 -3.85 58.96 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.413 -0.358 . . . . 3.4500000000000002 111.87 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.588 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 81.35 -61.43 4.61 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.762 -0.732 . . . . 0.76000000000000001 111.813 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.3 p -75.14 1.82 12.33 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.617 0.246 . . . . 1.6399999999999999 111.628 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -110.52 8.89 23.16 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.018 0.437 . . . . 2.0 110.803 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 79' ' ' GLY . 32.0 pt -92.24 148.9 4.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 O-C-N 121.48 -0.762 . . . . 1.7 110.446 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.31 -46.91 4.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.751 -0.38 . . . . 1.5900000000000001 111.835 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.599 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.9 m-20 -129.68 146.37 51.46 Favored 'General case' 0 C--O 1.211 -0.968 0 O-C-N 122.34 -0.225 . . . . 2.2200000000000002 110.85 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 tt -150.99 111.18 4.14 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.114 -1.439 . . . . 2.8599999999999999 107.114 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -105.41 109.13 20.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.026 -0.731 . . . . 1.8799999999999999 109.026 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.444 -0.765 0 CA-C-O 121.412 0.625 . . . . 2.7000000000000002 110.545 178.27 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' ' HB ' ' A' ' 35' ' ' ILE . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 109.449 -1.46 . . . . 1.0700000000000001 109.449 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.2 m -103.38 142.38 34.33 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.125 1.462 . . . . 1.8100000000000001 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -89.23 106.71 18.62 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 122.464 0.306 . . . . 4.3499999999999996 110.508 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.47 -173.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-O 121.507 0.67 . . . . 2.4100000000000001 110.087 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 36.6 m -139.48 124.82 19.07 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.311 -1.366 . . . . 1.3300000000000001 107.311 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.49 HD21 HG22 ' A' ' 82' ' ' ILE . 6.1 tt -133.31 135.85 45.09 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.335 -0.617 . . . . 1.45 109.335 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 66.4 mt -106.96 122.51 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 109.281 -0.637 . . . . 0.71999999999999997 109.281 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.5 t -84.76 162.3 19.67 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.811 0.694 . . . . 1.3400000000000001 109.232 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -57.9 -3.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.822 1.416 . . . . 2.1200000000000001 114.822 -178.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 8.05 38.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.466 0.65 . . . . 0.69999999999999996 109.256 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.612 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 6.2 mm-40 68.03 28.8 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.255 1.422 . . . . 2.5899999999999999 109.768 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 48.0 mm -107.44 128.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.277 0.473 . . . . 1.1699999999999999 112.277 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -89.1 117.44 28.1 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.25 1.02 . . . . 4.71 110.202 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 23' ' ' SER . 98.3 m-85 -107.85 148.59 29.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.386 0.274 . . . . 3.0099999999999998 111.148 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -138.99 126.7 22.0 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.798 -1.556 . . . . 2.4500000000000002 106.798 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.44 -155.33 25.88 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.304 -0.718 . . . . 0.45000000000000001 111.304 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.75 128.91 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 113.978 1.103 . . . . 0.93000000000000005 113.978 -177.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.674 HD13 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.66 156.48 30.72 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.821 -1.081 . . . . 1.72 112.625 173.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -110.73 -39.21 4.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.835 -0.621 . . . . 1.1100000000000001 110.806 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -151.81 153.9 35.14 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.658 -0.497 . . . . 0.93999999999999995 109.658 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.87 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.941 -0.763 . . . . 1.45 108.941 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -103.06 95.73 6.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.449 0.642 . . . . 2.5600000000000001 109.49 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.1 m -52.88 -41.38 64.27 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.859 1.264 . . . . 2.7599999999999998 114.133 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -55.45 -42.86 74.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.013 0.746 . . . . 3.2200000000000002 113.013 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.81 -0.01 25.66 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.142 0.496 . . . . 2.2599999999999998 109.82 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m 64.21 18.9 11.54 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.548 1.139 . . . . 2.2799999999999998 111.033 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.8 p -79.43 125.08 29.09 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.105 0.479 . . . . 1.21 111.025 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -101.21 124.06 54.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.784 -0.644 . . . . 0.88 109.469 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.9 103.5 16.03 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 108.036 -1.098 . . . . 0.51000000000000001 108.036 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.618 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -100.05 147.13 25.96 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 106.114 -1.81 . . . . 1.75 106.114 -176.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.504 ' H ' HD13 ' A' ' 48' ' ' LEU . . . -148.94 129.82 14.28 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.479 -1.304 . . . . 0.76000000000000001 107.479 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttp 48.95 54.62 10.55 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.068 0.947 . . . . 3.6299999999999999 112.697 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.618 ' HB ' ' CD1' ' A' ' 48' ' ' LEU . 6.6 p -66.97 114.12 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.424 -0.807 . . . . 1.52 109.613 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 106.761 -1.57 . . . . 5.3200000000000003 106.761 -179.349 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.749 0.309 . . . . 5.54 111.736 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.405 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -137.73 131.14 42.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-O 121.106 0.479 . . . . 3.7999999999999998 110.383 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.52 128.98 65.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.194 -0.669 . . . . 2.4199999999999999 109.194 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.41 130.38 43.55 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 109.441 -0.578 . . . . 2.3100000000000001 109.441 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -68.47 -10.47 55.65 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.295 0.85 . . . . 3.4500000000000002 113.295 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.7 -48.98 3.33 Favored Glycine 0 C--O 1.212 -1.239 0 C-N-CA 120.831 -0.699 . . . . 0.76000000000000001 112.305 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 m -76.31 -16.49 59.76 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.054 0.931 . . . . 1.6399999999999999 109.188 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.23 24.7 6.89 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.659 -1.155 . . . . 2.0 112.124 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 79' ' ' GLY . 21.0 pt -112.73 150.97 14.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.552 -0.859 . . . . 1.7 110.493 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.612 ' HE3' ' OE1' ' A' ' 29' ' ' GLU . 71.6 mmtt -92.89 -54.5 3.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.788 -0.642 . . . . 1.5900000000000001 110.526 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -161.65 159.01 26.94 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.21 -1.033 . . . . 2.2200000000000002 108.21 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 82' ' ' ILE . 1.5 pt? -156.13 147.91 22.97 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.803 0.335 . . . . 2.8599999999999999 110.419 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.7 t -124.21 130.8 53.15 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.153 -0.684 . . . . 1.8799999999999999 109.153 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 116.134 -0.484 . . . . 2.7000000000000002 111.376 -177.657 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.535 0 N-CA-C 109.953 -1.259 . . . . 1.0700000000000001 109.953 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 t -96.45 124.85 40.58 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.448 -0.945 . . . . 1.8100000000000001 108.448 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -68.03 121.37 15.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.533 0.938 . . . . 4.3499999999999996 113.533 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 36' ' ' LEU . 10.9 tt -153.19 152.04 10.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-N 115.412 -0.813 . . . . 2.4100000000000001 110.492 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.788 ' O ' ' HB3' ' A' ' 85' ' ' LEU . 20.0 m -115.3 144.53 43.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.989 -1.856 . . . . 1.3300000000000001 105.989 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.977 ' HA ' ' HB2' ' A' ' 85' ' ' LEU . 31.1 tp -147.97 129.88 15.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.529 1.307 . . . . 1.45 114.529 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 85' ' ' LEU . 66.6 mt -95.12 119.64 43.46 Favored 'Isoleucine or valine' 0 C--N 1.387 2.23 0 C-N-CA 119.82 -0.752 . . . . 0.71999999999999997 109.77 174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -89.49 166.13 13.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.946 -0.57 . . . . 1.3400000000000001 109.48 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -47.52 -19.61 0.19 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 115.04 1.496 . . . . 2.1200000000000001 115.04 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 27' ' ' LYS . . . -74.39 -2.92 27.47 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.708 0.29 . . . . 0.69999999999999996 110.43 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 74.41 22.74 2.1 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.633 1.173 . . . . 2.5899999999999999 107.882 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 53.9 mt -109.99 129.48 64.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.152 -1.385 . . . . 1.1699999999999999 110.971 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.422 ' HB3' HG12 ' A' ' 25' ' ' ILE . 38.9 ptt180 -92.06 119.84 32.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.74 -0.663 . . . . 4.71 110.308 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.35 159.15 16.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.976 -0.75 . . . . 3.0099999999999998 108.976 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -142.43 128.01 19.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.226 -1.398 . . . . 2.4500000000000002 107.226 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 175.0 -128.87 1.47 Allowed Glycine 1 CA--C 1.442 -4.469 0 N-CA-C 109.998 -1.241 . . . . 0.45000000000000001 109.998 -176.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.441 HD11 ' CB ' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -135.5 161.31 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.48 0 C-N-CA 118.934 -1.106 . . . . 0.93000000000000005 113.287 -174.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HB2' HG21 ' A' ' 22' ' ' ILE . 3.3 tm? -99.44 140.34 33.76 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.507 -1.224 . . . . 1.72 109.389 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' N ' HD13 ' A' ' 36' ' ' LEU . 76.9 t80 -105.88 -54.69 2.44 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 123.239 0.337 . . . . 1.1100000000000001 111.121 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.5 m -153.93 154.63 34.17 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 109.744 -0.465 . . . . 0.93999999999999995 109.744 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.414 HG13 HD11 ' A' ' 36' ' ' LEU . 82.2 mt -130.29 142.56 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.797 0.332 . . . . 1.45 111.416 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.468 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 2.7 t70 -111.35 116.1 30.41 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.636 0.775 . . . . 2.5600000000000001 110.428 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -76.79 -18.18 58.58 Favored 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 113.035 0.754 . . . . 2.7599999999999998 113.035 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -69.7 -54.98 11.28 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.85 -0.531 . . . . 3.2200000000000002 111.443 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -103.9 5.72 35.89 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.953 0.406 . . . . 2.2599999999999998 110.058 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.1 t 65.02 24.38 12.59 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.996 -1.002 . . . . 2.2799999999999998 109.817 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 70.3 p -77.51 141.45 39.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.884 0.849 . . . . 1.21 111.525 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.5 t -115.55 126.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.168 -0.924 . . . . 0.88 110.143 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.89 99.52 10.83 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.511 -0.922 . . . . 0.51000000000000001 108.511 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 tt -101.3 126.12 48.01 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.759 -1.941 . . . . 1.75 105.759 -176.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' A' ' 74' ' ' TYR . . . -155.1 156.56 36.04 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 107.703 -1.221 . . . . 0.76000000000000001 107.703 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.441 ' CB ' HD11 ' A' ' 35' ' ' ILE . 49.6 mttm 68.26 21.27 8.53 Favored 'General case' 0 C--O 1.2 -1.507 0 CA-C-O 121.993 0.901 . . . . 3.6299999999999999 109.171 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.673 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.7 p -67.1 166.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.424 -1.324 . . . . 1.52 107.424 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 C--N 1.302 -1.485 0 C-N-CA 118.341 -1.344 . . . . 5.3200000000000003 114.239 -172.613 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 21.3 t80 . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 115.56 1.689 . . . . 5.54 115.56 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.3 pt -150.82 147.14 15.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.568 0.699 . . . . 3.7999999999999998 110.94 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.75 129.15 52.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.6 -0.889 . . . . 2.4199999999999999 108.6 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 -98.11 152.24 19.53 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.893 -0.323 . . . . 2.3100000000000001 110.154 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.435 ' C ' HG22 ' A' ' 45' ' ' THR . 22.1 mmm180 -78.05 6.3 8.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.046 -0.525 . . . . 3.4500000000000002 111.193 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.28 -57.6 4.05 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 111.532 -0.627 . . . . 0.76000000000000001 111.532 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.8 t -74.51 5.22 4.94 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.409 1.099 . . . . 1.6399999999999999 108.792 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' GLY . 16.4 t70 -89.88 -11.9 40.56 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-N 114.619 -1.173 . . . . 2.0 109.872 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 79' ' ' GLY . 33.2 pt -100.25 153.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.284 -0.966 . . . . 1.7 113.397 -174.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.0 -68.18 0.75 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.471 -1.24 . . . . 1.5900000000000001 110.274 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.622 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 24.1 t70 -173.32 115.27 0.25 Allowed 'General case' 0 CA--C 1.479 -1.773 0 CA-C-O 118.543 -0.741 . . . . 2.2200000000000002 110.111 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.977 ' HB2' ' HA ' ' A' ' 24' ' ' LEU 0.842 17.7 mt -162.24 156.78 22.08 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 119.458 3.133 . . . . 2.8599999999999999 119.458 170.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -141.55 159.07 42.99 Favored 'General case' 0 CA--C 1.563 1.481 0 N-CA-C 110.476 -0.194 . . . . 1.8799999999999999 110.476 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.408 ' HA ' HG13 ' A' ' 22' ' ' ILE . 33.7 m . . . . . 0 C--N 1.36 1.045 0 C-N-CA 123.745 0.818 . . . . 2.7000000000000002 111.6 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.856 0 N-CA-C 113.698 0.239 . . . . 1.0700000000000001 113.698 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 61.3 m -82.64 138.82 34.04 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.216 0.206 . . . . 1.8100000000000001 111.086 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 116.61 31.45 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.468 -0.938 . . . . 4.3499999999999996 108.468 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' CD1' ' A' ' 85' ' ' LEU . 14.1 pt -140.71 153.37 21.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.956 -0.698 . . . . 2.4100000000000001 109.543 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -100.08 116.85 33.05 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 107.235 -1.394 . . . . 1.3300000000000001 107.235 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 84' ' ' ASP . 63.9 tp -123.12 129.08 50.97 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.094 -0.503 . . . . 1.45 110.284 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.2 mt -110.45 120.37 61.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.263 -0.575 . . . . 0.71999999999999997 110.122 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.3 t -75.09 158.42 33.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.006 -0.997 . . . . 1.3400000000000001 108.791 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -56.38 -8.08 0.47 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.148 1.536 . . . . 2.1200000000000001 115.148 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.82 10.06 25.04 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.335 -0.617 . . . . 0.69999999999999996 109.335 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.77 26.6 9.44 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 125.801 1.64 . . . . 2.5899999999999999 109.987 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.97 129.36 52.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 1.1699999999999999 110.854 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -86.22 120.99 28.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.445 -0.798 . . . . 4.71 110.917 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.78 133.27 55.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.934 -0.765 . . . . 3.0099999999999998 108.934 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.72 129.13 24.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.083 -1.821 . . . . 2.4500000000000002 106.083 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.478 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . 172.83 -165.52 37.91 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 110.786 -0.926 . . . . 0.45000000000000001 110.786 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.569 HD13 ' H ' ' A' ' 35' ' ' ILE 0.338 0.2 OUTLIER -94.67 118.83 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 117.849 -1.54 . . . . 0.93000000000000005 114.777 -175.714 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.98 135.52 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.778 -1.556 . . . . 1.72 109.119 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.49 -45.11 4.33 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 123.899 0.749 . . . . 1.1100000000000001 111.676 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -156.15 153.92 30.04 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 110.156 -0.313 . . . . 0.93999999999999995 110.156 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.78 134.13 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 107.845 -1.168 . . . . 1.45 107.845 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.508 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 8.8 t70 -94.9 98.38 10.67 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.935 -1.505 . . . . 2.5600000000000001 106.935 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 m -66.93 -15.74 63.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.619 0.6 . . . . 2.7599999999999998 112.619 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.3 -46.03 36.01 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.517 0.675 . . . . 3.2200000000000002 110.048 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -103.56 -5.98 22.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.646 0.778 . . . . 2.2599999999999998 110.334 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 m 68.08 19.83 9.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.132 1.373 . . . . 2.2799999999999998 111.311 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 75.0 p -79.3 146.53 32.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.095 0.474 . . . . 1.21 111.318 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -111.68 127.49 68.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.135 -0.484 . . . . 0.88 110.007 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.34 113.38 26.72 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-O 121.166 0.507 . . . . 0.51000000000000001 110.377 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 74' ' ' TYR . 96.8 mt -100.08 136.74 39.52 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.717 -0.674 . . . . 1.75 109.231 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.67 117.88 24.44 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.409 -0.589 . . . . 0.76000000000000001 109.409 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 35' ' ' ILE . 23.4 mtpp 65.17 38.39 6.06 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.317 1.047 . . . . 3.6299999999999999 109.517 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 ' HA3' ' A' ' 34' ' ' GLY . 3.4 p -66.44 114.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 109.023 -0.732 . . . . 1.52 109.023 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 . . . . . 0 C--N 1.314 -0.976 0 N-CA-C 108.807 -0.812 . . . . 5.3200000000000003 108.807 -179.124 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.522 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 7.3 m-85 . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 110.023 -0.362 . . . . 5.54 110.023 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.48 139.18 11.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 109.831 -0.433 . . . . 3.7999999999999998 109.831 175.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.27 134.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.215 -0.661 . . . . 2.4199999999999999 109.215 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -108.87 147.21 32.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 110.061 -0.348 . . . . 2.3100000000000001 110.061 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' C ' HG22 ' A' ' 45' ' ' THR . 16.5 mmt180 -71.55 -5.53 33.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.638 0.977 . . . . 3.4500000000000002 113.638 -174.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.552 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.14 -58.19 4.6 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 120.874 -0.679 . . . . 0.76000000000000001 112.766 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.1 p -67.44 -3.42 8.37 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.533 0.733 . . . . 1.6399999999999999 111.665 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.3 m-20 -118.41 19.54 13.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.83 -1.077 . . . . 2.0 111.597 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 79' ' ' GLY . 37.0 pt -98.8 138.81 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.07 -0.652 . . . . 1.7 111.216 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -93.34 -56.3 2.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.386 0.612 . . . . 1.5900000000000001 110.052 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.1 m-20 -122.93 136.45 54.87 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.57 -0.741 . . . . 2.2200000000000002 110.68 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 24' ' ' LEU . 58.8 tp -143.52 103.72 4.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.397 -1.705 . . . . 2.8599999999999999 106.397 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -141.32 134.45 29.3 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.381 -0.528 . . . . 1.8799999999999999 110.931 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 C--N 1.312 -1.039 0 N-CA-C 108.513 -0.921 . . . . 2.7000000000000002 108.513 178.58 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.63 0 N-CA-C 108.51 -1.836 . . . . 1.0700000000000001 108.51 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 33.9 t -93.06 129.37 39.03 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.339 -0.985 . . . . 1.8100000000000001 108.339 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -87.23 114.99 24.32 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.599 -1.26 . . . . 4.3499999999999996 107.599 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -140.86 176.4 4.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 C-N-CA 120.138 -0.625 . . . . 2.4100000000000001 110.225 -175.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.465 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 15.1 m -139.14 113.24 8.71 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.774 -1.103 . . . . 1.3300000000000001 108.268 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.56 148.14 47.99 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.641 0.258 . . . . 1.45 110.751 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.1 mt -119.11 128.28 75.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.027 0.441 . . . . 0.71999999999999997 109.939 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -75.54 161.9 28.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 1.3400000000000001 109.293 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -48.11 -35.06 10.74 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 123.24 0.616 . . . . 2.1200000000000001 112.353 -176.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.9 15.7 2.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.119 0.967 . . . . 0.69999999999999996 111.907 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 69.0 25.71 5.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.847 1.259 . . . . 2.5899999999999999 109.46 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.7 mm -94.59 120.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.444 -0.798 . . . . 1.1699999999999999 109.892 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HD3' ' OE1' ' A' ' 33' ' ' GLU . 16.8 ttm180 -86.22 139.42 31.06 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.778 -0.646 . . . . 4.71 111.177 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -135.22 121.07 19.7 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 123.852 0.861 . . . . 3.0099999999999998 109.916 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 41.4 mt-10 -125.66 143.4 51.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.688 -1.227 . . . . 2.4500000000000002 107.688 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.23 12.06 Favored Glycine 0 CA--C 1.476 -2.351 0 N-CA-C 109.234 -1.547 . . . . 0.45000000000000001 109.234 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.446 HG13 ' HE2' ' A' ' 50' ' ' LYS 0.261 0.1 OUTLIER -113.31 121.96 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 N-CA-C 114.427 1.269 . . . . 0.93000000000000005 114.427 177.967 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 20' ' ' SER . 2.9 tm? -68.56 137.02 53.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.523 -1.671 . . . . 1.72 108.448 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -105.39 -48.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.106 -0.497 . . . . 1.1100000000000001 111.128 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.1 m -158.35 155.68 29.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.375 -0.602 . . . . 0.93999999999999995 109.375 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -133.12 117.6 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 108.307 -0.998 . . . . 1.45 108.307 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.78 95.42 6.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 2.5600000000000001 107.085 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.41 -19.21 64.48 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 123.084 0.553 . . . . 2.7599999999999998 111.795 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -61.25 -36.94 81.35 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 122.085 -0.384 . . . . 3.2200000000000002 110.96 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -125.61 -2.98 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.72 0.771 . . . . 2.2599999999999998 110.188 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.4 m 72.07 19.07 4.71 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.752 1.221 . . . . 2.2799999999999998 112.486 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.9 p -71.07 133.23 46.12 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.298 0.571 . . . . 1.21 111.135 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.3 t -102.3 123.0 55.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.556 -0.747 . . . . 0.88 109.93 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.65 115.36 30.2 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.119 0.485 . . . . 0.51000000000000001 111.425 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 4.4 mm? -104.7 140.86 37.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.583 -0.735 . . . . 1.75 111.491 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.69 136.22 18.0 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.545 -0.539 . . . . 0.76000000000000001 109.545 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HE2' HG13 ' A' ' 35' ' ' ILE . 29.2 mtmm 70.47 23.62 4.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.444 1.097 . . . . 3.6299999999999999 109.901 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 21.7 t -68.53 117.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.03 -0.986 . . . . 1.52 109.007 -173.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 . . . . . 0 N--CA 1.434 -1.26 0 N-CA-C 107.96 -1.126 . . . . 5.3200000000000003 107.96 -179.032 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 20.8 p90 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 113.563 0.949 . . . . 5.54 113.563 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.98 155.24 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.01 -0.541 . . . . 3.7999999999999998 109.702 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.2 mm -118.45 135.52 58.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.764 -0.828 . . . . 2.4199999999999999 108.764 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.62 149.35 28.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.043 0.449 . . . . 2.3100000000000001 111.451 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -67.24 -11.94 58.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 3.4500000000000002 112.057 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.62 -66.27 3.74 Favored Glycine 0 C--O 1.213 -1.213 0 C-N-CA 121.206 -0.521 . . . . 0.76000000000000001 112.949 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 t -62.43 -15.46 49.43 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.146 0.974 . . . . 1.6399999999999999 110.897 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -93.19 7.43 44.33 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 124.715 1.206 . . . . 2.0 113.107 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 79' ' ' GLY . 26.6 pt -75.37 147.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.101 -0.639 . . . . 1.7 111.461 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.38 -44.22 6.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.379 -0.373 . . . . 1.5900000000000001 111.447 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -174.47 148.01 1.18 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.293 -1.003 . . . . 2.2200000000000002 108.293 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 151.46 25.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 112.259 0.466 . . . . 2.8599999999999999 112.259 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 t -131.9 138.73 48.51 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.589 -0.893 . . . . 1.8799999999999999 108.589 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.305 -1.363 0 CA-C-N 116.536 -0.302 . . . . 2.7000000000000002 111.089 -179.916 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 113.962 0.345 . . . . 1.0700000000000001 113.962 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.1 m -93.04 120.51 33.42 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 109.892 -0.41 . . . . 1.8100000000000001 109.892 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -87.01 107.76 18.56 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 116.57 -0.287 . . . . 4.3499999999999996 111.041 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -127.76 163.55 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.614 -0.513 . . . . 2.4100000000000001 109.614 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 86' ' ' THR . 28.9 m -122.85 112.09 17.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.223 -1.029 . . . . 1.3300000000000001 108.223 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 84' ' ' ASP . 27.1 tp -122.13 125.48 46.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.231 0.539 . . . . 1.45 112.315 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 53.8 mt -92.14 117.24 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.769 -0.651 . . . . 0.71999999999999997 110.204 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.3 t -76.28 162.55 27.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.958 -1.019 . . . . 1.3400000000000001 108.957 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -10.66 0.59 Allowed 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 125.094 1.358 . . . . 2.1200000000000001 113.854 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -0.12 47.59 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.939 0.495 . . . . 0.69999999999999996 110.453 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 72.24 30.65 2.03 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 122.857 1.313 . . . . 2.5899999999999999 107.637 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -115.56 129.54 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.611 -1.177 . . . . 1.1699999999999999 110.667 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.466 ' HE ' ' CD ' ' A' ' 33' ' ' GLU . 34.9 ttp180 -93.63 103.2 15.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.825 -0.435 . . . . 4.71 109.825 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -89.06 125.49 35.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.681 -0.859 . . . . 3.0099999999999998 108.681 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.466 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 29.9 mt-10 -126.19 127.13 45.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.002 -1.11 . . . . 2.4500000000000002 108.002 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 176.43 -155.51 19.04 Favored Glycine 0 CA--C 1.476 -2.382 0 CA-C-O 118.105 -1.386 . . . . 0.45000000000000001 109.859 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.442 HD11 ' HB3' ' A' ' 50' ' ' LYS 0.437 0.2 OUTLIER -103.14 139.66 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 C-N-CA 115.064 -2.654 . . . . 0.93000000000000005 117.303 -176.544 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB2' HD12 ' A' ' 22' ' ' ILE . 3.2 tm? -86.61 140.61 29.68 Favored 'General case' 0 C--O 1.271 2.194 0 CA-C-N 113.929 -1.487 . . . . 1.72 107.816 176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.468 ' N ' HD13 ' A' ' 36' ' ' LEU . 85.5 t80 -119.65 -55.09 2.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.94 1.4 . . . . 1.1100000000000001 111.812 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -135.06 -179.2 5.47 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.348 0.499 . . . . 0.93999999999999995 112.348 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.7 mm -134.34 131.85 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 120.874 0.369 . . . . 1.45 111.974 -173.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.52 80.67 3.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.438 1.095 . . . . 2.5600000000000001 109.198 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -55.52 -31.82 62.41 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.103 0.779 . . . . 2.7599999999999998 113.103 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -56.2 -30.77 62.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.931 0.893 . . . . 3.2200000000000002 112.497 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.496 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 19.5 m120 -125.44 18.94 8.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.598 -0.519 . . . . 2.2599999999999998 109.598 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.9 p 54.52 34.02 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.291 1.437 . . . . 2.2799999999999998 110.782 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.645 HG21 ' N ' ' A' ' 79' ' ' GLY 0.496 0.8 OUTLIER -104.22 -174.88 2.64 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 120.423 3.49 . . . . 1.21 120.423 -171.417 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 77' ' ' PHE . 2.0 m -131.34 127.38 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 113.316 -1.765 . . . . 0.88 113.463 -163.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.4 ' CB ' HD12 ' A' ' 76' ' ' ILE . . . -104.21 107.23 18.04 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.383 -0.826 . . . . 0.51000000000000001 109.283 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.577 ' O ' ' HB2' ' A' ' 74' ' ' TYR . 6.0 mp -102.33 130.13 48.96 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.444 0.64 . . . . 1.75 110.743 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 74' ' ' TYR . . . -127.27 126.98 43.63 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 106.777 -1.564 . . . . 0.76000000000000001 106.777 176.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 31.5 mtmm 83.26 15.88 0.31 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 124.137 0.898 . . . . 3.6299999999999999 112.855 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.59 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.4 p -83.17 105.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.579 -1.648 . . . . 1.52 110.372 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 51' ' ' VAL . 1.5 tmt_? . . . . . 0 C--O 1.198 -1.613 0 N-CA-C 104.653 -2.351 . . . . 5.3200000000000003 104.653 169.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 48' ' ' LEU 0.264 19.1 p90 . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 115.367 1.618 . . . . 5.54 115.367 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.59 153.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 109.994 -0.373 . . . . 3.7999999999999998 109.994 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' CB ' ' A' ' 47' ' ' ALA . 28.4 mm -110.88 133.65 55.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.063 -1.088 . . . . 2.4199999999999999 108.063 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.535 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.9 m-85 -100.46 142.1 32.4 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 118.726 -1.19 . . . . 2.3100000000000001 108.232 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.596 ' C ' HG21 ' A' ' 45' ' ' THR . 5.8 mpt_? -110.02 149.17 30.36 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-O 121.481 0.657 . . . . 3.4500000000000002 110.745 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.645 ' N ' HG21 ' A' ' 45' ' ' THR . . . -52.9 -23.17 14.35 Favored Glycine 0 C--N 1.276 -2.788 0 C-N-CA 126.842 2.163 . . . . 0.76000000000000001 112.791 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 p -93.91 -13.01 27.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.674 -0.763 . . . . 1.6399999999999999 110.85 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.04 -7.63 10.82 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.435 -0.802 . . . . 2.0 112.04 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.6 pt -83.06 142.84 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.344 0.868 . . . . 1.7 113.344 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -101.21 -65.83 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 1.5900000000000001 111.124 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.441 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.7 m-20 -140.28 149.02 42.29 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 112.655 0.613 . . . . 2.2200000000000002 112.655 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.5 tp -134.25 131.16 38.14 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.68 -0.691 . . . . 2.8599999999999999 110.26 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 23' ' ' SER . 9.0 t -141.74 161.29 38.31 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.096 -1.076 . . . . 1.8799999999999999 108.096 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.308 -1.206 0 N-CA-C 109.518 -0.549 . . . . 2.7000000000000002 109.518 -177.824 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.295 0 N-CA-C 111.058 -0.817 . . . . 1.0700000000000001 111.058 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.4 m -94.09 121.86 36.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.086 -0.709 . . . . 1.8100000000000001 109.086 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 5.2 mptt -89.92 94.31 9.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.989 -1.115 . . . . 4.3499999999999996 107.989 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 87' ' ' VAL . 1.8 pp -137.77 -179.18 2.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 120.438 -0.505 . . . . 2.4100000000000001 110.318 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.8 p -132.18 131.33 42.1 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.303 -0.999 . . . . 1.3300000000000001 108.303 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.712 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 6.5 tt -135.97 145.74 46.49 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 108.295 -1.002 . . . . 1.45 108.295 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.0 mt -116.4 128.77 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.71 -0.677 . . . . 0.71999999999999997 109.851 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -76.9 170.52 16.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.154 -0.684 . . . . 1.3400000000000001 109.154 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -58.77 -23.87 60.78 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.08 0.952 . . . . 2.1200000000000001 112.221 -173.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.48 25.4 5.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.016 -0.538 . . . . 0.69999999999999996 110.298 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.606 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 0.8 OUTLIER 66.59 28.72 9.21 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.618 -0.719 . . . . 2.5899999999999999 112.397 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 52.1 mm -89.46 97.71 7.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.883 -0.599 . . . . 1.1699999999999999 110.555 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.728 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.0 136.62 33.51 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.619 -0.719 . . . . 4.71 111.066 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.712 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 1.9 p90 -126.34 163.19 23.81 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.692 -0.803 . . . . 3.0099999999999998 110.67 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.86 126.22 17.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.064 -1.458 . . . . 2.4500000000000002 107.064 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . 158.64 -150.64 21.42 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 120.97 -0.633 . . . . 0.45000000000000001 111.547 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.25 0.1 OUTLIER -110.73 115.51 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 114.369 1.248 . . . . 0.93000000000000005 114.369 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 5.3 tt -77.42 147.14 36.15 Favored 'General case' 0 C--O 1.252 1.184 0 CA-C-N 114.205 -1.362 . . . . 1.72 109.65 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -108.5 -52.59 2.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.278 0.362 . . . . 1.1100000000000001 110.089 -175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.7 m -143.11 151.49 40.79 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.43 -1.693 . . . . 0.93999999999999995 106.43 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -159.47 103.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 C-N-CA 118.088 -1.445 . . . . 1.45 112.93 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 6.4 m-20 -127.38 131.3 50.36 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-N 115.555 -0.748 . . . . 2.5600000000000001 112.19 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.2 t -69.04 -35.36 76.5 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 113.365 0.876 . . . . 2.7599999999999998 113.365 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.46 -60.82 2.13 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.553 -1.659 . . . . 3.2200000000000002 110.832 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -136.07 -24.61 1.26 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 116.739 2.126 . . . . 2.2599999999999998 116.739 178.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.2 m -96.19 44.88 1.07 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.234 1.016 . . . . 2.2799999999999998 109.046 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 70.8 p -38.3 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 1 C-N-CA 134.141 4.976 . . . . 1.21 116.886 -178.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 39' ' ' ILE . 9.6 t -91.81 101.82 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 CA-C-N 115.112 -0.949 . . . . 0.88 109.197 -163.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.51 111.93 22.97 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 113.933 -1.485 . . . . 0.51000000000000001 107.451 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.439 HD21 HG21 ' A' ' 51' ' ' VAL . 58.7 tp -114.5 127.24 55.71 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.289 -0.869 . . . . 1.75 109.361 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.19 155.08 45.26 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 107.217 -1.401 . . . . 0.76000000000000001 107.217 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 51.8 pttt 50.28 27.87 2.89 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.133 0.973 . . . . 3.6299999999999999 113.534 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 34' ' ' GLY . 4.5 p -68.25 111.08 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.019 0.914 . . . . 1.52 109.855 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 N--CA 1.406 -2.628 0 C-N-CA 125.396 1.478 . . . . 5.3200000000000003 108.351 177.284 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 110.496 -0.187 . . . . 5.54 110.496 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 pt -141.24 146.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 121.62 -0.675 . . . . 3.7999999999999998 112.607 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.51 151.48 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.139 -1.059 . . . . 2.4199999999999999 108.139 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.59 ' O ' ' HB ' ' A' ' 45' ' ' THR . 97.6 m-85 -124.12 139.52 53.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.992 -0.373 . . . . 2.3100000000000001 109.992 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 21.1 mmm180 -43.93 -26.32 0.26 Allowed 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 116.124 1.898 . . . . 3.4500000000000002 116.124 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.512 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 74.21 -64.19 2.06 Favored Glycine 0 C--O 1.209 -1.454 0 C-N-CA 120.972 -0.633 . . . . 0.76000000000000001 112.557 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.0 t -73.38 -7.65 52.55 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.82 0.848 . . . . 1.6399999999999999 110.311 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 16.4 m-20 -121.16 30.1 6.99 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.973 -0.558 . . . . 2.0 110.316 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 79' ' ' GLY . 2.1 pp -77.44 163.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.845 -0.535 . . . . 1.7 112.42 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.606 ' HE3' ' OE2' ' A' ' 29' ' ' GLU . 15.6 tppt? -105.85 -62.05 1.42 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.937 0.399 . . . . 1.5900000000000001 110.07 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.79 150.4 29.33 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.551 -0.75 . . . . 2.2200000000000002 110.305 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.55 132.58 10.73 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 124.55 1.14 . . . . 2.8599999999999999 110.957 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 9.4 t -125.03 139.96 53.33 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.495 -0.928 . . . . 1.8799999999999999 108.495 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 22' ' ' ILE . 54.7 t . . . . . 0 C--O 1.251 1.147 0 CA-C-N 116.201 -0.454 . . . . 2.7000000000000002 110.355 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo . . . . . 0 CA--C 1.549 1.249 0 N-CA-C 114.388 0.88 . . . . 3.73 114.388 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 59.58 -148.81 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.686 1.195 . . . . 8.0399999999999991 113.587 170.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . 0.269 49.4 mm 94.54 -75.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.906 0 C-N-CA 126.192 1.797 . . . . 3.8100000000000001 113.514 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.99 -159.59 7.97 Favored Glycine 0 C--N 1.304 -1.199 0 C-N-CA 120.365 -0.921 . . . . 1.0700000000000001 112.8 -176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 46.4 t -88.28 123.65 33.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.514 -0.55 . . . . 1.8100000000000001 109.514 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 8.4 mptt -82.32 121.35 26.57 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.105 -0.702 . . . . 4.3499999999999996 109.105 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -140.58 167.78 17.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.876 -0.787 . . . . 2.4100000000000001 108.876 -178.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 20.5 t -123.81 124.52 42.86 Favored 'General case' 0 N--CA 1.404 -2.738 0 N-CA-C 107.628 -1.249 . . . . 1.3300000000000001 107.628 174.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 82' ' ' ILE . 5.3 tt -116.45 130.71 56.91 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.154 -0.93 . . . . 1.45 109.581 -176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.478 HD13 ' HB3' ' A' ' 84' ' ' ASP . 2.9 mp -105.52 119.91 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.215 0 CA-C-N 116.332 -0.395 . . . . 0.71999999999999997 110.154 175.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 75.9 p -78.2 169.6 18.0 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.28 -0.418 . . . . 1.3400000000000001 110.599 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -49.12 -26.02 2.49 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.809 1.04 . . . . 2.1200000000000001 113.809 -175.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.17 10.9 17.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.804 0.335 . . . . 0.69999999999999996 110.836 -177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 63.96 39.97 7.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.261 1.024 . . . . 2.5899999999999999 111.087 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.9 mm -106.11 127.09 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 114.047 -1.433 . . . . 1.1699999999999999 109.88 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.6 ptm180 -89.84 142.68 27.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.262 0.467 . . . . 4.71 112.262 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 23' ' ' SER . 57.4 m-85 -138.33 143.79 40.08 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.681 -1.229 . . . . 3.0099999999999998 107.681 176.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.46 134.51 55.02 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 120.886 0.374 . . . . 2.4500000000000002 110.044 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -166.01 -169.38 29.55 Favored Glycine 0 CA--C 1.467 -2.962 0 N-CA-C 111.064 -0.814 . . . . 0.45000000000000001 111.064 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.776 HD11 ' HG3' ' A' ' 50' ' ' LYS 0.345 1.4 pp -113.01 108.74 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.528 0 CA-C-O 123.051 1.405 . . . . 0.93000000000000005 113.293 177.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' A' ' 22' ' ' ILE . 3.4 tm? -55.25 135.61 49.59 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 113.627 -1.624 . . . . 1.72 111.041 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -113.04 -48.14 3.0 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.516 -0.766 . . . . 1.1100000000000001 111.553 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.0 m -154.09 153.11 31.31 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 121.848 -0.532 . . . . 0.93999999999999995 109.701 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.1 mt -134.42 126.44 48.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 108.777 -0.823 . . . . 1.45 108.777 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.487 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 18.7 m-20 -89.54 95.77 10.41 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.82 -1.178 . . . . 2.5600000000000001 107.82 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.9 m -56.06 -29.0 59.86 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 113.351 0.871 . . . . 2.7599999999999998 113.351 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.19 -39.93 90.03 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-O 121.029 0.442 . . . . 3.2200000000000002 111.511 -177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -109.79 0.5 18.83 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 121.798 -0.564 . . . . 2.2599999999999998 110.345 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.1 m 65.18 16.44 10.55 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.047 -0.979 . . . . 2.2799999999999998 110.645 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 40' ' ' ASP . 30.4 p -75.77 135.65 40.29 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 121.201 0.524 . . . . 1.21 111.132 -175.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 68.7 t -104.45 125.7 59.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.846 -0.615 . . . . 0.88 110.005 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.33 106.41 17.58 Favored 'General case' 0 C--O 1.253 1.272 0 CA-C-O 121.198 0.523 . . . . 0.51000000000000001 109.76 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 46.6 mt -100.2 150.23 22.74 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.507 -0.77 . . . . 1.75 111.888 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.404 ' O ' HD12 ' A' ' 35' ' ' ILE . . . -147.75 134.39 19.89 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 105.132 -2.173 . . . . 0.76000000000000001 105.132 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.776 ' HG3' HD11 ' A' ' 35' ' ' ILE 0.407 4.4 tptt 49.66 58.61 5.24 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 124.808 2.242 . . . . 3.6299999999999999 113.148 -179.407 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.551 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 44.6 t -77.38 113.94 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 CA-C-N 112.886 -1.961 . . . . 1.52 106.204 173.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.501 ' HD3' ' OE1' ' A' ' 73' ' ' GLU . 20.9 tpt180 -169.46 157.21 7.17 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.265 -1.383 . . . . 5.3200000000000003 107.265 177.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.6 m -61.43 156.27 19.67 Favored 'General case' 0 CA--C 1.559 1.311 0 O-C-N 123.402 0.439 . . . . 4.0 110.547 176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -132.5 95.08 3.54 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.687 0.995 . . . . 6.75 113.687 -173.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.38 101.31 0.4 Allowed Glycine 0 C--O 1.208 -1.503 0 C-N-CA 118.978 -1.582 . . . . 5.9000000000000004 113.148 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.514 ' HA ' HG23 ' A' ' 61' ' ' THR . 62.1 p 69.27 133.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.708 1.603 . . . . 7.0499999999999998 112.555 -178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.636 ' HG3' ' H ' ' A' ' 59' ' ' ARG . 10.8 pt-20 -86.6 -149.53 0.14 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 125.041 1.336 . . . . 8.3800000000000008 108.448 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -70.7 3.99 2.79 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.718 1.247 . . . . 11.699999999999999 110.593 177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.636 ' H ' ' HG3' ' A' ' 57' ' ' GLU . 39.5 mmt180 -131.8 149.78 74.37 Favored Pre-proline 0 N--CA 1.418 -2.05 0 C-N-CA 125.835 1.654 . . . . 12.15 106.797 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -75.8 44.69 1.33 Allowed 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 122.9 2.4 . . . . 9.3200000000000003 110.529 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.514 HG23 ' HA ' ' A' ' 56' ' ' THR 0.304 32.5 p 51.72 75.38 0.21 Allowed 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 122.331 1.062 . . . . 7.5700000000000003 113.693 -171.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 59' ' ' ARG . 6.2 m-20 -79.44 -5.42 54.68 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.365 -1.289 . . . . 10.539999999999999 108.48 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -157.55 94.62 2.11 Favored Pre-proline 0 N--CA 1.412 -2.334 0 N-CA-C 104.73 -2.322 . . . . 13.1 104.73 -178.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -45.54 126.56 8.75 Favored 'Trans proline' 0 C--N 1.321 -0.915 0 C-N-CA 123.997 3.131 . . . . 7.79 113.006 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 49.1 mm -88.09 137.23 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 114.858 -1.064 . . . . 5.96 110.092 -173.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.1 155.77 36.22 Favored Pre-proline 0 C--N 1.283 -2.29 0 CA-C-N 113.958 -1.474 . . . . 4.6900000000000004 108.137 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -58.63 86.23 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.643 2.228 . . . . 6.1900000000000004 114.155 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -136.55 90.75 2.59 Favored 'General case' 0 C--N 1.276 -2.625 0 CA-C-N 114.028 -1.442 . . . . 8.8000000000000007 107.249 172.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.559 ' OD1' ' HD3' ' A' ' 50' ' ' LYS . 9.0 t70 -144.73 145.96 31.95 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.726 -1.212 . . . . 6.5499999999999998 107.726 -171.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.23 156.48 36.76 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.646 0.736 . . . . 7.3899999999999997 111.403 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.773 HG23 ' H ' ' A' ' 50' ' ' LYS . 27.4 m -100.46 105.57 17.05 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 113.167 0.802 . . . . 4.6100000000000003 113.167 -171.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -120.04 -38.01 3.0 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.122 0.487 . . . . 7.5999999999999996 111.493 177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE1' ' HD3' ' A' ' 52' ' ' ARG . 45.2 mt-10 -80.79 -4.82 55.96 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 114.316 1.228 . . . . 6.8600000000000003 114.316 -176.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB3' ' CG2' ' A' ' 71' ' ' THR . 16.1 p90 -49.48 150.57 1.86 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 113.791 1.034 . . . . 5.54 113.791 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.8 tt -162.98 147.2 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.862 -0.608 . . . . 3.7999999999999998 110.361 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 76' ' ' ILE . 1.7 mp -107.49 129.72 60.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.115 -1.068 . . . . 2.4199999999999999 108.115 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -103.67 148.07 26.48 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 116.523 -0.308 . . . . 2.3100000000000001 111.735 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -59.73 -13.71 11.22 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 124.229 1.012 . . . . 3.4500000000000002 113.529 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.11 -58.72 4.94 Favored Glycine 0 CA--C 1.496 -1.109 0 C-N-CA 120.946 -0.645 . . . . 0.76000000000000001 111.875 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.3 t -65.99 -11.52 48.47 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.243 0.544 . . . . 1.6399999999999999 110.685 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 3.8 m-20 -98.05 20.78 11.72 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.431 0.692 . . . . 2.0 111.506 176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.59 HD12 HD21 ' A' ' 24' ' ' LEU . 40.3 mm -101.07 132.38 46.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 C-N-CA 119.149 -1.02 . . . . 1.7 110.334 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -87.38 -28.51 22.13 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.804 -0.635 . . . . 1.5900000000000001 111.463 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.478 ' HB3' HD13 ' A' ' 25' ' ' ILE . 20.1 t70 -166.35 135.13 2.98 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 112.274 0.472 . . . . 2.2200000000000002 112.274 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.8 mt -122.28 100.37 6.92 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.587 -0.733 . . . . 2.8599999999999999 110.325 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.5 m -109.96 116.71 32.09 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.124 0.488 . . . . 1.8799999999999999 110.483 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.8 m -95.81 154.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.672 -0.694 . . . . 2.7000000000000002 111.334 -178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 54.0 t -109.17 -32.82 7.07 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.728 -0.215 . . . . 3.3900000000000001 111.51 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 9.9 pt-20 -138.6 116.09 9.09 Favored Pre-proline 0 N--CA 1.45 -0.45 0 CA-C-O 120.88 0.372 . . . . 5.0700000000000003 111.903 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 89' ' ' GLU . 5.2 Cg_exo -77.72 112.18 3.26 Favored 'Trans proline' 0 CA--C 1.552 1.395 0 C-N-CA 123.167 2.578 . . . . 6.3099999999999996 111.89 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -62.96 -39.12 42.49 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.071 2.514 . . . . 8.5899999999999999 112.706 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -129.83 101.16 18.57 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.343 -0.39 . . . . 12.69 110.063 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.62 -28.36 37.82 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.617 2.212 . . . . 13.220000000000001 111.252 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.2 mt -111.33 122.35 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 107.978 -1.119 . . . . 15.380000000000001 107.978 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 80.2 mtp . . . . . 0 C--N 1.312 -1.063 0 CA-C-O 118.399 -0.81 . . . . 16.629999999999999 109.344 -177.537 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.548 1.188 0 CA-C-O 121.364 0.485 . . . . 3.73 112.196 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -77.61 90.35 3.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.036 -0.529 . . . . 8.0399999999999991 109.804 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.0 mt -108.84 -77.58 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.939 -0.573 . . . . 3.8100000000000001 112.265 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -107.06 -164.83 22.18 Favored Glycine 0 C--O 1.262 1.853 0 C-N-CA 120.69 -0.767 . . . . 1.0700000000000001 113.636 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -89.76 145.73 24.98 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 123.482 0.713 . . . . 1.8100000000000001 109.492 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.538 ' N ' ' HD2' ' A' ' 21' ' ' LYS . 10.3 mptt -92.05 114.05 26.49 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.448 -0.945 . . . . 4.3499999999999996 108.448 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 86' ' ' THR . 10.8 tt -151.93 150.61 12.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 116.17 -0.468 . . . . 2.4100000000000001 111.536 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.5 m -104.01 127.84 51.57 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 107.509 -1.293 . . . . 1.3300000000000001 107.509 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD13 HD13 ' A' ' 85' ' ' LEU . 40.0 tp -123.5 128.71 50.18 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.491 -0.322 . . . . 1.45 110.587 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 62.9 mt -104.29 124.63 58.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.685 -0.857 . . . . 0.71999999999999997 108.685 174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.2 p -80.0 160.18 25.97 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.444 -0.947 . . . . 1.3400000000000001 108.444 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -54.8 -12.04 0.72 Allowed 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.627 0.973 . . . . 2.1200000000000001 113.627 178.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' N ' ' HD3' ' A' ' 27' ' ' LYS . . . -85.05 5.53 29.14 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.386 0.675 . . . . 0.69999999999999996 110.013 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' HA ' ' OE1' ' A' ' 29' ' ' GLU . 3.1 tp10 70.46 30.65 3.17 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.153 1.781 . . . . 2.5899999999999999 108.958 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -108.34 128.11 64.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 115.381 -0.827 . . . . 1.1699999999999999 111.544 -175.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -86.15 124.62 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.386 -0.825 . . . . 4.71 111.04 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -121.46 127.65 51.31 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.528 -0.545 . . . . 3.0099999999999998 109.528 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -118.69 126.35 51.71 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.113 0.482 . . . . 2.4500000000000002 109.734 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -177.28 -151.67 9.32 Favored Glycine 0 CA--C 1.468 -2.874 0 N-CA-C 110.63 -0.988 . . . . 0.45000000000000001 110.63 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 50' ' ' LYS 0.317 1.1 pp -116.72 116.64 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 CA-C-O 122.192 0.996 . . . . 0.93000000000000005 112.605 179.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.435 HD21 ' CG1' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -62.39 133.1 54.58 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 113.93 -1.486 . . . . 1.72 108.373 -179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -94.76 -55.98 2.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.573 -0.451 . . . . 1.1100000000000001 112.14 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.5 m -153.86 154.06 33.24 Favored 'General case' 0 CA--C 1.553 1.09 0 O-C-N 122.013 -0.429 . . . . 0.93999999999999995 110.33 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 76.7 mt -130.7 133.79 62.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 109.254 -0.647 . . . . 1.45 109.254 177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 7.8 t70 -92.93 110.61 22.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.893 -0.781 . . . . 2.5600000000000001 108.893 171.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 m -73.46 -8.77 57.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 115.819 -0.628 . . . . 2.7599999999999998 112.129 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -79.63 -56.35 4.36 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.838 -0.745 . . . . 3.2200000000000002 111.168 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -96.47 0.34 50.18 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-N 115.7 -0.682 . . . . 2.2599999999999998 109.432 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.7 m 65.68 21.1 11.62 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.456 -1.247 . . . . 2.2799999999999998 111.259 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.567 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 77.3 p -73.07 154.53 40.38 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 121.184 0.516 . . . . 1.21 111.675 -175.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.435 ' CG1' HD21 ' A' ' 36' ' ' LEU . 59.8 t -124.94 125.1 69.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.724 -0.671 . . . . 0.88 110.056 -175.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.59 109.37 21.45 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 109.018 -0.734 . . . . 0.51000000000000001 109.018 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.556 ' HG ' ' CG2' ' A' ' 51' ' ' VAL . 45.7 tp -113.01 129.07 56.62 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.947 -0.57 . . . . 1.75 109.579 -177.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -158.55 156.55 30.38 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 108.395 -0.965 . . . . 0.76000000000000001 108.395 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.667 ' HA ' ' OG1' ' A' ' 71' ' ' THR . 48.8 mttp 60.08 29.78 19.32 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.102 0.876 . . . . 3.6299999999999999 109.885 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.556 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 46.6 t -67.0 114.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 CA-C-N 114.731 -1.122 . . . . 1.52 109.086 -176.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -169.82 164.42 9.83 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.36 -0.978 . . . . 5.3200000000000003 108.36 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.4 p -63.28 154.59 31.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.196 0.813 . . . . 4.0 113.196 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -123.81 126.86 47.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.326 -0.852 . . . . 6.75 110.397 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.23 90.12 1.18 Allowed Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 119.687 -1.244 . . . . 5.9000000000000004 112.157 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.0 m -143.51 -100.44 0.12 Allowed 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 115.502 1.668 . . . . 7.0499999999999998 115.502 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 56.52 -91.5 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.046 0.938 . . . . 8.3800000000000008 113.461 -175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.99 12.95 31.72 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 113.189 0.811 . . . . 11.699999999999999 113.189 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.576 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 mmp_? -130.17 98.49 21.01 Favored Pre-proline 0 N--CA 1.395 -3.21 0 N-CA-C 106.501 -1.666 . . . . 12.15 106.501 174.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -63.72 84.97 0.14 Allowed 'Trans proline' 0 N--CA 1.432 -2.105 0 C-N-CA 121.882 1.722 . . . . 9.3200000000000003 110.513 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 10.0 t -32.08 -49.87 0.2 Allowed 'General case' 0 CA--C 1.564 1.508 0 CA-C-N 114.855 -1.066 . . . . 7.5700000000000003 112.589 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.1 t70 176.85 -75.55 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.514 1.525 . . . . 10.539999999999999 108.071 177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.523 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 90.2 mtt180 -143.26 -62.27 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.062 0 CA-C-N 115.211 -0.904 . . . . 13.1 112.047 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 25.7 Cg_endo -60.12 103.21 0.2 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 C-N-CA 122.279 1.986 . . . . 7.79 116.173 -176.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.9 mt -119.7 147.53 23.29 Favored 'Isoleucine or valine' 0 C--O 1.257 1.459 0 N-CA-C 106.482 -1.673 . . . . 5.96 106.482 171.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.38 100.17 14.97 Favored Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 109.173 -0.677 . . . . 4.6900000000000004 109.173 170.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -83.08 12.0 3.09 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.232 1.955 . . . . 6.1900000000000004 111.565 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 72.26 89.05 0.1 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 113.732 -1.576 . . . . 8.8000000000000007 112.162 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -132.77 -73.79 0.5 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.16 -0.927 . . . . 6.5499999999999998 108.634 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 177.51 -167.98 0.06 Allowed 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.076 -1.824 . . . . 7.3899999999999997 106.076 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.667 ' OG1' ' HA ' ' A' ' 50' ' ' LYS . 87.1 m -155.83 145.89 21.49 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.712 -0.848 . . . . 4.6100000000000003 108.712 -175.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -105.87 -25.92 11.94 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.707 -0.849 . . . . 7.5999999999999996 108.707 177.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.64 -7.28 25.36 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.734 1.614 . . . . 6.8600000000000003 112.64 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -64.22 146.57 54.08 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 112.461 0.541 . . . . 5.54 112.461 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 tt -157.92 140.71 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 116.139 -0.482 . . . . 3.7999999999999998 110.518 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 46.9 mm -102.7 135.45 39.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.342 -0.984 . . . . 2.4199999999999999 108.342 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.4 150.84 27.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.535 -0.543 . . . . 2.3100000000000001 109.535 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.644 ' HB2' ' OD1' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -81.64 10.51 5.93 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.017 0.437 . . . . 3.4500000000000002 111.418 -179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.477 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 84.41 -61.16 4.75 Favored Glycine 0 CA--C 1.47 -2.767 0 N-CA-C 111.53 -0.628 . . . . 0.76000000000000001 111.53 175.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -62.4 -12.06 19.38 Favored 'General case' 0 CA--C 1.582 2.188 0 CA-C-O 121.092 0.472 . . . . 1.6399999999999999 111.254 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.644 ' OD1' ' HB2' ' A' ' 78' ' ' ARG . 9.3 m-20 -82.53 -0.56 47.2 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 123.352 0.661 . . . . 2.0 112.268 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 79' ' ' GLY . 1.9 pp -79.6 140.65 16.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 C-N-CA 119.18 -1.008 . . . . 1.7 112.652 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -95.64 -56.1 2.8 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.983 -0.747 . . . . 1.5900000000000001 108.983 173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.429 ' O ' HD12 ' A' ' 24' ' ' LEU . 19.9 t70 -136.0 139.15 42.92 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.195 -0.912 . . . . 2.2200000000000002 108.666 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.462 HD13 HD13 ' A' ' 24' ' ' LEU . 38.3 tp -135.96 99.59 4.19 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.323 -1.362 . . . . 2.8599999999999999 107.323 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.515 ' O ' HG13 ' A' ' 22' ' ' ILE . 51.1 m -132.35 110.54 10.64 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.077 0.465 . . . . 1.8799999999999999 111.285 -176.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.9 136.8 22.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 CA-C-N 115.706 -0.679 . . . . 2.7000000000000002 109.956 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.1 t -178.26 119.16 0.09 Allowed 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.054 0.542 . . . . 3.3900000000000001 109.93 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.423 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 10.5 mp0 -70.85 137.51 85.27 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 109.176 -0.676 . . . . 5.0700000000000003 109.176 174.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -46.23 -44.69 19.54 Favored 'Trans proline' 0 CA--C 1.575 2.55 0 C-N-CA 123.553 2.835 . . . . 6.3099999999999996 116.3 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 89' ' ' GLU . 12.7 Cg_endo -78.97 92.9 1.12 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 CA-C-N 120.931 1.368 . . . . 8.5899999999999999 112.079 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -128.1 86.25 58.52 Favored Pre-proline 0 C--N 1.296 -1.739 0 N-CA-C 107.163 -1.421 . . . . 12.69 107.163 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.32 -27.37 23.89 Favored 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 122.601 2.201 . . . . 13.220000000000001 112.551 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 58.9 mt -78.33 -20.28 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.325 -0.991 . . . . 15.380000000000001 108.325 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 C--O 1.245 0.855 0 CA-C-O 117.294 -1.336 . . . . 16.629999999999999 111.91 -175.885 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo . . . . . 0 N--CA 1.449 -1.097 0 N-CA-C 114.088 0.765 . . . . 3.73 114.088 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -136.63 -179.77 5.89 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 115.281 -0.872 . . . . 8.0399999999999991 109.26 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 tp -172.96 -39.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 122.897 0.479 . . . . 3.8100000000000001 110.034 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -95.61 -161.19 33.45 Favored Glycine 0 C--N 1.315 -0.615 0 N-CA-C 110.934 -0.866 . . . . 1.0700000000000001 110.934 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.2 p -92.76 130.98 38.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 112.564 0.579 . . . . 1.8100000000000001 112.564 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 34' ' ' GLY . 64.4 mmtt -74.01 112.6 10.29 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.019 0.528 . . . . 4.3499999999999996 110.684 175.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -141.13 164.99 19.83 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.855 -0.794 . . . . 2.4100000000000001 108.855 179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB3' ' HB ' ' A' ' 86' ' ' THR . 35.7 t -122.41 115.72 22.76 Favored 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 107.916 -1.142 . . . . 1.3300000000000001 107.916 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 77' ' ' PHE . 3.4 tt -123.04 128.69 50.49 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.298 -1.371 . . . . 1.45 107.298 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.7 mt -99.06 122.88 51.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.712 -0.395 . . . . 0.71999999999999997 109.981 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.0 p -76.1 162.26 28.16 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.561 -0.745 . . . . 1.3400000000000001 110.413 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -52.18 -23.45 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.526 1.13 . . . . 2.1200000000000001 113.733 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.81 22.66 3.47 Favored 'General case' 0 C--O 1.214 -0.814 0 C-N-CA 122.841 0.456 . . . . 0.69999999999999996 110.266 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.263 10.8 pt-20 50.35 50.7 18.24 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.879 1.272 . . . . 2.5899999999999999 112.677 -177.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.7 mt -119.08 118.65 58.35 Favored 'Isoleucine or valine' 0 C--O 1.254 1.32 0 CA-C-N 114.455 -1.248 . . . . 1.1699999999999999 110.247 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -81.64 109.17 15.82 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.534 -0.757 . . . . 4.71 110.768 -178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -105.57 134.19 49.09 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.145 -0.479 . . . . 3.0099999999999998 110.443 173.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -134.9 129.87 35.01 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.992 -0.744 . . . . 2.4500000000000002 108.992 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.455 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . -174.83 -151.68 8.64 Favored Glycine 0 CA--C 1.481 -2.078 0 N-CA-C 110.43 -1.068 . . . . 0.45000000000000001 110.43 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.43 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -110.95 107.18 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 CA-C-O 121.413 0.625 . . . . 0.93000000000000005 112.35 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.599 ' HA ' HD23 ' A' ' 48' ' ' LEU . 6.9 tt -58.41 137.88 56.96 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.434 -1.257 . . . . 1.72 111.301 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -99.44 -60.56 1.51 Allowed 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.294 -0.867 . . . . 1.1100000000000001 112.023 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 m -151.75 154.03 35.49 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 121.94 -0.475 . . . . 0.93999999999999995 110.052 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.81 129.54 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.807 -1.183 . . . . 1.45 107.807 178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -87.81 105.31 17.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.986 -1.116 . . . . 2.5600000000000001 107.986 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -73.02 -6.08 43.13 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.925 0.713 . . . . 2.7599999999999998 112.925 -175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -84.76 -56.24 3.69 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.293 0.568 . . . . 3.2200000000000002 110.007 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -89.65 -9.67 48.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.758 -0.656 . . . . 2.2599999999999998 110.226 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m 70.28 21.86 5.66 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.264 1.025 . . . . 2.2799999999999998 109.697 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.4 p -83.69 144.15 29.57 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.726 -0.67 . . . . 1.21 111.405 -176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.8 t -107.41 128.03 62.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.928 -0.578 . . . . 0.88 110.56 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -100.97 110.5 22.54 Favored 'General case' 0 C--O 1.258 1.547 0 N-CA-C 109.455 -0.572 . . . . 0.51000000000000001 109.455 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.599 HD23 ' HA ' ' A' ' 36' ' ' LEU . 11.8 mt -108.24 146.68 32.49 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.23 -0.895 . . . . 1.75 112.141 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -153.69 146.29 24.16 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.47 -1.307 . . . . 0.76000000000000001 107.47 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.496 ' HA ' HG23 ' A' ' 71' ' ' THR . 44.3 mtpt 62.43 29.55 17.17 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 124.013 0.821 . . . . 3.6299999999999999 111.157 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.584 HG22 HD22 ' A' ' 48' ' ' LEU . 49.9 t -69.42 111.64 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 119.538 -0.865 . . . . 1.52 109.816 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -170.02 127.27 0.86 Allowed 'General case' 0 N--CA 1.429 -1.505 0 C-N-CA 124.985 1.314 . . . . 5.3200000000000003 108.673 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 70.4 m -119.35 79.81 1.47 Allowed 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.388 -0.597 . . . . 4.0 109.388 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -176.12 98.23 0.06 Allowed 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.645 -0.872 . . . . 6.75 108.645 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -123.72 -157.42 9.81 Favored Glycine 1 N--CA 1.395 -4.041 0 N-CA-C 106.344 -2.702 . . . . 5.9000000000000004 106.344 172.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.484 HG22 ' HB ' ' A' ' 61' ' ' THR . 31.7 p 62.1 -40.12 0.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 125.66 1.584 . . . . 7.0499999999999998 112.619 -174.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.463 ' H ' ' C ' ' A' ' 55' ' ' GLY . 8.7 mm-40 54.32 62.87 2.37 Favored 'General case' 0 C--O 1.253 1.253 0 C-N-CA 125.069 1.347 . . . . 8.3800000000000008 109.14 -175.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 66.64 32.35 7.12 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 114.201 -1.363 . . . . 11.699999999999999 112.898 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.441 ' O ' ' HB ' ' A' ' 56' ' ' THR . 28.4 mmt180 -133.5 -179.05 0.97 Allowed Pre-proline 0 C--O 1.21 -0.986 0 C-N-CA 123.348 0.659 . . . . 12.15 109.343 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -105.93 57.36 0.02 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.664 0 C-N-CA 121.947 1.764 . . . . 9.3200000000000003 111.76 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.484 ' HB ' HG22 ' A' ' 56' ' ' THR . 24.9 m -72.24 88.5 1.15 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.112 -0.949 . . . . 7.5700000000000003 108.995 174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -97.8 -52.96 3.56 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.636 -1.166 . . . . 10.539999999999999 112.03 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.509 ' HB2' ' HD3' ' A' ' 64' ' ' PRO . 98.2 mtt180 -100.38 -54.38 0.16 Allowed Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 113.223 0.823 . . . . 13.1 113.223 -176.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 63' ' ' ARG . 38.5 Cg_endo -80.8 105.88 1.74 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 121.044 1.163 . . . . 7.79 112.627 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 pt -131.98 152.02 36.1 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 123.627 0.771 . . . . 5.96 111.844 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.99 131.74 39.84 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.125 0.97 . . . . 4.6900000000000004 112.708 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.52 97.57 1.04 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 122.88 2.387 . . . . 6.1900000000000004 113.306 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.504 ' HG3' ' OE2' ' A' ' 70' ' ' GLU . 60.6 ttp180 54.13 86.17 0.05 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.53 1.132 . . . . 8.8000000000000007 112.589 176.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -99.69 -40.64 7.67 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.15 -0.932 . . . . 6.5499999999999998 110.2 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.504 ' OE2' ' HG3' ' A' ' 68' ' ' ARG . 18.9 mm-40 74.99 171.69 0.28 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 125.319 1.448 . . . . 7.3899999999999997 112.164 177.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 50' ' ' LYS . 15.8 p -99.43 -89.05 0.33 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.105 0.78 . . . . 4.6100000000000003 113.105 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.586 ' CD2' ' HG2' ' A' ' 73' ' ' GLU . 30.0 t80 -169.14 -90.92 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 112.198 0.444 . . . . 7.5999999999999996 112.198 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.586 ' HG2' ' CD2' ' A' ' 72' ' ' PHE . 9.0 mm-40 -91.49 -25.05 19.46 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 117.912 0.323 . . . . 6.8600000000000003 111.456 -178.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 26.4 m-85 72.59 177.59 0.25 Allowed 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.811 1.245 . . . . 5.54 109.907 -176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.1 pt -134.62 137.16 51.65 Favored 'Isoleucine or valine' 0 C--N 1.347 0.483 0 CA-C-O 121.463 0.649 . . . . 3.7999999999999998 111.749 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mm -119.5 129.1 75.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-N 115.313 -0.858 . . . . 2.4199999999999999 109.176 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 24' ' ' LEU . 20.7 m-85 -98.95 137.32 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.091 -0.504 . . . . 2.3100000000000001 111.192 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 39.3 mmt180 -64.99 -13.65 58.25 Favored 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 123.322 0.649 . . . . 3.4500000000000002 112.084 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 82.01 -61.9 4.61 Favored Glycine 0 CA--C 1.496 -1.141 0 C-N-CA 120.585 -0.816 . . . . 0.76000000000000001 111.988 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.0 p -63.41 -27.43 69.29 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.244 0.545 . . . . 1.6399999999999999 111.649 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 2.0 m-20 -98.38 21.4 11.11 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.182 -0.917 . . . . 2.0 112.701 -174.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 79' ' ' GLY . 40.4 pt -87.01 142.67 12.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 119.431 -0.908 . . . . 1.7 110.406 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' HG2' ' HA ' ' A' ' 27' ' ' LYS . 73.3 mmtt -88.94 -60.34 1.98 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.078 -0.51 . . . . 1.5900000000000001 111.098 176.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -145.04 152.46 40.15 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-N 116.402 -0.363 . . . . 2.2200000000000002 110.185 -176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.18 102.05 5.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 O-C-N 123.921 0.763 . . . . 2.8599999999999999 109.291 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 23' ' ' SER . 68.5 m -97.98 120.12 37.81 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 115.879 -0.601 . . . . 1.8799999999999999 109.949 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.2 p -97.1 147.68 6.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 115.956 -0.566 . . . . 2.7000000000000002 110.534 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 58.2 m -100.78 -30.14 11.87 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 112.715 0.635 . . . . 3.3900000000000001 112.715 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -151.97 158.43 33.87 Favored Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 109.428 -0.582 . . . . 5.0700000000000003 109.428 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.36 113.63 2.36 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.59 2.194 . . . . 6.3099999999999996 112.635 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -57.42 -43.71 49.2 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.815 2.343 . . . . 8.5899999999999999 112.803 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.1 ttpp 60.42 86.87 0.14 Allowed Pre-proline 0 CA--C 1.554 1.114 0 O-C-N 123.621 0.576 . . . . 12.69 111.585 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.04 -40.19 6.8 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.347 2.031 . . . . 13.220000000000001 111.86 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.21 174.64 7.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 C-N-CA 123.048 0.539 . . . . 15.380000000000001 110.52 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 C--N 1.307 -1.262 0 N-CA-C 109.455 -0.572 . . . . 16.629999999999999 109.455 178.004 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo . . . . . 0 C--O 1.256 1.378 0 N-CA-C 113.02 0.354 . . . . 3.73 113.02 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -41.3 143.89 0.39 Allowed 'General case' 0 C--O 1.248 0.995 0 C-N-CA 125.242 1.417 . . . . 8.0399999999999991 114.078 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 16.3 tt -176.46 -37.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.266 -1.334 . . . . 3.8100000000000001 108.284 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -137.97 -177.2 15.0 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 110.137 -1.185 . . . . 1.0700000000000001 110.137 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.8 m -88.81 139.62 30.27 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 117.077 0.438 . . . . 1.8100000000000001 109.823 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -87.69 106.71 18.23 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.69 -0.804 . . . . 4.3499999999999996 112.025 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.85 146.27 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 C-N-CA 123.135 0.574 . . . . 2.4100000000000001 110.518 178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 t -107.68 111.78 24.16 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 106.635 -1.617 . . . . 1.3300000000000001 106.635 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.599 HD12 ' O ' ' A' ' 84' ' ' ASP . 61.6 tp -121.6 129.67 52.99 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.554 0.216 . . . . 1.45 111.062 -175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.58 118.64 53.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 109.645 -0.502 . . . . 0.71999999999999997 109.645 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.9 p -78.45 162.83 26.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.488 -0.778 . . . . 1.3400000000000001 110.313 178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 -10.01 0.3 Allowed 'General case' 0 C--O 1.211 -0.926 0 N-CA-C 115.896 1.813 . . . . 2.1200000000000001 115.896 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.12 13.69 16.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.542 -0.54 . . . . 0.69999999999999996 109.542 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 63.41 28.28 15.45 Favored 'General case' 0 C--O 1.248 1.022 0 C-N-CA 125.259 1.424 . . . . 2.5899999999999999 110.058 -178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.47 129.01 66.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.712 -0.676 . . . . 1.1699999999999999 111.611 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.8 ptm85 -87.11 118.98 26.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.909 -0.587 . . . . 4.71 111.932 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -113.29 125.79 54.68 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.251 -1.018 . . . . 3.0099999999999998 108.251 173.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -134.99 131.61 37.35 Favored 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 107.334 -1.358 . . . . 2.4500000000000002 107.334 -175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 179.91 -158.53 22.23 Favored Glycine 0 CA--C 1.49 -1.49 0 N-CA-C 111.306 -0.718 . . . . 0.45000000000000001 111.306 -175.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.54 ' H ' HD13 ' A' ' 35' ' ' ILE 0.31 0.2 OUTLIER -92.4 109.66 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.581 0 CA-C-O 122.314 1.054 . . . . 0.93000000000000005 113.606 -177.062 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.5 tp -67.06 133.42 49.85 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.568 -1.651 . . . . 1.72 109.847 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -111.95 -59.21 2.02 Favored 'General case' 0 N--CA 1.424 -1.763 0 C-N-CA 120.46 -0.496 . . . . 1.1100000000000001 110.566 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.7 m -141.19 160.59 39.78 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 109.977 -0.379 . . . . 0.93999999999999995 109.977 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 71.4 mt -131.56 123.78 53.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.638 -1.616 . . . . 1.45 106.638 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.488 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 14.7 m-20 -86.84 94.24 9.51 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 106.647 -1.612 . . . . 2.5600000000000001 106.647 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 36.9 p -57.73 -26.34 61.65 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.454 -0.794 . . . . 2.7599999999999998 112.943 -173.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -52.31 -50.27 62.56 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.567 0.747 . . . . 3.2200000000000002 111.475 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -112.94 6.01 17.59 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 120.951 0.405 . . . . 2.2599999999999998 109.973 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.7 m 64.93 22.03 12.41 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.25 1.02 . . . . 2.2799999999999998 110.817 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.493 HG22 ' C ' ' A' ' 78' ' ' ARG . 33.1 p -73.99 148.42 42.1 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.86 -0.609 . . . . 1.21 110.933 -178.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.86 126.92 65.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 116.442 -0.345 . . . . 0.88 110.572 -174.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.33 101.54 11.24 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 121.452 0.644 . . . . 0.51000000000000001 110.232 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.643 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 91.3 mt -100.76 153.98 19.01 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.427 -0.806 . . . . 1.75 109.679 178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -147.53 136.46 22.14 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 109.425 -0.583 . . . . 0.76000000000000001 109.425 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.52 ' C ' HG21 ' A' ' 71' ' ' THR . 88.4 mttt 56.21 36.6 27.72 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.555 0.742 . . . . 3.6299999999999999 111.77 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.643 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 86.7 t -67.3 117.19 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 CA-C-N 114.694 -1.139 . . . . 1.52 111.761 -176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' NH2' ' HA ' ' A' ' 71' ' ' THR . 21.7 tpp180 -165.03 150.65 9.73 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 106.964 -1.495 . . . . 5.3200000000000003 106.964 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.2 m -133.06 145.54 50.88 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.371 -0.603 . . . . 4.0 109.371 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -141.38 -91.64 0.14 Allowed 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 113.338 0.866 . . . . 6.75 113.338 175.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.64 -56.57 0.02 OUTLIER Glycine 0 CA--C 1.496 -1.145 0 C-N-CA 119.953 -1.117 . . . . 5.9000000000000004 112.443 -177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.621 ' HB ' ' CA ' ' A' ' 61' ' ' THR . 53.3 m -127.39 131.13 50.37 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 112.891 0.7 . . . . 7.0499999999999998 112.891 -177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -98.93 -43.23 6.8 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.643 0.608 . . . . 8.3800000000000008 112.643 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.64 -61.77 2.09 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.493 0.717 . . . . 11.699999999999999 110.39 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.574 ' O ' HG22 ' A' ' 56' ' ' THR . 78.8 mtp180 -89.26 175.8 3.67 Favored Pre-proline 0 C--N 1.312 -1.024 0 N-CA-C 106.124 -1.806 . . . . 12.15 106.124 175.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -91.54 35.93 0.28 Allowed 'Trans proline' 0 N--CA 1.448 -1.147 0 CA-C-N 121.231 1.475 . . . . 9.3200000000000003 114.093 -177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.621 ' CA ' ' HB ' ' A' ' 56' ' ' THR . 1.3 t 46.97 -163.25 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 125.634 1.574 . . . . 7.5700000000000003 112.398 177.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' N ' HG23 ' A' ' 61' ' ' THR . 2.3 m-20 -49.72 -62.79 1.36 Allowed 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 125.546 1.538 . . . . 10.539999999999999 110.518 174.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.47 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 40.0 ttm180 -156.15 -55.14 0.02 OUTLIER Pre-proline 0 CA--C 1.57 1.715 0 CA-C-N 115.37 -0.832 . . . . 13.1 112.828 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 66.9 Cg_endo -90.18 126.19 1.32 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 121.689 1.592 . . . . 7.79 114.235 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.549 HG23 HG22 ' A' ' 61' ' ' THR . 0.1 OUTLIER -134.11 138.81 49.55 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.521 0 CA-C-N 115.413 -0.812 . . . . 5.96 110.213 177.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.68 118.52 67.45 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 109.162 -0.681 . . . . 4.6900000000000004 109.162 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.95 17.5 0.83 Allowed 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.16 2.573 . . . . 6.1900000000000004 111.792 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 77.69 -22.95 0.26 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 125.783 1.633 . . . . 8.8000000000000007 111.603 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -91.82 9.45 32.7 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.597 0.359 . . . . 6.5499999999999998 110.966 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -105.51 -20.59 13.43 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.339 0.59 . . . . 7.3899999999999997 110.552 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.52 HG21 ' C ' ' A' ' 50' ' ' LYS . 41.3 m -76.64 154.73 34.04 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.895 -0.593 . . . . 4.6100000000000003 110.195 -177.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -59.48 161.96 5.35 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.623 -0.88 . . . . 7.5999999999999996 108.623 172.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -47.68 -60.54 2.48 Favored 'General case' 0 C--O 1.251 1.157 0 O-C-N 123.977 0.798 . . . . 6.8600000000000003 112.756 -172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 22.8 p90 175.61 179.8 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.128 0.571 . . . . 5.54 111.132 175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 tp -145.23 132.23 15.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 120.942 0.401 . . . . 3.7999999999999998 110.238 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.3 mm -112.35 126.07 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.073 -0.714 . . . . 2.4199999999999999 109.073 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.447 ' HE2' HD12 ' A' ' 48' ' ' LEU . 90.2 m-85 -101.36 160.94 14.0 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 110.091 -0.337 . . . . 2.3100000000000001 110.091 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' C ' HG22 ' A' ' 45' ' ' THR . 10.0 mpt_? -85.2 -3.85 58.96 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.413 -0.358 . . . . 3.4500000000000002 111.87 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.588 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 81.35 -61.43 4.61 Favored Glycine 0 CA--C 1.489 -1.564 0 C-N-CA 120.762 -0.732 . . . . 0.76000000000000001 111.813 175.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 42.3 p -75.14 1.82 12.33 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 120.617 0.246 . . . . 1.6399999999999999 111.628 177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -110.52 8.89 23.16 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.018 0.437 . . . . 2.0 110.803 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 79' ' ' GLY . 32.0 pt -92.24 148.9 4.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 O-C-N 121.48 -0.762 . . . . 1.7 110.446 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -104.31 -46.91 4.28 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.751 -0.38 . . . . 1.5900000000000001 111.835 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.599 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.9 m-20 -129.68 146.37 51.46 Favored 'General case' 0 C--O 1.211 -0.968 0 O-C-N 122.34 -0.225 . . . . 2.2200000000000002 110.85 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.5 tt -150.99 111.18 4.14 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.114 -1.439 . . . . 2.8599999999999999 107.114 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -105.41 109.13 20.99 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.026 -0.731 . . . . 1.8799999999999999 109.026 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.57 104.09 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-O 121.412 0.625 . . . . 2.7000000000000002 110.545 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 15.0 p -148.07 97.22 2.76 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.79 0.805 . . . . 3.3900000000000001 112.292 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -107.57 149.76 39.28 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-N 115.099 -0.955 . . . . 5.0700000000000003 110.153 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -89.76 108.35 0.4 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 122.852 2.368 . . . . 6.3099999999999996 112.062 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -90.37 145.13 4.09 Favored 'Trans proline' 0 N--CA 1.438 -1.751 0 C-N-CA 122.197 1.931 . . . . 8.5899999999999999 112.736 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -134.57 94.14 17.56 Favored Pre-proline 0 N--CA 1.432 -1.363 0 N-CA-C 105.628 -1.99 . . . . 12.69 105.628 177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -78.62 -51.75 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.663 1.575 . . . . 13.220000000000001 113.183 -174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.5 mt -146.47 -58.16 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 106.762 -1.57 . . . . 15.380000000000001 106.762 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.433 -1.299 0 N-CA-C 107.73 -1.211 . . . . 16.629999999999999 107.73 176.718 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD3' ' CG ' ' A' ' 54' ' ' PHE . 63.4 Cg_endo . . . . . 0 CA--C 1.542 0.896 0 CA-C-O 120.707 0.211 . . . . 3.73 112.641 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -154.71 -70.24 0.13 Allowed 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 123.866 0.866 . . . . 8.0399999999999991 108.741 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -164.36 160.45 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.271 2.203 0 CA-C-N 114.931 -1.032 . . . . 3.8100000000000001 108.375 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.481 ' HA3' ' HB ' ' A' ' 35' ' ' ILE . . . 150.96 159.09 8.62 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 109.449 -1.46 . . . . 1.0700000000000001 109.449 177.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.605 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 25.2 m -103.38 142.38 34.33 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.125 1.462 . . . . 1.8100000000000001 111.07 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -89.23 106.71 18.62 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 122.464 0.306 . . . . 4.3499999999999996 110.508 -176.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.47 -173.45 0.96 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.973 0 CA-C-O 121.507 0.67 . . . . 2.4100000000000001 110.087 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 36.6 m -139.48 124.82 19.07 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.311 -1.366 . . . . 1.3300000000000001 107.311 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.49 HD21 HG22 ' A' ' 82' ' ' ILE . 6.1 tt -133.31 135.85 45.09 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.335 -0.617 . . . . 1.45 109.335 -176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 66.4 mt -106.96 122.51 61.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 109.281 -0.637 . . . . 0.71999999999999997 109.281 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.5 t -84.76 162.3 19.67 Favored 'General case' 0 N--CA 1.429 -1.508 0 O-C-N 123.811 0.694 . . . . 1.3400000000000001 109.232 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HA ' ' HG2' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -57.9 -3.41 0.22 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.822 1.416 . . . . 2.1200000000000001 114.822 -178.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.68 8.05 38.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.466 0.65 . . . . 0.69999999999999996 109.256 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.612 ' OE1' ' HE3' ' A' ' 83' ' ' LYS . 6.2 mm-40 68.03 28.8 6.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.255 1.422 . . . . 2.5899999999999999 109.768 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 48.0 mm -107.44 128.54 62.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 112.277 0.473 . . . . 1.1699999999999999 112.277 -175.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -89.1 117.44 28.1 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.25 1.02 . . . . 4.71 110.202 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' HA ' ' A' ' 23' ' ' SER . 98.3 m-85 -107.85 148.59 29.36 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 122.386 0.274 . . . . 3.0099999999999998 111.148 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -138.99 126.7 22.0 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 106.798 -1.556 . . . . 2.4500000000000002 106.798 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 168.44 -155.33 25.88 Favored Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 111.304 -0.718 . . . . 0.45000000000000001 111.304 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 20' ' ' SER . 0.2 OUTLIER -121.75 128.91 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 113.978 1.103 . . . . 0.93000000000000005 113.978 -177.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.674 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.66 156.48 30.72 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.821 -1.081 . . . . 1.72 112.625 173.12 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -110.73 -39.21 4.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.835 -0.621 . . . . 1.1100000000000001 110.806 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -151.81 153.9 35.14 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 109.658 -0.497 . . . . 0.93999999999999995 109.658 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.87 124.41 37.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.941 -0.763 . . . . 1.45 108.941 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -103.06 95.73 6.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.449 0.642 . . . . 2.5600000000000001 109.49 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.1 m -52.88 -41.38 64.27 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 124.859 1.264 . . . . 2.7599999999999998 114.133 -175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -55.45 -42.86 74.85 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.013 0.746 . . . . 3.2200000000000002 113.013 -174.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -105.81 -0.01 25.66 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.142 0.496 . . . . 2.2599999999999998 109.82 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 m 64.21 18.9 11.54 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.548 1.139 . . . . 2.2799999999999998 111.033 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.8 p -79.43 125.08 29.09 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.105 0.479 . . . . 1.21 111.025 -176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.4 t -101.21 124.06 54.67 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.784 -0.644 . . . . 0.88 109.469 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.9 103.5 16.03 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 108.036 -1.098 . . . . 0.51000000000000001 108.036 176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.618 ' CD1' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -100.05 147.13 25.96 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 106.114 -1.81 . . . . 1.75 106.114 -176.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.504 ' H ' HD13 ' A' ' 48' ' ' LEU . . . -148.94 129.82 14.28 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 107.479 -1.304 . . . . 0.76000000000000001 107.479 -175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 18.1 pttp 48.95 54.62 10.55 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.068 0.947 . . . . 3.6299999999999999 112.697 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.618 ' HB ' ' CD1' ' A' ' 48' ' ' LEU . 6.6 p -66.97 114.12 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.424 -0.807 . . . . 1.52 109.613 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.56 ' HB3' ' CE2' ' A' ' 54' ' ' PHE . 12.7 tpt180 -169.22 170.73 8.45 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 106.761 -1.57 . . . . 5.3200000000000003 106.761 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.7 m -79.13 124.03 27.93 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.786 -0.45 . . . . 4.0 109.786 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 96.1 m-85 -137.25 146.87 45.28 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.958 -0.564 . . . . 6.75 111.182 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.555 ' O ' HG22 ' A' ' 61' ' ' THR . . . 145.8 125.51 1.73 Allowed Glycine 0 C--O 1.171 -3.816 0 CA-C-O 118.45 -1.194 . . . . 5.9000000000000004 110.211 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.5 m -175.35 -89.9 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.724 0 C-N-CA 124.51 1.124 . . . . 7.0499999999999998 112.538 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.329 8.2 mm-40 70.61 -90.84 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 125.845 1.658 . . . . 8.3800000000000008 112.569 -170.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -92.82 -25.79 17.97 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 120.53 -0.468 . . . . 11.699999999999999 111.296 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -141.37 144.35 33.72 Favored Pre-proline 0 CA--C 1.461 -2.445 0 C-N-CA 119.13 -1.028 . . . . 12.15 109.715 -169.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -67.8 86.57 0.37 Allowed 'Trans proline' 0 N--CA 1.437 -1.85 0 C-N-CA 121.495 1.464 . . . . 9.3200000000000003 110.109 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 55' ' ' GLY . 7.5 t -57.16 -179.01 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.778 -1.101 . . . . 7.5700000000000003 111.579 175.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.64 97.49 2.17 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.0 -1.482 . . . . 10.539999999999999 107.0 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 88.15 83.04 0.04 OUTLIER Pre-proline 0 C--N 1.311 -1.069 0 C-N-CA 127.024 2.13 . . . . 13.1 108.495 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 51.7 Cg_exo -58.98 -178.45 0.13 Allowed 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 124.476 3.45 . . . . 7.79 115.751 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 55' ' ' GLY . 34.7 pt -87.18 149.09 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.425 0 CA-C-N 115.263 -0.881 . . . . 5.96 112.445 -175.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.453 ' HB3' ' CE1' ' A' ' 54' ' ' PHE . . . -101.95 131.8 22.33 Favored Pre-proline 0 C--N 1.291 -1.971 0 CA-C-N 113.816 -1.538 . . . . 4.6900000000000004 109.94 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.69 32.93 0.52 Allowed 'Trans proline' 0 CA--C 1.551 1.332 0 C-N-CA 122.871 2.381 . . . . 6.1900000000000004 112.074 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 72.42 106.54 0.07 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.363 1.465 . . . . 8.8000000000000007 112.915 -175.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -85.16 -75.05 0.37 Allowed 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.514 -0.766 . . . . 6.5499999999999998 109.557 170.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 176.97 122.5 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.508 0.671 . . . . 7.3899999999999997 112.441 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.4 m -161.27 100.07 1.2 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.094 -1.076 . . . . 4.6100000000000003 108.094 174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -112.03 -37.93 4.93 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.853 -0.739 . . . . 7.5999999999999996 111.281 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.32 -20.66 31.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.867 0.365 . . . . 6.8600000000000003 111.636 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 62.08 -168.17 0.19 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.476 1.51 . . . . 5.54 111.736 177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.405 HD13 ' H ' ' A' ' 75' ' ' ILE . 0.2 OUTLIER -137.73 131.14 42.75 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-O 121.106 0.479 . . . . 3.7999999999999998 110.383 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.6 mm -109.52 128.98 65.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.194 -0.669 . . . . 2.4199999999999999 109.194 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -96.41 130.38 43.55 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 109.441 -0.578 . . . . 2.3100000000000001 109.441 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -68.47 -10.47 55.65 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.295 0.85 . . . . 3.4500000000000002 113.295 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.7 -48.98 3.33 Favored Glycine 0 C--O 1.212 -1.239 0 C-N-CA 120.831 -0.699 . . . . 0.76000000000000001 112.305 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.9 m -76.31 -16.49 59.76 Favored 'General case' 0 C--N 1.287 -2.152 0 CA-C-O 122.054 0.931 . . . . 1.6399999999999999 109.188 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -98.23 24.7 6.89 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.659 -1.155 . . . . 2.0 112.124 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 79' ' ' GLY . 21.0 pt -112.73 150.97 14.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 C-N-CA 119.552 -0.859 . . . . 1.7 110.493 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.612 ' HE3' ' OE1' ' A' ' 29' ' ' GLU . 71.6 mmtt -92.89 -54.5 3.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.788 -0.642 . . . . 1.5900000000000001 110.526 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -161.65 159.01 26.94 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.21 -1.033 . . . . 2.2200000000000002 108.21 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 82' ' ' ILE . 1.5 pt? -156.13 147.91 22.97 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.803 0.335 . . . . 2.8599999999999999 110.419 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.7 t -124.21 130.8 53.15 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.153 -0.684 . . . . 1.8799999999999999 109.153 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.1 p -126.36 122.98 62.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 116.134 -0.484 . . . . 2.7000000000000002 111.376 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 47.2 t 174.21 -48.21 0.01 OUTLIER 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.163 -1.051 . . . . 3.3900000000000001 108.163 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 178.03 162.21 0.61 Allowed Pre-proline 0 C--O 1.248 1.02 0 N-CA-C 106.089 -1.819 . . . . 5.0700000000000003 106.089 -172.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.46 117.26 2.08 Favored 'Trans proline' 0 CA--C 1.554 1.521 0 C-N-CA 122.062 1.842 . . . . 6.3099999999999996 114.217 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -84.85 167.4 11.24 Favored 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 122.681 2.254 . . . . 8.5899999999999999 111.968 174.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 64.24 90.75 0.09 OUTLIER Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 124.591 1.157 . . . . 12.69 112.77 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.47 -66.56 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.289 1.993 . . . . 13.220000000000001 111.575 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 26.7 pt -144.78 16.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 123.804 0.842 . . . . 15.380000000000001 108.758 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.099 -0.953 . . . . 16.629999999999999 109.594 -175.891 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HG3' ' H ' ' A' ' 66' ' ' ALA . 93.2 Cg_endo . . . . . 0 CA--C 1.588 3.225 0 CA-C-O 120.52 0.133 . . . . 3.73 111.835 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -117.83 -91.16 0.55 Allowed 'General case' 0 C--O 1.239 0.543 0 N-CA-C 114.183 1.179 . . . . 8.0399999999999991 114.183 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.0 tp 166.22 154.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 107.285 -1.376 . . . . 3.8100000000000001 107.285 -172.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.93 -177.55 47.59 Favored Glycine 0 N--CA 1.433 -1.535 0 N-CA-C 109.953 -1.259 . . . . 1.0700000000000001 109.953 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 t -96.45 124.85 40.58 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.448 -0.945 . . . . 1.8100000000000001 108.448 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -68.03 121.37 15.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.533 0.938 . . . . 4.3499999999999996 113.533 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 36' ' ' LEU . 10.9 tt -153.19 152.04 10.78 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-N 115.412 -0.813 . . . . 2.4100000000000001 110.492 -178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.788 ' O ' ' HB3' ' A' ' 85' ' ' LEU . 20.0 m -115.3 144.53 43.61 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 105.989 -1.856 . . . . 1.3300000000000001 105.989 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.977 ' HA ' ' HB2' ' A' ' 85' ' ' LEU . 31.1 tp -147.97 129.88 15.28 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.529 1.307 . . . . 1.45 114.529 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.462 ' H ' ' HB2' ' A' ' 85' ' ' LEU . 66.6 mt -95.12 119.64 43.46 Favored 'Isoleucine or valine' 0 C--N 1.387 2.23 0 C-N-CA 119.82 -0.752 . . . . 0.71999999999999997 109.77 174.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.1 p -89.49 166.13 13.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.946 -0.57 . . . . 1.3400000000000001 109.48 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD2' ' N ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -47.52 -19.61 0.19 Allowed 'General case' 0 N--CA 1.508 2.445 0 N-CA-C 115.04 1.496 . . . . 2.1200000000000001 115.04 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 27' ' ' LYS . . . -74.39 -2.92 27.47 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 120.708 0.29 . . . . 0.69999999999999996 110.43 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 74.41 22.74 2.1 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 124.633 1.173 . . . . 2.5899999999999999 107.882 177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 53.9 mt -109.99 129.48 64.87 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 CA-C-N 114.152 -1.385 . . . . 1.1699999999999999 110.971 -175.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.422 ' HB3' HG12 ' A' ' 25' ' ' ILE . 38.9 ptt180 -92.06 119.84 32.12 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.74 -0.663 . . . . 4.71 110.308 177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -107.35 159.15 16.6 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.976 -0.75 . . . . 3.0099999999999998 108.976 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -142.43 128.01 19.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 107.226 -1.398 . . . . 2.4500000000000002 107.226 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 175.0 -128.87 1.47 Allowed Glycine 1 CA--C 1.442 -4.469 0 N-CA-C 109.998 -1.241 . . . . 0.45000000000000001 109.998 -176.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.441 HD11 ' CB ' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -135.5 161.31 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.48 0 C-N-CA 118.934 -1.106 . . . . 0.93000000000000005 113.287 -174.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.425 ' HB2' HG21 ' A' ' 22' ' ' ILE . 3.3 tm? -99.44 140.34 33.76 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.507 -1.224 . . . . 1.72 109.389 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' N ' HD13 ' A' ' 36' ' ' LEU . 76.9 t80 -105.88 -54.69 2.44 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 123.239 0.337 . . . . 1.1100000000000001 111.121 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.5 m -153.93 154.63 34.17 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 109.744 -0.465 . . . . 0.93999999999999995 109.744 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.414 HG13 HD11 ' A' ' 36' ' ' LEU . 82.2 mt -130.29 142.56 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.797 0.332 . . . . 1.45 111.416 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.468 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 2.7 t70 -111.35 116.1 30.41 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 123.636 0.775 . . . . 2.5600000000000001 110.428 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.4 m -76.79 -18.18 58.58 Favored 'General case' 0 CA--C 1.581 2.163 0 N-CA-C 113.035 0.754 . . . . 2.7599999999999998 113.035 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -69.7 -54.98 11.28 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 121.85 -0.531 . . . . 3.2200000000000002 111.443 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -103.9 5.72 35.89 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 120.953 0.406 . . . . 2.2599999999999998 110.058 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.1 t 65.02 24.38 12.59 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.996 -1.002 . . . . 2.2799999999999998 109.817 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 70.3 p -77.51 141.45 39.62 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-O 121.884 0.849 . . . . 1.21 111.525 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 96.5 t -115.55 126.26 73.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.168 -0.924 . . . . 0.88 110.143 -176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -97.89 99.52 10.83 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.511 -0.922 . . . . 0.51000000000000001 108.511 176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' CD2' ' HB ' ' A' ' 51' ' ' VAL . 2.7 tt -101.3 126.12 48.01 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 105.759 -1.941 . . . . 1.75 105.759 -176.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB1' ' HA ' ' A' ' 73' ' ' GLU . . . -155.1 156.56 36.04 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 107.703 -1.221 . . . . 0.76000000000000001 107.703 -174.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 70' ' ' GLU . 49.6 mttm 68.26 21.27 8.53 Favored 'General case' 0 C--O 1.2 -1.507 0 CA-C-O 121.993 0.901 . . . . 3.6299999999999999 109.171 175.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.673 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.7 p -67.1 166.81 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 107.424 -1.324 . . . . 1.52 107.424 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.552 ' HG3' ' HA ' ' A' ' 69' ' ' ASP . 44.6 ttp180 -71.58 102.21 2.68 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.341 -1.344 . . . . 5.3200000000000003 114.239 -172.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.3 t -92.78 -172.98 3.19 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.953 -1.499 . . . . 4.0 106.953 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -109.16 -9.46 15.03 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.872 -0.731 . . . . 6.75 111.762 -174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.57 149.87 24.66 Favored Glycine 0 N--CA 1.407 -3.281 0 C-N-CA 119.802 -1.19 . . . . 5.9000000000000004 110.614 -175.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.8 p 63.55 99.15 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 124.991 1.317 . . . . 7.0499999999999998 111.776 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -100.03 21.33 12.91 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.188 -0.914 . . . . 8.3800000000000008 110.428 -173.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 168.46 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 125.776 1.63 . . . . 11.699999999999999 110.934 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.434 ' HD3' ' OD2' ' A' ' 62' ' ' ASP . 45.1 mtp180 -97.44 158.8 32.52 Favored Pre-proline 0 C--N 1.311 -1.084 0 CA-C-N 115.518 -0.765 . . . . 12.15 109.179 -177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.69 42.93 0.42 Allowed 'Trans proline' 0 CA--C 1.558 1.698 0 C-N-CA 123.511 2.808 . . . . 9.3200000000000003 112.938 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.562 HG21 ' HA ' ' A' ' 64' ' ' PRO . 26.0 m 71.74 112.37 0.06 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.179 0.992 . . . . 7.5700000000000003 113.171 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.434 ' OD2' ' HD3' ' A' ' 59' ' ' ARG . 9.5 m-20 -98.0 4.15 49.39 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.8 0.81 . . . . 10.539999999999999 110.102 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -163.7 86.14 1.26 Allowed Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 106.589 -1.634 . . . . 13.1 106.589 -176.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.562 ' HA ' HG21 ' A' ' 61' ' ' THR . 0.1 OUTLIER -25.72 116.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.967 1 C-N-CA 125.553 4.168 . . . . 7.79 116.042 -176.203 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.4 pt -86.67 153.2 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 113.173 -1.831 . . . . 5.96 112.256 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 67' ' ' PRO . . . -79.13 168.48 26.52 Favored Pre-proline 0 C--N 1.29 -1.98 0 CA-C-N 114.034 -1.439 . . . . 4.6900000000000004 108.245 -178.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 3.9 Cg_exo -34.15 115.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 124.425 3.417 . . . . 6.1900000000000004 114.22 178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -45.89 107.61 0.11 Allowed 'General case' 0 C--O 1.245 0.857 0 CA-C-N 113.25 -1.795 . . . . 8.8000000000000007 114.409 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.552 ' HA ' ' HG3' ' A' ' 52' ' ' ARG . 7.6 t70 -178.5 -169.12 0.17 Allowed 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 101.931 -3.359 . . . . 6.5499999999999998 101.931 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 45.5 mm-40 62.86 176.89 0.15 Allowed 'General case' 0 CA--C 1.582 2.197 0 CA-C-N 119.528 1.058 . . . . 7.3899999999999997 113.652 175.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.585 HG22 ' N ' ' A' ' 51' ' ' VAL . 6.1 t -175.98 -167.99 0.25 Allowed 'General case' 0 CA--C 1.568 1.659 0 C-N-CA 123.695 0.798 . . . . 4.6100000000000003 110.219 175.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -86.54 -168.49 2.25 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.534 0.733 . . . . 7.5999999999999996 110.012 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.626 ' HA ' ' HB1' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -51.37 -7.47 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 126.527 1.931 . . . . 6.8600000000000003 116.203 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 21.3 t80 53.27 -109.9 0.5 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.56 1.689 . . . . 5.54 115.56 172.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.3 pt -150.82 147.14 15.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 121.568 0.699 . . . . 3.7999999999999998 110.94 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.75 129.15 52.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.6 -0.889 . . . . 2.4199999999999999 108.6 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 100.0 m-85 -98.11 152.24 19.53 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.893 -0.323 . . . . 2.3100000000000001 110.154 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' C ' HG22 ' A' ' 45' ' ' THR . 22.1 mmm180 -78.05 6.3 8.18 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.046 -0.525 . . . . 3.4500000000000002 111.193 -177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.537 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 78.28 -57.6 4.05 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 111.532 -0.627 . . . . 0.76000000000000001 111.532 178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.8 t -74.51 5.22 4.94 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 122.409 1.099 . . . . 1.6399999999999999 108.792 174.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 79' ' ' GLY . 16.4 t70 -89.88 -11.9 40.56 Favored 'General case' 0 C--O 1.195 -1.784 0 CA-C-N 114.619 -1.173 . . . . 2.0 109.872 -178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 79' ' ' GLY . 33.2 pt -100.25 153.76 4.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.284 -0.966 . . . . 1.7 113.397 -174.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.0 -68.18 0.75 Allowed 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 114.471 -1.24 . . . . 1.5900000000000001 110.274 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.622 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 24.1 t70 -173.32 115.27 0.25 Allowed 'General case' 0 CA--C 1.479 -1.773 0 CA-C-O 118.543 -0.741 . . . . 2.2200000000000002 110.111 -174.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.977 ' HB2' ' HA ' ' A' ' 24' ' ' LEU 0.842 17.7 mt -162.24 156.78 22.08 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 119.458 3.133 . . . . 2.8599999999999999 119.458 170.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.4 m -141.55 159.07 42.99 Favored 'General case' 0 CA--C 1.563 1.481 0 N-CA-C 110.476 -0.194 . . . . 1.8799999999999999 110.476 -172.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.408 ' HA ' HG13 ' A' ' 22' ' ' ILE . 33.7 m -56.18 155.45 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.045 0 C-N-CA 123.745 0.818 . . . . 2.7000000000000002 111.6 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 44.8 t -103.75 -14.22 16.16 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.133 -0.485 . . . . 3.3900000000000001 110.749 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -107.71 148.99 38.38 Favored Pre-proline 0 N--CA 1.45 -0.435 0 C-N-CA 120.175 -0.61 . . . . 5.0700000000000003 109.746 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.04 113.23 3.51 Favored 'Trans proline' 0 CA--C 1.555 1.536 0 C-N-CA 122.106 1.871 . . . . 6.3099999999999996 112.292 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -74.26 123.29 8.15 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.741 2.294 . . . . 8.5899999999999999 111.786 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -121.96 100.93 42.62 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 108.82 -0.808 . . . . 12.69 108.82 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -87.03 36.79 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.118 2.545 . . . . 13.220000000000001 111.265 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.4 mt 79.8 -40.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.932 1.293 . . . . 15.380000000000001 110.43 -178.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.425 -1.681 0 CA-C-O 118.545 -0.741 . . . . 16.629999999999999 109.755 176.882 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 CA--C 1.545 1.057 0 N-CA-C 113.237 0.437 . . . . 3.73 113.237 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -130.09 101.31 5.76 Favored 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 109.68 -0.489 . . . . 8.0399999999999991 109.68 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.35 -52.32 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 111.928 0.344 . . . . 3.8100000000000001 111.928 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.87 -140.94 11.76 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 115.707 -0.679 . . . . 1.0700000000000001 113.698 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 61.3 m -82.64 138.82 34.04 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 122.216 0.206 . . . . 1.8100000000000001 111.086 -177.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.84 116.61 31.45 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.468 -0.938 . . . . 4.3499999999999996 108.468 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.404 HD12 ' CD1' ' A' ' 85' ' ' LEU . 14.1 pt -140.71 153.37 21.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 119.956 -0.698 . . . . 2.4100000000000001 109.543 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -100.08 116.85 33.05 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 107.235 -1.394 . . . . 1.3300000000000001 107.235 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 84' ' ' ASP . 63.9 tp -123.12 129.08 50.97 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.094 -0.503 . . . . 1.45 110.284 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.2 mt -110.45 120.37 61.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 120.263 -0.575 . . . . 0.71999999999999997 110.122 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.3 t -75.09 158.42 33.15 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.006 -0.997 . . . . 1.3400000000000001 108.791 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HG3' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -56.38 -8.08 0.47 Allowed 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.148 1.536 . . . . 2.1200000000000001 115.148 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.82 10.06 25.04 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.335 -0.617 . . . . 0.69999999999999996 109.335 177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 66.77 26.6 9.44 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 125.801 1.64 . . . . 2.5899999999999999 109.987 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.4 mt -100.97 129.36 52.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 1.1699999999999999 110.854 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -86.22 120.99 28.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.445 -0.798 . . . . 4.71 110.917 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -119.78 133.27 55.67 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.934 -0.765 . . . . 3.0099999999999998 108.934 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -139.72 129.13 24.14 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.083 -1.821 . . . . 2.4500000000000002 106.083 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.478 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . 172.83 -165.52 37.91 Favored Glycine 0 CA--C 1.485 -1.821 0 N-CA-C 110.786 -0.926 . . . . 0.45000000000000001 110.786 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 35' ' ' ILE 0.338 0.2 OUTLIER -94.67 118.83 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.589 0 C-N-CA 117.849 -1.54 . . . . 0.93000000000000005 114.777 -175.714 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.98 135.52 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.778 -1.556 . . . . 1.72 109.119 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.49 -45.11 4.33 Favored 'General case' 0 N--CA 1.438 -1.035 0 O-C-N 123.899 0.749 . . . . 1.1100000000000001 111.676 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.5 m -156.15 153.92 30.04 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 110.156 -0.313 . . . . 0.93999999999999995 110.156 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -125.78 134.13 67.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 107.845 -1.168 . . . . 1.45 107.845 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.508 ' HB3' ' OG1' ' A' ' 45' ' ' THR . 8.8 t70 -94.9 98.38 10.67 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.935 -1.505 . . . . 2.5600000000000001 106.935 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 m -66.93 -15.74 63.87 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.619 0.6 . . . . 2.7599999999999998 112.619 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -75.3 -46.03 36.01 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.517 0.675 . . . . 3.2200000000000002 110.048 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -103.56 -5.98 22.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.646 0.778 . . . . 2.2599999999999998 110.334 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.4 m 68.08 19.83 9.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.132 1.373 . . . . 2.2799999999999998 111.311 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 40' ' ' ASP . 75.0 p -79.3 146.53 32.9 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.095 0.474 . . . . 1.21 111.318 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -111.68 127.49 68.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 116.135 -0.484 . . . . 0.88 110.007 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.34 113.38 26.72 Favored 'General case' 0 C--O 1.254 1.306 0 CA-C-O 121.166 0.507 . . . . 0.51000000000000001 110.377 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' O ' ' HB3' ' A' ' 74' ' ' TYR . 96.8 mt -100.08 136.74 39.52 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 115.717 -0.674 . . . . 1.75 109.231 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.67 117.88 24.44 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 109.409 -0.589 . . . . 0.76000000000000001 109.409 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 35' ' ' ILE . 23.4 mtpp 65.17 38.39 6.06 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 124.317 1.047 . . . . 3.6299999999999999 109.517 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.478 HG23 ' HA3' ' A' ' 34' ' ' GLY . 3.4 p -66.44 114.75 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 109.023 -0.732 . . . . 1.52 109.023 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -169.3 94.03 0.29 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.807 -0.812 . . . . 5.3200000000000003 108.807 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -92.77 103.17 15.56 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 120.008 -0.677 . . . . 4.0 109.536 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 t80 179.15 32.84 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 108.294 -1.002 . . . . 6.75 108.294 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.77 -74.91 0.88 Allowed Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.076 -1.059 . . . . 5.9000000000000004 113.015 -177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.622 ' HB ' ' H ' ' A' ' 61' ' ' THR 0.397 0.7 OUTLIER 53.07 116.46 0.0 OUTLIER 'General case' 0 C--O 1.198 -1.606 0 N-CA-C 116.0 1.852 . . . . 7.0499999999999998 116.0 -174.391 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' OE2' HD13 ' A' ' 65' ' ' ILE . 10.0 mm-40 -95.91 -95.76 0.19 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.015 -0.538 . . . . 8.3800000000000008 111.11 177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.62 -10.86 59.74 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.255 1.026 . . . . 11.699999999999999 109.063 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.548 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 66.1 mtp180 -94.35 166.27 15.76 Favored Pre-proline 0 C--O 1.198 -1.65 0 N-CA-C 105.709 -1.96 . . . . 12.15 105.709 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.583 ' HB2' HG21 ' A' ' 56' ' ' THR 0.368 81.1 Cg_exo 0.6 -13.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.402 3.384 2 C-N-CA 129.541 6.827 . . . . 9.3200000000000003 125.094 -175.513 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.622 ' H ' ' HB ' ' A' ' 56' ' ' THR . 2.1 m -83.52 -40.67 18.87 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 119.243 0.928 . . . . 7.5700000000000003 110.36 170.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 72.84 -39.68 0.45 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.317 1.047 . . . . 10.539999999999999 113.619 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.461 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 41.8 ttm180 -154.48 -62.56 0.02 OUTLIER Pre-proline 0 CA--C 1.583 2.221 0 N-CA-C 113.948 1.092 . . . . 13.1 113.948 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 97.8 Cg_endo -79.78 102.13 1.44 Allowed 'Trans proline' 0 C--N 1.38 2.207 0 C-N-CA 121.943 1.762 . . . . 7.79 113.652 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.411 HD13 ' OE2' ' A' ' 57' ' ' GLU . 11.8 mt -89.47 145.52 7.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 CA-C-O 120.739 0.304 . . . . 5.96 111.228 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.65 156.42 64.26 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 123.69 0.796 . . . . 4.6900000000000004 111.307 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.56 122.48 5.54 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.382 2.055 . . . . 6.1900000000000004 113.083 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -72.89 10.94 0.76 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.37 0.507 . . . . 8.8000000000000007 112.37 177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -117.28 -3.39 11.47 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.262 0.553 . . . . 6.5499999999999998 110.625 -176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -63.2 -54.32 39.42 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.859 -0.61 . . . . 7.3899999999999997 111.121 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.6 m -84.78 103.15 13.61 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.212 -0.662 . . . . 4.6100000000000003 109.212 176.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -114.9 -38.55 3.89 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 113.829 1.048 . . . . 7.5999999999999996 113.829 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -75.83 -15.86 60.17 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 113.019 0.748 . . . . 6.8600000000000003 113.019 -176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.522 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 7.3 m-85 69.38 -174.69 0.19 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.729 1.211 . . . . 5.54 110.023 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.8 tt -153.48 139.18 11.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 109.831 -0.433 . . . . 3.7999999999999998 109.831 175.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.9 mm -114.27 134.71 56.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.215 -0.661 . . . . 2.4199999999999999 109.215 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -108.87 147.21 32.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 110.061 -0.348 . . . . 2.3100000000000001 110.061 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' C ' HG22 ' A' ' 45' ' ' THR . 16.5 mmt180 -71.55 -5.53 33.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.638 0.977 . . . . 3.4500000000000002 113.638 -174.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.552 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.14 -58.19 4.6 Favored Glycine 0 CA--C 1.495 -1.186 0 C-N-CA 120.874 -0.679 . . . . 0.76000000000000001 112.766 176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.1 p -67.44 -3.42 8.37 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.533 0.733 . . . . 1.6399999999999999 111.665 176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.3 m-20 -118.41 19.54 13.35 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 114.83 -1.077 . . . . 2.0 111.597 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 79' ' ' GLY . 37.0 pt -98.8 138.81 22.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 C-N-CA 120.07 -0.652 . . . . 1.7 111.216 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 35.7 mmtp -93.34 -56.3 2.99 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.386 0.612 . . . . 1.5900000000000001 110.052 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' HD12 ' A' ' 24' ' ' LEU . 1.1 m-20 -122.93 136.45 54.87 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.57 -0.741 . . . . 2.2200000000000002 110.68 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD13 HD13 ' A' ' 24' ' ' LEU . 58.8 tp -143.52 103.72 4.13 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.397 -1.705 . . . . 2.8599999999999999 106.397 -178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -141.32 134.45 29.3 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.381 -0.528 . . . . 1.8799999999999999 110.931 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.6 t -85.89 132.56 31.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.513 -0.921 . . . . 2.7000000000000002 108.513 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 9.4 p -87.77 -30.61 20.14 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.687 0.625 . . . . 3.3900000000000001 112.687 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -127.22 101.86 24.74 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.986 0.422 . . . . 5.0700000000000003 110.715 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -72.11 109.82 2.79 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 122.751 2.301 . . . . 6.3099999999999996 112.519 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -88.18 115.64 0.92 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 122.672 2.248 . . . . 8.5899999999999999 113.612 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -116.9 95.83 47.59 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.954 -0.566 . . . . 12.69 110.335 173.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.56 -52.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.755 2.303 . . . . 13.220000000000001 112.692 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 45.3 mm -124.61 -72.16 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.967 0 CA-C-N 115.939 -0.573 . . . . 15.380000000000001 110.102 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.527 1.131 . . . . 16.629999999999999 110.469 -177.723 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.487 1.092 0 N-CA-C 113.3 0.462 . . . . 3.73 113.3 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -136.61 134.92 37.9 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.197 -0.668 . . . . 8.0399999999999991 109.197 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 18.1 tt -69.39 161.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.532 -0.758 . . . . 3.8100000000000001 112.559 -174.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.37 176.73 39.5 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 108.51 -1.836 . . . . 1.0700000000000001 108.51 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 33.9 t -93.06 129.37 39.03 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.339 -0.985 . . . . 1.8100000000000001 108.339 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -87.23 114.99 24.32 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.599 -1.26 . . . . 4.3499999999999996 107.599 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.2 OUTLIER -140.86 176.4 4.88 Favored 'Isoleucine or valine' 0 C--O 1.25 1.087 0 C-N-CA 120.138 -0.625 . . . . 2.4100000000000001 110.225 -175.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.465 ' HA ' ' HG2' ' A' ' 33' ' ' GLU . 15.1 m -139.14 113.24 8.71 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.774 -1.103 . . . . 1.3300000000000001 108.268 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.3 tt -124.56 148.14 47.99 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 120.641 0.258 . . . . 1.45 110.751 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.1 mt -119.11 128.28 75.81 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.027 0.441 . . . . 0.71999999999999997 109.939 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.2 t -75.54 161.9 28.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.346 -0.843 . . . . 1.3400000000000001 109.293 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.574 ' HE2' ' HB3' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -48.11 -35.06 10.74 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 123.24 0.616 . . . . 2.1200000000000001 112.353 -176.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.9 15.7 2.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.119 0.967 . . . . 0.69999999999999996 111.907 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 69.0 25.71 5.86 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.847 1.259 . . . . 2.5899999999999999 109.46 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.7 mm -94.59 120.3 43.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.444 -0.798 . . . . 1.1699999999999999 109.892 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.442 ' HD3' ' OE1' ' A' ' 33' ' ' GLU . 16.8 ttm180 -86.22 139.42 31.06 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.778 -0.646 . . . . 4.71 111.177 -177.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -135.22 121.07 19.7 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 123.852 0.861 . . . . 3.0099999999999998 109.916 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.465 ' HG2' ' HA ' ' A' ' 23' ' ' SER . 41.4 mt-10 -125.66 143.4 51.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.688 -1.227 . . . . 2.4500000000000002 107.688 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 161.02 -146.23 12.06 Favored Glycine 0 CA--C 1.476 -2.351 0 N-CA-C 109.234 -1.547 . . . . 0.45000000000000001 109.234 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.446 HG13 ' HE2' ' A' ' 50' ' ' LYS 0.261 0.1 OUTLIER -113.31 121.96 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.907 0 N-CA-C 114.427 1.269 . . . . 0.93000000000000005 114.427 177.967 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.408 ' HB3' ' HB3' ' A' ' 20' ' ' SER . 2.9 tm? -68.56 137.02 53.98 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.523 -1.671 . . . . 1.72 108.448 173.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -105.39 -48.65 3.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 116.106 -0.497 . . . . 1.1100000000000001 111.128 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 73.1 m -158.35 155.68 29.18 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.375 -0.602 . . . . 0.93999999999999995 109.375 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.3 mt -133.12 117.6 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 108.307 -0.998 . . . . 1.45 108.307 175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -79.78 95.42 6.0 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.085 -1.45 . . . . 2.5600000000000001 107.085 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.4 m -63.41 -19.21 64.48 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 123.084 0.553 . . . . 2.7599999999999998 111.795 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -61.25 -36.94 81.35 Favored 'General case' 0 CA--C 1.568 1.662 0 O-C-N 122.085 -0.384 . . . . 3.2200000000000002 110.96 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -125.61 -2.98 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.72 0.771 . . . . 2.2599999999999998 110.188 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.4 m 72.07 19.07 4.71 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.752 1.221 . . . . 2.2799999999999998 112.486 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.9 p -71.07 133.23 46.12 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 121.298 0.571 . . . . 1.21 111.135 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.3 t -102.3 123.0 55.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 115.556 -0.747 . . . . 0.88 109.93 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -104.65 115.36 30.2 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-O 121.119 0.485 . . . . 0.51000000000000001 111.425 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.625 ' HB3' ' CG2' ' A' ' 51' ' ' VAL . 4.4 mm? -104.7 140.86 37.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.583 -0.735 . . . . 1.75 111.491 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.69 136.22 18.0 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.545 -0.539 . . . . 0.76000000000000001 109.545 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.531 ' H ' HG23 ' A' ' 71' ' ' THR . 29.2 mtmm 70.47 23.62 4.81 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 124.444 1.097 . . . . 3.6299999999999999 109.901 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 48' ' ' LEU . 21.7 t -68.53 117.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.03 -0.986 . . . . 1.52 109.007 -173.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -166.04 178.22 6.53 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 107.96 -1.126 . . . . 5.3200000000000003 107.96 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -66.75 156.68 34.78 Favored 'General case' 0 C--O 1.246 0.871 0 N-CA-C 110.079 -0.341 . . . . 4.0 110.079 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -77.51 144.06 37.97 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.698 0.761 . . . . 6.75 110.807 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.43 -125.17 2.77 Favored Glycine 0 C--N 1.273 -2.954 0 CA-C-N 114.521 -1.218 . . . . 5.9000000000000004 111.686 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.9 t -145.38 148.31 33.22 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 109.644 -0.502 . . . . 7.0499999999999998 109.644 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -107.61 -20.24 13.29 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.437 -0.801 . . . . 8.3800000000000008 111.881 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' CG ' ' HG3' ' A' ' 59' ' ' ARG . 16.2 p-10 -129.16 -16.93 3.94 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 113.669 0.989 . . . . 11.699999999999999 113.669 -174.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.591 ' HG3' ' CG ' ' A' ' 58' ' ' ASP . 76.9 mtt180 -123.49 -163.57 0.05 OUTLIER Pre-proline 0 C--N 1.308 -1.202 0 N-CA-C 108.82 -0.807 . . . . 12.15 108.82 -173.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.521 ' CD ' ' HB3' ' A' ' 59' ' ' ARG . 98.1 Cg_endo -105.31 37.64 0.04 OUTLIER 'Trans proline' 0 CA--C 1.574 2.483 0 C-N-CA 121.713 1.608 . . . . 9.3200000000000003 113.746 173.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.443 HG21 HG23 ' A' ' 65' ' ' ILE . 15.3 t 45.59 -177.14 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.788 0 N-CA-C 114.685 1.365 . . . . 7.5700000000000003 114.685 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.88 -57.98 4.79 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.111 -1.07 . . . . 10.539999999999999 108.111 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 81.7 mtp180 -150.52 -51.8 0.02 OUTLIER Pre-proline 0 CA--C 1.571 1.756 0 CA-C-N 114.711 -1.131 . . . . 13.1 111.918 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.426 ' CD ' ' H ' ' A' ' 63' ' ' ARG . 56.6 Cg_endo -97.43 147.58 0.84 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 122.443 2.095 . . . . 7.79 115.9 -174.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG23 HG21 ' A' ' 61' ' ' THR . 2.2 pp -139.15 151.55 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.403 1.081 . . . . 5.96 111.71 177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.16 100.28 12.9 Favored Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.411 -0.358 . . . . 4.6900000000000004 110.613 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.77 46.62 2.28 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.306 2.671 . . . . 6.1900000000000004 112.807 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . 0.299 16.9 ptm180 56.55 97.54 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.289 1.436 . . . . 8.8000000000000007 113.374 -177.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -89.51 -4.4 57.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.643 -1.162 . . . . 6.5499999999999998 108.921 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 67.15 15.52 10.07 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.975 1.31 . . . . 7.3899999999999997 110.543 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.531 HG23 ' H ' ' A' ' 50' ' ' LYS . 24.9 m 72.43 87.29 0.11 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.142 1.377 . . . . 4.6100000000000003 111.561 -177.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -120.0 -32.96 4.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.469 -0.787 . . . . 7.5999999999999996 110.408 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -78.28 -4.94 50.41 Favored 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 113.454 0.909 . . . . 6.8600000000000003 113.454 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 20.8 p90 -51.85 148.11 6.14 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 124.13 0.972 . . . . 5.54 113.563 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.98 155.24 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.01 -0.541 . . . . 3.7999999999999998 109.702 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.2 mm -118.45 135.52 58.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 108.764 -0.828 . . . . 2.4199999999999999 108.764 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.62 149.35 28.17 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.043 0.449 . . . . 2.3100000000000001 111.451 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -67.24 -11.94 58.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.374 -0.83 . . . . 3.4500000000000002 112.057 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.452 ' O ' HG12 ' A' ' 82' ' ' ILE . . . 80.62 -66.27 3.74 Favored Glycine 0 C--O 1.213 -1.213 0 C-N-CA 121.206 -0.521 . . . . 0.76000000000000001 112.949 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.2 t -62.43 -15.46 49.43 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-O 122.146 0.974 . . . . 1.6399999999999999 110.897 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -93.19 7.43 44.33 Favored 'General case' 0 C--O 1.253 1.263 0 C-N-CA 124.715 1.206 . . . . 2.0 113.107 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 79' ' ' GLY . 26.6 pt -75.37 147.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 C-N-CA 120.101 -0.639 . . . . 1.7 111.461 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.38 -44.22 6.61 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 116.379 -0.373 . . . . 1.5900000000000001 111.447 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -174.47 148.01 1.18 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.293 -1.003 . . . . 2.2200000000000002 108.293 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.9 151.46 25.52 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 112.259 0.466 . . . . 2.8599999999999999 112.259 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.3 t -131.9 138.73 48.51 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.589 -0.893 . . . . 1.8799999999999999 108.589 175.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.62 155.02 6.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 116.536 -0.302 . . . . 2.7000000000000002 111.089 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 84.2 m -126.41 97.34 5.01 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.762 0.792 . . . . 3.3900000000000001 109.382 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 38.5 mt-10 -127.5 148.05 64.93 Favored Pre-proline 0 C--N 1.304 -1.409 0 CA-C-N 114.391 -1.277 . . . . 5.0700000000000003 108.318 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -57.89 -41.37 69.85 Favored 'Trans proline' 0 CA--C 1.584 3.022 0 C-N-CA 122.566 2.177 . . . . 6.3099999999999996 115.494 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 89' ' ' GLU . 88.6 Cg_exo -51.55 123.9 13.18 Favored 'Trans proline' 0 C--N 1.404 3.456 0 C-N-CA 122.213 1.942 . . . . 8.5899999999999999 112.801 176.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm 66.53 75.59 0.32 Allowed Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.313 1.045 . . . . 12.69 109.995 -177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.24 -22.84 45.93 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.31 2.007 . . . . 13.220000000000001 113.237 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 29.5 pt -116.6 -10.76 12.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.472 0.545 . . . . 15.380000000000001 112.472 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 C--O 1.251 1.173 0 O-C-N 124.47 1.106 . . . . 16.629999999999999 111.525 -175.631 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HG3' ' HD2' ' A' ' 67' ' ' PRO . 1.6 Cg_endo . . . . . 0 CA--C 1.57 2.3 0 N-CA-C 112.824 0.279 . . . . 3.73 112.824 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 91.76 38.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 126.061 1.744 . . . . 8.0399999999999991 113.901 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD13 ' HB3' ' A' ' 69' ' ' ASP . 2.6 mp -101.11 -43.22 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 119.577 -0.849 . . . . 3.8100000000000001 113.142 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' H ' HG21 ' A' ' 35' ' ' ILE . . . -154.64 -142.16 3.39 Favored Glycine 0 C--N 1.3 -1.463 0 C-N-CA 119.313 -1.422 . . . . 1.0700000000000001 113.962 -173.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.1 m -93.04 120.51 33.42 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 109.892 -0.41 . . . . 1.8100000000000001 109.892 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -87.01 107.76 18.56 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-N 116.57 -0.287 . . . . 4.3499999999999996 111.041 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 36' ' ' LEU . 0.1 OUTLIER -127.76 163.55 31.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.614 -0.513 . . . . 2.4100000000000001 109.614 178.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 86' ' ' THR . 28.9 m -122.85 112.09 17.45 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.223 -1.029 . . . . 1.3300000000000001 108.223 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 84' ' ' ASP . 27.1 tp -122.13 125.48 46.26 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.231 0.539 . . . . 1.45 112.315 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 53.8 mt -92.14 117.24 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 115.769 -0.651 . . . . 0.71999999999999997 110.204 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.3 t -76.28 162.55 27.83 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.958 -1.019 . . . . 1.3400000000000001 108.957 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -10.66 0.59 Allowed 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 125.094 1.358 . . . . 2.1200000000000001 113.854 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.09 -0.12 47.59 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 122.939 0.495 . . . . 0.69999999999999996 110.453 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 72.24 30.65 2.03 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 122.857 1.313 . . . . 2.5899999999999999 107.637 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 49.6 mm -115.56 129.54 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.611 -1.177 . . . . 1.1699999999999999 110.667 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.466 ' HE ' ' CD ' ' A' ' 33' ' ' GLU . 34.9 ttp180 -93.63 103.2 15.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.825 -0.435 . . . . 4.71 109.825 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -89.06 125.49 35.04 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.681 -0.859 . . . . 3.0099999999999998 108.681 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.466 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 29.9 mt-10 -126.19 127.13 45.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.002 -1.11 . . . . 2.4500000000000002 108.002 -177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 176.43 -155.51 19.04 Favored Glycine 0 CA--C 1.476 -2.382 0 CA-C-O 118.105 -1.386 . . . . 0.45000000000000001 109.859 -177.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.518 HG21 ' H ' ' A' ' 19' ' ' GLY 0.437 0.2 OUTLIER -103.14 139.66 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 C-N-CA 115.064 -2.654 . . . . 0.93000000000000005 117.303 -176.544 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB2' HD12 ' A' ' 22' ' ' ILE . 3.2 tm? -86.61 140.61 29.68 Favored 'General case' 0 C--O 1.271 2.194 0 CA-C-N 113.929 -1.487 . . . . 1.72 107.816 176.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.468 ' N ' HD13 ' A' ' 36' ' ' LEU . 85.5 t80 -119.65 -55.09 2.13 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.94 1.4 . . . . 1.1100000000000001 111.812 -176.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 p -135.06 -179.2 5.47 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.348 0.499 . . . . 0.93999999999999995 112.348 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.7 mm -134.34 131.85 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 CA-C-O 120.874 0.369 . . . . 1.45 111.974 -173.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -94.52 80.67 3.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.438 1.095 . . . . 2.5600000000000001 109.198 177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.2 m -55.52 -31.82 62.41 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.103 0.779 . . . . 2.7599999999999998 113.103 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -56.2 -30.77 62.76 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.931 0.893 . . . . 3.2200000000000002 112.497 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.496 ' HB2' ' OG1' ' A' ' 45' ' ' THR . 19.5 m120 -125.44 18.94 8.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.598 -0.519 . . . . 2.2599999999999998 109.598 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.9 p 54.52 34.02 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.291 1.437 . . . . 2.2799999999999998 110.782 -175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.645 HG21 ' N ' ' A' ' 79' ' ' GLY 0.496 0.8 OUTLIER -104.22 -174.88 2.64 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 120.423 3.49 . . . . 1.21 120.423 -171.417 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG23 ' HB2' ' A' ' 77' ' ' PHE . 2.0 m -131.34 127.38 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.547 0 CA-C-N 113.316 -1.765 . . . . 0.88 113.463 -163.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.4 ' CB ' HD12 ' A' ' 76' ' ' ILE . . . -104.21 107.23 18.04 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 115.383 -0.826 . . . . 0.51000000000000001 109.283 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.577 ' O ' ' HB2' ' A' ' 74' ' ' TYR . 6.0 mp -102.33 130.13 48.96 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.444 0.64 . . . . 1.75 110.743 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' A' ' 74' ' ' TYR . . . -127.27 126.98 43.63 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 106.777 -1.564 . . . . 0.76000000000000001 106.777 176.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.641 ' HA ' HG22 ' A' ' 71' ' ' THR . 31.5 mtmm 83.26 15.88 0.31 Allowed 'General case' 0 N--CA 1.438 -1.066 0 O-C-N 124.137 0.898 . . . . 3.6299999999999999 112.855 -177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.59 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.4 p -83.17 105.3 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 117.579 -1.648 . . . . 1.52 110.372 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.578 ' HB3' ' O ' ' A' ' 70' ' ' GLU . 1.5 tmt_? 178.8 149.67 0.24 Allowed 'General case' 0 C--O 1.198 -1.613 0 N-CA-C 104.653 -2.351 . . . . 5.3200000000000003 104.653 169.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.61 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 6.8 t -169.95 -177.49 2.62 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 121.277 1.853 . . . . 4.0 110.079 160.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -166.34 -31.72 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.058 0 O-C-N 124.468 1.105 . . . . 6.75 110.539 174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.605 ' HA3' ' CG2' ' A' ' 65' ' ' ILE . . . 90.68 142.0 9.7 Favored Glycine 0 N--CA 1.41 -3.084 0 C-N-CA 119.482 -1.342 . . . . 5.9000000000000004 112.728 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.434 ' CG2' ' HA ' ' A' ' 60' ' ' PRO . 89.7 m 64.92 106.44 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 124.532 1.133 . . . . 7.0499999999999998 111.883 -178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -112.83 -103.6 0.4 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 114.945 1.461 . . . . 8.3800000000000008 114.945 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -62.09 -19.25 62.76 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.434 1.272 . . . . 11.699999999999999 114.434 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -135.14 130.42 19.31 Favored Pre-proline 0 N--CA 1.419 -1.985 0 N-CA-C 106.151 -1.796 . . . . 12.15 106.151 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HA ' ' CG2' ' A' ' 56' ' ' THR . 17.3 Cg_exo -66.02 82.55 0.26 Allowed 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.112 1.875 . . . . 9.3200000000000003 111.732 176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.5 t -69.59 -174.24 0.68 Allowed 'General case' 0 CA--C 1.565 1.523 0 C-N-CA 120.49 -0.484 . . . . 7.5700000000000003 109.788 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -147.82 -41.29 0.17 Allowed 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.028 0.442 . . . . 10.539999999999999 111.593 -170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.535 ' HB3' ' HD3' ' A' ' 64' ' ' PRO . 29.8 ttm180 -95.88 -54.84 0.22 Allowed Pre-proline 0 CA--C 1.568 1.648 0 CA-C-N 115.77 -0.65 . . . . 13.1 112.553 -172.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 63' ' ' ARG . 6.1 Cg_endo -93.18 104.01 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.224 1.949 . . . . 7.79 111.969 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.605 ' CG2' ' HA3' ' A' ' 55' ' ' GLY . 18.9 mm -113.12 151.95 14.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.106 -0.701 . . . . 5.96 109.106 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' N ' HG22 ' A' ' 65' ' ' ILE . . . -85.08 109.1 18.38 Favored Pre-proline 0 N--CA 1.434 -1.239 0 N-CA-C 109.977 -0.379 . . . . 4.6900000000000004 109.977 173.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 65' ' ' ILE . 73.9 Cg_endo -85.6 50.71 2.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.811 2.341 . . . . 6.1900000000000004 107.543 175.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.61 ' HA ' ' HB3' ' A' ' 53' ' ' SER 0.266 30.3 mmt180 106.7 -179.44 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 129.165 2.986 . . . . 8.8000000000000007 110.697 -173.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.587 ' HB3' HD13 ' A' ' 18' ' ' ILE . 0.9 OUTLIER 82.18 105.65 0.06 Allowed 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 113.785 1.031 . . . . 6.5499999999999998 113.785 -176.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 44.1 tt0 141.45 115.25 0.0 OUTLIER 'General case' 1 N--CA 1.549 4.503 0 C-N-CA 125.928 1.691 . . . . 7.3899999999999997 115.001 168.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.641 HG22 ' HA ' ' A' ' 50' ' ' LYS . 2.9 t -168.46 159.73 10.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.97 . . . . 4.6100000000000003 109.975 169.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -110.4 -25.84 9.86 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.067 0.461 . . . . 7.5999999999999996 110.242 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.27 -53.45 7.31 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.0 -0.545 . . . . 6.8600000000000003 110.102 -172.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 48' ' ' LEU 0.264 19.1 p90 57.27 161.69 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 126.622 1.969 . . . . 5.54 115.367 -178.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -151.59 153.65 9.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 109.994 -0.373 . . . . 3.7999999999999998 109.994 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' CB ' ' A' ' 47' ' ' ALA . 28.4 mm -110.88 133.65 55.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.063 -1.088 . . . . 2.4199999999999999 108.063 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.535 ' O ' ' HB ' ' A' ' 45' ' ' THR . 4.9 m-85 -100.46 142.1 32.4 Favored 'General case' 0 N--CA 1.427 -1.609 0 C-N-CA 118.726 -1.19 . . . . 2.3100000000000001 108.232 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.596 ' C ' HG21 ' A' ' 45' ' ' THR . 5.8 mpt_? -110.02 149.17 30.36 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-O 121.481 0.657 . . . . 3.4500000000000002 110.745 -177.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.645 ' N ' HG21 ' A' ' 45' ' ' THR . . . -52.9 -23.17 14.35 Favored Glycine 0 C--N 1.276 -2.788 0 C-N-CA 126.842 2.163 . . . . 0.76000000000000001 112.791 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.7 p -93.91 -13.01 27.62 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 114.674 -0.763 . . . . 1.6399999999999999 110.85 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -118.04 -7.63 10.82 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.435 -0.802 . . . . 2.0 112.04 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 23.6 pt -83.06 142.84 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 113.344 0.868 . . . . 1.7 113.344 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -101.21 -65.83 0.95 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.052 -0.976 . . . . 1.5900000000000001 111.124 171.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.441 ' O ' HD12 ' A' ' 24' ' ' LEU . 6.7 m-20 -140.28 149.02 42.29 Favored 'General case' 0 CA--C 1.495 -1.145 0 N-CA-C 112.655 0.613 . . . . 2.2200000000000002 112.655 -176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.5 tp -134.25 131.16 38.14 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.68 -0.691 . . . . 2.8599999999999999 110.26 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 23' ' ' SER . 9.0 t -141.74 161.29 38.31 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.096 -1.076 . . . . 1.8799999999999999 108.096 175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.3 p -111.67 140.72 29.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.518 -0.549 . . . . 2.7000000000000002 109.518 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 42.7 t -94.87 -44.51 7.71 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 120.359 -0.536 . . . . 3.3900000000000001 109.61 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -141.16 116.44 7.24 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.572 -0.529 . . . . 5.0700000000000003 109.572 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -77.74 110.0 2.85 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.925 1.75 . . . . 6.3099999999999996 108.574 171.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.6 135.38 19.79 Favored 'Trans proline' 0 N--CA 1.441 -1.595 0 C-N-CA 121.788 1.659 . . . . 8.5899999999999999 113.163 -175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' HE3' ' HA ' ' A' ' 95' ' ' MET . 63.6 tttp 73.43 87.9 0.09 OUTLIER Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 114.677 -1.147 . . . . 12.69 111.886 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.14 -29.34 6.58 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 123.096 2.531 . . . . 13.220000000000001 112.39 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 32.3 pt -116.12 138.46 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 CA-C-N 115.956 -0.565 . . . . 15.380000000000001 109.478 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.456 ' HA ' ' HE3' ' A' ' 92' ' ' LYS . 98.3 mmm . . . . . 0 C--N 1.298 -1.649 0 CA-C-O 118.865 -0.588 . . . . 16.629999999999999 109.802 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.404 ' HD2' ' CA ' ' A' ' 55' ' ' GLY . 40.4 Cg_exo . . . . . 0 N--CA 1.505 2.175 0 N-CA-C 115.822 1.432 . . . . 3.73 115.822 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' H ' HD12 ' A' ' 18' ' ' ILE . 34.3 p90 -140.31 12.13 2.36 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.157 -0.474 . . . . 8.0399999999999991 109.796 177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.507 HD12 ' H ' ' A' ' 17' ' ' TYR . 2.2 mp -75.93 103.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.353 0.597 . . . . 3.8100000000000001 111.433 -172.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.36 -170.67 22.88 Favored Glycine 0 C--N 1.284 -2.322 0 CA-C-N 114.427 -1.26 . . . . 1.0700000000000001 111.058 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.421 ' HB2' ' HB3' ' A' ' 36' ' ' LEU . 21.4 m -94.09 121.86 36.01 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.086 -0.709 . . . . 1.8100000000000001 109.086 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 21' ' ' LYS . 5.2 mptt -89.92 94.31 9.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.989 -1.115 . . . . 4.3499999999999996 107.989 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 87' ' ' VAL . 1.8 pp -137.77 -179.18 2.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 120.438 -0.505 . . . . 2.4100000000000001 110.318 -177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.8 p -132.18 131.33 42.1 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.303 -0.999 . . . . 1.3300000000000001 108.303 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.712 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 6.5 tt -135.97 145.74 46.49 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 108.295 -1.002 . . . . 1.45 108.295 -176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 52.0 mt -116.4 128.77 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 CA-C-N 115.71 -0.677 . . . . 0.71999999999999997 109.851 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.9 t -76.9 170.52 16.34 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 109.154 -0.684 . . . . 1.3400000000000001 109.154 176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -58.77 -23.87 60.78 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.08 0.952 . . . . 2.1200000000000001 112.221 -173.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.48 25.4 5.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.016 -0.538 . . . . 0.69999999999999996 110.298 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.606 ' OE2' ' HE3' ' A' ' 83' ' ' LYS . 0.8 OUTLIER 66.59 28.72 9.21 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 115.618 -0.719 . . . . 2.5899999999999999 112.397 178.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 25' ' ' ILE . 52.1 mm -89.46 97.71 7.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.883 -0.599 . . . . 1.1699999999999999 110.555 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.728 ' HD3' ' H ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -85.0 136.62 33.51 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.619 -0.719 . . . . 4.71 111.066 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.712 ' CE2' ' HB3' ' A' ' 24' ' ' LEU . 1.9 p90 -126.34 163.19 23.81 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 119.692 -0.803 . . . . 3.0099999999999998 110.67 176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -141.86 126.22 17.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.064 -1.458 . . . . 2.4500000000000002 107.064 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA3' HG23 ' A' ' 51' ' ' VAL . . . 158.64 -150.64 21.42 Favored Glycine 0 N--CA 1.469 0.846 0 C-N-CA 120.97 -0.633 . . . . 0.45000000000000001 111.547 -178.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . 0.25 0.1 OUTLIER -110.73 115.51 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 N-CA-C 114.369 1.248 . . . . 0.93000000000000005 114.369 -177.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 20' ' ' SER . 5.3 tt -77.42 147.14 36.15 Favored 'General case' 0 C--O 1.252 1.184 0 CA-C-N 114.205 -1.362 . . . . 1.72 109.65 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -108.5 -52.59 2.74 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.278 0.362 . . . . 1.1100000000000001 110.089 -175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.7 m -143.11 151.49 40.79 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 106.43 -1.693 . . . . 0.93999999999999995 106.43 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -159.47 103.91 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 C-N-CA 118.088 -1.445 . . . . 1.45 112.93 -178.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.568 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 6.4 m-20 -127.38 131.3 50.36 Favored 'General case' 0 CA--C 1.478 -1.82 0 CA-C-N 115.555 -0.748 . . . . 2.5600000000000001 112.19 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.2 t -69.04 -35.36 76.5 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 113.365 0.876 . . . . 2.7599999999999998 113.365 -176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -75.46 -60.82 2.13 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.553 -1.659 . . . . 3.2200000000000002 110.832 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.331 0.1 OUTLIER -136.07 -24.61 1.26 Allowed 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 116.739 2.126 . . . . 2.2599999999999998 116.739 178.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.2 m -96.19 44.88 1.07 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.234 1.016 . . . . 2.2799999999999998 109.046 -172.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 77' ' ' PHE . 70.8 p -38.3 -169.41 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.387 1 C-N-CA 134.141 4.976 . . . . 1.21 116.886 -178.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 39' ' ' ILE . 9.6 t -91.81 101.82 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.56 0 CA-C-N 115.112 -0.949 . . . . 0.88 109.197 -163.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.51 111.93 22.97 Favored 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 113.933 -1.485 . . . . 0.51000000000000001 107.451 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.439 HD21 HG21 ' A' ' 51' ' ' VAL . 58.7 tp -114.5 127.24 55.71 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.289 -0.869 . . . . 1.75 109.361 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -142.19 155.08 45.26 Favored 'General case' 0 N--CA 1.416 -2.152 0 N-CA-C 107.217 -1.401 . . . . 0.76000000000000001 107.217 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.488 ' HA ' ' OG1' ' A' ' 71' ' ' THR . 51.8 pttt 50.28 27.87 2.89 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 124.133 0.973 . . . . 3.6299999999999999 113.534 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.472 HG23 ' HA3' ' A' ' 34' ' ' GLY . 4.5 p -68.25 111.08 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 122.019 0.914 . . . . 1.52 109.855 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -171.82 -174.76 1.39 Allowed 'General case' 0 N--CA 1.406 -2.628 0 C-N-CA 125.396 1.478 . . . . 5.3200000000000003 108.351 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 14.6 m -70.41 -174.77 0.9 Allowed 'General case' 0 CA--C 1.571 1.759 0 O-C-N 124.091 0.87 . . . . 4.0 110.545 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.436 ' HB2' ' HB ' ' A' ' 65' ' ' ILE . 76.2 m-85 -78.72 -98.48 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 114.47 1.285 . . . . 6.75 114.47 -172.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . -142.29 -76.35 0.04 OUTLIER Glycine 0 C--O 1.213 -1.198 0 C-N-CA 120.761 -0.733 . . . . 5.9000000000000004 114.407 -174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.575 HG23 ' C ' ' A' ' 59' ' ' ARG . 87.7 m 68.12 -68.29 0.17 Allowed 'General case' 0 CA--C 1.567 1.617 0 C-N-CA 123.509 0.723 . . . . 7.0499999999999998 112.617 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . 0.274 8.2 mm-40 82.68 -43.59 0.13 Allowed 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 127.019 2.128 . . . . 8.3800000000000008 112.494 -177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -151.7 -28.28 0.18 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 112.475 0.546 . . . . 11.699999999999999 112.475 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.575 ' C ' HG23 ' A' ' 56' ' ' THR . 81.1 mtp180 -138.5 137.4 20.28 Favored Pre-proline 0 CA--C 1.504 -0.817 0 C-N-CA 120.182 -0.607 . . . . 12.15 109.452 -173.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 59' ' ' ARG . 12.2 Cg_exo -69.67 66.55 1.72 Allowed 'Trans proline' 0 N--CA 1.484 0.919 0 C-N-CA 123.143 2.562 . . . . 9.3200000000000003 111.724 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.638 ' O ' HG12 ' A' ' 65' ' ' ILE . 15.0 t -113.06 -154.12 0.54 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.116 -0.947 . . . . 7.5700000000000003 110.275 -177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 61' ' ' THR . 15.8 t70 30.74 71.01 0.08 Allowed 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 128.825 2.85 . . . . 10.539999999999999 111.254 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 65' ' ' ILE . 15.9 mmm180 66.07 80.01 0.23 Allowed Pre-proline 0 C--O 1.212 -0.886 0 CA-C-N 112.916 -1.947 . . . . 13.1 107.775 -175.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -14.93 88.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.6 1 C-N-CA 125.896 4.397 . . . . 7.79 117.168 -167.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 61' ' ' THR . 6.0 pt -101.05 153.8 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 112.766 -2.016 . . . . 5.96 112.788 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 53' ' ' SER . . . -104.69 149.41 37.44 Favored Pre-proline 0 C--O 1.175 -2.859 0 N-CA-C 106.787 -1.56 . . . . 4.6900000000000004 106.787 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 53' ' ' SER . 72.4 Cg_endo -81.59 132.37 7.79 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 CA-C-N 121.539 1.585 . . . . 6.1900000000000004 114.557 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -75.68 161.09 29.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.792 -0.64 . . . . 8.8000000000000007 110.768 176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -125.65 -3.09 7.26 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.506 0.67 . . . . 6.5499999999999998 109.45 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 69.95 165.06 0.27 Allowed 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 125.153 1.381 . . . . 7.3899999999999997 112.526 177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.488 ' OG1' ' HA ' ' A' ' 50' ' ' LYS . 21.1 p -138.02 165.45 26.55 Favored 'General case' 0 C--O 1.244 0.811 0 N-CA-C 109.326 -0.62 . . . . 4.6100000000000003 109.326 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -120.73 -71.85 0.72 Allowed 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 120.216 -0.594 . . . . 7.5999999999999996 112.56 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -78.11 -24.03 47.67 Favored 'General case' 0 C--O 1.247 0.972 0 N-CA-C 113.119 0.785 . . . . 6.8600000000000003 113.119 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 66.13 174.42 0.23 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.943 1.297 . . . . 5.54 110.496 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.8 pt -141.24 146.41 23.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 121.62 -0.675 . . . . 3.7999999999999998 112.607 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.2 mm -116.51 151.48 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.139 -1.059 . . . . 2.4199999999999999 108.139 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.59 ' O ' ' HB ' ' A' ' 45' ' ' THR . 97.6 m-85 -124.12 139.52 53.85 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.992 -0.373 . . . . 2.3100000000000001 109.992 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.562 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 21.1 mmm180 -43.93 -26.32 0.26 Allowed 'General case' 0 C--O 1.213 -0.825 0 N-CA-C 116.124 1.898 . . . . 3.4500000000000002 116.124 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.512 ' O ' HG13 ' A' ' 82' ' ' ILE . . . 74.21 -64.19 2.06 Favored Glycine 0 C--O 1.209 -1.454 0 C-N-CA 120.972 -0.633 . . . . 0.76000000000000001 112.557 -177.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.0 t -73.38 -7.65 52.55 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 123.82 0.848 . . . . 1.6399999999999999 110.311 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 16.4 m-20 -121.16 30.1 6.99 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.973 -0.558 . . . . 2.0 110.316 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 79' ' ' GLY . 2.1 pp -77.44 163.24 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 121.845 -0.535 . . . . 1.7 112.42 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.606 ' HE3' ' OE2' ' A' ' 29' ' ' GLU . 15.6 tppt? -105.85 -62.05 1.42 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.937 0.399 . . . . 1.5900000000000001 110.07 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -152.79 150.4 29.33 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.551 -0.75 . . . . 2.2200000000000002 110.305 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.55 132.58 10.73 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 124.55 1.14 . . . . 2.8599999999999999 110.957 176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.426 ' O ' ' HB ' ' A' ' 22' ' ' ILE . 9.4 t -125.03 139.96 53.33 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.495 -0.928 . . . . 1.8799999999999999 108.495 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.443 ' HA ' HG22 ' A' ' 22' ' ' ILE . 54.7 t -113.86 102.71 14.27 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-N 116.201 -0.454 . . . . 2.7000000000000002 110.355 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' CYS . . . . . . . . . . . . . 23.9 p -169.63 121.55 0.71 Allowed 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 115.988 -0.551 . . . . 3.3900000000000001 111.481 178.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -95.0 117.82 66.76 Favored Pre-proline 0 N--CA 1.427 -1.618 0 N-CA-C 107.774 -1.195 . . . . 5.0700000000000003 107.774 172.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.21 109.3 1.52 Allowed 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.562 2.175 . . . . 6.3099999999999996 112.896 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -88.65 93.75 0.38 Allowed 'Trans proline' 0 N--CA 1.434 -2.022 0 C-N-CA 122.271 1.981 . . . . 8.5899999999999999 111.579 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 58.49 87.64 0.14 Allowed Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.112 0.965 . . . . 12.69 113.285 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -69.21 -51.83 0.41 Allowed 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.069 1.846 . . . . 13.220000000000001 111.919 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 23.2 pt -143.05 19.76 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 115.883 -0.599 . . . . 15.380000000000001 109.842 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 C--N 1.314 -0.946 0 N-CA-C 110.009 -0.367 . . . . 16.629999999999999 110.009 -176.462 . . . . . . . . 0 0 . 1 stop_ save_